Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ABCG1	ABC8	ENSG00000160179	"ATP binding cassette subfamily G member 1"	P45844	21	42199689-42297244	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 122.6;Syncytiotrophoblasts: 63.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 35.5;neutrophil: 36.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 36.6"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 25.5;JURKAT: 38.4;MCF7: 33.2;MOLT-4: 31.5;OE19: 54.9;RPMI-8226: 25.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031470, HPA031471"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Vesicles"		"HPA031470: AB_10599188, HPA031471: AB_10600201"	"unprognostic (2.89e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.96e-2)"	"unprognostic (4.20e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.66e-3)"	"unprognostic (6.37e-2)"	"prognostic favorable (7.16e-6)"	"unprognostic (1.40e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.42e-2)"	17.2	37.7	18.3	12.1	25.5	8.1	15.2	14.4	20.2	8.1	20.0	14.1	17.5	4.9	3.9	4.1	6.3	13.8	10.5	15.5	17.0	10.2	6.3	29.4	18.1	12.0	19.9	6.3	5.3	24.4	10.7	13.7	13.3	6.2	15.0	29.1	16.1	7.0	19.6	16.8	22.0	4.0	12.2	31.2	15.9	1.1	20.3	18.9	8.5	6.2	12.1	12.9	5.0	24.7	0.0	6.0	4.6	2.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	3.1	1.9	0.8	0.0	0.7	0.9	0.0	8.8	0.0	8.5	0.5	10.2	19.2	0.0	17.4	0.0	0.4	2.0	25.5	0.1	3.9	0.0	18.2	38.4	0.0	0.1	0.0	33.2	31.5	0.2	1.4	54.9	10.3	0.4	0.0	25.8	0.0	2.8	22.3	5.8	3.7	13.5	0.0	0.4	5.7	0.9	11.8	0.0	4.7	0.1	0.0	13.1	4.2	0.0	0.1	3.3	0.5	1.7	1.7	35.5	3.0	0.5	5.6	5.5	6.1	6.0	1.1	7.0	5.8	5.0	36.6	7.4	0.3	2.5	7.4	2.1	18.3	25.5	14.4	20.2	15.5	17.0	12.0	19.9	13.3	12.2	20.3	24.7	38.2	6.4	8.2	0.3	21.3	8.9	6.9	3.2	5.7	48.4	4.1	6.9	9.5	4.3	5.9	25.8	50.1	7.0	7.0	33.4	3.9	2.6	4.5	21.6	6.3	33.8	3.5	5.7	13.2	1.2	1.8	7.5	11.2	45.3	0.0	1.2	42.8	0.6	16.0	11.8	17.8	12.1	8.2	44.5	23.4	7.6	0.3	20.9	3.6	7.5	4.3	16.1	3.1	43.2	40.6	2.3	8.3	1.9	4.0	3.0	36.6	1.1	4.5	122.6	6.6	1.6	3.5	0.6	0.5	1.0	6.7	63.1	21.4	10.4	1.1	9.1
ABI1	"ABI-1, E3B1, SSH3BP1"	ENSG00000136754	"Abl interactor 1"	Q8IZP0	10	26746593-26861087	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 278.2;Suprabasal keratinocytes: 270.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008375, HPA068407"	Approved		Approved	"Plasma membrane,Cell Junctions"		NA	NA		440000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cell Junctions"		"CAB008375: AB_592744, HPA068407: AB_2685983"	"unprognostic (2.83e-3)"	"unprognostic (8.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.88e-3)"	"unprognostic (2.03e-1)"	"unprognostic (6.04e-2)"	"unprognostic (4.38e-1)"	"unprognostic (2.40e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.18e-1)"	28.9	16.2	28.5	35.0	29.2	83.8	29.8	28.3	38.9	30.4	20.9	32.0	32.4	23.6	19.2	53.0	23.8	24.9	16.3	37.4	28.8	27.6	24.9	28.1	48.1	24.7	26.8	26.6	19.9	20.1	12.9	28.3	25.4	20.8	33.0	18.9	32.9	19.1	20.0	42.9	34.1	23.8	26.2	32.3	31.8	14.2	28.0	44.5	22.6	19.6	53.7	34.7	36.5	27.1	55.0	28.6	21.1	21.9	34.4	39.5	34.1	50.9	31.2	35.0	37.5	33.7	61.7	101.1	23.2	51.7	23.0	57.7	28.0	37.0	41.0	65.2	24.2	44.5	18.0	29.0	23.6	23.2	43.9	28.1	54.6	35.3	21.8	41.5	43.7	33.5	30.7	67.2	40.5	25.4	49.8	26.0	18.8	37.5	13.5	51.4	41.2	69.2	48.0	22.9	17.1	18.5	41.3	44.5	46.8	29.4	27.7	35.5	50.6	27.3	33.2	34.4	25.5	15.0	24.0	108.7	38.7	61.1	17.4	77.3	35.5	91.4	42.1	43.2	40.8	57.2	40.9	48.5	39.4	47.7	37.7	41.7	64.3	35.8	45.4	34.1	76.5	57.2	28.5	29.2	28.3	38.9	37.4	28.8	24.7	26.8	25.4	26.2	28.0	27.1	44.4	41.7	37.7	278.2	89.3	246.2	127.9	74.0	123.5	9.6	40.5	26.5	23.2	38.6	73.5	25.8	2.1	36.4	75.7	69.7	13.7	56.3	11.3	72.1	41.3	41.9	44.9	43.8	81.6	52.1	46.9	45.9	42.3	111.5	57.7	22.3	32.9	25.6	75.8	16.8	133.7	54.9	83.4	80.5	116.3	5.7	22.1	92.1	92.5	106.8	89.8	48.2	73.2	128.7	47.4	82.2	52.1	22.2	56.8	132.5	52.7	39.0	86.2	10.0	32.9	29.8	40.3	14.7	10.8	109.6	270.6	77.2	71.0	27.2	41.3	195.4
AC129492.3		ENSG00000263620	"Novel protein"		17	8150816-8162975	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"brain: 81.6;skeletal muscle: 32.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 37.0;HEK 293: 27.0;REH: 20.1"															NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"																						13.6	2.1	21.1	0.3	37.8	1.7	0.6	1.3	81.6	0.9	0.0	7.8	2.3	2.0	0.0	0.3	1.2	0.2	14.4	38.6	17.5	3.6	2.2	3.3	0.2	20.4	8.2	0.0	4.4	0.9	0.0	0.6	17.6	3.6	0.3	0.1	2.2	6.1	32.2	4.2	4.4	0.5	0.0	10.1	9.6	1.0	18.2	0.0	0.1	0.0	0.5	0.7	0.2	30.4	6.5	0.2	0.7	0.0	0.7	0.0	9.9	8.8	0.0	0.8	0.0	0.0	0.0	6.1	9.2	0.0	5.9	7.9	0.3	1.3	0.0	37.0	27.0	1.8	0.0	0.0	3.2	0.5	12.1	0.0	0.0	0.6	0.0	0.6	1.3	6.7	5.2	0.0	0.0	2.4	1.9	3.0	1.5	0.0	13.9	20.1	0.9	8.1	0.3	0.0	4.2	6.7	2.6	0.0	3.5	0.0	3.0	2.8	13.9	0.0	7.5	1.6	7.4	14.5	10.8	6.8	0.0	1.8	4.6	81.8	38.1	152.8	138.4	47.1	125.0	129.5	141.1	159.3	34.8	113.0	166.2	144.9	199.4	127.2	57.1	94.1	114.5	63.3	21.1	37.8	1.3	81.6	38.6	17.5	20.4	8.2	17.6	0.0	18.2	30.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC244197.3		ENSG00000241489	"Novel protein"		X	149477104-149540926	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 3.2;Alveolar cells type 2: 2.2;granulocytes: 5.1;Respiratory ciliated cells: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 15.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 60: Granulocytes - Receptor signaling"				"unprognostic (1.57e-2)"	"unprognostic (2.77e-2)"	"unprognostic (5.48e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.81e-2)"	"unprognostic (9.16e-3)"	"unprognostic (4.51e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.01e-3)"	"unprognostic (4.33e-2)"	"unprognostic (1.37e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.90e-2)"	"unprognostic (3.27e-4)"	8.9	12.7	29.4	7.5	20.4	8.7	10.0	0.0	30.7	12.0	10.3	10.1	9.6	23.6	61.4	9.4	26.4	10.9	17.8	33.0	3.4	10.3	5.1	16.1	9.2	9.7	3.0	24.6	14.9	11.4	45.4	8.3	7.0	17.9	15.0	20.5	17.2	19.4	6.9	20.1	10.2	12.6	0.2	12.6	11.4	8.1	7.6	8.0	15.3	5.7	9.9	11.0	10.7	7.7	5.9	20.1	12.4	4.4	6.3	5.8	2.1	3.8	3.9	3.1	8.9	2.8	9.8	10.2	9.4	8.5	7.8	17.3	1.7	6.4	2.8	11.8	5.9	1.8	15.2	1.5	2.4	2.6	14.3	10.5	5.4	7.7	5.7	18.5	3.5	4.7	1.6	12.6	4.1	15.4	2.3	1.9	1.0	8.4	6.0	2.4	3.1	6.9	8.9	6.2	6.4	6.5	2.7	4.8	1.2	6.4	4.2	2.0	8.9	6.0	7.4	5.5	4.1	11.0	4.6	3.9	8.9	4.7	2.7	0.3	3.1	15.7	5.7	2.9	3.0	1.6	1.8	2.7	1.9	0.9	0.9	0.8	11.5	3.1	5.1	2.0	5.6	5.4	29.4	20.4	0.0	30.7	33.0	3.4	9.7	3.0	7.0	0.2	7.6	7.7	0.0	3.2	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	5.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
ACTN1		ENSG00000072110	"Actinin alpha 1"	P12814	14	68874128-68979440	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 524.5"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 351.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 364.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004303, HPA006035"	Approved		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA		210000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane, Actin filaments, Focal adhesion sites"		"CAB004303: AB_626633, HPA006035: AB_1078095"	"unprognostic (4.40e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (6.19e-3)"	"prognostic unfavorable (7.63e-5)"	"unprognostic (3.62e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (9.08e-10)"	"unprognostic (2.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.05e-3)"	"prognostic unfavorable (8.00e-4)"	117.4	40.7	27.3	149.5	55.8	149.3	103.5	0.1	32.0	118.4	20.1	449.8	49.8	313.1	60.3	154.4	152.1	143.9	121.4	29.7	14.7	46.7	61.8	100.0	47.5	24.5	11.0	61.8	46.8	9.1	27.3	96.1	7.3	174.3	109.0	28.2	116.4	295.1	21.7	59.3	106.9	524.5	4.2	55.9	171.7	21.2	32.9	32.6	35.0	13.3	50.7	305.9	83.3	28.8	871.9	262.3	158.6	121.4	275.2	180.5	592.4	749.3	712.0	770.0	571.1	211.8	196.6	0.7	256.5	744.7	310.4	370.9	126.8	790.3	965.2	4.6	38.5	118.2	133.5	179.0	494.0	85.4	14.3	231.7	152.1	479.8	540.3	551.6	428.6	48.2	56.9	1.4	612.0	246.9	10.1	181.1	124.7	217.9	198.1	59.3	294.1	32.6	292.0	225.6	57.0	68.7	649.9	96.8	177.1	474.8	146.0	170.9	546.0	1085.2	432.8	126.9	662.5	113.8	47.8	3.9	314.4	115.7	584.4	64.6	67.5	137.1	5.7	28.8	7.1	0.1	22.7	12.4	45.5	0.2	103.9	92.2	364.2	4.5	8.9	2.0	9.6	89.2	27.3	55.8	0.1	32.0	29.7	14.7	24.5	11.0	7.3	4.2	32.9	28.8	44.7	38.5	25.1	19.6	4.0	119.3	154.9	137.4	82.0	74.7	88.6	157.6	60.3	51.5	36.0	42.3	246.0	155.3	3.0	17.2	3.9	186.8	34.0	65.8	112.8	135.5	38.5	21.9	102.7	144.9	351.8	88.9	34.1	90.2	7.6	15.9	129.5	96.6	79.5	18.5	29.7	57.3	59.0	100.9	82.1	10.7	35.8	96.4	30.2	34.7	105.1	6.0	4.1	9.0	4.3	203.7	28.0	245.6	0.6	132.6	2.4	15.3	47.8	80.8	177.5	30.0	270.6	19.4	18.4	51.8	59.8	66.9	22.7	20.9	47.0	67.1
ADAM8	"CD156, CD156A, MS2"	ENSG00000151651	"ADAM metallopeptidase domain 8"	P78325	10	133262420-133276868	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 68.6;lymphoid tissue: 48.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 54.7;Extravillous trophoblasts: 96.4;Langerhans cells: 124.9;monocytes: 81.3;NK-cells: 82.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 21.2"	"Group enriched"	"Detected in many"	5	"basophil: 107.4;eosinophil: 259.0;neutrophil: 139.4"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 259.0"	"Cell line enhanced"	"Detected in many"		"A-431: 60.0;BEWO: 81.8;CAPAN-2: 70.4;HaCaT: 69.8;HDLM-2: 45.9;U-87 MG: 34.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064637	Approved				"Intracellular and membrane"	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA064637: AB_2685306"	"unprognostic (8.24e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.27e-3)"	"unprognostic (5.18e-2)"	"unprognostic (8.26e-2)"	"unprognostic (6.47e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.94e-3)"	"unprognostic (3.37e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavorable (3.99e-10)"	"unprognostic (1.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.32e-2)"	5.6	2.4	2.1	22.1	2.3	68.6	2.7	1.4	21.2	4.2	1.7	3.6	5.8	2.2	2.1	3.5	6.0	5.1	2.5	1.8	1.8	4.7	8.4	21.5	11.6	3.2	1.9	3.0	4.3	0.3	3.6	3.1	4.4	4.5	1.6	1.5	4.2	1.1	1.2	3.2	11.3	2.1	1.6	48.5	11.5	2.6	5.9	4.0	3.8	1.7	8.2	11.9	3.2	3.4	60.0	1.7	0.5	0.9	0.4	0.1	81.8	0.7	1.4	0.3	0.4	4.6	70.4	1.0	1.7	0.1	0.5	69.8	0.2	11.9	0.1	45.9	1.0	0.8	0.5	0.0	0.7	3.6	15.9	0.2	1.1	0.6	1.0	3.7	0.1	0.5	3.2	2.4	0.0	4.8	0.2	20.2	0.3	7.1	1.7	0.4	0.7	6.6	0.8	1.4	0.1	0.8	0.4	0.2	1.0	1.1	1.0	2.0	1.7	0.0	1.5	0.6	1.0	3.4	2.2	0.6	34.5	2.0	0.2	107.4	24.8	259.0	22.2	9.2	15.9	10.2	14.8	21.4	37.2	5.6	5.6	8.2	139.4	24.7	9.4	0.7	16.9	25.2	2.1	2.3	1.4	21.2	1.8	1.8	3.2	1.9	4.4	1.6	5.9	3.4	1.3	3.2	10.5	3.3	23.2	7.8	6.6	14.3	0.0	4.3	2.2	1.8	2.4	2.8	9.5	0.0	8.4	7.7	54.7	0.3	1.9	3.1	1.0	1.5	0.9	1.7	0.0	5.7	3.5	2.7	96.4	2.4	6.1	2.1	12.6	1.1	2.5	2.4	23.3	0.0	3.0	0.6	2.0	8.8	124.9	0.4	0.9	33.9	7.2	0.0	81.3	0.2	82.4	2.0	2.9	39.1	0.1	0.0	20.7	11.0	0.3	0.5	10.0	5.1	0.0	0.8	1.0	1.5	0.8	0.6	6.5	20.0	39.4	0.2	0.5	42.5
ADGRG3	"GPR97, Pb99, PGR26"	ENSG00000182885	"Adhesion G protein-coupled receptor G3"	Q86Y34	16	57668277-57689378	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"bone marrow: 147.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 4.4;dendritic cells: 2.9;Endothelial cells: 2.8;Erythroid cells: 5.3;T-cells: 4.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"cerebral cortex: 10.6"	"Immune cell enhanced"	"Detected in some"		"eosinophil: 142.3;neutrophil: 169.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 169.8"	"Group enriched"	"Detected in some"	6	"NB-4: 5.0;SK-MEL-30: 2.1;U-937: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA040469	Uncertain					NA	NA		1200000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA040469: AB_10794032"	"unprognostic (4.41e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.14e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.50e-4)"	"unprognostic (5.25e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.67e-3)"	"unprognostic (4.75e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.90e-1)"	8.5	0.3	0.1	14.6	0.2	147.0	1.7	0.1	10.6	1.1	0.3	1.6	2.2	1.0	0.0	1.0	4.3	2.3	1.2	0.1	0.1	0.8	2.3	12.0	0.3	0.2	0.2	0.4	0.7	0.0	0.2	1.7	2.0	0.6	1.4	0.0	0.4	0.1	0.3	0.7	3.4	2.6	0.1	29.4	1.3	0.3	0.4	0.6	3.2	2.8	0.4	3.8	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	75.5	0.0	142.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	169.8	36.4	0.1	0.0	0.0	0.9	0.1	0.2	0.1	10.6	0.1	0.1	0.2	0.2	2.0	0.1	0.4	0.1	1.0	9.6	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.6	0.0	1.8	0.0	0.0	0.3	2.9	0.0	0.0	0.1	0.6	0.5	0.2	2.8	0.0	5.3	0.1	0.0	0.1	0.9	0.0	0.4	2.5	0.2	2.2	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.0	0.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.2	1.5	0.0	0.0	0.2	0.2	0.0	0.7	0.1	0.0	0.1	4.2	0.0	0.0	0.1
ADIPOR1	"ACDCR1, PAQR1"	ENSG00000159346	"Adiponectin receptor 1"	Q96A54	1	202940826-202958572	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 329.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 6: Erythroid cells - Oxygen transport"				"unprognostic (1.67e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.95e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (5.27e-4)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.79e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.84e-1)"	"unprognostic (8.63e-2)"	59.8	58.5	56.1	49.1	60.1	215.2	63.6	58.7	64.2	55.4	82.9	55.6	46.5	40.9	91.4	110.9	68.6	48.2	92.6	56.8	57.7	70.4	106.2	80.5	48.0	61.2	58.6	47.7	91.7	107.1	45.5	100.0	60.2	53.7	59.8	135.6	106.6	47.4	136.5	110.8	47.4	50.9	60.1	65.8	63.3	48.7	58.7	50.2	56.6	140.2	77.9	70.9	69.2	65.2	97.0	87.2	53.4	59.9	111.4	85.4	276.8	103.4	123.9	108.8	99.4	88.7	114.7	63.5	75.3	120.6	86.3	118.0	81.3	145.5	96.5	118.5	93.5	48.6	104.3	72.6	109.7	101.6	71.6	101.7	235.0	115.9	118.3	108.4	108.8	111.7	128.1	133.5	111.2	105.6	85.3	77.4	119.7	87.1	103.1	66.7	128.7	125.7	106.5	111.0	89.2	90.8	109.6	166.5	135.5	143.6	121.1	99.4	95.7	78.9	62.2	39.4	117.3	137.8	197.4	71.4	113.5	58.9	94.5	362.2	361.8	455.4	136.0	253.6	143.8	157.9	143.4	134.1	209.8	165.2	141.5	124.3	825.9	126.0	259.6	146.1	179.5	557.4	56.1	60.1	58.7	64.2	56.8	57.7	61.2	58.6	60.2	60.1	58.7	65.2	40.7	35.3	52.5	6.8	46.8	235.0	95.2	109.8	75.7	24.8	81.9	54.2	59.7	32.9	79.3	53.3	29.2	112.7	42.8	49.3	68.4	73.8	68.2	58.8	24.5	53.4	49.1	329.0	13.7	86.3	172.4	40.9	37.2	54.3	37.3	18.8	58.5	60.8	104.2	11.8	15.1	49.1	85.5	148.5	89.7	62.5	28.6	107.6	85.4	15.9	85.0	38.0	42.2	9.5	20.0	120.0	43.5	24.5	116.0	133.1	67.3	65.9	82.5	54.9	39.5	29.2	61.7	26.4	27.2	79.3	228.9	202.8	47.1	29.2	41.7	206.6
AHCTF1	ELYS	ENSG00000153207	"AT-hook containing transcription factor 1"	Q8WYP5	1	246839098-246931948	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, mRNA transport, Protein transport, Translocation, Transport"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 116.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 3.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031658	Uncertain		Supported	"Nuclear membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Nuclear membrane"		"HPA031658: AB_10601968"	"unprognostic (3.10e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.11e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.53e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (3.49e-8)"	"unprognostic (7.65e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.52e-2)"	12.6	7.5	4.4	8.4	6.4	16.9	9.7	11.4	6.2	9.1	5.7	9.1	6.5	8.8	6.6	9.2	7.0	7.4	6.6	4.7	6.2	9.8	10.9	7.2	9.1	3.3	5.6	16.2	10.0	13.1	6.4	8.8	3.7	7.6	6.9	8.1	6.8	7.9	11.0	8.0	6.6	7.9	3.8	9.2	8.5	32.5	7.0	12.2	13.7	15.7	9.0	10.3	7.1	4.8	37.9	25.9	24.6	20.7	24.3	23.6	32.4	24.2	19.3	29.1	24.2	26.5	19.4	37.6	24.6	21.6	16.4	34.1	40.3	20.9	49.7	21.0	9.0	26.4	29.0	24.2	17.4	40.8	17.8	22.8	18.5	37.9	38.4	13.9	21.9	18.5	61.2	24.4	27.8	12.5	31.5	19.2	42.4	34.1	18.4	30.4	32.6	32.1	18.3	28.0	22.1	28.6	34.9	19.5	20.3	18.3	22.1	29.2	20.1	26.3	22.5	33.2	55.7	25.8	38.9	45.4	19.5	27.0	26.2	0.3	0.2	0.7	0.5	0.1	0.5	0.7	0.7	0.6	0.2	0.4	0.8	0.6	3.0	0.4	0.4	0.4	0.8	0.3	4.4	6.4	11.4	6.2	4.7	6.2	3.3	5.6	3.7	3.8	7.0	4.8	53.7	35.3	35.0	37.2	32.9	30.0	22.4	10.3	40.5	19.8	15.9	21.7	21.1	7.2	20.7	5.5	8.4	14.1	27.4	15.7	3.9	12.5	63.7	29.1	30.9	25.9	21.6	20.8	62.2	12.4	10.8	30.5	21.9	28.8	12.0	20.3	17.2	14.3	9.3	18.5	55.7	12.9	10.2	13.2	13.8	23.7	36.1	57.4	3.6	29.0	17.7	8.9	26.8	46.8	51.3	16.2	13.0	39.1	35.8	27.7	11.9	8.8	20.4	17.1	32.9	70.9	26.1	116.7	37.6	27.3	30.7	13.5	31.3	21.4	12.4	26.2
AKIRIN1	"C1orf108, FLJ12666"	ENSG00000174574	"Akirin 1"	Q9H9L7	1	38991276-39006059	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"Early spermatids: 1546.1;Late spermatids: 1455.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051871	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Nuclear membrane"	"HPA051871: AB_2681646"	"unprognostic (1.16e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.35e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-3)"	"prognostic unfavorable (5.39e-7)"	"unprognostic (3.53e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.49e-3)"	"unprognostic (1.47e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.77e-3)"	"unprognostic (5.17e-2)"	46.0	29.9	37.5	33.5	41.3	77.2	23.1	41.8	43.8	21.9	41.3	35.1	24.2	28.7	42.3	29.2	25.0	41.8	38.5	38.6	47.4	42.9	53.2	30.0	42.3	45.9	45.1	19.6	27.7	43.2	40.0	26.5	47.2	36.3	36.2	37.5	24.4	35.8	30.1	17.3	26.8	41.9	42.4	31.7	33.3	83.2	49.8	41.5	36.1	30.4	42.1	41.2	18.6	48.1	61.4	28.0	117.3	96.9	56.3	66.2	83.8	70.0	73.1	69.2	70.1	73.2	49.5	48.3	63.3	67.1	49.6	41.8	114.7	62.8	110.8	72.2	58.3	142.7	41.6	92.5	74.2	137.5	75.3	68.5	80.5	90.4	73.6	61.6	64.9	61.8	99.0	46.6	87.8	25.2	58.5	60.2	248.2	45.9	47.1	92.4	85.4	48.2	77.7	73.9	81.3	55.2	77.8	41.4	160.1	182.8	37.9	70.6	58.3	42.3	68.4	46.2	72.1	67.1	92.5	102.6	72.7	80.4	73.3	35.7	39.3	83.7	33.4	33.9	50.6	33.7	54.4	51.7	55.4	30.2	63.3	42.0	102.8	72.0	38.8	41.7	54.7	53.1	37.5	41.3	41.8	43.8	38.6	47.4	45.9	45.1	47.2	42.4	49.8	48.1	48.5	64.1	43.9	25.1	83.8	137.9	77.1	34.0	56.9	48.1	69.0	48.6	45.1	31.5	40.1	38.6	47.9	72.9	111.6	48.6	93.9	45.6	1546.1	108.2	56.7	43.5	94.8	57.9	32.9	40.5	76.9	49.9	37.2	93.9	47.6	55.1	35.0	37.3	45.5	55.5	26.6	49.6	36.7	39.9	109.9	1455.5	44.1	65.2	42.7	16.9	85.1	52.1	42.2	23.6	73.2	50.5	37.2	45.5	53.2	67.8	23.9	41.8	38.9	45.0	52.6	61.3	77.5	77.3	103.9	43.4	138.5	167.5	99.9	34.0	41.8	81.4
AREL1	"FIEL1, KIAA0317"	ENSG00000119682	"Apoptosis resistant E3 ubiquitin protein ligase 1"	O15033	14	74653437-74713117	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051306	Uncertain					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"			"HPA051306: AB_2681433"	"unprognostic (1.92e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.58e-3)"	"unprognostic (9.32e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.12e-1)"	"prognostic favorable (4.67e-6)"	"unprognostic (6.73e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.52e-1)"	"unprognostic (7.18e-2)"	6.2	6.9	4.3	10.4	4.7	16.9	6.7	3.1	4.8	7.8	3.3	10.4	11.8	6.5	7.1	10.0	10.4	6.7	10.6	6.7	5.0	14.6	5.3	9.0	10.0	3.1	4.1	6.8	9.5	15.4	4.5	8.3	2.6	8.4	12.3	13.3	9.7	7.7	9.9	7.8	12.7	8.4	3.7	8.5	9.8	17.1	5.6	13.1	15.5	13.1	13.3	10.0	5.6	3.5	19.2	24.6	25.1	23.6	21.3	14.1	19.3	20.7	23.5	25.2	25.1	19.2	22.2	16.4	10.8	26.6	22.9	25.3	26.9	23.2	32.4	30.4	12.7	25.5	14.5	13.7	14.2	18.5	23.9	18.4	15.8	18.6	20.0	31.6	25.0	23.5	20.3	17.1	32.9	25.8	19.2	7.8	15.4	26.0	24.2	19.5	28.4	10.2	20.5	42.6	24.6	33.0	18.1	23.9	13.4	16.6	21.0	18.5	34.6	23.8	28.5	14.3	24.3	22.6	32.8	32.2	28.8	14.0	18.8	2.2	3.5	7.1	4.6	5.1	3.3	2.1	2.8	4.2	4.5	1.4	2.9	2.6	6.8	3.4	2.7	2.1	2.6	3.4	4.3	4.7	3.1	4.8	6.7	5.0	3.1	4.1	2.6	3.7	5.6	3.5	3.7	12.8	4.6	23.2	6.5	3.6	3.4	6.0	7.4	12.3	7.0	3.7	11.1	5.7	7.5	11.0	27.1	4.2	11.2	18.3	1.9	6.6	3.1	7.2	7.1	5.0	14.9	21.0	24.8	9.2	3.3	4.6	12.8	10.5	1.3	10.3	6.4	12.9	8.0	16.8	24.1	11.6	8.2	15.0	5.3	4.6	8.7	9.6	5.4	23.4	13.9	5.2	11.3	22.6	32.5	11.2	6.5	6.8	9.1	6.8	11.8	5.1	7.3	11.7	0.0	4.4	4.9	6.7	11.1	10.5	3.3	5.9	8.4	6.4	11.5	6.3
ARHGAP15	BM046	ENSG00000075884	"Rho GTPase activating protein 15"	Q53QZ3	2	143091362-143768352	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 79.8;lymphoid tissue: 75.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 126.3;Early spermatids: 132.3;granulocytes: 88.5;Microglial cells: 250.1;NK-cells: 89.6;T-cells: 149.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 59.4;HEL: 75.8;HL-60: 124.3;MOLT-4: 82.0;NB-4: 100.4;THP-1: 131.0;U-698: 89.5;U-937: 63.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032125			Uncertain	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA		38000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA032125: AB_10671370"	"unprognostic (1.59e-2)"	"unprognostic (2.40e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.62e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (6.95e-5)"	"unprognostic (4.40e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.58e-2)"	"unprognostic (6.94e-2)"	6.9	5.9	1.4	27.1	1.3	79.8	7.6	2.3	2.3	4.1	1.9	7.3	6.8	2.6	9.7	4.0	2.8	11.4	5.6	1.2	2.2	4.4	10.2	9.8	59.3	3.0	1.9	1.8	1.3	1.7	1.0	4.0	2.7	4.3	7.7	1.3	4.2	5.1	1.2	2.0	15.1	3.9	1.9	44.9	7.5	7.4	2.1	75.2	4.5	2.2	46.3	11.4	4.3	4.0	0.3	0.1	4.9	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	59.4	0.2	0.1	0.1	0.1	0.2	0.1	0.3	14.6	0.0	75.8	0.5	0.1	0.0	124.3	1.2	0.0	0.0	0.2	0.2	0.1	0.0	47.0	0.3	4.4	0.0	0.1	82.0	100.4	0.3	0.0	0.1	44.7	0.6	22.7	0.0	0.1	0.2	0.4	0.3	0.2	1.0	0.1	4.5	131.0	0.6	0.4	1.2	0.1	0.2	1.0	0.3	89.5	0.7	63.9	3.9	181.8	32.0	140.1	97.7	34.3	161.6	94.3	172.8	125.7	56.3	86.2	119.0	101.7	207.2	121.4	40.5	54.3	147.7	99.9	1.4	1.3	2.3	2.3	1.2	2.2	3.0	1.9	2.7	1.9	2.1	4.0	8.2	0.0	9.6	2.0	126.3	5.6	0.1	0.0	0.0	0.3	1.8	2.0	3.9	1.5	2.5	0.0	0.0	0.2	78.9	0.3	0.0	0.1	132.3	1.8	2.3	4.3	0.0	26.3	12.2	0.0	0.3	9.7	8.6	3.5	88.5	0.0	8.6	0.8	21.3	1.7	6.8	0.0	0.0	39.9	30.9	17.5	14.9	43.0	8.8	250.1	34.9	0.4	89.6	20.6	3.2	0.0	0.0	3.4	65.8	0.2	0.0	0.7	2.2	0.3	46.0	2.7	31.6	68.4	1.2	0.4	4.5	0.3	149.2	0.1	0.2	0.2
ARHGAP25	KIAA0053	ENSG00000163219	"Rho GTPase activating protein 25"	P42331	2	68679601-68826833	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 72.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 88.7;granulocytes: 210.8;Microglial cells: 88.1;NK-cells: 103.0;T-cells: 53.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 657.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 66.7;HMC-1: 256.1;NB-4: 47.3;U-266/70: 50.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035346, HPA061395"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Vesicles"		"HPA035346: AB_10601116, HPA061395: AB_2684501"	"unprognostic (1.13e-3)"	"prognostic favorable (7.72e-4)"	"unprognostic (2.45e-2)"	"unprognostic (4.44e-3)"	"unprognostic (8.07e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (3.10e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.49e-2)"	11.1	5.2	5.2	38.8	5.4	37.4	8.0	5.6	7.9	6.0	5.1	7.2	6.2	6.7	22.7	4.3	4.7	11.7	6.7	5.2	5.6	7.1	10.1	21.3	71.4	7.6	6.0	16.7	2.1	2.3	3.5	10.7	6.7	5.0	9.6	0.6	5.1	3.8	3.2	6.2	23.3	8.3	7.1	72.8	8.8	2.5	7.0	27.3	5.1	8.4	67.3	11.9	4.7	8.4	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	20.8	0.5	0.0	0.1	2.5	0.0	20.5	0.0	2.3	0.0	66.7	0.0	0.0	1.0	14.8	256.1	0.2	2.4	0.4	8.1	0.0	0.0	22.2	0.4	23.6	0.0	0.0	17.2	47.3	1.2	0.2	0.0	18.7	4.3	0.8	0.0	5.4	4.1	0.6	0.2	0.0	1.4	1.4	0.0	12.3	3.5	0.1	0.9	0.1	0.5	50.8	29.0	16.8	0.2	33.3	0.3	234.8	60.8	528.7	171.3	75.9	107.0	156.4	76.2	150.0	37.4	100.8	54.2	95.2	657.3	170.6	94.8	52.3	102.0	132.0	5.2	5.4	5.6	7.9	5.2	5.6	7.6	6.0	6.7	7.1	7.0	8.4	14.1	3.2	15.0	0.3	88.7	5.6	12.4	2.9	5.7	0.8	0.7	6.1	1.4	1.5	2.0	0.0	0.0	0.5	35.1	0.1	1.9	0.1	1.8	0.7	0.6	16.6	3.0	11.6	15.5	0.2	0.4	3.5	2.0	0.4	210.8	0.1	15.4	1.0	48.6	0.0	0.9	0.5	2.0	27.3	12.8	3.6	1.5	22.6	1.8	88.1	40.9	0.5	103.0	0.5	0.9	0.0	0.1	2.6	34.7	1.2	0.0	0.2	5.2	0.2	6.6	0.8	2.1	0.6	1.3	2.5	1.4	0.3	53.7	1.8	0.2	2.5
ARHGAP9	"10C, MGC1295"	ENSG00000123329	"Rho GTPase activating protein 9"	Q9BRR9	12	57472264-57488814	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 119.7;lymphoid tissue: 100.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 171.0;Early spermatids: 96.8;NK-cells: 123.6;Spermatocytes: 89.0;T-cells: 108.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 388.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 27.6;HMC-1: 116.2;MOLT-4: 22.5;NB-4: 22.1;THP-1: 34.9;U-937: 27.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA078822			Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Cell Junctions"	"HPA078822: "	"unprognostic (1.02e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.91e-2)"	"prognostic favorable (6.61e-5)"	"unprognostic (1.24e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.79e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (7.90e-9)"	"unprognostic (1.60e-1)"	"unprognostic (6.32e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.91e-2)"	10.8	4.2	4.2	34.3	6.1	119.7	4.1	8.1	11.1	2.6	4.7	7.7	8.2	3.4	1.6	4.6	7.4	10.5	3.9	4.4	5.3	5.1	7.5	22.0	56.9	7.8	5.8	1.6	3.5	0.6	2.2	5.2	8.8	4.3	10.7	0.5	4.7	1.8	1.3	2.2	37.6	5.9	5.6	100.7	8.8	19.3	6.1	34.9	4.5	6.4	60.7	9.5	3.6	6.4	0.2	0.0	0.2	0.5	0.0	0.0	0.1	0.4	0.5	0.1	0.2	0.1	0.0	14.3	0.3	0.3	0.0	0.2	0.4	0.0	0.0	0.7	0.0	27.6	0.1	0.0	1.1	16.4	116.2	0.7	0.0	0.0	0.3	0.2	0.0	14.3	0.5	7.9	0.0	0.0	22.5	22.1	1.0	0.0	0.0	9.1	10.2	4.6	0.0	0.1	3.9	3.0	0.0	0.0	0.4	0.5	0.0	34.9	0.9	0.2	0.3	0.1	0.1	9.2	7.2	13.3	0.3	27.3	0.5	51.9	86.1	243.4	43.3	89.2	30.0	35.9	47.3	39.6	72.1	44.0	61.9	46.0	388.9	68.2	71.0	97.4	63.6	70.8	4.2	6.1	8.1	11.1	4.4	5.3	7.8	5.8	8.8	5.6	6.1	6.4	2.2	0.0	14.2	1.0	49.1	1.5	0.2	0.0	1.8	0.2	1.6	2.9	2.1	1.5	1.3	0.0	2.1	0.4	171.0	0.6	0.0	0.2	96.8	0.6	0.8	1.5	0.0	11.6	3.7	0.0	0.6	2.4	4.6	0.8	12.0	0.0	3.6	1.2	43.5	0.0	1.9	0.5	0.0	39.0	19.7	44.8	1.8	35.1	0.0	8.4	34.8	0.0	123.6	0.0	0.2	0.2	0.1	0.0	50.8	0.2	0.0	0.3	2.2	0.7	0.0	0.6	1.2	89.0	17.5	0.4	1.4	0.3	108.2	0.3	0.4	0.1
ARHGEF40	"FLJ10357, solo"	ENSG00000165801	"Rho guanine nucleotide exchange factor 40"	Q8TER5	14	21070273-21090248	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 6.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030745, HPA030746, HPA030757"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"		"HPA030745: , HPA030746: AB_10599613, HPA030757: AB_10600203"	"unprognostic (6.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.55e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.27e-2)"	"unprognostic (9.84e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.01e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.95e-2)"	21.0	47.2	9.6	5.3	11.1	1.6	18.5	10.0	9.2	24.8	6.2	14.5	3.7	18.9	12.2	3.5	13.2	14.8	12.3	8.9	11.1	10.1	26.9	14.2	2.3	13.5	10.5	19.3	24.0	10.7	9.0	6.5	10.5	12.3	6.2	2.8	20.2	18.6	10.5	7.4	7.9	9.7	10.1	27.8	9.5	4.3	12.1	3.1	15.8	6.1	1.7	13.8	13.3	12.1	3.3	2.9	30.8	5.8	24.5	37.1	1.1	11.4	28.1	12.1	9.4	1.4	7.5	0.0	1.8	20.9	12.2	5.0	2.6	3.7	4.3	6.6	1.1	4.6	3.4	9.0	3.5	3.0	16.5	15.5	2.4	10.3	3.1	22.6	0.0	0.0	1.4	1.3	9.6	0.3	0.0	8.6	8.1	0.8	0.5	1.0	23.2	1.4	7.6	4.1	0.7	11.6	6.4	0.6	8.9	6.0	2.7	10.1	5.9	25.4	17.5	11.9	5.9	2.6	0.0	0.0	8.8	4.2	7.5	0.0	1.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	6.2	0.1	0.0	0.1	0.0	0.4	9.6	11.1	10.0	9.2	8.9	11.1	13.5	10.5	10.5	10.1	12.1	12.1	12.7	6.4	5.0	32.0	2.5	4.8	8.0	5.8	1.8	9.2	6.6	11.3	13.4	47.1	3.2	14.7	0.0	1.4	0.5	10.0	19.6	21.2	1.0	17.6	13.1	11.0	7.8	1.7	0.3	10.2	0.9	20.4	18.3	3.5	38.0	11.6	8.2	31.5	14.1	5.0	6.2	9.1	4.1	46.9	14.6	2.3	24.2	22.0	23.2	17.8	23.6	24.6	1.0	21.1	8.9	16.4	6.6	24.0	3.1	6.3	1.0	7.1	1.7	6.8	26.3	18.6	21.9	3.1	2.8	0.6	4.4	1.2	3.5	14.6	18.7	6.1
ARID3B	"BDP, DRIL2"	ENSG00000179361	"AT-rich interaction domain 3B"	Q8IVW6	15	74541206-74598131	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 24.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 43.8;Early spermatids: 45.4;Glandular and luminal cells: 45.6;Late spermatids: 65.8;Rod photoreceptor cells: 50.8;Syncytiotrophoblasts: 64.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 10.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 87.8;SuSa: 95.4;U-266/70: 53.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 28.8"	HPA050320	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA050320: AB_2681085"	"unprognostic (2.97e-1)"	"unprognostic (5.91e-2)"	"unprognostic (6.41e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.33e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.42e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.45e-3)"	"unprognostic (2.20e-1)"	2.8	2.4	3.1	6.1	2.4	24.6	2.6	5.2	3.4	3.3	6.6	4.9	4.4	2.3	1.9	6.2	2.5	2.4	2.3	3.3	4.4	3.6	4.0	7.3	7.2	2.9	3.4	1.5	5.7	1.7	6.2	15.7	2.9	4.6	4.0	18.7	3.8	1.7	3.4	3.2	7.0	1.6	2.3	9.5	7.1	22.1	3.7	6.0	3.8	2.2	6.3	3.2	3.9	2.8	7.6	3.1	40.7	8.9	1.5	0.8	43.8	1.8	2.0	2.5	2.7	49.9	3.6	0.7	2.0	1.9	14.3	9.0	49.8	6.8	2.2	47.7	11.6	29.5	6.0	13.7	1.0	4.7	18.5	1.0	3.0	4.2	4.3	2.0	4.3	11.7	26.1	16.8	0.7	1.8	12.9	15.7	87.8	3.2	2.7	5.7	1.6	12.1	2.4	7.9	10.4	18.4	2.2	4.5	8.8	95.4	5.8	8.5	2.7	3.4	4.3	2.7	5.6	53.0	36.1	5.3	1.8	7.3	1.3	2.6	1.9	7.0	5.0	1.5	3.0	3.1	2.9	3.8	1.4	1.4	2.2	2.9	13.0	4.0	2.0	1.9	4.4	3.4	3.1	2.4	5.2	3.4	3.3	4.4	2.9	3.4	2.9	2.3	3.7	2.8	3.5	3.2	5.6	10.7	11.8	5.2	5.2	3.5	3.4	23.9	4.4	2.3	1.2	4.3	1.9	0.0	43.8	36.0	10.2	10.2	0.0	2.5	45.4	20.5	4.4	4.8	5.4	9.7	7.3	3.5	20.6	2.3	8.6	45.6	2.5	4.2	4.2	2.5	8.3	11.8	7.8	6.0	0.0	8.7	9.1	65.8	2.8	9.5	3.6	5.6	6.4	5.9	18.6	5.5	7.8	7.6	8.4	3.0	19.2	7.8	7.0	1.7	3.8	50.8	0.0	1.5	1.8	17.2	19.4	10.4	3.3	64.0	12.8	5.5	4.0	8.0
ARID5A	"MRF-1, RP11-363D14"	ENSG00000196843	"AT-rich interaction domain 5A"	Q03989	2	96536743-96552634	"Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 137.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"HDLM-2: 295.3;RPMI-8226: 117.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002860, HPA023879"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Nucleoli	"HPA002860: , HPA023879: AB_1845014"	"prognostic favorable (2.05e-6)"	"unprognostic (1.08e-3)"	"unprognostic (1.69e-2)"	"unprognostic (3.89e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (4.24e-8)"	"unprognostic (2.74e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.13e-2)"	32.6	4.5	8.1	19.5	8.9	11.8	38.8	8.7	11.1	18.5	7.7	25.9	5.0	25.2	2.0	7.8	24.1	12.3	28.8	7.8	8.7	12.3	8.5	48.1	19.0	14.3	10.8	10.8	6.9	2.2	9.3	9.6	11.5	23.2	2.3	2.2	10.2	2.6	23.5	11.3	19.8	7.3	10.6	22.8	14.6	5.6	10.2	10.3	13.0	2.3	9.9	19.9	15.4	9.6	3.4	1.9	1.6	5.4	2.7	3.0	7.5	5.1	17.2	6.1	5.3	3.1	0.9	1.1	3.8	2.9	9.1	4.6	1.4	0.3	2.1	295.3	4.1	6.9	1.1	5.8	3.4	4.7	4.9	2.1	5.7	5.0	0.9	5.3	5.4	8.1	5.4	38.5	2.4	2.9	8.7	16.1	3.3	1.5	0.2	12.2	11.3	117.5	0.7	2.5	2.2	1.1	0.5	0.6	4.3	1.3	0.2	10.0	6.0	5.4	6.7	6.2	4.6	24.7	21.5	3.1	3.0	11.1	4.9	10.5	7.9	32.8	15.3	6.9	14.9	5.9	13.1	14.6	10.3	6.5	14.1	14.4	21.5	27.5	5.5	18.4	16.0	14.9	8.1	8.9	8.7	11.1	7.8	8.7	14.3	10.8	11.5	10.6	10.2	9.6	97.1	3.2	18.3	3.9	59.9	52.4	46.5	17.0	5.7	24.8	80.3	44.7	14.7	8.6	14.7	3.7	31.3	4.9	121.1	10.8	3.9	33.7	14.2	16.7	26.8	82.2	0.0	3.4	1.5	30.9	9.0	41.2	11.2	32.4	61.9	2.1	38.6	28.7	72.6	0.0	1.6	10.7	20.3	41.5	137.1	36.7	3.7	61.6	58.7	15.9	66.6	6.5	123.6	3.5	1.3	29.1	23.9	6.4	54.5	28.2	0.6	10.6	8.3	25.7	46.0	49.1	120.1	3.2	17.9	1.1	32.5	4.0	98.2	2.1	7.8	26.9
ARL5B	ARL8	ENSG00000165997	"ADP ribosylation factor like GTPase 5B"	Q96KC2	10	18659431-18681639	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 314.7;Langerhans cells: 304.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027002	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 44: Endometrium - Transcription"			"HPA027002: AB_10601685"	"unprognostic (1.12e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.04e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.77e-2)"	"unprognostic (7.86e-2)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.23e-1)"	"unprognostic (2.55e-1)"	"unprognostic (8.34e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.83e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.07e-1)"	11.1	20.8	3.2	7.8	3.5	19.6	6.5	6.0	5.6	8.1	4.5	7.5	9.3	9.3	3.7	8.5	4.7	14.1	6.8	3.6	4.0	5.7	29.8	9.7	7.1	3.4	3.9	7.9	9.0	6.1	6.8	13.1	3.6	6.3	8.4	5.7	7.2	3.6	4.3	6.6	10.0	6.7	4.0	5.6	6.4	5.7	3.9	13.5	8.2	6.2	7.1	12.6	5.9	4.3	14.8	8.1	36.5	14.2	10.4	11.9	22.1	12.5	6.0	11.8	19.9	26.7	12.4	18.3	5.0	6.5	7.6	14.2	25.5	9.1	15.0	5.9	19.5	18.4	9.5	38.2	26.7	8.8	10.3	11.9	12.4	11.3	12.3	11.5	18.7	13.8	23.7	19.0	9.4	7.0	21.1	6.4	25.2	15.4	3.5	26.1	23.8	12.0	10.5	12.7	4.7	30.4	9.6	10.0	17.9	27.9	5.9	10.1	12.7	6.7	20.5	12.9	10.6	10.1	13.8	24.9	6.7	7.3	6.2	1.2	0.7	0.5	0.5	0.8	0.7	0.5	0.5	0.6	0.9	0.5	0.8	0.6	0.9	1.0	0.5	0.5	0.7	0.5	3.2	3.5	6.0	5.6	3.6	4.0	3.4	3.9	3.6	4.0	3.9	4.3	70.1	38.5	26.0	10.4	36.1	152.3	76.0	42.9	122.9	9.9	84.3	50.4	16.7	21.5	36.9	9.2	6.2	26.7	53.5	96.8	5.9	25.9	74.5	117.1	52.1	54.5	65.4	16.4	12.4	15.8	39.1	44.9	72.9	314.7	101.1	26.6	15.7	44.8	13.4	10.1	12.1	65.2	14.2	25.3	304.3	15.8	6.8	94.1	58.7	12.2	8.0	9.1	7.2	19.1	14.7	20.8	81.6	5.7	49.0	63.8	58.5	8.1	34.5	7.4	6.6	41.9	50.8	27.8	15.5	134.6	167.1	43.2	47.1	21.5	43.5	153.1
ASB16	FLJ30165	ENSG00000161664	"Ankyrin repeat and SOCS box containing 16"	Q96NS5	17	44170447-44179084	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 67.7"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.4;Horizontal cells: 1.7;Inhibitory neurons: 1.6;NK-cells: 2.1;Oligodendrocyte precursor cells: 1.5;Rod photoreceptor cells: 2.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 9.8"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 11.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA066834	Approved		Approved	"Focal adhesion sites"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 37: Myocytes - Muscle contraction"	"Focal adhesion sites"		"HPA066834: AB_2685732"	"unprognostic (2.72e-2)"	"unprognostic (8.47e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.03e-2)"	"unprognostic (6.13e-2)"	"unprognostic (7.23e-4)"	"unprognostic (5.84e-2)"	"unprognostic (3.97e-2)"	"unprognostic (8.53e-3)"	"unprognostic (7.33e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.07e-3)"	0.8	1.0	0.8	2.3	0.9	2.2	0.6	9.8	1.2	1.1	0.0	1.5	2.1	1.9	0.0	1.0	1.4	1.1	4.6	0.5	0.3	1.1	0.6	1.1	3.3	1.5	1.8	1.7	3.6	1.6	1.9	0.6	1.6	1.6	0.0	2.3	2.0	0.2	67.7	3.2	2.1	0.6	0.1	3.1	2.0	1.0	1.1	0.0	1.2	13.1	0.0	1.2	0.8	1.6	2.1	3.9	4.6	4.2	0.0	0.0	3.7	4.2	0.0	0.0	0.0	3.0	2.3	3.2	2.5	0.0	1.0	4.9	0.0	0.0	0.0	5.0	6.8	2.0	8.0	3.4	0.0	2.1	6.2	0.0	0.0	0.0	0.0	1.2	0.0	4.7	3.7	7.6	0.0	3.5	2.6	4.0	1.3	0.7	4.5	8.0	4.4	4.8	0.0	3.1	4.6	2.6	2.0	0.6	0.7	1.3	6.0	2.0	2.1	5.7	5.1	3.5	2.7	11.8	6.2	2.9	1.3	3.0	3.8	2.3	1.3	5.8	1.7	1.2	2.0	2.5	1.8	1.6	0.7	1.9	2.3	1.5	4.1	2.6	1.1	1.6	1.9	1.6	0.8	0.9	9.8	1.2	0.5	0.3	1.5	1.8	1.6	0.1	1.1	1.6	0.0	0.0	0.0	0.3	0.5	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	1.4	0.2	0.1	0.1	0.0	0.2	0.0	0.2	0.7	0.0	0.1	1.7	1.6	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	1.0	0.0	0.7	2.1	1.5	1.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.6	0.2	0.3	0.4	0.3	0.0	0.0	0.2	0.3	0.1	0.1
ATG12	"APG12, APG12L"	ENSG00000145782	"Autophagy related 12"	O94817	5	115828200-115841837	"Predicted intracellular proteins, Transporters"	"Autophagy, Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013272, HPA068989"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"		"CAB013272: AB_2533272, HPA068989: "	"unprognostic (2.48e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.87e-2)"	"unprognostic (5.51e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.54e-7)"	"unprognostic (1.27e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (4.99e-4)"	"unprognostic (5.11e-2)"	15.5	10.5	12.3	10.7	12.7	11.3	10.2	12.9	16.9	12.0	10.5	10.4	11.6	10.8	11.9	11.3	9.8	11.6	9.7	12.6	13.3	7.1	18.4	10.4	13.6	13.2	13.2	12.0	9.5	7.4	8.7	13.6	13.7	10.8	11.1	9.6	7.9	10.9	11.1	9.0	11.9	12.7	12.7	11.2	8.8	9.4	12.8	14.0	8.6	12.6	11.6	11.8	8.8	15.0	20.7	10.9	26.3	24.1	42.9	57.4	20.0	34.9	38.3	22.6	36.5	15.8	16.5	17.8	14.5	32.1	35.3	11.3	20.5	29.4	36.4	93.2	20.2	11.5	13.0	14.8	33.7	12.8	22.0	43.0	31.5	25.1	29.6	26.3	27.6	19.0	16.8	24.4	43.5	13.5	27.2	20.2	17.9	15.7	23.6	19.8	25.4	25.7	15.7	13.7	25.8	27.6	37.3	14.7	36.6	20.0	20.3	19.2	28.3	41.3	18.9	38.2	36.0	18.7	31.5	28.9	37.7	27.2	39.6	15.4	11.5	19.3	11.8	13.6	16.5	12.3	14.3	11.7	10.3	12.2	14.6	14.1	20.9	14.4	17.4	13.8	12.3	11.0	12.3	12.7	12.9	16.9	12.6	13.3	13.2	13.2	13.7	12.7	12.8	15.0	52.5	44.8	41.0	17.0	82.8	85.8	65.4	81.6	44.3	42.3	46.8	36.1	45.2	38.6	56.9	25.8	77.2	61.8	92.3	50.3	37.2	60.6	28.7	49.0	60.7	55.1	41.8	23.8	28.5	81.6	134.1	75.2	36.2	55.8	96.9	48.8	47.5	57.9	68.2	30.3	26.5	54.5	59.0	72.1	69.8	14.9	64.0	53.7	53.4	19.7	76.8	34.1	99.9	26.7	35.5	105.5	45.8	53.8	50.1	68.4	56.3	44.3	49.7	59.2	26.3	39.5	50.5	50.0	45.1	40.0	84.7	88.7	78.8	45.1	46.0	78.1
B3GNT2	"B3GN-T1, B3GN-T2, B3GNT-2, B3GNT1, BETA3GNT"	ENSG00000170340	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2"	Q9NY97	2	62196115-62224731	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 115.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005997	Approved		Approved	Vesicles		NA	NA		99000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 14: REH - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA005997: AB_1845234"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.63e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.55e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.25e-1)"	17.3	20.8	6.6	13.3	13.6	72.7	26.1	5.9	9.8	25.9	9.0	19.4	27.7	24.6	6.2	25.1	12.7	27.4	19.0	6.8	8.6	33.4	21.8	34.2	24.1	6.9	8.3	5.9	39.7	7.6	13.2	30.6	9.7	10.8	24.3	5.2	15.5	8.2	3.2	11.0	14.4	24.1	6.1	14.9	18.2	7.6	8.5	25.5	19.5	9.0	18.3	20.1	12.8	6.7	20.7	14.0	20.9	9.3	22.5	10.0	60.0	19.8	21.8	15.4	20.5	29.2	32.5	22.3	17.8	18.5	21.6	19.4	13.3	16.6	26.5	46.8	10.8	55.1	6.4	17.2	16.8	33.2	23.8	12.3	30.7	29.6	10.5	11.0	23.4	15.3	30.4	13.7	18.9	15.7	63.7	49.6	20.0	37.4	5.8	115.0	14.4	12.3	29.2	20.1	20.1	14.9	14.1	29.9	23.5	33.4	8.6	38.7	26.7	18.6	16.4	31.7	19.9	38.2	14.4	96.2	14.6	56.5	18.4	14.9	9.0	56.2	20.0	8.6	28.0	14.8	14.7	34.6	10.6	16.6	17.3	26.0	21.3	41.0	11.7	13.3	26.2	17.6	6.6	13.6	5.9	9.8	6.8	8.6	6.9	8.3	9.7	6.1	8.5	6.7	40.3	64.1	9.8	2.0	31.4	71.5	30.9	20.8	92.2	15.6	40.0	20.7	9.2	18.6	21.9	18.4	0.0	40.9	43.8	42.7	23.5	24.0	0.1	51.1	30.3	31.8	9.5	61.6	11.2	57.2	38.3	19.5	36.7	97.3	3.8	9.7	37.5	21.3	60.4	0.0	3.4	22.7	87.5	20.5	58.5	0.7	2.5	34.4	35.6	14.0	19.7	8.6	18.6	2.5	7.2	36.3	24.8	2.2	25.8	25.5	14.2	19.0	19.1	2.1	65.7	8.1	68.2	0.3	1.6	77.4	64.8	65.3	45.9	10.6	13.9	41.1
B3GNT8	"B3GALT7, beta3Gn-T8, BGALT15"	ENSG00000177191	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8"	Q7Z7M8	19	41425359-41428730	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 44.5;vagina: 19.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 37.2;Distal enterocytes: 58.1;Ionocytes: 44.7;Paneth cells: 45.0;Proximal enterocytes: 68.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"basophil: 95.0;eosinophil: 117.5;neutrophil: 159.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 159.0"	"Cell line enhanced"	"Detected in some"		"HMC-1: 6.5;HUVEC TERT2: 3.5;K-562: 3.1;THP-1: 3.4;U-937: 5.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043669	Enhanced				"Intracellular and membrane"	NA	NA		57000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA043669: AB_2678608"	"unprognostic (6.89e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (6.44e-3)"	"unprognostic (6.51e-3)"	"unprognostic (1.84e-2)"	"unprognostic (9.92e-3)"	"unprognostic (7.30e-2)"	"unprognostic (2.56e-2)"	"prognostic favorable (9.31e-6)"	"unprognostic (5.04e-2)"	"unprognostic (2.62e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.46e-1)"	2.3	1.2	0.2	1.6	0.4	3.9	2.0	1.1	0.4	11.1	0.2	10.5	15.5	2.4	0.3	44.5	1.8	0.5	6.4	0.1	0.2	3.9	0.5	9.0	0.7	0.5	0.2	0.8	1.5	0.5	1.9	0.5	0.6	3.3	2.7	0.1	6.3	2.6	0.8	5.3	15.3	0.8	0.0	8.6	2.0	0.2	0.3	0.3	1.2	0.9	1.6	2.7	19.5	0.7	0.2	0.0	0.2	0.0	0.3	1.4	0.3	0.4	0.1	0.0	0.0	2.1	0.0	0.1	0.5	1.0	0.0	1.4	0.0	0.3	0.0	0.1	0.2	0.0	0.1	1.1	0.5	0.5	6.5	1.7	1.2	0.0	0.0	0.0	3.5	0.1	3.1	0.2	0.0	0.5	0.0	2.0	0.5	0.0	0.0	0.1	0.4	0.0	0.1	0.7	0.9	0.6	0.0	0.1	0.0	0.2	0.0	3.4	1.3	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.1	5.5	0.0	95.0	16.3	117.5	2.4	12.3	28.4	0.0	1.2	5.2	6.0	0.0	0.1	0.6	159.0	1.5	26.5	0.5	0.6	7.1	0.2	0.4	1.1	0.4	0.1	0.2	0.5	0.2	0.6	0.0	0.3	0.7	0.9	6.4	37.2	0.0	0.0	1.8	5.2	16.3	2.2	0.4	1.4	2.2	0.5	0.0	10.6	23.9	0.0	0.9	0.3	58.1	3.9	5.8	0.0	0.8	0.5	1.7	15.0	1.3	0.1	0.6	2.1	3.0	0.5	1.8	5.1	0.1	2.5	0.0	11.2	0.0	0.1	23.8	44.7	8.8	0.6	0.0	1.5	5.6	0.0	0.0	3.8	0.1	1.0	0.0	0.1	2.9	45.0	0.7	0.1	7.4	68.7	0.3	3.5	0.4	0.0	0.6	2.7	0.0	0.1	20.5	1.7	2.3	1.2	0.0	18.5	13.4
BANP	"BEND1, DKFZp761H172, FLJ10177, FLJ20538, SMAR1, SMARBP1"	ENSG00000172530	"BTG3 associated nuclear protein"	Q8N9N5	16	87949244-88077318	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047164	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA047164: AB_2679964"	"unprognostic (1.82e-1)"	"unprognostic (7.84e-3)"	"unprognostic (4.73e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.35e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.68e-3)"	"unprognostic (4.98e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.89e-2)"	8.8	9.3	8.1	9.5	8.8	12.1	7.8	16.0	9.5	10.2	11.3	8.8	5.1	9.6	3.3	7.5	9.6	4.9	8.0	9.1	8.9	9.0	13.9	7.4	9.6	10.6	9.0	12.3	8.7	6.2	9.9	7.7	9.8	8.1	3.6	6.4	7.9	5.1	10.2	8.0	8.7	4.3	7.3	12.1	7.5	11.0	10.3	10.4	8.0	5.1	6.4	9.3	8.3	12.1	12.5	19.7	9.6	14.4	8.4	10.1	32.2	14.8	7.4	14.3	9.7	21.6	17.0	16.8	19.6	3.5	13.0	14.2	14.4	6.7	5.2	13.1	15.5	10.5	12.9	18.0	7.1	11.2	8.3	3.0	10.7	8.8	6.3	12.9	8.9	10.9	17.9	9.3	8.8	14.5	15.5	14.6	16.5	9.7	23.6	16.4	11.1	12.4	8.5	5.9	14.2	11.7	18.8	11.0	13.8	14.1	13.5	14.3	11.0	15.4	10.7	9.1	14.8	7.6	13.9	25.7	9.2	17.2	15.1	22.9	19.9	40.7	22.2	18.2	18.7	25.1	23.5	19.9	24.7	21.5	24.9	22.3	64.5	24.5	22.5	29.7	23.0	19.5	8.1	8.8	16.0	9.5	9.1	8.9	10.6	9.0	9.8	7.3	10.3	12.1	12.0	9.6	8.3	15.0	28.6	14.9	11.8	7.4	6.2	14.2	14.1	13.2	5.8	10.0	5.1	16.5	4.2	19.4	42.2	9.2	3.9	12.5	5.8	10.7	9.7	13.6	12.1	4.4	32.7	8.0	27.3	16.3	4.1	13.4	8.2	17.9	5.3	10.3	12.4	26.9	28.3	8.9	2.0	11.1	48.3	8.2	10.8	22.6	19.6	20.6	16.0	11.6	22.6	23.1	28.6	11.0	8.6	10.9	21.2	16.2	10.0	7.8	6.3	17.2	13.1	10.8	22.7	33.7	22.7	6.2	21.3	56.6	19.1	10.2	8.9	17.2
BBIP1	"bA348N5.3, BBIP10, BBS18, NCRNA00081"	ENSG00000214413	"BBSome interacting protein 1"	A8MTZ0	10	110898730-110919201	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"		"Bardet-Biedl syndrome, Ciliopathy, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 102.8"	"Group enriched"	"Detected in all"	4	"Early spermatids: 597.4;Late spermatids: 501.6;Spermatocytes: 399.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA055206	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA055206: AB_2682737"	"unprognostic (6.05e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.25e-3)"	"unprognostic (3.08e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.00e-2)"	"unprognostic (6.79e-3)"	"unprognostic (3.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.85e-2)"	17.6	24.9	25.8	16.0	29.9	10.1	15.5	29.8	41.2	18.7	23.7	16.6	10.3	16.6	25.3	10.5	20.0	12.3	20.4	25.3	26.9	29.8	23.5	14.1	16.4	28.8	26.9	19.5	13.8	19.0	25.6	13.8	29.0	19.2	10.7	50.1	10.5	16.2	15.5	7.3	12.4	16.0	27.2	16.7	14.3	102.8	26.6	17.8	21.7	10.1	16.6	16.2	12.9	37.2	22.1	28.9	33.0	34.0	41.4	51.0	9.8	27.2	56.4	30.9	42.7	14.4	26.9	13.3	19.2	44.9	31.4	21.5	23.9	30.1	47.5	26.9	28.6	22.0	28.3	18.9	54.4	18.9	37.0	31.8	27.1	42.4	75.7	68.9	50.3	23.7	16.5	49.8	37.0	13.9	23.8	27.0	14.0	15.3	18.1	10.5	59.7	18.8	48.6	13.9	24.9	39.6	20.7	9.1	45.4	21.1	10.4	16.9	36.5	22.3	27.2	27.3	38.2	27.9	26.0	19.9	63.4	33.5	17.6	25.5	11.2	47.6	9.7	15.0	11.5	8.2	14.5	12.0	9.5	7.2	17.6	14.9	53.6	7.8	13.0	8.4	18.8	7.4	25.8	29.9	29.8	41.2	25.3	26.9	28.8	26.9	29.0	27.2	26.6	37.2	32.3	25.6	10.0	25.8	24.2	11.2	36.2	41.4	17.1	32.3	13.9	16.3	18.5	22.8	24.3	22.0	31.3	19.3	21.4	9.5	105.7	35.8	597.4	60.4	27.1	26.4	16.9	18.3	58.8	34.5	25.6	27.7	14.3	24.4	16.5	21.0	25.4	22.1	20.0	45.4	52.6	18.4	50.8	22.4	15.8	501.6	46.6	22.4	23.2	14.0	27.1	52.4	26.8	27.6	67.5	36.0	12.0	33.8	32.2	21.6	13.5	69.4	75.7	63.8	52.6	46.0	32.7	399.5	36.5	12.5	11.9	12.3	27.2	21.0	10.0	29.7
BICRAL	"GLTSCR1L, KIAA0240"	ENSG00000112624	"BRD4 interacting chromatin remodeling complex associated protein like"	Q6AI39	6	42746958-42868560	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 10.3;Alveolar cells type 1: 9.6;Alveolar cells type 2: 9.4;Breast glandular cells: 10.2;Breast myoepithelial cells: 9.1;dendritic cells: 11.6;Endometrial stromal cells: 9.6;Glandular and luminal cells: 9.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029390, HPA029391"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA029390: AB_10599730, HPA029391: AB_10599949"	"unprognostic (2.30e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.46e-2)"	"unprognostic (9.25e-2)"	"prognostic favorable (5.47e-4)"	"unprognostic (2.74e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.54e-3)"	"unprognostic (4.71e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.54e-2)"	8.5	5.7	4.5	8.3	4.4	7.7	9.5	15.9	6.9	9.4	1.1	7.6	6.1	11.3	7.7	6.5	10.2	7.2	7.0	4.2	5.0	6.1	5.7	7.8	12.2	4.8	4.0	16.2	7.0	10.4	5.8	5.2	5.1	9.2	9.5	14.3	8.3	8.1	8.0	8.7	6.7	9.6	2.9	9.8	7.5	5.0	4.0	11.6	11.3	9.4	12.2	7.7	7.3	7.4	6.2	4.9	4.3	6.9	8.7	10.0	3.7	5.4	5.6	4.7	3.6	2.2	4.4	14.4	4.8	9.1	7.2	4.8	4.2	5.6	7.7	10.8	2.7	10.1	4.9	6.3	4.6	8.6	8.8	6.2	10.6	4.6	8.4	8.9	4.9	8.4	9.8	12.5	5.6	7.4	1.4	4.9	4.8	24.3	3.0	8.9	2.5	14.3	4.8	4.0	14.6	7.8	6.1	8.7	6.1	4.1	7.6	10.0	5.7	6.5	6.4	4.3	5.4	11.3	7.0	21.6	3.9	10.8	4.7	2.3	0.5	2.8	2.2	0.4	1.9	1.2	1.3	2.1	0.4	1.3	1.2	1.6	3.7	1.6	0.8	0.7	1.6	0.6	4.5	4.4	15.9	6.9	4.2	5.0	4.8	4.0	5.1	2.9	4.0	7.4	10.3	9.6	9.4	0.0	4.2	0.0	0.0	0.0	0.0	0.0	10.2	9.1	0.0	0.0	4.3	3.7	0.0	2.3	11.6	0.0	0.0	3.8	0.0	6.2	9.6	3.1	0.0	0.0	0.0	3.8	2.1	3.9	0.0	9.8	1.3	8.4	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	3.6	0.0	0.0	3.5	0.0	0.0	4.3	2.9	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	1.4	5.0	5.2	0.0	0.0
BIN3		ENSG00000147439	"Bridging integrator 3"	Q9NQY0	8	22620418-22669148	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Septation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 94.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023769	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 5: Muller glia cells - Visual perception"			"HPA023769: AB_1845361"	"unprognostic (4.93e-3)"	"unprognostic (4.42e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.76e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.20e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.66e-1)"	18.6	28.4	13.4	8.5	14.1	40.3	17.6	13.2	16.3	12.4	14.4	11.4	6.8	9.6	9.4	15.8	15.1	9.5	11.5	14.0	13.6	21.0	14.0	11.6	10.4	14.1	13.2	10.4	9.7	12.5	12.6	8.4	13.8	15.5	9.9	7.7	11.6	9.4	9.2	13.9	11.1	8.0	12.8	13.3	12.6	10.4	13.5	13.3	13.2	4.4	10.9	13.5	12.9	13.7	20.6	17.5	7.7	16.6	19.9	18.4	8.6	18.2	31.0	28.4	23.2	7.2	7.9	16.6	8.0	20.0	19.9	22.7	14.9	19.0	19.4	12.6	10.1	13.8	9.0	13.6	16.7	14.3	14.8	19.0	22.2	20.9	11.1	18.0	18.4	9.7	27.5	10.2	14.8	10.0	22.8	31.7	14.6	26.9	7.6	11.4	8.2	8.1	28.4	16.2	4.0	8.8	8.7	6.4	94.2	10.3	6.2	12.7	17.7	8.8	10.8	18.1	13.7	6.8	6.1	15.1	25.1	10.3	58.5	56.3	34.2	78.3	29.0	33.9	30.0	25.8	29.5	21.9	27.5	29.1	28.9	23.5	94.9	36.4	26.1	24.9	41.0	36.9	13.4	14.1	13.2	16.3	14.0	13.6	14.1	13.2	13.8	12.8	13.5	13.7	31.7	9.6	13.0	9.1	16.5	9.8	30.9	32.9	5.2	14.0	11.5	10.0	1.1	18.6	17.2	14.7	41.7	42.8	14.7	24.0	15.6	25.1	28.5	26.7	15.3	21.0	19.8	14.3	13.3	27.6	22.5	14.0	21.4	28.4	31.7	13.6	17.2	6.1	20.2	25.2	9.8	22.1	34.6	9.6	8.7	4.9	18.3	13.0	19.6	8.4	18.6	69.3	32.0	4.0	7.2	41.7	26.1	12.0	8.5	23.4	16.7	13.9	34.1	33.8	13.1	25.4	14.6	18.0	14.0	5.4	11.5	79.4	15.0	24.4	18.2	41.2
BLOC1S2	"BLOS2, BORCS2, FLJ30135, MGC10120"	ENSG00000196072	"Biogenesis of lysosomal organelles complex 1 subunit 2"	Q6QNY1	10	100273280-100286680	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048088, HPA055010"	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA048088: AB_2680259, HPA055010: AB_2682670"	"unprognostic (3.64e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.75e-2)"	"unprognostic (4.37e-2)"	"unprognostic (8.64e-3)"	"unprognostic (3.10e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.53e-1)"	26.3	34.7	33.0	25.9	34.3	73.4	24.4	32.7	42.9	25.3	27.5	18.1	15.5	14.6	22.7	57.9	15.9	14.5	25.1	34.1	38.5	35.3	40.9	30.7	38.2	35.3	35.8	18.1	25.9	25.4	36.1	16.0	37.3	23.5	18.4	18.9	27.9	9.8	74.5	42.1	23.4	11.5	35.4	44.1	22.3	21.0	34.6	23.0	22.9	22.9	34.5	19.9	33.4	38.5	36.5	36.5	49.2	56.1	52.3	47.8	44.5	62.0	60.5	31.4	39.6	24.9	30.6	34.4	34.1	38.0	25.2	37.2	25.0	78.9	31.7	53.9	36.9	20.4	33.3	62.5	45.9	59.9	62.3	37.2	86.7	30.6	98.9	51.7	55.0	42.7	28.2	56.7	68.3	44.2	50.5	36.6	26.6	38.4	29.2	13.6	45.1	30.0	47.9	49.2	23.5	31.4	27.9	15.6	68.2	47.7	57.3	33.4	43.7	19.0	37.1	33.3	57.9	56.0	69.1	67.0	56.6	61.4	19.7	63.1	51.6	81.1	26.5	70.6	39.3	74.7	33.3	30.2	59.7	94.0	28.9	32.5	106.8	35.0	70.7	38.4	47.3	44.6	33.0	34.3	32.7	42.9	34.1	38.5	35.3	35.8	37.3	35.4	34.6	38.5	33.4	25.6	31.4	10.1	103.6	66.4	45.0	171.3	57.5	27.3	40.3	39.0	22.6	18.6	50.9	35.0	12.5	85.1	68.1	19.5	92.0	61.8	33.3	20.8	26.5	36.7	28.8	42.5	16.8	70.9	71.6	38.9	27.5	25.4	86.3	21.5	30.4	30.3	133.3	21.9	14.8	19.7	85.5	108.0	71.9	36.2	22.7	82.3	40.9	14.0	127.1	29.1	74.2	14.1	17.4	94.4	23.1	17.7	32.3	38.9	26.3	72.5	38.0	24.0	6.6	51.1	29.4	84.4	54.7	102.4	77.3	45.7	68.3	27.3	26.1	31.4
BMT2	"C7orf60, DKFZp762M126, FLJ31818, SAMTOR"	ENSG00000164603	"Base methyltransferase of 25S rRNA 2 homolog"	Q1RMZ1	7	112819147-112939875	"Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 12.9;Extravillous trophoblasts: 25.9;Hofbauer cells: 9.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044405, HPA050733"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA044405: AB_10959783, HPA050733: AB_2681223"	"unprognostic (5.26e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.61e-5)"	"unprognostic (1.50e-3)"	"unprognostic (1.61e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.94e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.22e-2)"	"unprognostic (9.10e-2)"	3.9	4.0	7.2	4.8	7.4	4.9	5.8	8.9	10.7	5.9	5.7	4.9	2.6	7.3	4.2	7.3	4.4	5.0	12.7	7.3	8.4	5.4	2.3	4.3	5.8	5.3	6.6	5.8	3.1	4.8	2.9	5.1	5.6	5.6	4.3	9.3	5.0	6.4	3.2	3.8	3.3	7.2	6.1	6.0	3.1	8.0	8.7	8.2	5.2	4.2	5.7	6.3	4.3	5.8	5.9	4.9	12.3	11.1	16.3	18.6	3.7	6.1	27.5	10.8	15.6	3.0	4.6	2.0	7.7	11.2	11.9	2.8	6.6	9.1	17.6	6.2	6.7	10.3	3.1	3.7	7.3	4.0	9.6	14.2	7.1	8.5	7.4	13.5	8.8	3.7	3.3	3.8	13.2	4.5	9.5	11.5	2.7	4.2	5.1	4.7	16.1	6.2	8.3	7.8	4.9	12.5	11.5	4.7	6.8	11.8	2.3	3.6	6.2	13.8	3.3	8.9	4.8	4.9	4.9	3.7	14.9	5.9	8.2	6.7	3.8	6.5	3.2	3.9	3.9	2.5	3.1	3.7	3.9	2.4	4.2	3.7	8.7	3.7	4.4	2.3	5.2	1.6	7.2	7.4	8.9	10.7	7.3	8.4	5.3	6.6	5.6	6.1	8.7	5.8	6.8	6.4	5.6	0.0	2.0	0.0	0.0	0.0	0.0	0.0	7.9	7.6	0.0	0.0	1.8	12.9	0.0	6.9	4.8	0.0	0.0	3.4	0.0	4.6	8.5	2.6	0.0	0.0	0.0	2.5	25.9	2.7	0.0	5.4	0.0	8.9	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	1.6	0.0	0.0	6.6	3.6	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	8.2	2.6	5.8	0.0	0.0
BRAP	"BRAP2, IMP, RNF52"	ENSG00000089234	"BRCA1 associated protein"	Q7Z569	12	111642146-111685956	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 67.2"	"Group enriched"	"Detected in all"	7	"Early spermatids: 319.6;Late spermatids: 380.1;Spermatocytes: 147.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040357, HPA058820"	Approved		Supported	"Nuclear membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Nuclear membrane"	"HPA040357: AB_10967924, HPA058820: AB_2683827"	"unprognostic (7.02e-2)"	"unprognostic (2.37e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (7.65e-6)"	"unprognostic (2.14e-1)"	"unprognostic (9.24e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.57e-2)"	"unprognostic (8.08e-2)"	9.6	8.8	7.8	7.9	9.2	33.6	9.2	9.8	9.8	8.0	7.3	9.6	9.2	8.8	6.9	9.5	8.5	7.5	9.7	8.1	8.8	8.5	10.0	8.0	10.5	8.8	9.2	9.8	8.2	10.5	6.2	10.6	8.8	8.3	9.2	9.1	8.4	8.3	19.8	12.8	8.8	9.4	8.5	9.0	7.7	67.2	8.4	12.8	9.9	14.0	10.8	9.2	8.1	10.6	14.6	21.1	16.9	19.5	17.7	14.8	28.2	20.0	16.7	22.8	17.5	28.6	10.0	28.0	11.7	19.1	12.9	17.6	23.8	16.4	24.2	18.0	15.4	34.8	12.9	19.4	22.2	30.7	22.5	16.9	22.8	19.7	31.8	19.6	20.0	19.0	36.7	8.9	19.0	18.6	25.7	29.6	22.8	15.4	22.1	23.6	18.4	25.1	15.0	30.3	20.9	15.5	23.5	19.8	19.5	19.3	21.7	19.3	18.8	14.6	13.5	13.3	14.4	22.6	30.9	30.4	13.8	16.8	16.3	22.7	16.8	32.3	17.5	17.5	17.3	16.1	18.5	17.9	15.1	16.5	17.1	17.6	32.7	23.1	14.6	10.9	24.7	16.1	7.8	9.2	9.8	9.8	8.1	8.8	8.8	9.2	8.8	8.5	8.4	10.6	11.6	22.4	11.2	14.7	14.9	11.2	8.9	9.7	12.0	8.9	8.8	7.5	12.7	17.2	10.8	11.0	29.2	13.7	13.7	15.4	5.9	13.5	319.6	11.9	11.6	11.4	9.6	22.9	24.7	7.7	14.9	12.3	15.3	12.4	8.2	13.3	10.4	9.1	10.9	3.3	23.3	12.9	14.2	9.8	11.5	380.1	13.4	11.7	3.6	10.3	19.7	8.6	17.5	13.0	23.3	14.5	12.7	13.5	15.0	13.4	13.5	14.6	13.8	11.8	6.6	11.6	15.1	147.8	38.6	15.4	12.6	22.4	13.5	10.2	11.0	14.5
C11orf54	PTD012	ENSG00000182919	"Chromosome 11 open reading frame 54"	Q9H0W9	11	93741591-93764749	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"kidney: 569.9;liver: 258.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 370.4;Proximal tubular cells: 1136.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040088, HPA040511"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA		1300000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear bodies"	Nucleoplasm	"HPA040088: AB_10795518, HPA040511: AB_10795369"	"unprognostic (3.32e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.58e-1)"	"prognostic favorable (5.06e-6)"	"unprognostic (2.19e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.41e-2)"	"unprognostic (6.53e-3)"	20.1	24.6	10.2	19.1	16.4	7.4	31.4	15.2	14.8	20.7	18.0	40.8	53.0	21.7	19.6	17.6	32.3	47.2	21.5	9.5	14.8	569.9	258.8	30.3	21.5	18.3	12.9	30.1	51.6	20.9	16.7	25.3	16.5	39.6	43.8	20.7	28.9	25.0	41.8	21.2	51.5	20.8	13.0	17.3	37.9	19.8	12.9	28.1	35.9	54.7	23.4	17.0	12.9	25.2	9.4	13.5	30.9	18.3	23.5	26.8	36.1	13.8	23.6	13.8	19.0	5.6	52.9	39.4	85.5	25.6	14.4	22.2	37.5	10.0	19.4	39.9	11.4	21.7	34.9	26.5	27.7	20.7	11.0	24.7	17.0	24.7	16.6	34.8	21.6	26.2	29.6	26.6	12.8	8.0	33.0	23.7	10.5	64.9	22.1	31.4	40.8	62.2	74.6	19.6	15.2	20.2	23.0	28.2	27.7	22.7	65.9	13.4	13.5	13.0	10.0	22.5	6.6	12.0	38.2	37.8	9.8	29.2	23.3	75.0	30.0	74.0	21.7	21.5	22.3	27.1	22.1	24.7	23.0	23.0	27.0	23.7	100.9	24.8	19.0	31.9	31.5	18.8	10.2	16.4	15.2	14.8	9.5	14.8	18.3	12.9	16.5	13.0	12.9	25.2	25.1	64.1	54.7	28.1	27.4	5.5	10.6	18.4	21.1	18.0	21.6	14.6	34.7	190.1	33.5	47.8	16.7	51.4	21.6	53.6	178.1	17.4	14.4	34.2	20.5	18.3	22.2	23.1	23.7	13.9	14.8	23.9	32.6	43.6	15.2	40.2	29.6	370.4	17.5	15.2	27.8	37.1	28.5	29.2	7.2	6.4	25.7	22.2	8.8	15.9	18.2	17.0	10.3	25.6	37.8	13.1	38.4	23.0	25.7	29.0	75.0	1136.3	36.2	19.7	6.6	28.9	17.0	38.6	17.4	17.6	9.9	62.0	21.1	16.3	35.6	22.9
C18orf32	FLJ23458	ENSG00000177576	"Chromosome 18 open reading frame 32"	Q8TCD1	18	49477243-49487252	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 238.5;Late spermatids: 233.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA040921	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 34: Spermatids - Unknown function"	Vesicles	Nucleoplasm	"HPA040921: AB_10795423"	"unprognostic (5.83e-2)"	"unprognostic (5.48e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.13e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.80e-2)"	"unprognostic (6.36e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.58e-3)"	"unprognostic (2.76e-2)"	"prognostic favorable (8.89e-9)"	"unprognostic (1.02e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.36e-2)"	41.5	66.7	10.8	5.6	13.8	6.8	39.8	15.3	20.0	34.9	8.3	46.0	6.1	35.6	5.6	32.3	34.5	6.6	59.3	11.3	13.5	79.6	86.8	46.5	7.9	14.8	13.0	38.8	47.0	18.5	67.9	6.9	14.0	39.4	10.2	24.6	43.7	8.4	37.9	27.8	39.9	7.3	13.4	39.2	58.1	40.9	13.1	8.5	43.9	7.2	10.4	38.8	32.6	18.7	4.3	3.2	14.4	13.3	12.3	8.8	8.6	5.5	7.6	6.0	6.8	0.5	3.7	4.9	8.6	7.9	9.0	11.1	5.1	10.6	12.6	11.3	4.1	4.2	2.3	5.4	11.2	5.1	11.2	9.9	21.0	5.0	6.1	16.0	12.2	10.1	4.1	11.4	9.9	1.9	4.6	2.5	4.7	4.9	5.9	4.0	3.6	3.8	7.1	5.0	10.7	12.3	5.1	3.4	4.4	19.8	3.1	2.3	13.1	9.6	5.0	1.7	6.9	13.4	24.1	9.1	5.2	5.9	7.1	27.4	8.4	25.8	8.4	8.8	8.7	8.9	6.9	7.7	6.6	7.4	6.6	8.4	41.4	6.2	11.3	9.5	8.2	10.3	10.8	13.8	15.3	20.0	11.3	13.5	14.8	13.0	14.0	13.4	13.1	18.7	20.2	44.8	29.2	0.0	50.8	5.5	4.6	21.2	39.3	35.0	26.2	15.0	5.5	31.5	22.4	23.9	43.8	22.9	33.8	92.9	39.2	87.5	238.5	38.1	21.0	17.5	95.5	20.2	0.0	82.7	17.7	28.7	63.2	30.3	45.6	5.3	23.6	40.4	22.1	18.5	0.0	57.3	32.6	38.0	12.0	233.1	17.1	48.1	23.2	0.0	73.9	41.4	34.0	0.0	0.0	92.3	77.5	10.1	83.0	5.6	92.7	57.2	42.4	36.3	19.7	10.3	22.7	12.7	13.9	58.4	7.7	38.7	43.4	4.5	40.8	5.2
C1orf52	"FLJ44982, gm117"	ENSG00000162642	"Chromosome 1 open reading frame 52"	Q8N6N3	1	85249953-85259672	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036072, HPA061790"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm		"HPA036072: AB_10602696, HPA061790: AB_2684610"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (5.37e-5)"	"unprognostic (6.67e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (4.93e-4)"	"prognostic unfavorable (1.17e-7)"	"unprognostic (8.01e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.14e-1)"	"unprognostic (2.05e-2)"	15.1	11.0	11.7	10.3	15.0	23.0	13.4	9.4	16.7	13.8	5.5	14.2	6.3	11.7	7.5	13.1	12.5	6.7	14.8	17.7	10.6	12.2	15.2	14.0	15.2	10.7	11.8	13.0	13.0	5.3	13.3	12.2	11.0	12.5	6.5	10.7	9.2	7.3	16.3	12.2	11.4	5.2	8.8	14.8	12.0	15.9	11.5	9.7	11.5	9.9	8.5	12.9	13.1	16.2	25.6	12.1	17.3	15.6	18.6	14.4	21.4	20.4	10.6	26.2	23.2	17.2	13.1	20.0	17.2	22.5	14.7	16.1	42.4	12.3	13.0	26.1	25.4	32.2	19.5	15.5	11.3	28.0	14.2	9.4	17.8	24.1	11.9	13.0	9.7	35.2	35.9	23.6	13.0	7.3	27.3	13.8	63.7	12.0	9.8	28.3	18.5	10.8	14.2	7.0	7.3	16.4	5.0	16.3	20.7	17.4	8.8	57.7	16.6	10.6	19.5	27.2	32.8	22.6	46.2	28.3	8.9	21.7	12.9	17.6	18.4	30.0	19.5	28.6	21.1	35.5	18.1	17.2	24.7	19.6	27.5	26.4	30.1	19.7	24.0	26.8	17.3	22.3	11.7	15.0	9.4	16.7	17.7	10.6	10.7	11.8	11.0	8.8	11.5	16.2	46.7	44.8	34.3	31.3	48.4	145.4	55.0	60.0	56.9	23.5	51.9	50.3	24.3	21.5	46.0	16.5	22.9	61.3	56.3	23.4	19.6	33.3	69.0	36.3	36.1	40.7	38.8	29.0	37.4	27.5	61.1	46.9	23.4	40.9	51.3	25.4	29.6	16.6	37.1	15.2	21.7	25.1	77.3	28.9	81.6	16.8	36.7	32.5	32.0	21.5	25.4	30.8	38.1	23.1	58.6	37.9	24.6	24.5	42.7	53.0	25.9	19.7	34.0	27.1	39.5	27.7	45.6	92.5	67.3	63.9	128.9	67.9	53.4	27.5	24.7	71.5
CALCOCO1	"calphoglin, Cocoa, KIAA1536"	ENSG00000012822	"Calcium binding and coiled-coil domain 1"	Q9P1Z2	12	53708517-53727745	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 109.6;hTERT-RPE1: 146.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038313, HPA038314"	Approved		Enhanced	Vesicles,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	Vesicles	"HPA038313: AB_10675794, HPA038314: AB_10672587"	"unprognostic (2.28e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.11e-2)"	"unprognostic (8.42e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.66e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.85e-3)"	"unprognostic (8.01e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.63e-3)"	"unprognostic (9.88e-3)"	125.7	71.3	81.0	25.0	92.7	35.0	115.3	93.5	100.3	102.4	95.0	163.1	31.0	105.3	69.1	71.2	101.7	55.6	142.9	82.0	81.9	73.8	57.0	98.3	33.8	85.2	81.4	110.9	108.3	65.6	80.2	50.3	87.1	90.6	35.4	47.6	119.8	55.5	264.2	180.8	88.3	53.2	78.1	91.0	126.5	49.5	82.7	36.3	89.2	120.6	37.5	125.0	96.4	88.7	12.1	13.8	20.4	26.8	109.6	71.5	13.1	26.4	56.2	19.4	26.6	6.7	52.7	4.9	23.7	61.3	10.0	15.8	8.2	22.3	20.7	20.1	17.1	9.9	31.5	5.4	53.3	4.2	22.0	99.8	58.2	20.3	19.8	146.7	35.2	22.0	8.1	46.7	34.2	5.2	13.5	15.9	4.2	10.9	15.1	13.6	11.3	17.2	31.9	8.4	11.7	21.0	15.1	8.3	26.7	42.5	24.6	13.0	41.2	10.0	13.0	9.5	3.8	42.5	12.8	1.8	46.1	4.9	12.8	85.2	19.6	76.7	26.1	22.4	18.7	14.5	17.8	20.8	11.6	17.1	15.7	17.6	72.0	20.2	23.7	8.8	33.4	23.8	81.0	92.7	93.5	100.3	82.0	81.9	85.2	81.4	87.1	78.1	82.7	88.7	33.0	35.3	14.4	18.9	19.8	32.4	19.0	16.7	30.1	34.3	32.8	27.6	11.7	25.8	16.8	22.0	35.5	23.8	26.0	13.6	5.9	16.7	40.7	27.1	19.4	23.4	28.6	32.0	31.1	11.7	8.8	29.2	16.8	17.5	7.6	29.1	31.8	17.9	15.9	26.9	33.3	18.7	24.4	26.0	15.3	54.0	47.5	28.6	19.6	11.2	21.9	25.3	64.9	20.6	22.6	22.0	17.5	41.3	53.5	20.1	25.9	14.0	26.5	44.6	19.7	28.6	29.5	24.2	9.3	16.7	50.7	45.6	27.3	27.5	13.0	26.4
CAMLG	"CAML, GET2"	ENSG00000164615	"Calcium modulating ligand"	P49069	5	134738495-134752157	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"ER-Golgi transport, Host-virus interaction, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 845.6;Late spermatids: 1655.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052636, HPA056472"	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles	"Nucleoplasm, Nucleoli"	"HPA052636: AB_2681893, HPA056472: AB_2683143"	"unprognostic (9.23e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.68e-2)"	"unprognostic (5.41e-3)"	"unprognostic (3.07e-1)"	"unprognostic (8.54e-2)"	"unprognostic (5.34e-3)"	"unprognostic (4.58e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.16e-1)"	52.3	37.2	50.6	17.5	52.1	31.7	42.1	50.7	69.4	57.0	48.2	54.8	34.4	45.8	48.2	29.5	45.3	27.4	26.9	52.3	55.9	29.7	29.3	28.6	26.2	51.9	53.8	68.6	30.7	27.0	43.1	17.9	54.3	34.9	15.9	29.1	29.0	31.8	60.4	36.7	30.4	28.5	52.8	26.1	36.5	51.3	52.1	25.8	27.0	35.6	25.3	44.2	41.1	53.3	27.5	22.2	33.0	64.1	76.3	118.3	14.4	39.0	55.8	26.8	52.8	38.9	40.1	113.9	56.2	27.5	42.7	34.2	29.2	46.9	35.0	54.3	54.5	29.9	33.2	32.8	56.3	13.7	89.2	96.9	49.5	35.1	57.9	92.3	54.8	49.0	18.6	47.1	39.9	31.2	43.1	58.2	17.1	34.7	21.5	46.2	40.7	44.3	46.0	26.4	52.2	36.9	27.1	15.3	97.1	40.8	48.4	33.9	53.2	24.5	16.4	40.2	35.2	45.8	55.1	42.5	46.2	48.5	14.8	62.0	26.4	60.7	30.5	31.8	41.1	43.5	43.5	38.4	29.1	39.5	45.0	44.2	47.9	31.4	44.6	26.1	52.6	31.6	50.6	52.1	50.7	69.4	52.3	55.9	51.9	53.8	54.3	52.8	52.1	53.3	86.8	38.5	36.4	13.7	92.9	167.1	107.0	113.6	157.1	80.5	121.9	124.7	45.1	100.1	68.9	42.3	25.0	50.3	93.3	42.8	92.0	63.9	845.6	57.6	116.4	99.5	62.4	76.6	29.4	90.9	62.5	107.4	32.6	61.7	123.4	66.6	102.4	69.1	69.9	55.5	32.0	69.4	107.8	111.5	130.8	1655.8	168.0	76.6	96.0	10.3	126.9	127.7	90.6	15.1	18.6	67.5	58.0	132.4	55.2	148.6	158.2	199.1	51.3	71.4	98.6	119.5	109.7	241.5	68.6	119.3	201.6	73.2	101.6	67.9	90.9	107.9
CASP8	"Casp-8, FLICE, MACH, MCH5"	ENSG00000064012	"Caspase 8"	Q14790	2	201233443-201287711	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 66.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 107.4;NK-cells: 132.8;Plasma cells: 73.4;T-cells: 86.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001302, CAB002047, HPA005688, HPA006191"	Approved		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"CAB002047: AB_563465, HPA001302: AB_1846057, HPA005688: AB_1846056, HPA006191: AB_2667535"	"unprognostic (5.21e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.60e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (2.10e-1)"	"unprognostic (4.79e-2)"	"prognostic favorable (1.25e-4)"	"unprognostic (7.75e-2)"	"unprognostic (5.11e-2)"	"prognostic unfavorable (1.27e-6)"	"unprognostic (7.67e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.53e-3)"	11.5	10.2	1.7	28.6	2.0	66.6	13.9	1.3	2.1	9.6	4.2	16.1	20.5	8.5	13.2	12.9	14.1	13.2	5.2	2.1	1.8	10.7	14.1	19.6	37.7	3.4	3.0	7.7	7.8	2.9	3.4	9.9	2.7	6.9	17.6	4.6	8.4	7.3	3.3	12.1	26.0	9.9	2.4	37.1	15.9	4.3	2.6	24.4	7.9	3.0	29.7	18.0	8.6	2.4	33.6	26.6	7.7	22.2	20.7	29.7	12.0	13.8	13.2	16.0	26.2	36.1	54.9	3.7	29.6	10.7	28.7	16.2	17.2	16.1	31.3	21.1	15.4	31.0	21.9	35.1	17.1	25.6	33.8	25.9	38.0	30.1	23.9	13.4	15.1	26.9	28.6	69.1	14.7	13.1	32.1	25.9	12.6	17.5	23.7	24.7	15.9	55.4	30.8	35.3	2.3	1.1	17.9	29.8	18.0	7.0	8.0	19.1	19.6	17.3	18.0	9.0	10.9	63.1	30.2	21.2	25.3	33.1	16.6	76.1	39.5	77.1	70.7	51.2	66.0	40.9	57.8	75.9	41.6	24.0	37.0	47.2	153.6	70.6	51.5	18.6	75.0	40.6	1.7	2.0	1.3	2.1	2.1	1.8	3.4	3.0	2.7	2.4	2.6	2.4	8.5	25.6	26.7	0.7	50.0	7.5	13.0	6.1	10.2	2.1	12.9	9.3	2.5	10.0	13.0	5.5	10.4	8.5	107.4	37.0	15.6	12.3	5.9	25.6	8.1	10.1	4.2	10.5	2.5	8.4	12.1	9.5	19.4	27.2	24.6	10.4	5.3	11.7	11.9	0.0	1.3	15.2	4.1	25.3	15.7	1.9	2.5	25.0	7.2	10.3	35.6	0.2	132.8	1.0	0.5	11.2	30.1	0.7	73.4	9.7	22.3	23.6	14.2	0.4	0.0	4.5	3.7	0.8	0.4	13.1	7.7	3.4	86.9	10.6	17.4	12.7
CCDC71L	"C7orf74, FLJ36031"	ENSG00000253276	"Coiled-coil domain containing 71 like"	Q8N9Z2	7	106654360-106661158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 78.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067925	Approved		Approved	"Golgi apparatus,Actin filaments,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Actin filaments"	Cytosol	"HPA067925: AB_2685925"	"unprognostic (1.51e-1)"	"prognostic unfavorable (9.08e-4)"	"unprognostic (7.26e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.95e-3)"	"unprognostic (9.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.38e-3)"	"unprognostic (6.03e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (2.53e-6)"	"unprognostic (3.34e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.35e-2)"	51.5	9.8	2.7	19.6	2.7	15.8	18.7	2.0	2.9	13.1	3.3	14.6	6.5	16.9	2.8	6.8	36.2	10.8	8.2	2.9	3.2	18.1	46.7	22.1	9.6	8.2	2.8	10.1	9.3	5.2	6.4	3.7	3.7	11.2	5.4	1.0	12.6	6.6	5.3	6.2	15.8	7.2	3.3	18.7	16.3	6.9	4.6	14.5	10.2	2.5	8.0	40.0	9.3	3.6	24.8	5.1	7.4	8.9	16.3	15.4	0.0	37.0	47.5	14.2	15.4	0.7	15.3	16.5	12.6	63.3	27.1	2.8	3.6	10.7	11.7	38.7	8.5	2.1	0.9	0.0	25.5	8.4	19.4	13.2	6.4	6.5	3.7	24.1	50.0	9.2	56.0	39.9	17.1	7.1	11.5	13.3	16.0	2.0	17.0	15.4	2.1	3.3	7.3	1.4	3.2	22.1	23.9	8.6	55.9	15.4	3.9	10.1	22.0	31.4	2.9	3.7	14.6	38.4	3.8	13.5	24.3	10.8	35.3	4.9	0.6	1.8	1.1	0.4	0.8	1.3	0.8	0.8	0.4	0.9	0.4	0.6	4.1	0.6	0.7	1.4	1.7	0.5	2.7	2.7	2.0	2.9	2.9	3.2	8.2	2.8	3.7	3.3	4.6	3.6	44.0	3.2	11.6	1.0	9.4	8.2	50.5	2.1	6.8	4.3	39.9	33.0	6.2	18.6	1.6	5.5	2.1	3.0	26.2	12.9	11.7	7.4	1.2	18.7	78.7	21.4	6.6	11.6	1.8	10.7	7.4	47.8	3.6	20.2	12.0	3.3	45.7	34.4	8.1	6.7	2.8	7.3	4.1	10.0	13.9	2.1	21.8	22.5	12.4	1.9	6.5	5.0	10.3	2.5	1.8	13.9	10.1	17.7	4.3	11.0	10.1	4.7	6.8	4.8	0.0	24.5	30.1	7.1	4.9	4.0	5.1	3.3	13.7	3.4	9.5	18.3
CDC123	"C10orf7, D123"	ENSG00000151465	"Cell division cycle 123"	O75794	10	12195965-12250589	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037830, HPA057540"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA037830: AB_10671368, HPA057540: AB_2732614"	"unprognostic (5.35e-3)"	"unprognostic (9.06e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (3.16e-7)"	"unprognostic (2.63e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.74e-2)"	"unprognostic (8.54e-2)"	"prognostic unfavorable (2.42e-6)"	"unprognostic (5.35e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.19e-2)"	44.9	40.0	38.1	53.8	44.3	73.5	45.9	40.6	46.1	43.5	39.1	54.1	37.1	39.0	46.9	50.1	42.3	34.0	61.0	41.7	41.5	42.6	55.6	35.8	69.1	40.3	38.4	31.4	29.4	42.3	33.0	50.8	40.5	35.4	58.3	29.7	31.5	39.3	49.7	44.3	39.1	53.4	41.3	45.3	35.4	35.7	40.1	65.2	41.5	52.5	81.1	63.6	34.7	43.7	155.4	187.4	148.3	157.1	125.4	136.3	117.7	137.0	94.2	194.8	205.5	274.0	186.5	259.7	123.5	153.6	116.1	157.7	237.0	223.3	172.0	176.8	206.6	199.3	142.8	266.6	162.1	151.6	159.0	131.3	118.9	214.0	126.5	98.0	206.3	320.6	224.2	114.5	178.6	135.0	208.3	133.8	221.4	223.1	76.3	195.7	111.9	234.0	173.2	86.3	72.3	140.8	139.6	165.4	152.6	120.4	180.7	179.2	200.9	107.7	127.6	167.9	166.6	112.5	233.5	320.7	135.4	155.3	69.7	133.8	99.2	242.2	103.6	117.0	108.1	158.6	114.8	115.0	139.0	170.5	93.5	99.9	233.4	121.1	129.4	116.0	143.5	167.3	38.1	44.3	40.6	46.1	41.7	41.5	40.3	38.4	40.5	41.3	40.1	43.7	48.6	32.1	35.9	18.3	51.5	54.2	49.2	162.1	39.9	28.5	28.0	32.3	56.4	24.3	75.8	35.0	6.2	120.8	55.3	25.1	86.1	91.1	7.9	26.8	39.5	49.7	20.9	36.8	33.2	82.6	138.2	46.3	26.5	26.1	49.4	36.6	34.2	37.6	101.3	26.9	27.9	31.9	105.8	25.9	34.0	10.1	41.7	37.2	46.2	21.5	79.3	43.3	45.3	19.6	23.5	84.3	34.3	45.9	44.2	46.5	30.7	73.0	62.5	29.9	39.5	32.3	59.8	50.2	41.5	46.5	74.0	77.6	51.3	72.4	47.0	50.7
CEACAM21	"FLJ13540, R29124_1"	ENSG00000007129	"CEA cell adhesion molecule 21"	Q3KPI0	19	41549518-41586844	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.5;lymphoid tissue: 10.2"	"Cell type enriched"	"Detected in some"	10	"Granulosa cells: 150.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HMC-1: 8.6;Karpas-707: 6.1;THP-1: 3.3;U-266/70: 5.8;U-937: 5.8"									HPA043411	Uncertain					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"			"HPA043411: AB_10794886"	"unprognostic (2.55e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.73e-2)"	"prognostic favorable (1.89e-5)"	"unprognostic (2.57e-1)"	"unprognostic (8.02e-4)"	"unprognostic (3.04e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.51e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.37e-6)"	"unprognostic (2.09e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.37e-1)"	1.3	0.7	1.4	2.2	0.8	17.5	0.8	0.8	1.3	2.2	0.6	0.8	0.6	2.6	0.3	0.4	0.7	0.5	0.5	0.8	2.8	0.7	1.2	3.8	5.3	1.9	2.7	0.4	0.2	0.1	0.4	1.5	2.2	0.6	0.6	0.0	0.5	3.6	0.1	0.2	2.6	0.5	1.8	10.2	0.9	1.1	3.9	2.2	0.6	0.1	3.5	0.8	0.3	1.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	6.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	5.8	1.0	1.0	0.0	5.8	0.0	0.1	6.0	27.3	29.7	11.7	20.1	10.8	25.6	20.8	6.9	15.1	21.3	21.0	30.2	19.2	7.0	12.4	26.6	17.9	1.4	0.8	0.8	1.3	0.8	2.8	1.9	2.7	2.2	1.8	3.9	1.2	1.5	0.0	0.0	0.3	5.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.6	1.8	0.0	0.1	7.2	0.0	0.0	0.0	5.4	7.3	0.1	2.0	0.0	5.7	0.1	0.0	0.1	0.3	0.0	2.2	4.5	150.8	10.0	0.3	9.4	0.0	0.7	0.0	0.0	9.0	0.6	10.3	0.0	6.2	1.8	15.0	1.0	0.0	9.2	0.0	0.1	0.0	0.0	0.4	10.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.6	0.6	0.0	0.0	0.3	8.8	0.0	0.0	0.0
CELF2	"BRUNOL3, CUGBP2, Etr-3, NAPOR-2"	ENSG00000048740	"CUGBP Elav-like family member 2"	O95319	10	10798397-11336675	"Predicted intracellular proteins"	"mRNA processing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 78.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 558.0;Excitatory neurons: 1676.4;Inhibitory neurons: 576.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 200.2;HMC-1: 186.2;REH: 86.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016395, HPA035813"	Enhanced		Supported	"Nucleoplasm,Vesicles,Midbody ring"		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Vesicles, Midbody ring"	"CAB016395: AB_2086271, HPA035813: AB_2674797"	"unprognostic (1.62e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.55e-2)"	"unprognostic (9.00e-2)"	"prognostic favorable (7.61e-4)"	"unprognostic (1.57e-1)"	"unprognostic (3.77e-2)"	"unprognostic (4.20e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.60e-3)"	"unprognostic (2.83e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.45e-1)"	39.6	5.7	33.7	30.7	42.7	78.9	17.7	0.2	42.0	14.2	0.0	16.5	9.2	15.0	5.0	21.4	13.3	17.2	37.5	42.5	7.2	3.0	4.3	28.2	42.4	0.9	13.9	46.8	4.4	3.5	6.5	8.6	0.4	14.1	17.9	35.4	9.6	12.2	17.6	8.6	23.4	23.2	8.6	31.1	10.3	7.6	23.7	60.7	8.5	15.0	29.4	16.2	8.0	21.0	0.1	0.0	47.6	0.0	7.4	2.7	5.3	7.0	0.2	1.1	0.2	0.1	0.0	0.1	5.3	6.1	0.0	0.1	6.8	0.2	0.4	40.4	11.9	200.2	0.7	0.0	1.7	58.0	186.2	3.0	0.3	0.4	0.0	0.7	6.7	70.6	9.3	80.7	59.6	0.0	71.9	42.0	19.3	0.0	0.0	86.7	50.8	18.0	3.4	0.0	7.1	0.5	0.1	0.2	51.1	15.2	0.0	39.0	0.1	8.9	2.5	29.9	0.1	30.7	30.1	9.3	2.9	68.8	21.6	68.0	43.2	90.8	54.8	57.5	69.2	48.1	54.1	60.5	53.4	51.0	56.1	52.7	115.1	73.5	67.8	37.9	60.9	63.5	33.7	42.7	0.2	42.0	42.5	7.2	0.9	13.9	0.4	8.6	23.7	21.0	20.4	160.3	147.3	558.0	165.6	19.9	3.4	5.8	12.5	68.2	18.8	13.7	122.7	5.7	22.4	12.9	102.2	1.1	233.5	11.8	15.6	1.6	135.9	5.3	11.3	34.7	59.3	45.2	1676.4	2.1	0.9	106.0	11.2	17.0	128.5	0.7	13.2	5.1	90.0	134.6	576.9	37.5	24.4	261.4	134.3	110.3	111.6	192.9	115.6	376.6	263.6	90.5	256.4	324.7	21.6	1.5	16.9	89.5	124.3	10.1	2.4	1.0	5.8	99.2	52.6	117.6	33.7	4.1	11.5	5.7	14.5	1.9	232.5	8.5	23.8	2.4
CERS4	"FLJ12089, LASS4, Trh1"	ENSG00000090661	"Ceramide synthase 4"	Q9HA82	19	8206736-8262421	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 71.3;Muller glia cells: 150.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 55.1;NB-4: 99.8;U-937: 61.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033734, HPA054729"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 5: Muller glia cells - Visual perception"	"Nucleoplasm, Vesicles"		"CAB033734: AB_2132977, HPA054729: "	"unprognostic (5.96e-2)"	"prognostic favorable (2.71e-4)"	"unprognostic (2.46e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (7.83e-4)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.45e-5)"	"unprognostic (1.48e-2)"	"unprognostic (3.32e-1)"	"prognostic favorable (8.05e-4)"	"unprognostic (1.77e-1)"	"prognostic favorable (9.63e-5)"	"unprognostic (6.08e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.91e-2)"	"unprognostic (8.08e-3)"	13.6	13.0	31.8	10.0	38.9	3.4	31.1	26.6	37.1	35.9	18.7	17.7	6.3	21.5	61.5	64.3	21.3	11.2	14.8	35.3	25.2	27.8	57.7	19.4	19.9	36.9	30.5	22.0	89.1	29.0	22.2	1.9	30.8	32.9	3.9	36.9	55.0	17.6	3.1	47.7	15.2	12.0	26.8	17.7	26.8	11.5	30.7	13.1	51.9	5.3	20.4	18.4	32.7	44.0	0.4	2.1	2.1	25.0	0.8	0.2	1.7	3.1	8.4	3.7	1.7	19.5	1.7	40.0	27.4	0.0	9.6	13.6	16.4	0.4	1.7	35.5	12.4	7.6	0.1	55.1	31.6	0.0	21.3	12.3	20.7	8.8	18.9	10.5	0.3	17.7	5.9	1.2	0.0	0.8	2.6	99.8	25.4	0.2	8.7	49.1	0.8	3.0	6.3	0.0	9.3	12.2	4.3	0.7	14.5	16.7	18.8	8.8	0.2	2.9	7.8	18.6	0.1	24.5	21.1	32.0	0.1	61.9	2.8	12.3	7.1	27.4	7.5	3.9	5.7	19.8	4.3	4.6	4.1	17.7	3.9	3.8	22.4	22.4	2.4	3.9	5.5	5.8	31.8	38.9	26.6	37.1	35.3	25.2	36.9	30.5	30.8	26.8	30.7	44.0	3.2	6.4	10.7	27.1	31.2	18.0	13.2	12.0	15.4	24.5	47.0	28.8	4.1	22.8	22.2	1.8	18.8	3.4	17.2	0.2	7.9	20.0	1.7	7.9	11.2	8.6	23.9	4.0	38.3	30.5	0.9	15.7	3.1	7.6	12.7	14.4	8.2	71.3	16.4	11.8	24.4	1.3	8.2	7.1	7.2	7.3	14.3	6.7	26.6	16.9	19.6	150.3	27.8	47.7	48.1	9.4	2.5	16.1	12.4	40.6	0.4	44.6	27.8	29.5	6.6	6.9	13.8	1.0	1.6	20.6	25.9	2.9	15.7	2.7	2.5	11.9
CHMP3	"CGI-149, NEDF, VPS24"	ENSG00000115561	"Charged multivesicular body protein 3"	Q9Y3E7	2	86503430-86563479	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA015673, HPA073383"	Supported					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA015673: AB_1858761, HPA073383: AB_2732224"	"unprognostic (2.49e-3)"	"unprognostic (1.32e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (3.92e-5)"	"unprognostic (2.67e-1)"	"unprognostic (6.16e-2)"	"unprognostic (8.40e-2)"	"prognostic unfavorable (7.39e-4)"	"unprognostic (1.20e-1)"	"prognostic favorable (5.32e-4)"	"unprognostic (1.34e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.64e-1)"	70.0	56.1	39.5	41.0	54.3	30.9	64.2	49.3	45.6	57.9	26.1	72.3	63.1	68.8	56.9	93.0	51.8	54.8	100.2	46.3	39.9	59.9	23.3	64.0	34.0	35.9	36.5	49.0	66.7	70.3	33.1	31.8	37.1	64.3	75.9	30.8	52.9	61.9	97.1	58.6	64.5	73.4	38.7	40.3	60.5	34.2	42.5	31.7	68.0	80.9	39.9	70.2	50.6	38.1	105.3	96.1	54.4	39.6	71.2	136.7	52.5	76.7	103.2	64.4	55.6	86.2	90.2	34.3	71.7	97.7	71.8	82.8	33.3	67.0	70.3	21.0	42.5	45.5	45.5	98.8	62.5	36.4	47.7	82.4	147.7	40.8	64.9	70.4	73.1	34.1	49.1	25.3	104.7	90.7	24.4	32.4	18.8	138.9	73.8	15.3	125.2	27.2	85.7	117.3	65.7	71.4	73.3	68.0	66.1	25.8	58.3	55.7	88.7	114.2	46.8	112.2	86.7	21.0	33.1	22.9	81.5	58.0	61.3	158.5	61.5	171.5	28.0	73.8	33.6	49.5	41.8	33.8	49.9	49.3	48.7	37.9	228.7	35.5	66.5	42.1	46.1	54.4	39.5	54.3	49.3	45.6	46.3	39.9	35.9	36.5	37.1	38.7	42.5	38.1	102.5	147.4	93.5	0.0	49.6	95.3	83.3	94.4	83.6	55.7	115.2	72.6	125.2	147.3	111.4	40.5	41.7	51.1	42.7	222.1	148.7	180.7	206.6	46.7	84.9	96.2	133.5	73.0	0.0	174.8	59.2	67.4	58.6	70.4	147.6	30.0	144.5	59.1	89.5	69.0	0.0	159.2	65.1	126.2	48.4	108.5	71.7	77.2	71.2	0.0	93.6	60.5	78.2	0.0	0.0	186.7	219.4	91.0	25.0	95.9	201.1	173.3	76.1	42.4	65.7	73.6	78.5	100.7	57.3	101.9	94.1	85.0	47.5	57.3	165.4	103.4
CHST11	"C4ST, C4St-1, C4ST1, HSA269537"	ENSG00000171310	"Carbohydrate sulfotransferase 11"	Q9NPF2	12	104455295-104762014	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	Transferase	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 39.0;choroid plexus: 59.1"	"Group enriched"	"Detected in many"	4	"Microglial cells: 281.1;Oligodendrocyte precursor cells: 1012.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 12.7;eosinophil: 11.2;neutrophil: 15.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 15.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052828	Approved		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		55000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Golgi apparatus"		"HPA052828: AB_2681966"	"unprognostic (6.35e-2)"	"unprognostic (2.68e-3)"	"unprognostic (2.28e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.64e-3)"	"unprognostic (9.21e-3)"	"unprognostic (3.12e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.22e-2)"	"unprognostic (5.44e-2)"	"prognostic unfavorable (7.59e-11)"	"unprognostic (1.64e-2)"	"unprognostic (5.60e-2)"	"unprognostic (5.40e-3)"	"prognostic unfavorable (8.42e-4)"	5.0	10.2	14.5	20.1	13.9	39.0	3.5	11.1	14.1	5.6	59.1	4.2	3.0	11.9	13.3	3.4	3.7	9.4	4.5	15.0	16.0	3.6	3.0	12.2	15.2	17.9	16.4	6.2	4.6	1.3	4.5	15.5	17.1	3.9	4.0	2.2	2.2	8.0	1.1	1.7	6.2	10.9	13.1	12.8	6.3	2.3	17.3	19.5	3.3	1.0	11.7	8.3	3.8	17.5	38.8	18.2	8.2	5.3	20.5	10.0	27.8	3.1	1.2	1.8	1.5	0.0	51.2	0.2	5.6	5.4	42.3	9.9	4.9	20.8	2.2	0.4	7.1	53.2	4.8	0.2	3.1	62.4	60.6	3.7	2.9	32.9	5.4	30.7	13.2	74.4	82.8	13.2	3.5	9.7	47.8	73.1	6.6	0.4	7.0	54.0	27.3	12.9	17.0	0.4	13.6	21.9	2.1	26.3	48.3	7.2	7.7	62.7	29.2	5.7	6.2	29.4	32.3	67.2	75.9	10.6	26.3	43.5	57.7	12.7	1.4	11.2	3.0	1.4	1.7	1.0	1.5	2.2	0.8	2.8	0.7	1.9	15.6	1.6	1.3	2.9	3.2	0.8	14.5	13.9	11.1	14.1	15.0	16.0	17.9	16.4	17.1	13.1	17.3	17.5	8.4	16.0	13.1	142.4	33.8	2.8	18.2	2.6	4.0	3.1	0.5	1.1	5.7	1.5	6.4	5.5	0.0	41.6	45.6	0.1	0.0	4.9	0.9	1.3	24.7	12.9	0.0	36.2	43.8	61.4	12.0	9.5	2.6	0.9	41.3	1.4	18.2	0.5	42.6	10.1	114.4	0.0	0.0	26.8	42.9	2.0	7.5	56.5	3.6	281.1	65.6	2.3	30.9	1012.8	3.5	28.6	0.0	17.0	64.0	3.9	0.0	6.0	8.1	0.6	6.6	1.8	12.8	0.6	2.5	0.9	2.8	26.5	49.0	15.5	0.3	3.7
CKLF	"C32, CKLF1, CKLF3, CKLF4, HSPC224, UCK-1"	ENSG00000217555	"Chemokine like factor"	Q9UBR5	16	66552563-66566251	"Predicted membrane proteins, Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 345.1;Spermatocytes: 300.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1384.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA062779			Approved	Vesicles	"Secreted to blood"	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA062779: AB_2684867"	"unprognostic (1.64e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.97e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (2.72e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.79e-2)"	"unprognostic (8.05e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.06e-9)"	"unprognostic (2.36e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (2.22e-4)"	"unprognostic (1.07e-1)"	36.5	31.1	26.3	54.8	26.2	68.2	36.0	27.4	29.8	27.7	25.9	42.1	31.8	23.8	27.4	19.2	31.1	40.3	16.5	25.7	28.8	21.0	29.6	36.2	61.5	28.1	27.6	25.6	17.9	58.0	19.7	29.7	28.9	15.5	42.5	9.7	19.7	18.4	14.8	16.9	38.7	33.5	27.9	67.0	25.6	56.8	26.4	90.0	23.7	20.1	51.2	46.1	20.0	29.6	194.6	169.2	34.7	101.5	92.7	76.1	25.5	95.2	72.4	101.7	150.9	158.8	231.4	75.8	116.6	81.8	106.4	102.5	70.5	57.2	142.1	94.2	35.3	55.5	145.0	197.3	56.0	175.7	144.1	52.0	45.3	126.9	44.9	122.1	122.8	229.4	90.8	212.8	129.2	64.8	169.9	172.1	11.5	114.0	273.1	287.5	184.2	215.6	343.2	106.3	48.8	58.8	290.5	19.3	93.0	23.3	55.5	116.5	76.6	146.5	131.8	51.0	113.5	100.3	224.0	393.0	123.5	151.5	121.1	807.1	380.9	773.3	187.6	203.9	238.9	100.6	174.8	186.6	317.6	97.7	92.7	126.4	1384.5	187.6	199.2	161.6	236.0	401.2	26.3	26.2	27.4	29.8	25.7	28.8	28.1	27.6	28.9	27.9	26.4	29.6	65.7	19.2	49.0	0.0	68.7	27.3	24.7	84.2	12.0	8.4	80.8	94.0	1.8	87.2	50.8	57.0	0.0	54.8	109.7	57.1	17.6	141.4	67.7	34.8	21.5	52.4	33.0	63.5	0.0	130.0	117.7	38.6	21.4	17.5	345.1	17.7	67.5	38.4	247.4	1.7	0.0	73.6	61.1	138.2	238.4	31.4	49.4	244.2	40.9	0.0	157.8	28.1	188.4	0.0	0.0	224.2	51.3	30.1	94.6	10.0	95.9	83.4	79.3	9.0	32.9	24.5	38.1	300.0	77.1	30.8	23.0	17.4	192.6	23.9	79.0	25.8
CKLF-CMTM1		ENSG00000254788	"CKLF-CMTM1 readthrough"		16	66552587-66579135	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"testis: 5.7"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Early spermatids: 3.9;granulocytes: 20.2;Late spermatids: 8.9;Respiratory ciliated cells: 2.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 17.4"									HPA017136	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 60: Granulocytes - Receptor signaling"			"HPA017136: AB_1846992"	"unprognostic (9.28e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.19e-2)"	"unprognostic (9.65e-2)"	"unprognostic (5.90e-3)"	"unprognostic (3.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.69e-2)"	"unprognostic (2.41e-4)"	"unprognostic (2.46e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.44e-1)"	0.8	0.8	1.5	2.9	1.6	0.8	0.7	1.8	1.8	1.1	0.7	1.1	0.8	1.8	1.1	0.9	1.4	1.5	1.0	1.7	2.3	1.1	0.5	1.4	1.6	1.8	1.4	1.9	1.4	1.0	1.0	1.3	1.9	0.8	0.6	0.9	0.7	0.8	0.2	0.7	1.7	1.0	1.1	2.0	1.1	5.7	1.8	3.3	1.1	0.3	1.0	0.8	0.9	1.7	4.7	5.9	2.3	5.6	2.6	5.1	0.8	5.4	2.9	4.6	7.0	2.1	4.9	1.8	2.9	0.6	1.4	3.5	2.8	0.3	3.0	5.3	1.5	0.4	1.9	0.2	1.9	4.0	3.0	0.2	0.3	2.7	0.6	8.3	2.7	6.3	2.1	5.0	3.6	1.4	9.1	5.0	1.4	0.6	2.4	17.4	8.2	5.9	4.1	1.3	3.5	4.9	9.4	0.6	1.7	0.2	2.2	2.1	1.9	6.3	11.3	4.5	2.0	3.0	6.6	7.1	4.1	4.0	10.5	9.8	4.1	11.8	2.8	1.7	3.0	0.4	1.1	1.8	3.6	0.7	0.5	1.4	12.9	2.0	2.1	1.4	4.0	3.0	1.5	1.6	1.8	1.8	1.7	2.3	1.8	1.4	1.9	1.1	1.8	1.7	0.0	3.2	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.2	3.9	0.0	0.1	0.1	0.0	0.4	0.0	0.2	0.1	0.2	0.0	0.0	20.2	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.7	8.9	0.3	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0
CLDN10	"CPETRL3, OSP-L"	ENSG00000134873	"Claudin 10"	P78369	13	95433604-95579759	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"		"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 135.2;pancreas: 216.5;salivary gland: 91.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 182.4;Cholangiocytes: 328.8;Club cells: 251.6;Ductal cells: 394.1;Glandular and luminal cells: 220.2;Proximal tubular cells: 285.9"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 19.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"eosinophil: 1.3;neutrophil: 4.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 4.1"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 14.9;NTERA-2: 12.7;RPTEC TERT1: 29.0;SuSa: 73.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012969, HPA042348"	Enhanced					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB012969: AB_2533386, HPA042348: AB_2677955"	"unprognostic (6.45e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.35e-1)"	"unprognostic (4.60e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.91e-3)"	"unprognostic (2.59e-3)"	"unprognostic (7.93e-2)"	"prognostic favorable (7.46e-5)"	"unprognostic (1.11e-2)"	"unprognostic (9.94e-2)"	"prognostic favorable (2.13e-4)"	"unprognostic (4.75e-3)"	1.0	0.1	33.0	0.0	31.3	3.2	3.1	28.6	45.8	30.4	24.1	0.3	1.1	9.3	20.8	7.9	19.2	25.5	0.5	32.6	30.5	135.2	3.7	2.1	0.0	27.9	30.2	0.9	216.5	0.4	3.1	0.8	27.2	1.3	0.4	2.7	91.5	0.4	0.1	16.8	0.2	0.4	27.4	0.7	0.9	1.5	30.1	0.5	0.2	0.7	27.4	0.5	0.4	29.8	0.0	0.0	0.9	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	2.7	0.0	4.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.3	1.9	0.0	0.0	2.9	0.0	0.1	0.0	0.5	14.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	12.7	0.2	0.0	0.0	0.1	0.0	29.0	0.0	0.2	0.1	0.0	0.0	0.0	73.3	0.7	1.8	0.6	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	33.0	31.3	28.6	45.8	32.6	30.5	27.9	30.2	27.2	27.4	30.1	29.8	0.6	0.0	0.0	93.4	1.0	0.3	5.5	182.4	0.0	0.3	22.6	5.0	0.8	328.8	251.6	99.3	0.0	15.0	0.4	0.0	135.0	394.1	3.4	83.2	28.5	4.2	0.0	0.0	0.6	82.5	7.9	1.4	0.0	220.2	0.0	0.1	1.1	0.4	1.9	0.0	1.6	0.0	77.3	0.3	0.3	2.5	0.0	2.8	69.4	4.7	1.6	78.7	0.0	33.7	0.4	103.1	0.0	0.4	0.1	22.1	0.0	285.9	43.3	3.8	6.6	0.2	16.8	12.2	19.9	1.5	0.6	23.1	2.2	0.5	0.0	5.0
CLK3		ENSG00000179335	"CDC like kinase 3"	P49761	15	74598500-74645414	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046817	Approved		Supported	"Nucleoplasm,Intermediate filaments"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Intermediate filaments"	"HPA046817: AB_10964124"	"unprognostic (4.10e-2)"	"unprognostic (8.43e-2)"	"prognostic unfavorable (2.05e-6)"	"unprognostic (1.91e-3)"	"unprognostic (7.91e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.14e-3)"	"prognostic unfavorable (5.92e-4)"	"unprognostic (1.35e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.25e-2)"	35.9	28.7	30.3	26.5	31.8	112.4	34.6	36.4	35.9	36.7	32.8	36.6	28.9	32.3	25.9	38.6	31.3	32.7	28.3	30.2	31.2	30.0	29.4	34.0	37.7	32.8	31.6	38.4	33.9	35.3	32.3	31.6	32.5	31.9	21.8	33.1	36.1	29.7	50.7	41.7	33.7	26.2	29.5	41.7	35.1	44.4	32.2	55.8	32.3	52.1	30.3	37.8	33.8	35.4	56.7	35.1	45.5	25.6	57.2	43.4	35.8	37.7	59.2	52.7	64.3	47.9	36.4	51.2	27.2	33.9	73.5	39.0	85.4	36.3	34.3	73.2	46.9	63.0	52.0	33.6	90.7	17.2	46.6	54.8	71.0	69.4	57.4	64.0	58.6	51.0	31.3	36.2	31.1	39.9	50.9	57.3	29.1	55.7	24.6	40.7	21.8	33.7	41.1	40.3	25.5	29.9	30.2	33.0	34.3	34.7	31.4	33.8	27.3	31.0	23.7	19.7	50.2	59.0	51.8	42.2	27.2	82.4	40.1	74.2	65.5	90.0	68.9	74.1	68.2	71.0	73.6	71.9	61.3	78.8	74.4	70.9	115.9	90.7	97.7	69.5	87.7	85.9	30.3	31.8	36.4	35.9	30.2	31.2	32.8	31.6	32.5	29.5	32.2	35.4	29.8	6.4	38.4	14.0	34.1	44.9	44.9	41.6	26.2	35.5	22.8	15.9	18.6	28.6	35.1	12.9	56.3	27.7	41.8	46.7	31.3	34.2	83.6	25.8	19.9	28.6	29.3	31.5	6.6	24.2	46.2	24.5	37.8	41.5	21.5	27.4	21.4	13.4	27.5	28.6	7.9	34.7	42.7	23.3	34.4	19.8	27.7	28.4	28.4	6.5	29.5	18.0	29.9	7.1	9.6	30.8	52.0	20.3	26.6	38.9	35.5	18.6	23.4	42.6	13.1	20.4	35.8	45.4	21.4	21.0	41.9	58.6	40.1	20.4	28.1	63.5
CLK4		ENSG00000113240	"CDC like kinase 4"	Q9HAZ1	5	178602664-178630615	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 297.5;Late spermatids: 518.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043746	Approved		Approved	"Actin filaments"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	"Actin filaments"		"HPA043746: AB_2678650"	"unprognostic (9.46e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.16e-3)"	"unprognostic (2.67e-1)"	"unprognostic (2.04e-2)"	"unprognostic (4.37e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.90e-3)"	"unprognostic (9.62e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.14e-3)"	13.8	11.9	14.0	7.8	14.9	10.4	13.6	22.9	20.1	20.1	14.0	14.4	9.4	12.8	11.9	10.1	13.7	9.8	13.0	14.1	14.5	13.4	13.7	10.8	17.6	15.0	14.0	18.3	17.6	7.9	10.3	10.8	15.2	16.7	6.6	34.4	13.0	8.3	17.8	15.1	12.6	5.5	14.0	18.6	12.5	15.2	14.2	16.6	16.6	21.1	10.0	12.5	21.0	19.3	8.1	7.2	6.8	10.0	19.9	15.9	11.2	7.6	8.8	4.5	8.4	7.7	6.6	4.6	6.0	3.2	5.2	10.4	8.9	6.0	7.5	16.8	6.8	1.8	15.2	8.8	7.4	3.8	5.7	7.2	8.8	7.6	9.6	15.1	3.2	3.1	4.1	13.4	5.5	3.3	5.2	13.8	3.4	5.4	4.5	4.8	6.0	6.7	4.2	2.3	7.4	5.0	8.4	4.7	8.4	3.8	5.1	8.0	6.9	9.5	3.4	4.9	8.4	8.4	3.5	3.5	6.8	9.0	5.0	7.7	5.9	12.7	8.9	4.1	12.6	12.8	9.5	8.4	5.9	10.2	12.2	9.5	16.1	8.4	4.3	7.4	9.6	4.9	14.0	14.9	22.9	20.1	14.1	14.5	15.0	14.0	15.2	14.0	14.2	19.3	31.9	16.0	27.8	45.7	57.8	31.9	44.5	18.4	40.9	70.8	23.5	21.6	22.9	11.5	23.7	14.7	39.6	20.1	52.1	12.2	5.9	9.4	297.5	22.8	30.1	25.4	6.0	38.7	79.6	4.7	18.4	29.2	20.4	19.8	27.9	36.1	18.9	13.0	10.1	28.6	40.5	10.7	14.2	13.9	24.7	518.3	30.7	21.4	16.0	43.1	18.3	29.6	27.8	61.9	60.6	7.2	16.5	29.3	36.5	23.9	25.0	10.1	26.8	81.3	19.7	17.1	30.9	30.3	18.4	19.7	24.6	15.9	42.0	24.1	10.2	26.9
CNN2		ENSG00000064666	"Calponin 2"	Q99439	19	1026586-1039068	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 274.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049095	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA		8400000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 58: T-cells - T-cell receptor"	Cytosol	"Nucleoplasm, Actin filaments"	"HPA049095: AB_2680627"	"unprognostic (2.52e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.49e-2)"	"unprognostic (3.89e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.58e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (4.70e-7)"	"unprognostic (1.28e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.54e-1)"	76.7	22.1	6.3	149.8	7.9	208.8	82.1	9.0	11.2	88.2	30.3	64.1	25.6	118.0	20.0	131.7	88.7	78.8	60.2	6.1	6.7	65.0	42.9	152.2	184.2	9.5	7.7	164.7	69.2	8.6	22.4	37.8	9.6	84.1	33.6	7.5	89.4	68.4	8.1	76.5	64.8	56.0	7.9	154.0	75.1	12.1	9.0	52.2	79.0	7.7	169.9	86.4	79.7	13.3	230.7	75.6	206.9	257.3	104.5	196.9	162.6	204.3	221.8	249.2	192.5	263.0	191.8	151.2	203.9	367.9	58.9	221.3	123.9	324.1	164.7	104.7	10.6	109.6	122.0	205.9	415.0	97.4	230.1	337.2	150.9	158.1	118.5	405.6	142.9	110.1	64.0	225.2	206.0	44.0	8.9	91.5	256.2	184.0	35.0	52.8	72.5	170.9	247.5	265.9	0.5	14.8	252.6	34.3	27.5	149.6	247.6	163.6	349.4	134.8	140.0	210.0	208.9	105.2	86.8	297.8	79.6	117.7	220.9	560.2	142.2	631.5	243.1	180.6	393.5	231.0	301.6	324.2	217.5	201.9	250.1	252.0	845.4	213.8	209.4	96.7	347.3	393.3	6.3	7.9	9.0	11.2	6.1	6.7	9.5	7.7	9.6	7.9	9.0	13.3	10.3	60.9	60.6	0.0	140.4	97.6	274.2	142.9	178.2	1.2	36.5	66.4	6.1	15.7	78.4	36.8	10.4	12.0	66.4	47.0	62.6	63.6	0.5	29.1	52.9	26.3	15.4	44.1	0.1	138.6	99.8	50.4	49.5	40.0	59.5	44.3	37.9	29.8	54.9	0.0	0.1	51.2	42.7	87.9	103.1	1.8	8.1	90.7	14.2	2.8	129.9	0.9	91.6	0.0	0.6	186.9	27.1	76.8	85.8	60.9	3.3	5.9	37.8	7.5	32.9	10.4	70.6	1.7	3.8	135.0	87.8	11.4	160.8	1.7	32.1	170.9
COQ10B	FLJ13448	ENSG00000115520	"Coenzyme Q10B"	Q9H8M1	2	197453423-197475308	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046057	Approved		Approved	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA046057: AB_2679518"	"unprognostic (9.17e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.82e-3)"	"unprognostic (8.28e-3)"	"unprognostic (5.76e-3)"	"unprognostic (4.55e-1)"	"unprognostic (2.93e-1)"	"unprognostic (7.18e-2)"	"unprognostic (6.00e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.13e-3)"	25.0	37.7	15.2	17.4	15.4	46.8	19.1	16.2	19.0	15.7	18.6	19.7	16.2	16.5	15.9	18.8	13.0	26.1	34.3	16.2	17.1	28.6	35.1	17.6	19.8	16.3	16.5	10.5	15.9	29.6	14.3	21.6	16.8	17.5	20.3	18.3	12.7	17.6	12.8	12.7	15.4	24.9	16.7	18.8	18.3	10.7	17.3	17.3	21.1	19.1	19.4	31.0	12.2	17.9	15.7	14.7	10.5	18.8	49.6	35.3	24.6	40.2	57.5	42.3	46.8	30.0	18.5	14.7	33.4	32.5	52.5	14.1	15.3	21.3	47.8	29.0	13.2	21.0	19.1	35.4	41.5	17.0	46.6	39.5	32.8	40.3	28.5	22.9	23.3	20.9	17.9	38.1	40.9	20.4	18.6	26.4	16.2	18.4	30.0	13.9	15.7	19.4	45.7	42.0	6.8	13.1	18.4	23.9	52.0	37.2	17.1	23.9	24.6	41.4	14.4	46.8	29.3	36.0	55.0	16.5	51.7	16.3	32.7	70.8	30.0	57.5	43.7	35.5	49.2	32.8	41.4	43.6	26.4	25.2	43.0	44.4	90.7	34.1	42.8	16.7	56.5	38.0	15.2	15.4	16.2	19.0	16.2	17.1	16.3	16.5	16.8	16.7	17.3	17.9	73.2	19.2	19.9	7.2	54.4	105.5	106.5	55.7	44.9	30.2	42.3	24.3	29.0	24.3	42.3	40.5	41.7	32.7	62.5	43.7	129.1	44.9	38.7	35.8	34.5	48.9	26.9	38.3	12.4	46.1	43.7	67.6	33.1	43.5	60.3	12.2	22.9	36.7	32.0	63.9	11.8	44.3	57.0	23.8	74.6	20.7	20.5	44.3	71.2	7.5	29.2	56.7	49.4	7.1	16.0	54.2	36.3	30.5	45.1	65.6	30.0	73.7	41.7	36.6	46.0	60.8	71.0	20.9	39.4	29.0	106.6	173.9	70.9	33.7	19.1	100.0
COQ8A	"ADCK3, CABC1, COQ8, SCAR9"	ENSG00000163050	"Coenzyme Q8A"	Q8NI60	1	226940286-226987544	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Ubiquinone biosynthesis"	"Kinase, Transferase"	"Disease variant, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"skeletal muscle: 1165.1;tongue: 484.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 21.9;Collecting duct cells: 33.1;Ductal cells: 21.2;Exocrine glandular cells: 32.7;Proximal tubular cells: 24.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 82.0;RPMI-8226: 78.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061662			Supported	Mitochondria		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA061662: AB_2684578"	"unprognostic (6.37e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.15e-3)"	"unprognostic (8.67e-2)"	"unprognostic (2.40e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.62e-1)"	63.9	123.8	7.1	10.3	8.0	26.1	35.8	17.3	8.1	16.5	16.1	30.8	29.9	15.9	0.5	32.2	24.6	19.7	123.5	7.1	5.6	14.4	35.7	9.6	12.7	8.9	5.4	34.1	93.8	6.4	5.3	6.5	9.8	18.5	6.4	1.3	32.7	11.7	1165.1	25.1	18.5	7.2	5.9	14.4	52.8	6.7	5.9	8.6	9.4	484.7	4.3	40.8	13.4	11.5	8.0	14.4	3.3	10.3	11.4	7.3	57.7	3.6	2.9	5.2	6.9	23.0	12.8	24.5	17.9	2.4	2.6	9.2	6.9	8.2	0.8	25.5	82.0	16.7	11.2	38.8	2.5	25.8	9.3	14.2	12.2	4.0	5.4	4.9	2.5	24.7	29.4	19.4	0.7	11.0	15.2	37.3	15.5	62.8	29.5	14.9	17.1	78.6	1.6	5.9	59.9	24.2	7.3	28.7	20.6	3.4	15.1	34.8	2.5	5.9	5.3	8.2	13.3	43.0	40.5	13.1	5.3	29.3	6.0	47.7	23.5	68.4	15.8	17.1	15.3	22.2	15.8	14.6	18.6	26.8	21.5	17.0	43.1	21.2	13.6	8.1	21.5	26.0	7.1	8.0	17.3	8.1	7.1	5.6	8.9	5.4	9.8	5.9	5.9	11.5	11.4	3.2	21.9	0.0	5.8	0.0	0.0	0.0	0.0	0.0	18.1	17.1	0.0	0.0	4.3	33.1	0.0	12.2	10.2	0.0	15.6	21.2	0.0	12.3	8.9	5.4	0.0	0.0	0.0	32.7	10.0	6.3	0.0	9.6	13.9	9.8	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	11.4	0.0	0.0	0.0	0.0	10.8	0.0	0.0	3.2	0.0	0.0	24.8	2.2	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	7.7	5.2	16.0	0.0	0.0
COX19	MGC104475	ENSG00000240230	"Cytochrome c oxidase assembly factor COX19"	Q49B96	7	898778-975549	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021226	Approved		Supported	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA021226: AB_1847176"	"unprognostic (1.83e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.76e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.96e-1)"	"unprognostic (5.60e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.37e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.74e-1)"	"unprognostic (9.14e-3)"	4.5	12.3	4.0	3.2	4.7	6.7	4.4	6.3	4.8	5.4	2.2	6.8	5.3	4.8	2.2	5.8	6.8	2.0	5.2	4.0	4.3	6.2	5.9	4.9	4.4	4.8	4.2	5.5	7.5	6.4	5.9	2.7	5.0	6.2	3.5	2.9	6.0	2.8	7.5	8.0	7.4	2.4	3.6	7.6	5.9	4.0	4.4	3.7	5.6	4.9	3.5	5.0	4.8	6.9	13.9	3.7	4.1	5.2	3.1	4.4	7.8	6.1	4.4	5.2	4.3	9.6	7.6	6.8	2.0	3.7	8.2	9.1	4.3	4.2	4.1	2.1	7.2	3.0	4.5	7.1	9.8	7.3	6.8	5.1	9.7	4.0	9.2	5.8	3.3	6.9	9.0	5.7	3.4	9.0	3.1	8.6	10.6	16.3	8.6	7.4	0.9	3.3	4.6	6.0	5.4	5.4	3.5	14.4	12.0	6.7	7.2	17.1	4.2	5.2	7.6	6.0	9.5	7.1	5.2	6.6	4.6	10.4	8.7	9.4	5.2	8.3	5.8	5.1	5.9	6.6	6.1	5.2	4.5	6.1	7.5	7.2	5.0	5.4	5.5	7.9	5.9	4.4	4.0	4.7	6.3	4.8	4.0	4.3	4.8	4.2	5.0	3.6	4.4	6.9	25.4	12.8	21.4	6.2	35.4	24.6	35.9	37.7	19.4	19.3	21.7	19.2	14.2	31.5	24.1	31.3	12.5	27.8	49.7	29.9	15.6	34.9	7.4	58.4	23.8	23.5	44.9	17.2	13.1	34.0	41.8	19.0	17.3	49.3	34.9	28.1	25.0	31.0	26.1	15.2	13.3	32.6	36.7	24.9	28.5	2.7	19.6	29.4	21.4	13.1	46.6	33.3	64.9	6.6	22.7	49.6	31.7	14.3	20.8	36.8	37.7	25.8	36.2	27.0	6.6	18.7	23.2	19.2	32.7	21.4	25.7	41.9	39.5	30.9	32.2	45.3
CSNK1G1	CK1gamma1	ENSG00000169118	"Casein kinase 1 gamma 1"	Q9HCP0	15	64165525-64356173	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 35.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 130.6;Late spermatids: 261.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018209			Supported	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA018209: AB_1847278"	"unprognostic (9.10e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.90e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.75e-2)"	"unprognostic (7.51e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.41e-1)"	4.0	3.4	6.1	6.1	6.9	9.0	6.0	6.4	7.7	5.4	6.3	5.0	3.9	4.5	6.7	7.9	7.3	4.0	2.9	10.4	7.1	5.3	2.9	5.3	5.9	2.8	4.3	5.2	4.1	6.3	4.7	4.9	2.6	3.7	5.4	14.5	3.6	4.4	4.1	6.6	3.8	5.3	3.6	5.9	4.3	35.0	6.8	9.3	7.9	3.3	6.8	5.5	4.6	4.9	6.8	14.2	10.0	13.2	8.3	11.4	8.9	8.3	8.5	13.8	12.5	11.5	13.2	10.8	4.3	13.3	14.2	15.4	26.7	16.5	16.1	20.6	6.8	10.1	11.2	8.0	9.8	18.9	11.4	10.3	21.7	14.0	20.0	11.9	15.4	10.6	12.3	10.4	12.8	9.4	9.7	5.8	9.4	8.9	7.4	16.1	12.5	8.6	11.2	26.8	16.2	9.9	11.1	6.5	9.5	16.4	11.4	7.4	16.8	12.6	14.9	9.8	10.5	12.3	26.0	8.8	11.6	13.5	7.9	0.4	1.9	3.1	2.8	2.8	4.0	1.8	2.5	2.1	1.4	1.8	2.4	2.3	4.5	2.8	2.3	2.1	2.2	1.3	6.1	6.9	6.4	7.7	10.4	7.1	2.8	4.3	2.6	3.6	6.8	4.9	10.9	28.9	11.3	35.6	12.9	11.6	10.5	13.7	19.9	47.1	11.6	7.9	7.3	11.5	12.7	5.5	68.8	6.9	12.6	12.2	1.9	9.6	130.6	37.4	17.9	12.2	22.8	7.8	69.4	7.0	9.0	10.3	15.3	24.6	3.8	15.8	10.4	4.4	10.4	10.1	49.8	10.5	6.1	9.7	10.0	261.1	6.2	14.1	7.2	40.3	13.5	7.9	5.2	40.2	41.3	12.0	7.5	10.1	14.3	11.1	8.2	9.7	23.3	29.3	6.6	14.4	11.8	31.9	19.8	26.7	15.6	4.1	13.2	7.9	10.4	13.2
CTDSP2	"OS4, PSR2, SCP2"	ENSG00000175215	"CTD small phosphatase 2"	O14595	12	57819927-57846729	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"RH-30: 1208.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052607	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Mitochondria	"HPA052607: AB_2681883"	"unprognostic (7.09e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.39e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.15e-1)"	"unprognostic (7.38e-3)"	"unprognostic (5.50e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.11e-1)"	90.9	82.5	66.8	65.4	80.0	45.7	81.8	79.7	69.3	84.0	61.0	108.9	54.3	96.4	51.4	67.0	89.9	64.7	72.4	64.6	63.0	66.2	58.8	113.9	66.1	90.7	80.6	107.3	119.4	68.2	40.3	94.3	76.5	70.1	83.2	30.1	109.1	82.8	122.3	88.9	77.0	94.8	71.4	75.5	89.9	32.3	74.3	104.8	68.1	102.8	77.5	85.2	71.8	83.4	83.1	35.4	165.6	105.8	145.6	248.8	55.0	87.4	165.1	85.2	75.4	45.6	131.5	101.3	98.1	187.5	33.2	64.8	70.0	85.3	88.8	34.2	29.7	140.3	54.4	37.0	135.4	64.3	78.3	239.7	88.9	77.3	65.1	181.9	135.0	60.6	74.5	172.9	43.4	38.2	69.1	38.3	84.3	52.5	44.4	91.0	1208.7	133.2	66.2	118.6	31.1	68.3	122.1	69.4	105.3	100.2	125.8	110.4	109.3	75.0	80.8	85.6	31.5	51.4	59.6	120.3	84.4	58.5	59.7	12.6	9.1	14.4	6.1	8.5	7.2	6.6	8.6	7.1	8.7	6.0	9.8	7.6	17.2	8.2	7.6	7.2	6.2	7.4	66.8	80.0	79.7	69.3	64.6	63.0	90.7	80.6	76.5	71.4	74.3	83.4	50.9	73.7	42.7	31.3	28.5	67.6	45.2	34.6	51.8	19.0	51.2	36.6	34.0	78.6	27.6	47.8	16.7	43.7	48.8	151.1	15.6	72.9	52.2	33.4	51.2	59.3	48.7	50.1	15.8	135.0	41.4	51.0	20.4	50.1	24.7	44.2	86.4	59.1	42.3	20.2	11.0	39.4	16.2	76.1	43.5	151.9	51.9	39.5	42.7	16.9	81.9	44.4	42.2	17.6	27.9	105.8	49.3	48.5	30.3	70.4	57.5	30.6	18.4	11.2	72.3	49.2	53.3	6.3	25.1	39.6	76.1	56.2	34.3	34.8	37.3	99.2
CUTC	CGI-32	ENSG00000119929	"CutC copper transporter"	Q9NTM9	10	99702558-99756134	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"skeletal muscle: 385.5;tongue: 204.2"	"Cell type enriched"	"Detected in all"	4	"Spermatocytes: 163.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038619, HPA058231"	Enhanced		Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA038619: AB_10672649, HPA058231: "	"unprognostic (1.25e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.67e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (3.81e-7)"	"unprognostic (1.00e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.97e-1)"	38.7	15.5	19.3	14.6	21.9	23.6	27.3	20.8	25.9	17.3	17.3	19.4	11.1	14.7	11.0	16.0	17.1	12.1	41.7	18.7	20.7	13.5	30.2	15.1	22.3	21.0	20.6	12.6	14.2	8.6	7.8	11.3	21.3	16.1	15.9	28.3	16.9	11.2	385.5	18.6	20.9	14.4	20.1	28.6	18.6	43.4	20.3	23.9	13.2	204.2	19.7	43.8	16.7	25.0	27.4	57.7	19.9	60.7	71.8	32.8	10.8	22.0	28.0	21.6	24.2	26.7	20.5	98.9	19.1	37.5	10.6	22.9	40.8	36.6	23.9	29.5	39.0	32.9	26.1	42.7	33.2	61.5	15.5	34.0	22.3	34.5	71.1	26.8	37.8	56.2	29.6	21.4	16.4	19.4	55.7	63.2	20.0	27.7	21.4	37.5	23.3	38.3	22.8	11.2	6.5	14.8	10.1	15.9	28.9	27.1	25.3	34.7	21.2	9.0	12.2	9.9	29.5	34.7	48.5	69.6	29.4	130.0	8.2	70.6	42.6	111.7	56.9	35.2	60.0	73.4	53.9	54.9	47.1	66.5	74.4	57.2	68.6	63.1	46.0	54.2	57.0	45.3	19.3	21.9	20.8	25.9	18.7	20.7	21.0	20.6	21.3	20.1	20.3	25.0	26.3	9.6	12.5	15.3	32.8	12.1	14.7	23.1	5.7	18.7	12.6	15.2	40.6	14.3	14.9	5.5	8.4	18.6	23.2	4.6	21.5	16.9	12.6	11.4	12.0	19.8	12.1	28.2	8.5	17.4	13.5	32.8	10.7	8.3	30.4	14.4	27.5	23.4	20.9	11.8	9.0	7.4	12.2	17.0	11.7	10.8	13.1	16.6	30.2	7.5	28.0	25.9	21.6	8.0	26.9	10.5	7.4	16.1	27.2	16.1	19.2	34.8	21.5	33.0	19.7	27.1	15.5	163.3	36.7	14.3	10.9	13.5	25.6	36.3	9.6	11.6
CYRIB	"BM-009, CYRI, CYRI-B, FAM49B"	ENSG00000153310	"CYFIP related Rac1 interactor B"	Q9NUQ9	8	129839593-130017129	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 198.6"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 117.7;dendritic cells: 66.2;Extravillous trophoblasts: 158.5;Hofbauer cells: 239.7;Syncytiotrophoblasts: 60.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009076	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		1100000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA009076: AB_1848402"	"unprognostic (4.35e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (2.80e-2)"	"unprognostic (9.61e-3)"	"prognostic unfavorable (3.02e-6)"	"unprognostic (4.75e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.62e-1)"	"prognostic unfavorable (3.09e-10)"	"unprognostic (3.85e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.46e-1)"	41.3	26.3	24.8	97.4	37.9	198.6	25.9	29.9	46.1	13.5	23.1	31.1	30.3	15.9	21.1	29.4	15.3	30.7	18.4	28.3	32.2	22.9	26.5	39.0	119.7	35.9	33.1	11.4	15.9	17.8	17.6	42.0	34.9	14.8	35.8	28.5	18.2	13.1	25.8	19.0	42.3	28.8	35.7	83.6	28.6	29.9	33.6	79.2	28.5	24.3	105.1	50.6	14.1	49.9	167.5	87.7	93.6	52.9	8.2	12.1	124.2	49.4	47.8	67.2	71.4	50.9	111.8	165.5	105.9	32.6	53.3	81.2	78.2	130.6	100.3	349.1	54.5	166.4	44.6	57.7	31.9	109.2	137.1	19.3	60.1	45.3	93.9	54.9	60.2	132.0	121.2	186.3	74.5	74.5	372.0	80.3	79.8	130.4	119.7	160.1	63.3	278.3	138.4	67.4	62.1	81.2	99.2	61.9	152.5	84.1	72.4	139.0	37.5	24.7	158.5	52.8	106.8	61.5	195.7	275.1	38.8	233.5	65.3	350.7	212.5	404.4	161.6	256.2	124.7	122.7	91.2	134.0	280.9	98.7	80.1	132.3	553.9	189.6	232.8	179.8	136.7	306.0	24.8	37.9	29.9	46.1	28.3	32.2	35.9	33.1	34.9	35.7	33.6	49.9	8.4	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	0.0	117.7	66.2	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	158.5	6.5	0.0	0.0	0.0	0.0	0.0	0.0	239.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	60.5	8.4	0.0	0.0	0.0
DAPK3	"ZIP, ZIPK"	ENSG00000167657	"Death associated protein kinase 3"	O43293	19	3958453-3971123	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Transcription, Transcription regulation, Translation regulation"	"Activator, Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028569	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol	Nucleoplasm	"HPA028569: AB_10794319"	"unprognostic (5.72e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.34e-3)"	"prognostic favorable (2.01e-5)"	"unprognostic (1.83e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.72e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.84e-3)"	"unprognostic (7.64e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (9.92e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.48e-2)"	"unprognostic (2.14e-1)"	49.9	25.4	15.0	29.0	15.2	18.9	47.2	14.3	27.9	58.3	18.9	92.2	30.9	85.0	8.2	37.0	55.4	36.0	106.2	16.8	13.9	27.6	30.4	72.5	21.2	16.2	15.4	48.4	36.4	19.0	38.5	31.9	18.8	53.3	11.0	9.0	41.3	39.3	113.6	51.2	44.4	36.6	11.9	29.6	61.4	42.6	17.4	15.4	31.0	21.1	11.3	59.5	45.3	17.3	79.2	61.1	37.5	47.6	27.5	30.9	57.8	106.0	84.5	84.7	55.5	113.4	23.3	43.4	50.8	93.8	59.6	61.7	36.9	60.3	30.7	64.0	61.2	17.5	76.7	65.9	87.2	42.7	63.1	70.6	73.6	77.0	44.0	50.8	71.2	29.2	56.3	73.2	52.5	51.0	42.4	31.9	58.5	31.8	48.6	52.5	55.3	40.5	51.0	60.9	59.1	41.1	71.4	84.9	61.1	43.8	61.4	33.1	134.8	108.3	49.3	98.1	134.5	81.1	72.4	50.7	86.3	44.0	59.0	32.5	18.0	32.5	23.0	20.3	16.7	15.9	17.8	21.6	16.2	16.6	13.1	12.9	29.8	24.3	14.3	18.6	23.6	14.6	15.0	15.2	14.3	27.9	16.8	13.9	16.2	15.4	18.8	11.9	17.4	17.3	24.1	25.6	10.5	6.5	17.0	100.7	99.7	84.1	27.9	15.2	23.9	15.6	29.2	24.3	35.0	11.0	2.1	50.5	14.5	69.2	17.6	90.3	40.3	27.9	28.2	38.3	27.4	7.0	9.6	88.2	79.1	27.8	40.8	37.5	20.3	24.8	21.4	7.9	22.9	11.8	7.1	48.2	48.8	13.6	22.8	23.6	22.7	16.6	37.4	8.4	25.7	12.8	30.9	6.0	6.7	117.7	49.9	22.6	13.3	46.1	59.6	14.3	18.8	10.7	32.9	19.9	53.0	34.6	15.7	24.4	71.7	93.2	15.1	26.2	29.7	46.3
DAPP1	BAM32	ENSG00000070190	"Dual adaptor of phosphotyrosine and 3-phosphoinositides 1"	Q9UN19	4	99816827-99870190	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 29.2;lymphoid tissue: 38.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 92.0;Langerhans cells: 188.5;monocytes: 235.5;Respiratory ciliated cells: 88.6;Urothelial cells: 221.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 61.2;RPMI-8226: 70.2;SK-BR-3: 30.6;U-698: 46.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB033822, HPA046074"	Approved					NA	NA		56000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 41: Macrophages - Immune response"			"CAB033822: AB_2245677, HPA046074: AB_2679525"	"unprognostic (9.30e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.68e-1)"	"unprognostic (9.09e-2)"	"unprognostic (4.71e-1)"	"unprognostic (5.13e-2)"	"unprognostic (4.01e-3)"	"unprognostic (2.24e-1)"	"unprognostic (8.45e-5)"	"unprognostic (2.88e-1)"	"unprognostic (3.91e-2)"	"unprognostic (9.32e-2)"	"unprognostic (4.60e-2)"	1.6	1.0	0.5	22.6	0.9	15.5	3.7	0.4	0.5	6.9	0.6	3.1	2.1	8.4	1.0	29.2	5.2	11.9	0.5	0.5	0.6	0.7	1.5	6.3	34.6	1.0	1.0	0.4	0.4	0.2	0.2	6.8	1.1	2.8	3.2	0.1	8.6	0.8	0.9	13.7	6.3	13.5	0.8	16.6	6.5	0.4	0.7	10.2	0.6	1.3	38.5	14.9	12.9	1.5	22.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	22.5	23.8	0.3	0.0	0.1	12.8	0.0	25.3	0.0	61.2	0.0	24.3	0.0	0.0	0.0	9.4	1.0	0.0	11.3	0.0	7.5	0.0	0.0	1.0	1.2	21.7	0.0	0.2	0.1	6.7	0.0	0.0	0.4	0.1	0.1	70.2	4.6	16.3	0.1	0.0	0.0	30.6	0.0	0.2	0.4	10.1	0.0	0.0	0.4	0.0	0.1	8.3	3.2	46.4	0.1	6.5	0.0	25.0	70.2	71.0	2.3	62.6	2.5	90.9	11.4	4.0	75.9	98.7	12.5	4.5	138.1	17.8	57.3	32.4	25.2	65.3	0.5	0.9	0.4	0.5	0.5	0.6	1.0	1.0	1.1	0.8	0.7	1.5	0.3	3.2	3.0	0.0	92.0	61.8	30.2	51.4	16.5	0.1	10.1	5.0	0.8	2.8	43.2	9.2	0.0	2.6	13.3	8.4	0.0	6.2	0.3	37.1	0.8	1.2	1.2	9.4	0.4	3.1	14.1	1.4	14.8	9.0	8.2	0.2	0.7	0.7	25.1	0.0	0.1	1.8	22.4	32.0	188.5	0.9	0.0	86.0	12.4	5.6	235.5	0.0	7.2	0.0	0.1	18.9	17.6	0.0	60.2	24.3	0.2	0.1	88.6	0.2	0.0	0.9	4.2	0.2	0.5	40.4	70.3	3.4	17.2	0.1	2.2	221.2
DEDD2	FLAME-3	ENSG00000160570	"Death effector domain containing 2"	Q8WXF8	19	42198598-42220140	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Paneth cells: 178.2;Syncytiotrophoblasts: 162.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043419			Approved	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA043419: AB_10960747"	"unprognostic (1.59e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.87e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.55e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.55e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.70e-2)"	"prognostic favorable (3.26e-6)"	7.0	11.4	16.1	6.6	16.5	12.8	5.8	17.3	23.1	9.4	17.4	8.8	6.7	7.3	3.1	12.3	10.1	2.1	8.6	16.3	24.0	10.7	12.9	13.8	5.3	17.3	18.2	11.3	9.5	4.2	19.3	3.6	21.2	10.6	2.1	3.4	10.0	3.3	9.8	13.0	9.9	1.3	15.3	17.8	9.5	11.7	19.9	7.0	9.9	3.4	4.1	8.8	11.0	23.4	17.1	32.4	2.3	2.8	5.7	1.3	10.5	6.5	5.6	5.2	3.3	9.3	12.2	10.5	12.8	1.9	6.1	7.0	11.1	2.4	2.3	9.0	28.5	5.2	8.7	15.9	6.9	5.8	10.6	0.8	6.3	3.8	5.2	9.5	2.9	4.5	26.7	12.3	1.5	7.2	6.5	21.1	6.0	15.8	22.3	6.8	4.4	9.8	4.1	5.6	19.0	7.1	6.0	18.1	3.6	3.4	3.1	7.2	5.7	3.9	12.6	1.6	12.3	21.4	10.3	3.3	5.8	9.3	4.0	81.7	56.4	94.7	47.9	73.1	51.7	40.6	44.2	46.7	34.6	39.0	39.9	41.2	126.2	40.9	83.1	48.6	46.4	71.9	16.1	16.5	17.3	23.1	16.3	24.0	17.3	18.2	21.2	15.3	19.9	23.4	13.4	6.4	7.5	2.9	47.6	46.4	67.0	30.2	18.2	26.0	33.5	24.5	7.6	21.5	14.4	14.7	12.5	29.1	57.6	101.8	11.7	26.0	32.4	38.4	8.6	19.1	92.2	53.2	5.6	24.2	47.8	15.5	20.4	36.0	70.6	10.0	9.3	8.2	36.6	15.2	5.5	67.0	20.3	31.7	73.6	5.9	13.4	47.4	39.2	2.8	44.5	20.9	75.2	2.5	5.5	45.9	178.2	12.8	34.1	60.7	52.9	20.7	21.4	22.9	6.6	10.3	19.9	18.1	21.1	21.9	53.6	162.0	70.8	17.7	48.7	90.2
DEF6	"IBP, SLAT, SWAP70L"	ENSG00000023892	"DEF6 guanine nucleotide exchange factor"	Q9H4E7	6	35297818-35321771	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 63.2;lymphoid tissue: 62.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 94.0;Late spermatids: 151.4;NK-cells: 88.6;T-cells: 78.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 83.3;MOLT-4: 75.5;NB-4: 99.3;REH: 68.8;THP-1: 78.9;U-937: 117.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA038975, HPA038976"	Enhanced		Enhanced	Nucleoplasm		Yes	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA038975: AB_10697544, HPA038976: AB_10673409"	"prognostic favorable (3.02e-6)"	"prognostic favorable (1.08e-4)"	"prognostic unfavorable (1.71e-4)"	"prognostic favorable (2.37e-4)"	"unprognostic (1.93e-1)"	"unprognostic (3.63e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.21e-3)"	"prognostic unfavorable (1.02e-8)"	"unprognostic (1.78e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.45e-3)"	5.8	3.6	5.9	33.5	5.9	63.2	6.0	6.3	7.2	8.0	7.3	9.8	10.2	2.8	8.5	28.2	4.4	7.2	2.6	5.9	6.6	4.7	5.2	14.7	48.6	8.7	7.0	3.1	21.6	1.3	8.3	7.7	8.0	21.0	7.4	2.2	15.8	4.8	1.7	28.5	30.7	3.5	7.7	62.9	16.3	26.7	8.1	50.2	8.3	1.1	38.1	10.2	16.5	8.8	24.0	0.0	0.8	0.6	0.1	0.3	29.0	2.6	3.6	0.6	0.7	1.5	10.0	28.1	8.3	1.3	0.1	15.5	0.0	19.6	0.4	1.0	1.1	31.7	0.4	12.6	0.7	57.5	40.0	4.5	24.6	0.3	22.0	0.1	0.0	83.3	14.3	65.7	0.1	12.3	75.5	99.3	1.3	3.0	2.8	68.8	0.6	38.4	2.5	17.8	0.4	0.2	2.1	5.8	5.5	1.1	15.9	78.9	3.8	0.3	0.6	0.1	0.3	37.2	37.1	23.3	0.0	117.7	0.2	49.2	39.5	119.7	78.6	29.7	62.4	34.2	63.3	76.8	55.2	31.3	65.1	65.2	69.3	72.9	27.8	36.6	73.1	64.3	5.9	5.9	6.3	7.2	5.9	6.6	8.7	7.0	8.0	7.7	8.1	8.8	1.7	6.4	8.0	1.3	49.2	11.9	16.9	15.0	20.5	2.5	5.4	7.2	0.8	2.8	8.2	5.5	0.0	25.0	52.3	4.2	0.0	0.9	56.3	2.2	0.8	3.1	4.2	6.7	2.0	10.0	17.2	2.2	26.0	3.0	17.7	1.5	2.9	0.9	94.0	3.3	1.0	9.9	2.0	28.0	26.4	151.4	2.8	31.7	7.2	17.8	30.0	0.8	88.6	0.5	0.5	8.0	8.9	1.9	57.9	6.0	3.1	0.3	5.8	1.7	0.0	0.6	1.2	40.0	0.9	20.0	11.8	12.6	78.3	1.0	9.1	13.0
DGAT2		ENSG00000062282	"Diacylglycerol O-acyltransferase 2"	Q96PD7	11	75759512-75801535	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 476.0;breast: 133.6;liver: 331.8;skin 1: 151.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 259.3;Hepatocytes: 116.4;Late spermatids: 64.1;Spermatocytes: 53.9;Spermatogonia: 53.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 19.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"eosinophil: 137.7;neutrophil: 348.6"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 348.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 80.4;HDLM-2: 62.5;Hep G2: 64.9;OE19: 124.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"basal ganglia: 22.0"	HPA013351			Approved	Vesicles,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 21: OE19 - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"	"Vesicles, Cytosol"		"HPA013351: AB_1847630"	"unprognostic (2.28e-1)"	"unprognostic (3.69e-1)"	"unprognostic (9.38e-2)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (3.63e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.59e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.49e-7)"	"unprognostic (2.03e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.60e-2)"	476.0	5.1	5.8	19.4	11.7	7.2	133.6	2.9	6.1	2.6	5.3	9.0	14.5	1.2	1.8	24.1	2.1	5.8	11.7	5.7	6.4	3.4	331.8	5.6	4.0	3.7	3.9	1.8	4.6	2.1	1.6	1.5	5.5	2.2	4.9	0.6	10.5	1.6	4.1	151.5	16.5	2.8	3.4	15.0	12.8	38.1	6.9	4.3	8.8	5.6	18.2	21.3	12.6	5.1	13.3	6.4	0.4	11.2	80.4	6.4	1.0	1.3	1.7	1.6	1.0	46.6	13.5	21.1	16.8	0.3	11.9	0.5	1.8	6.5	4.4	62.5	1.2	1.5	4.0	64.9	0.9	7.4	7.2	26.8	33.6	7.3	10.6	4.4	1.2	20.9	1.2	27.6	0.7	8.5	5.1	16.7	3.6	124.0	31.5	0.0	0.1	24.8	1.2	35.8	22.6	1.4	12.3	1.9	2.9	2.7	4.4	26.6	1.6	14.1	7.0	0.3	9.1	16.3	40.0	28.8	10.2	23.7	25.3	19.4	22.1	137.7	0.0	4.4	0.4	7.4	0.4	0.0	6.1	7.6	0.1	0.2	348.6	0.0	5.0	1.8	0.0	5.7	5.8	11.7	2.9	6.1	5.7	6.4	3.7	3.9	5.5	3.4	6.9	5.1	3.2	6.4	5.4	0.3	5.0	1.1	0.9	3.0	0.6	0.9	5.2	7.0	3.5	0.0	2.7	0.0	2.1	0.5	0.3	0.6	0.0	1.7	259.3	3.3	0.2	0.5	1.2	2.7	2.9	0.5	0.1	0.7	10.7	0.2	0.0	2.1	2.9	116.4	2.2	1.7	1.3	4.8	0.0	4.1	13.1	64.1	2.1	4.2	1.8	0.0	4.0	0.4	0.0	0.0	1.0	3.7	2.2	0.7	0.9	2.8	1.2	2.2	3.4	0.0	6.6	0.6	1.0	53.9	53.5	0.3	8.0	0.8	0.5	0.2	3.0	15.7
DGCR2	"DGS-C, IDD, KIAA0163, LAN, SEZ-12"	ENSG00000070413	"DiGeorge syndrome critical region gene 2"	P98153	22	19036282-19122454	"Predicted membrane proteins"	"Cell adhesion"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA000873	Uncertain					NA	NA		84000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA000873: AB_1847632"	"unprognostic (1.68e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.33e-2)"	"unprognostic (6.28e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.86e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.06e-2)"	"prognostic favorable (8.72e-7)"	"unprognostic (3.63e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.27e-2)"	"unprognostic (6.28e-3)"	25.3	28.6	45.7	14.9	40.4	7.4	26.4	34.6	48.9	30.0	24.7	34.0	26.2	32.9	12.9	46.5	27.7	19.0	33.6	44.1	42.8	31.1	30.6	28.6	16.8	45.2	43.3	35.9	44.6	26.3	33.1	16.4	43.6	34.7	16.0	9.1	33.7	23.5	27.2	61.3	28.8	15.6	38.3	25.5	30.2	25.3	52.0	16.7	39.8	19.5	12.5	31.2	32.1	38.6	43.2	26.5	32.6	58.3	57.9	23.2	31.8	28.3	34.8	27.2	26.8	45.7	47.9	22.7	38.7	30.7	19.4	79.7	24.2	27.2	11.4	19.4	44.4	15.3	16.0	37.0	35.1	28.8	33.4	33.3	61.6	21.1	24.3	23.4	30.3	14.2	115.6	19.3	14.0	45.0	15.2	31.0	27.3	67.8	19.1	26.5	34.4	8.9	46.2	46.8	44.4	32.8	52.1	36.0	32.6	17.6	33.5	25.9	27.0	50.0	25.6	26.3	23.1	21.5	8.5	14.9	23.7	16.5	38.9	9.5	10.3	16.5	6.1	5.3	5.3	4.3	6.5	6.1	6.8	4.7	7.8	6.4	23.5	4.6	3.9	4.0	9.5	11.3	45.7	40.4	34.6	48.9	44.1	42.8	45.2	43.3	43.6	38.3	52.0	38.6	16.4	19.2	27.0	34.3	10.0	9.7	10.8	17.1	17.6	30.1	23.4	20.6	18.0	30.0	23.3	27.6	14.6	17.2	9.5	59.7	0.0	24.9	13.7	9.6	11.2	13.7	19.9	4.2	35.7	21.9	19.0	13.5	27.0	16.9	8.2	24.5	21.4	27.3	12.1	37.0	43.7	30.3	18.3	18.5	4.7	22.2	17.1	10.4	8.8	22.5	16.4	18.5	11.3	54.8	32.6	30.9	24.0	22.6	11.1	18.8	27.7	10.6	14.0	23.0	13.1	14.4	15.1	12.6	12.9	22.1	12.4	10.8	11.8	17.7	28.4	16.8
DHRS7	"retDSR4, SDR34C1"	ENSG00000100612	"Dehydrogenase/reductase 7"	Q9Y394	14	60144119-60169856	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 615.8"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 840.4"	"Cancer enriched"	"Detected in all"	5	"prostate cancer: 199.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031121, HPA078401"	Enhanced		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Mitochondria"		"HPA031121: AB_10600803, HPA078401: "	"prognostic favorable (6.42e-4)"	"unprognostic (5.20e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-1)"	"prognostic unfavorable (2.51e-4)"	"unprognostic (4.65e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.59e-1)"	"prognostic favorable (1.92e-10)"	"unprognostic (8.35e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	62.1	103.4	50.8	43.8	53.9	61.0	58.5	59.2	75.4	48.9	50.2	73.0	108.9	49.8	96.5	44.3	45.9	59.1	47.1	49.9	55.1	100.5	146.4	64.2	45.5	62.3	54.9	64.9	76.8	226.8	54.7	29.6	63.3	409.9	69.5	111.1	317.5	134.6	615.8	46.6	181.0	51.0	57.8	45.4	182.3	9.8	52.0	39.2	120.3	136.0	49.4	51.7	41.1	65.6	221.3	52.9	41.8	89.3	219.6	74.4	42.8	74.3	186.4	26.5	59.0	37.3	149.8	21.5	41.7	76.8	78.0	92.7	57.2	108.3	34.5	156.1	36.0	53.7	28.7	60.9	110.1	71.8	1.7	63.3	116.7	47.6	153.0	50.8	52.5	66.2	18.2	52.6	61.4	59.2	40.9	67.2	18.6	151.2	55.4	42.7	50.8	24.4	118.3	70.5	83.4	99.8	72.6	118.0	168.2	52.7	72.7	32.5	35.8	126.6	38.7	36.9	44.2	18.3	7.9	45.0	62.6	64.8	93.5	743.5	213.1	519.6	335.7	159.1	340.6	184.4	238.9	298.5	185.0	167.0	134.6	258.5	835.4	294.7	224.0	388.8	215.5	450.2	50.8	53.9	59.2	75.4	49.9	55.1	62.3	54.9	63.3	57.8	52.0	65.6	109.6	54.5	102.5	16.0	72.2	34.0	70.3	233.2	52.3	25.7	81.2	57.4	27.6	160.2	138.4	86.5	83.4	29.6	210.4	101.3	19.6	222.5	2.1	56.2	55.5	89.7	46.5	20.4	12.2	165.9	88.7	87.9	120.8	120.0	178.5	22.9	48.5	166.4	94.4	42.1	19.0	102.2	386.6	54.5	70.6	3.5	82.3	98.7	108.5	16.9	172.5	94.4	299.7	26.2	20.1	210.6	114.5	84.2	99.0	263.4	840.4	44.1	57.0	70.7	85.5	66.4	73.7	1.6	2.9	47.0	25.4	20.8	152.1	19.7	79.2	47.1
DHX58	"D11LGP2, LGP2"	ENSG00000108771	"DExH-box helicase 58"	Q96C10	17	42101404-42112714	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"monocytes: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 45.5;BJ hTERT+ SV40 Large T+ RasG12V: 52.9;SK-MEL-30: 27.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA018670, HPA019570"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Golgi apparatus, Cytosol"	Nucleoplasm	"HPA018670: AB_1847665, HPA019570: AB_1847666"	"prognostic favorable (3.45e-4)"	"unprognostic (1.03e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.45e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.05e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.27e-2)"	"unprognostic (8.65e-2)"	"unprognostic (8.01e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.31e-3)"	8.9	11.9	5.5	10.2	6.1	12.3	7.6	4.7	7.4	7.7	4.9	7.0	8.5	7.0	5.9	6.4	11.5	12.1	4.9	4.6	4.8	7.3	14.5	11.8	12.5	6.9	5.4	11.9	6.0	7.2	6.9	7.0	6.2	8.7	5.1	0.6	18.6	8.2	3.7	7.5	8.5	7.3	7.5	18.4	9.3	10.8	5.4	12.5	5.5	4.3	7.4	8.0	5.9	6.7	2.5	0.0	0.1	1.3	11.3	9.9	0.3	3.3	22.4	45.5	52.9	0.3	14.6	0.2	3.4	5.4	10.2	2.0	0.2	3.5	1.7	9.3	0.3	3.9	2.6	0.9	12.6	3.6	8.6	15.9	5.9	4.0	3.9	8.0	5.5	23.5	0.0	12.8	2.5	0.0	21.7	4.5	0.4	0.6	0.0	7.8	0.0	1.2	5.2	8.6	0.4	0.0	1.5	5.9	27.0	0.0	7.9	3.8	2.4	2.3	0.1	0.8	1.1	4.3	3.8	0.2	4.6	3.3	2.6	2.3	7.7	6.9	3.1	9.7	4.8	4.6	4.7	2.9	5.9	3.5	5.1	3.8	3.2	6.8	8.6	2.0	4.4	5.0	5.5	6.1	4.7	7.4	4.6	4.8	6.9	5.4	6.2	7.5	5.4	6.7	9.1	9.6	3.4	6.8	4.8	1.5	3.9	6.2	3.4	1.0	3.5	3.7	1.7	8.6	7.6	7.3	0.0	4.0	4.7	2.3	1.9	7.0	9.0	4.5	2.9	7.0	0.0	0.4	1.9	6.9	4.6	4.1	3.6	4.0	1.3	7.5	3.3	14.0	9.8	0.0	2.4	3.2	4.1	7.0	0.7	12.1	8.7	7.4	3.6	8.4	39.9	2.4	2.1	4.0	1.8	5.7	4.3	9.1	1.3	5.4	3.9	5.7	11.6	0.6	0.0	3.7	3.8	18.1	1.0	2.3	1.6	0.8	6.6	8.2	1.9	2.9
DMD	"BMD, DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272, MRX85"	ENSG00000198947	Dystrophin	P11532	X	31097677-33339609	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters"		Actin-binding	"Cancer-related genes, Cardiomyopathy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 452.8;Excitatory neurons: 1275.8;Inhibitory neurons: 719.8;Oligodendrocyte precursor cells: 1161.6;Oligodendrocytes: 610.2;Rod photoreceptor cells: 375.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 8.0"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.3"	"Group enriched"	"Detected in many"	7	"B-cells: 1.1;granulocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"AF22: 27.9;Hep G2: 30.3;RH-30: 25.0;SuSa: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000119, HPA002725, HPA023885"	Enhanced					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB000119: , HPA002725: AB_1078714, HPA023885: AB_1847931"	"unprognostic (3.91e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.60e-4)"	"unprognostic (6.98e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.84e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.82e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.51e-2)"	16.3	14.7	11.8	5.3	12.5	0.6	16.8	0.2	14.2	7.1	7.1	38.0	5.4	18.1	11.2	9.1	16.8	21.5	37.8	15.5	0.5	5.4	50.0	7.2	4.7	1.1	0.6	13.9	52.9	4.3	4.4	15.1	0.4	13.4	8.4	80.0	30.2	30.7	73.4	11.5	9.4	22.0	0.0	2.3	15.5	8.3	4.8	3.3	7.3	67.4	6.4	21.1	7.2	9.9	0.3	0.2	27.9	0.3	0.3	0.3	7.6	6.1	0.6	2.8	3.1	13.3	0.6	0.4	0.2	12.5	2.3	8.5	10.5	15.0	4.2	7.4	8.6	3.3	10.5	30.3	14.7	1.2	3.7	3.3	9.5	4.6	17.1	15.3	6.1	2.0	2.9	0.4	8.3	0.5	4.4	0.6	13.3	0.1	9.8	0.3	25.0	0.1	0.3	3.3	0.5	8.5	0.1	2.3	2.8	27.7	2.2	0.1	1.6	0.3	0.5	1.1	4.6	0.4	23.8	0.6	1.0	2.3	14.4	0.8	0.1	2.0	0.1	0.1	0.1	1.1	0.1	0.1	0.3	0.9	0.1	0.1	4.3	0.1	0.1	0.4	0.2	0.1	11.8	12.5	0.2	14.2	15.5	0.5	1.1	0.6	0.4	0.0	4.8	9.9	8.5	28.9	25.3	164.9	6.7	20.1	7.0	6.3	3.4	78.0	26.5	50.0	452.8	7.2	15.0	3.7	308.6	33.7	0.7	0.8	3.9	3.8	22.4	22.5	1.4	9.9	8.4	0.0	1275.8	12.3	9.5	26.1	3.6	5.6	1.3	37.9	6.1	49.8	4.2	11.8	719.8	1.3	6.1	4.8	5.4	20.5	89.2	3.5	19.6	94.6	6.7	54.9	0.0	1161.6	610.2	6.0	0.1	118.8	0.2	3.6	3.6	2.1	60.4	375.9	118.3	95.2	50.3	4.0	8.8	1.8	11.5	5.1	1.0	33.1	4.2	4.8
EEPD1	KIAA1706	ENSG00000122547	"Endonuclease/exonuclease/phosphatase family domain containing 1"	Q7L9B9	7	36153254-36301538	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 46.9"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 88.0;Oligodendrocytes: 175.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 51.8;neutrophil: 46.4"	"Group enriched"	"Detected in many"	6	"granulocytes: 51.8;T-cells: 23.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 18.3;PC-3: 22.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053668			Approved	"Nuclear speckles,Vesicles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear speckles"	Vesicles	"HPA053668: AB_2682223"	"unprognostic (1.30e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.54e-3)"	"unprognostic (5.21e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.76e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.75e-2)"	"unprognostic (7.89e-2)"	"unprognostic (8.77e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.59e-2)"	19.5	5.2	9.8	4.0	12.5	8.1	18.3	10.6	14.2	10.2	7.3	12.0	9.9	7.7	3.6	7.1	7.3	11.7	11.1	10.4	10.6	5.9	24.0	8.1	4.6	12.0	12.8	8.5	11.5	2.2	4.4	4.0	12.7	12.5	3.8	1.5	4.1	3.4	46.9	12.8	11.5	5.6	10.3	10.8	17.0	5.3	13.0	12.8	3.1	12.8	3.0	10.9	9.1	19.2	2.2	5.9	1.8	5.6	16.2	3.5	0.1	1.5	7.2	1.1	2.0	1.2	4.5	5.9	1.8	2.2	16.8	2.4	2.4	2.8	1.0	18.3	4.0	0.7	0.5	11.0	1.5	0.9	5.5	7.3	1.7	0.7	0.4	4.5	0.1	4.4	7.3	0.6	1.2	2.3	6.1	14.6	8.2	7.4	22.4	1.6	2.0	1.3	3.6	4.7	4.4	3.1	0.5	0.8	2.2	3.2	1.8	7.0	0.5	2.2	6.5	1.5	1.7	4.3	5.1	0.0	5.4	3.8	1.4	23.1	5.9	51.8	3.0	3.6	5.2	0.3	23.0	6.6	3.2	0.0	5.0	1.5	46.4	3.9	1.6	2.9	11.6	4.2	9.8	12.5	10.6	14.2	10.4	10.6	12.0	12.8	12.7	10.3	13.0	19.2	32.4	0.0	0.5	30.0	1.3	2.7	14.7	1.8	1.8	4.2	4.9	7.2	4.0	34.3	2.1	0.0	20.9	0.2	0.9	10.8	5.9	26.2	17.4	8.4	3.0	14.8	9.6	1.3	28.4	7.4	0.3	4.0	20.9	7.2	8.9	0.9	3.9	16.9	25.3	6.7	88.0	6.2	0.0	5.8	5.5	3.6	5.0	9.8	3.6	45.0	3.8	2.0	0.0	1.5	175.4	16.9	12.6	16.6	0.7	8.7	19.4	1.9	2.6	1.4	6.6	2.1	6.6	0.7	5.4	4.2	4.0	0.5	3.3	6.4	6.2	10.2
EGLN2	"HIFPH1, PHD1"	ENSG00000269858	"Egl-9 family hypoxia inducible factor 2"	Q96KS0	19	40798996-40808434	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 269.1;Late spermatids: 740.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056649			Supported	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA056649: AB_2683203"	"unprognostic (1.11e-2)"	"prognostic favorable (2.88e-4)"	"unprognostic (9.40e-3)"	"unprognostic (6.01e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.47e-3)"	"unprognostic (1.51e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (7.10e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.38e-3)"	57.6	58.5	99.3	50.0	99.8	52.1	47.6	95.1	140.9	70.0	79.6	65.4	34.3	53.9	31.5	40.2	45.5	39.1	67.8	103.4	96.2	54.2	57.7	74.3	62.4	97.3	99.3	59.0	36.6	27.7	44.5	48.3	97.7	59.9	28.5	16.6	39.2	45.1	40.0	27.4	46.7	40.9	90.5	116.8	47.6	232.1	99.9	41.9	55.8	40.8	44.1	57.9	57.9	98.1	46.5	123.4	55.9	54.4	71.1	51.5	36.5	49.4	41.1	68.9	75.4	102.8	45.7	41.1	41.1	59.3	62.5	29.3	70.8	56.3	36.4	51.7	40.5	54.8	76.4	39.4	76.1	42.7	71.6	63.9	58.5	65.8	37.4	43.3	86.0	44.3	79.3	37.3	73.4	32.9	78.9	70.2	48.7	72.4	42.6	72.7	27.7	27.8	74.0	70.2	51.4	46.9	80.9	62.9	67.2	47.2	83.4	114.0	80.5	85.9	61.7	35.7	59.5	18.7	29.6	75.6	63.0	61.4	65.5	93.2	72.5	190.5	85.8	83.4	91.1	85.2	101.7	90.3	62.6	90.0	105.2	89.6	261.6	61.4	82.3	45.5	100.2	110.5	99.3	99.8	95.1	140.9	103.4	96.2	97.3	99.3	97.7	90.5	99.9	98.1	2.8	22.4	16.8	0.0	43.9	48.8	55.2	33.8	17.6	40.5	3.3	0.8	22.2	31.5	30.7	3.7	14.6	58.1	19.0	83.0	0.0	15.8	269.1	0.9	1.5	49.9	44.9	30.7	0.0	10.1	26.5	27.6	23.9	1.2	17.2	0.8	72.8	33.7	66.7	21.9	0.0	33.9	48.8	39.8	62.4	740.8	63.0	26.3	40.9	0.0	38.5	24.4	60.8	0.0	0.0	14.0	71.0	52.3	8.7	67.6	54.9	1.4	23.0	17.8	39.5	14.6	17.2	159.4	52.5	14.2	38.4	132.6	33.2	2.1	43.7	69.8
ELOVL5	"dJ483K16.1, HELO1, SCA38"	ENSG00000012660	"ELOVL fatty acid elongase 5"	Q9NYP7	6	53267398-53349179	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017042, HPA047752, HPA054197"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 35: Glandular cells - Unknown function"	"Endoplasmic reticulum"		"CAB017042: , HPA047752: AB_2680147, HPA054197: AB_2682413"	"unprognostic (7.33e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.23e-1)"	"unprognostic (6.40e-2)"	"prognostic unfavorable (1.94e-6)"	"unprognostic (1.58e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (6.80e-4)"	"unprognostic (2.76e-2)"	242.4	134.7	51.3	74.9	67.0	114.6	199.2	74.6	79.2	48.9	49.4	40.0	28.3	39.8	49.7	28.4	46.0	51.3	37.8	50.8	65.3	38.9	108.9	68.4	106.7	80.7	69.0	32.3	15.4	24.3	28.5	40.2	74.5	128.0	18.3	36.5	24.8	103.0	9.9	32.9	47.5	52.4	67.7	56.1	22.8	82.5	65.8	107.3	45.1	19.5	102.4	67.1	27.0	98.9	137.2	98.1	168.0	309.0	436.0	250.8	71.3	155.8	174.2	123.2	171.5	87.4	154.5	154.4	110.3	163.3	193.1	78.9	168.0	142.6	183.7	131.2	117.5	153.1	85.0	122.9	239.0	122.2	107.2	233.6	109.8	123.6	153.9	124.5	139.1	301.4	194.2	87.3	90.3	14.9	364.4	107.9	91.2	5.2	73.6	139.9	115.3	54.3	232.7	80.6	155.7	107.1	129.3	66.9	135.2	108.7	152.3	112.9	133.0	134.7	118.5	242.2	208.8	72.8	72.1	116.2	70.2	173.6	97.8	47.6	49.2	183.7	34.9	34.9	56.5	88.4	58.1	42.7	77.9	101.5	27.8	26.3	261.5	36.7	45.0	20.4	110.0	50.6	51.3	67.0	74.6	79.2	50.8	65.3	80.7	69.0	74.5	67.7	65.8	98.9	48.6	80.1	50.7	75.4	118.3	52.4	108.2	36.8	44.3	11.6	177.3	70.9	23.3	21.5	40.2	12.9	2.1	25.3	55.5	2.1	15.6	34.9	94.2	37.4	53.2	54.4	25.0	77.0	25.8	36.1	58.2	54.8	3.1	66.4	99.0	28.4	39.3	88.7	35.5	8.4	29.8	1.6	16.2	57.3	114.6	181.0	20.8	55.5	48.0	39.4	53.5	83.2	39.1	49.3	111.2	27.8	1.4	32.0	45.2	169.2	21.9	48.4	58.5	6.0	65.7	27.3	77.5	27.0	18.9	35.7	60.9	31.2	97.2	60.0	4.4	73.4
EMC2	"KIAA0103, TTC35"	ENSG00000104412	"ER membrane protein complex subunit 2"	Q15006	8	108443601-108489196	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 190.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022838	Approved					NA	NA		11000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA022838: AB_2670967"	"prognostic unfavorable (2.64e-4)"	"unprognostic (1.45e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.87e-2)"	"unprognostic (4.36e-1)"	"unprognostic (5.46e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.15e-3)"	40.8	38.2	20.1	5.3	21.4	3.5	36.7	20.7	25.3	33.9	19.7	42.9	6.0	27.7	10.1	39.8	31.0	6.7	49.0	19.3	20.4	40.1	34.6	35.5	6.2	21.9	20.2	29.5	41.0	9.6	32.3	9.3	21.3	27.2	8.5	10.2	33.0	7.5	57.3	30.9	27.6	7.3	21.0	26.6	35.1	38.7	20.0	4.6	30.2	10.9	6.1	33.7	33.8	26.3	10.5	5.8	5.0	6.0	9.0	10.1	4.5	4.1	6.5	7.1	6.5	4.8	6.7	4.9	8.7	6.8	5.2	4.6	9.8	10.7	9.0	10.4	9.7	7.9	12.0	7.0	13.7	4.6	4.8	10.7	13.2	6.1	12.0	10.9	9.3	5.6	7.3	5.2	9.4	11.8	6.4	7.0	4.6	17.1	9.9	2.8	6.0	8.0	16.0	5.6	5.4	3.4	4.8	1.3	10.0	7.4	8.3	7.7	5.4	5.0	4.4	9.2	5.4	5.3	11.8	4.9	12.6	10.8	7.7	11.6	6.1	10.4	9.0	5.9	8.1	6.3	8.1	10.7	6.3	6.0	9.6	9.6	7.9	6.9	6.8	10.3	8.5	5.6	20.1	21.4	20.7	25.3	19.3	20.4	21.9	20.2	21.3	21.0	20.0	26.3	47.3	32.1	49.5	50.9	22.8	27.5	52.5	157.7	27.3	17.9	18.6	20.8	66.8	37.1	98.7	36.8	14.6	57.2	25.8	19.8	86.1	52.0	72.8	48.4	28.4	37.4	21.1	9.9	30.9	46.5	47.6	43.9	17.3	28.7	35.5	20.8	32.9	24.7	47.7	18.5	37.8	23.6	93.6	20.5	16.1	24.6	36.7	21.3	32.0	24.4	38.6	57.9	16.5	44.7	102.1	34.2	27.5	37.2	27.6	31.4	40.3	102.4	98.6	30.5	65.7	39.3	64.6	190.8	71.6	20.5	27.3	73.5	24.4	45.9	22.2	42.5
EVI2B	"CD361, D17S376, EVDB"	ENSG00000185862	"Ecotropic viral integration site 2B"	P34910	17	31303770-31314105	"CD markers, Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 189.0;lymphoid tissue: 169.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 233.2;Kupffer cells: 522.3;Langerhans cells: 169.8;Macrophages: 271.9;monocytes: 426.4;T-cells: 170.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1366.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 1366.0;monocytes: 381.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 87.9;HL-60: 99.9;HMC-1: 133.3;Karpas-707: 96.4;NB-4: 79.4;RPMI-8226: 147.7;THP-1: 124.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA007346, HPA053383"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"		"HPA007346: , HPA053383: "	"unprognostic (1.07e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (1.56e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.73e-2)"	24.6	11.0	6.4	100.9	7.3	189.0	13.8	7.3	11.6	13.1	8.7	27.9	23.7	7.4	4.3	11.8	7.8	30.5	6.7	6.3	8.4	5.1	24.9	61.1	159.5	13.3	10.3	5.5	3.0	3.8	1.8	15.4	10.8	7.4	30.5	1.2	11.8	6.1	2.0	5.1	39.2	17.0	7.7	158.8	33.7	3.7	8.5	76.4	5.3	12.2	169.8	38.5	4.1	11.1	0.6	0.7	0.0	0.0	6.5	8.3	0.1	0.8	5.8	6.7	12.4	0.0	3.4	87.9	0.1	5.5	26.4	0.6	0.0	1.2	7.5	0.1	0.0	2.1	0.0	0.0	66.0	99.9	133.3	15.3	0.0	3.9	5.3	2.2	6.9	7.3	1.4	96.4	19.8	0.0	29.4	79.4	0.1	0.0	0.0	51.0	0.4	147.7	0.3	0.2	0.0	0.1	0.4	0.2	0.5	0.0	0.0	124.8	7.2	1.9	0.2	0.7	7.0	18.4	0.9	18.9	8.6	34.0	2.2	1005.3	328.9	798.7	79.2	240.1	76.8	183.6	120.8	102.8	149.9	146.2	91.9	87.5	1366.0	44.2	381.9	86.3	173.6	251.4	6.4	7.3	7.3	11.6	6.3	8.4	13.3	10.3	10.8	7.7	8.5	11.1	2.1	0.0	14.8	0.7	233.2	5.4	0.7	0.7	1.8	0.2	1.5	1.7	1.0	2.8	6.7	1.8	0.0	0.6	129.0	1.3	0.0	0.3	8.3	0.1	0.3	5.6	0.0	6.5	2.7	0.0	0.8	4.0	1.5	0.4	82.2	0.0	7.5	2.3	89.1	0.0	3.1	0.1	2.0	522.3	169.8	9.0	0.0	271.9	37.4	11.2	426.4	0.0	117.4	4.0	31.7	1.0	0.0	0.4	110.4	0.4	0.1	1.1	2.4	0.8	19.7	1.2	1.9	0.4	0.4	0.4	3.7	0.3	170.9	0.0	1.3	1.1
F5		ENSG00000198734	"Coagulation factor V"	P12259	1	169511951-169586588	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"choroid plexus: 142.8;liver: 176.2;placenta: 46.9"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 74.4;Cytotrophoblasts: 82.7;Hepatocytes: 253.4;Syncytiotrophoblasts: 59.5"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 69.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 4.1;eosinophil: 8.1;neutrophil: 7.0;T-reg: 6.2"	"Group enriched"	"Detected in many"	13	"granulocytes: 8.1;monocytes: 4.1;T-cells: 6.2"	"Group enriched"	"Detected in some"	23	"Hep G2: 32.8;OE19: 125.5"	"Group enriched"	"Detected in many"	5	"basal ganglia: 2.7;hippocampal formation: 6.6;pons and medulla: 4.4;thalamus: 5.4"	"Group enriched"	"Detected in all"	7	"amygdala: 39.9;basal ganglia: 35.0;cerebral cortex: 67.9;hippocampal formation: 61.4;olfactory bulb: 27.6"	HPA002036			Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	7670000000	13000000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"HPA002036: AB_1078787"	"unprognostic (3.67e-2)"	"unprognostic (2.77e-4)"	"unprognostic (5.42e-2)"	"unprognostic (2.56e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.39e-4)"	"unprognostic (3.46e-3)"	"unprognostic (9.25e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.99e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (3.39e-4)"	"unprognostic (7.15e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.31e-1)"	1.1	0.0	0.3	3.2	1.4	3.7	0.6	4.4	1.3	0.1	142.8	0.3	0.9	0.1	0.2	0.2	3.5	17.6	2.7	4.4	1.6	1.5	176.2	0.9	2.2	1.9	2.2	0.0	0.8	0.0	1.6	46.9	2.4	1.3	0.6	1.0	6.2	0.0	0.2	1.3	0.3	1.1	0.8	1.8	4.9	0.5	2.2	0.5	0.4	0.2	2.3	3.8	0.1	4.2	0.0	0.6	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.2	1.5	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	32.8	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	125.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	4.1	8.1	0.0	0.2	0.0	0.0	1.4	0.2	0.4	0.0	0.3	0.0	7.0	0.0	0.0	0.0	6.2	1.1	0.3	1.4	4.4	1.3	4.4	1.6	1.9	2.2	2.4	0.8	2.2	4.2	0.0	3.2	0.6	1.6	0.7	0.1	6.1	0.0	0.0	0.3	0.7	0.3	9.4	74.4	1.9	0.0	2.1	82.7	0.1	0.3	0.0	2.4	2.4	0.9	0.0	2.4	25.2	0.0	5.4	0.2	2.3	5.3	4.1	0.2	0.0	2.8	3.6	253.4	5.3	0.0	2.6	0.1	0.0	12.3	0.4	0.3	0.0	7.1	3.6	0.0	18.2	1.0	2.1	0.5	1.0	1.9	0.0	0.0	0.1	1.8	0.0	0.2	3.1	0.1	0.0	2.4	0.2	0.5	0.5	0.0	0.0	59.5	2.5	0.0	0.0	11.8
FAM217B	"C20orf177, dJ551D2.5"	ENSG00000196227	"Family with sequence similarity 217 member B"	Q9NTX9	20	59933764-59948680	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041021, HPA056698"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA041021: AB_10959734, HPA056698: AB_2683212"	"unprognostic (1.78e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.32e-2)"	"unprognostic (9.43e-2)"	"unprognostic (5.05e-2)"	"unprognostic (9.04e-8)"	"unprognostic (2.78e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.63e-2)"	4.8	4.0	8.6	6.3	10.3	13.6	4.9	5.7	17.3	4.8	0.1	4.2	5.1	6.8	5.6	4.6	5.5	4.1	9.9	10.8	6.7	5.3	2.0	5.3	9.3	6.1	6.9	10.7	3.0	3.8	6.9	6.3	6.4	7.5	3.5	8.2	4.3	9.0	15.5	3.5	5.9	4.5	5.9	6.3	4.6	9.5	7.4	9.4	6.8	17.4	8.8	3.6	3.1	12.1	9.1	6.1	14.0	9.6	6.6	9.8	11.2	12.7	10.8	13.8	9.9	31.9	19.4	20.0	21.0	5.3	11.1	21.9	15.2	10.6	13.4	11.1	9.6	18.7	15.5	18.5	4.2	30.2	24.3	5.7	12.9	10.2	3.3	5.6	4.1	23.8	13.6	8.2	9.0	16.6	53.0	16.4	13.6	8.5	12.5	12.7	13.8	19.5	5.3	14.1	14.2	16.9	17.0	21.8	18.9	12.9	21.2	21.1	5.8	11.4	13.3	11.8	6.8	14.0	25.7	23.9	15.8	19.4	7.6	9.3	5.9	8.2	8.5	3.7	10.3	4.9	8.0	7.7	6.5	5.7	8.2	8.8	11.1	8.0	3.6	5.2	7.6	6.0	8.6	10.3	5.7	17.3	10.8	6.7	6.1	6.9	6.4	5.9	7.4	12.1	16.0	16.0	19.4	25.5	18.5	5.4	5.4	13.6	10.2	35.6	16.4	16.0	34.9	10.0	12.1	11.0	22.9	23.4	22.2	11.7	17.6	5.5	29.9	8.4	15.5	16.7	8.4	11.3	33.5	8.2	12.0	18.0	7.1	6.6	29.1	19.3	17.2	5.0	19.1	60.6	32.6	5.3	8.2	34.0	13.4	24.9	17.4	13.2	12.4	12.2	32.4	24.4	44.3	22.6	27.9	8.1	5.1	10.1	16.8	9.6	26.3	14.5	17.5	32.0	32.9	36.2	16.6	52.4	16.2	11.0	5.4	6.8	23.3	13.1	9.5	9.7
FGD3	"FLJ00004, ZFYVE5"	ENSG00000127084	"FYVE, RhoGEF and PH domain containing 3"	Q5JSP0	9	92947523-93036236	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.4;lymphoid tissue: 32.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 41.8;Early spermatids: 66.1;Late spermatids: 99.0;NK-cells: 69.0;T-cells: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 43.9;Karpas-707: 61.4;RT4: 33.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA020963, HPA021018"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		11000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA020963: AB_2670542, HPA021018: AB_2670564"	"unprognostic (5.66e-3)"	"prognostic favorable (5.51e-4)"	"unprognostic (5.05e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (2.23e-7)"	"unprognostic (2.26e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.56e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.22e-2)"	4.7	1.3	1.8	21.9	1.6	39.4	3.5	1.8	4.9	1.5	2.5	3.0	3.1	1.1	0.4	2.4	2.1	4.6	2.0	1.6	2.7	4.9	2.0	10.2	30.8	3.4	2.6	1.4	7.6	0.4	0.7	3.5	3.5	1.7	2.3	0.0	4.9	1.5	1.1	3.2	11.3	2.7	2.7	29.5	4.3	6.5	3.5	32.4	3.3	2.2	17.6	8.1	3.5	4.0	13.3	0.2	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	16.0	9.1	11.3	0.6	0.0	0.1	8.4	0.6	0.0	0.0	19.7	0.1	17.4	0.1	0.6	0.0	4.8	43.9	0.0	0.3	0.0	0.0	0.0	0.0	18.8	0.7	61.4	0.0	22.8	20.7	20.4	0.4	4.3	1.1	20.1	0.0	16.3	0.1	33.5	1.2	0.4	0.0	14.4	0.4	0.4	5.8	21.4	0.0	0.0	0.6	0.1	0.1	6.2	6.6	5.4	3.1	10.3	0.0	142.9	50.6	139.6	49.5	63.4	49.9	28.6	51.4	46.6	37.5	36.9	50.1	44.7	178.2	39.1	99.2	16.8	48.4	74.0	1.8	1.6	1.8	4.9	1.6	2.7	3.4	2.6	3.5	2.7	3.5	4.0	1.7	22.4	9.2	0.0	25.3	0.8	0.6	0.4	0.6	0.1	5.8	1.8	2.5	4.3	2.3	9.2	0.0	2.9	41.8	0.4	0.0	7.2	66.1	1.2	0.2	2.1	1.8	11.8	0.6	0.2	3.2	0.9	0.0	0.6	19.6	3.7	1.8	0.8	15.5	0.0	1.6	0.6	0.0	22.3	6.2	99.0	0.3	20.7	1.8	12.2	20.1	0.4	69.0	5.0	0.5	0.4	0.1	0.4	15.8	0.1	0.0	0.7	0.3	3.9	0.0	0.3	0.8	1.6	2.4	0.5	1.0	4.5	47.3	0.1	0.4	0.5
FNDC3B	"DKFZp762K137, FAD104, FLJ23399, PRO4979, YVTM2421"	ENSG00000075420	"Fibronectin type III domain containing 3B"	Q53EP0	3	172039578-172401669	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 283.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 29.4;hypothalamus: 8.2;pons: 9.4;thalamus: 14.4"	"Immune cell enhanced"	"Detected in many"		"neutrophil: 37.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 37.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007859	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA007859: AB_1078900"	"unprognostic (7.18e-2)"	"prognostic unfavorable (2.41e-5)"	"unprognostic (6.03e-2)"	"unprognostic (6.38e-2)"	"prognostic unfavorable (6.94e-4)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (9.85e-4)"	"unprognostic (2.17e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (9.06e-5)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (5.65e-7)"	"unprognostic (4.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.00e-2)"	34.4	25.5	1.1	26.3	1.1	37.0	16.6	0.6	29.4	26.0	11.9	19.8	13.0	21.9	18.2	9.2	12.5	19.4	24.4	3.5	8.2	17.5	28.5	21.8	8.9	3.3	3.4	22.8	28.3	15.0	8.5	52.7	9.4	12.9	19.6	4.4	21.3	15.6	21.2	7.0	11.4	25.4	0.7	14.7	20.6	9.3	14.4	6.8	32.4	18.5	11.0	38.6	9.5	1.9	47.4	55.9	36.0	43.5	107.6	73.6	87.6	68.3	73.1	43.3	58.3	30.5	100.5	4.2	178.9	99.0	85.6	27.4	12.4	53.2	74.9	27.5	9.2	6.0	34.8	78.6	109.2	62.1	100.1	75.5	24.9	80.8	75.9	102.8	116.7	8.1	10.9	32.6	44.3	14.8	2.4	24.9	20.8	18.0	22.0	5.4	37.5	21.9	44.8	42.1	2.2	10.8	62.2	30.6	53.9	49.3	31.1	28.5	182.6	60.5	28.5	78.9	52.2	67.3	84.0	9.3	63.5	32.7	61.0	13.5	8.3	20.4	4.2	5.3	1.8	1.1	1.3	2.3	4.7	0.1	1.4	2.5	37.5	4.6	2.7	0.7	1.2	3.4	1.1	1.1	0.6	29.4	3.5	8.2	3.3	3.4	9.4	0.7	14.4	1.9	54.8	86.6	49.0	115.2	19.2	63.9	51.4	61.1	39.3	7.5	27.4	31.9	51.0	41.5	47.9	46.0	12.5	41.4	29.2	53.1	15.6	69.8	16.2	73.7	73.4	61.5	16.8	16.4	37.9	45.6	99.6	103.7	32.6	179.5	15.2	95.2	58.2	68.9	47.1	0.0	43.9	30.7	12.2	59.2	53.3	9.3	57.5	65.1	69.4	155.5	52.2	17.4	39.1	115.6	31.4	78.5	44.8	54.5	283.6	67.8	16.1	35.7	33.6	11.5	52.6	89.4	69.1	2.3	3.2	18.6	33.5	34.8	23.1	26.0	26.2	88.4
FOXD2	"FKHL17, FREAC9"	ENSG00000186564	"Forkhead box D2"	O60548	1	47438044-47440691	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 5.8"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 22.2;Enteroendocrine cells: 9.1;Intestinal goblet cells: 12.6;Paneth cells: 11.1;Sertoli cells: 6.6;Undifferentiated cells: 18.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 3.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AN3-CA: 14.4;WM-115: 23.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"spinal cord: 4.0"							NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (5.10e-2)"	"unprognostic (4.55e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.39e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.81e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.25e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.79e-12)"	"unprognostic (1.00e-3)"	"unprognostic (1.68e-1)"	"unprognostic (9.58e-2)"	"unprognostic (5.91e-2)"	0.4	0.8	0.3	0.6	0.4	0.0	0.3	0.3	1.0	1.1	2.1	5.8	0.3	0.3	0.2	0.1	0.3	0.0	0.1	0.2	0.6	1.9	0.6	0.3	0.1	0.1	1.4	0.1	0.1	0.1	1.1	0.2	0.2	1.3	4.6	0.2	0.3	0.2	0.2	0.2	0.4	0.1	0.2	0.6	0.7	0.4	0.3	0.1	0.2	1.0	0.0	0.2	0.4	0.2	0.8	0.4	0.0	14.4	0.1	0.1	0.4	0.4	0.1	0.0	0.1	1.0	0.2	0.2	0.6	0.0	1.2	0.2	0.6	0.0	0.0	1.8	2.3	0.5	0.3	0.1	0.0	0.2	1.3	0.0	0.8	0.0	0.0	0.3	0.0	0.8	0.4	0.1	0.1	0.4	0.2	0.6	0.0	0.4	0.5	1.9	1.1	0.7	0.0	0.9	2.0	0.0	0.6	0.8	2.0	0.4	4.0	1.1	0.3	0.5	1.5	0.1	0.7	0.4	0.2	0.3	0.6	0.9	23.2	0.2	0.1	0.4	0.5	0.1	0.4	0.2	0.2	0.4	0.0	0.2	0.1	0.3	0.4	0.1	0.1	0.0	0.1	0.0	0.3	0.4	0.3	1.0	0.2	0.6	0.1	1.4	0.2	0.2	0.3	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.3	0.1	1.3	0.0	0.2	0.0	0.0	0.0	1.4	22.2	0.0	0.2	0.4	0.1	1.1	0.3	9.1	0.0	0.0	0.7	0.0	0.8	1.1	0.1	0.0	0.0	0.0	1.3	0.1	0.0	0.0	12.6	0.0	1.4	0.8	1.1	0.0	0.4	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.2	11.1	0.7	0.0	0.0	1.3	0.2	0.4	0.2	6.6	0.2	2.0	0.7	1.5	0.0	0.1	0.0	1.0	0.0	18.1	0.0
FPGT-TNNI3K		ENSG00000259030	"FPGT-TNNI3K readthrough"		1	74198235-74544393	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"heart muscle: 8.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 13.1;Cardiomyocytes: 10.2;Cone photoreceptor cells: 10.4;Excitatory neurons: 10.3;Inhibitory neurons: 11.2;Oligodendrocyte precursor cells: 17.1;Oligodendrocytes: 26.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.3;CAPAN-2: 2.2;SiHa: 3.1"									HPA072331			Approved	Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA072331: "	"unprognostic (6.29e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.44e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.37e-2)"	"unprognostic (6.76e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.11e-2)"	"unprognostic (7.87e-3)"	2.4	1.2	0.8	0.5	1.3	0.4	1.4	2.9	1.9	1.1	0.0	1.8	0.3	1.4	0.8	1.4	1.3	0.8	8.7	1.0	1.2	1.6	0.4	1.4	0.6	1.0	1.0	1.3	0.5	1.0	1.4	0.5	1.4	1.2	0.7	3.4	0.9	1.3	3.5	2.1	0.8	1.5	1.1	1.5	1.0	0.8	0.9	0.2	1.1	1.8	0.6	1.3	1.1	2.4	0.0	0.5	0.3	0.7	0.4	2.3	0.0	1.0	0.5	0.1	0.1	0.5	2.2	0.0	1.5	0.1	0.0	0.0	0.1	1.5	0.2	0.0	0.0	0.8	0.0	0.0	0.3	0.2	0.1	0.9	0.9	0.0	0.1	0.3	0.1	0.1	0.0	0.8	0.5	0.0	0.0	0.1	0.0	0.8	0.4	1.1	1.8	0.0	0.2	0.0	0.5	1.5	3.1	0.1	0.1	0.0	0.0	1.0	0.1	0.3	0.1	0.1	0.4	0.1	0.0	0.9	0.4	0.5	0.4	1.3	1.6	1.4	0.4	1.9	1.2	0.9	1.4	0.8	0.9	0.9	1.8	0.9	1.8	0.4	0.5	0.8	1.6	1.6	0.8	1.3	2.9	1.9	1.0	1.2	1.0	1.0	1.4	1.1	0.9	2.4	0.5	3.2	1.1	13.1	0.9	0.1	0.5	0.2	0.0	4.9	0.6	0.9	10.2	1.5	0.7	0.0	10.4	0.2	0.2	0.5	0.0	0.2	1.4	0.6	0.3	0.9	3.0	0.0	10.3	1.0	0.2	1.3	0.0	0.2	2.5	1.6	1.8	0.5	0.2	5.0	11.2	0.2	0.0	0.9	0.3	0.6	2.8	0.7	1.8	7.5	0.1	1.1	0.0	17.1	26.7	1.3	1.6	0.7	0.3	0.3	0.0	1.4	1.6	2.7	0.0	1.5	1.1	2.1	1.7	0.1	0.1	0.0	0.4	0.8	0.5	0.2
FUZ	"CPLANE3, FLJ22688, Fy"	ENSG00000010361	"Fuzzy planar cell polarity protein"	Q9BT04	19	49806866-49817376	"Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 78.7"	"Group enriched"	"Detected in many"	18	"Early spermatids: 1243.5;Late spermatids: 2329.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041779, HPA042196"	Approved		Approved	Cytosol		No	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA041779: AB_10793974, HPA042196: AB_10797383"	"unprognostic (2.40e-3)"	"unprognostic (1.31e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.36e-3)"	"unprognostic (9.67e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.50e-5)"	"unprognostic (1.26e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.70e-1)"	9.3	17.6	17.3	2.8	21.0	6.2	9.3	18.8	20.8	11.2	19.7	12.1	4.2	11.1	7.3	6.8	19.5	5.2	13.6	16.4	16.8	16.8	7.1	7.7	4.6	19.9	19.1	15.4	12.3	7.1	12.5	4.0	18.2	11.2	1.9	4.9	7.5	7.3	20.4	6.6	6.9	4.1	19.5	8.8	10.2	78.7	18.7	6.0	11.5	12.4	2.2	9.0	8.2	20.4	0.1	10.6	9.5	12.2	8.9	9.5	2.7	5.2	5.4	7.9	11.0	0.9	17.2	3.1	10.6	4.9	2.5	4.3	2.7	9.2	3.5	11.7	20.5	13.0	7.6	0.0	10.1	7.6	7.0	10.1	6.3	16.1	4.0	6.2	7.5	18.6	3.0	8.7	4.1	0.5	14.1	15.4	15.7	8.4	6.3	24.4	7.7	7.4	9.7	2.7	26.5	31.0	1.0	10.8	17.9	3.7	6.2	4.7	3.7	6.6	5.9	1.9	1.9	24.9	26.5	8.4	7.6	0.2	8.4	7.0	4.6	17.7	4.9	2.2	4.1	5.3	3.1	4.2	3.8	6.0	3.8	4.3	10.6	3.8	1.6	15.0	3.8	2.6	17.3	21.0	18.8	20.8	16.4	16.8	19.9	19.1	18.2	19.5	18.7	20.4	9.2	0.0	2.8	6.2	8.4	3.8	19.3	10.1	8.6	7.2	14.5	14.6	3.9	17.2	7.3	7.3	4.2	17.5	12.2	1.9	66.5	15.3	1243.5	61.6	8.0	6.5	2.4	19.3	2.7	5.1	12.1	11.1	6.1	8.1	10.2	11.5	13.6	5.8	13.2	10.1	3.0	3.5	12.2	7.1	7.6	2329.6	27.7	6.7	0.0	2.8	7.9	26.1	5.2	2.0	9.9	4.5	6.1	17.7	10.9	8.0	7.3	86.1	35.4	11.3	0.0	17.1	9.9	95.3	13.5	5.0	4.1	12.0	6.4	13.7	5.5	14.1
FXR2	FMR1L2	ENSG00000129245	"FMR1 autosomal homolog 2"	P51116	17	7591230-7614897	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 120.9"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 63.9;Rod photoreceptor cells: 55.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011205, HPA022997"	Supported		Supported	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"CAB011205: AB_476964, HPA022997: AB_1849208"	"unprognostic (9.57e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.15e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.49e-6)"	"unprognostic (2.79e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.64e-1)"	"unprognostic (7.79e-2)"	"unprognostic (7.67e-2)"	19.7	27.9	31.5	11.4	34.3	9.8	17.4	36.5	37.9	21.2	26.9	26.7	13.9	21.7	11.6	20.9	20.1	10.9	66.0	33.2	40.0	22.2	20.6	19.2	14.1	41.1	40.9	20.4	16.2	30.7	33.0	15.5	43.4	21.6	11.5	37.7	19.9	18.2	120.9	22.5	17.4	17.1	33.4	16.8	19.9	27.4	37.2	20.8	17.1	84.4	15.1	23.3	19.4	34.9	36.6	48.3	43.8	45.7	36.7	25.0	33.7	54.2	45.1	77.2	53.2	27.2	11.9	33.8	34.8	37.2	34.1	40.1	58.2	24.8	51.4	39.1	62.4	19.6	42.2	15.9	35.7	0.2	39.8	23.5	35.8	58.8	56.4	43.3	27.1	26.9	35.4	11.6	38.8	18.6	26.9	19.3	26.2	18.9	25.8	37.9	26.6	21.3	28.2	13.0	26.1	47.2	37.3	24.3	37.8	41.3	25.3	14.5	24.3	36.0	22.5	24.0	64.8	19.0	18.6	15.5	41.3	15.8	48.0	2.6	0.8	2.5	0.9	1.0	1.3	0.5	1.5	1.9	1.3	0.9	1.2	1.3	2.1	1.0	0.6	0.9	1.8	0.8	31.5	34.3	36.5	37.9	33.2	40.0	41.1	40.9	43.4	33.4	37.2	34.9	10.3	32.1	17.9	10.7	7.7	11.5	15.4	7.9	2.8	46.9	10.4	8.3	41.7	8.6	9.5	16.5	31.3	15.9	15.1	12.0	1.9	11.6	1.8	11.1	9.2	10.5	9.6	15.6	10.3	9.3	11.5	10.8	10.7	11.0	2.5	12.9	15.0	11.7	9.1	63.9	12.0	10.1	10.2	7.3	9.7	2.7	9.6	7.1	0.0	3.7	7.4	23.3	16.5	8.5	12.4	17.6	12.5	15.4	6.3	15.4	15.5	8.9	7.6	55.8	6.6	14.2	17.7	22.9	28.2	8.7	14.3	17.1	7.6	14.6	7.4	10.3
GABARAPL2	"ATG8, ATG8C, GATE-16, GATE16, GEF2"	ENSG00000034713	"GABA type A receptor associated protein like 2"	P60520	16	75566375-75577881	"Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036726	Uncertain		Uncertain	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA036726: AB_10672476"	"unprognostic (3.29e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.30e-2)"	"unprognostic (7.00e-2)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (2.58e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.95e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.33e-2)"	"prognostic favorable (5.95e-8)"	"unprognostic (3.11e-3)"	"unprognostic (3.84e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.85e-1)"	129.2	166.9	269.1	68.0	278.1	101.6	122.3	297.7	310.8	105.9	237.2	118.5	67.1	101.3	158.1	91.9	106.0	84.1	279.9	259.7	294.9	153.8	113.6	111.3	94.7	280.8	278.4	108.7	81.4	209.5	169.0	113.8	289.2	113.7	81.4	201.4	100.8	102.2	262.9	135.0	90.1	98.6	306.0	112.0	99.7	78.3	282.4	102.1	124.5	186.7	98.9	95.3	104.8	320.2	103.4	85.9	142.7	67.7	217.1	189.9	72.6	118.2	169.9	158.0	176.4	79.8	129.1	148.1	143.0	135.3	95.2	86.6	107.6	110.6	193.9	64.8	208.7	86.9	72.2	119.1	118.2	84.1	151.3	132.0	153.5	133.3	98.6	143.0	130.5	130.5	130.3	58.4	160.2	145.7	125.4	161.0	85.8	114.5	95.8	139.4	69.0	179.6	166.2	66.4	167.7	175.5	184.7	43.7	177.4	113.3	140.1	130.4	119.5	67.9	104.7	100.0	64.5	166.2	172.8	310.6	163.6	80.6	102.6	345.1	148.8	370.8	128.4	140.3	163.0	215.0	135.2	146.8	176.8	199.0	121.4	114.6	502.5	115.3	157.0	274.1	208.1	241.5	269.1	278.1	297.7	310.8	259.7	294.9	280.8	278.4	289.2	306.0	282.4	320.2	341.0	86.6	136.2	30.7	163.9	274.9	278.8	311.4	141.7	247.9	196.5	236.2	361.4	145.8	212.5	174.7	45.9	251.3	188.5	201.5	686.7	183.9	48.2	209.6	112.8	270.1	277.8	457.6	37.0	175.4	120.6	203.5	80.5	162.4	110.1	85.9	239.8	128.5	223.9	307.9	39.6	156.4	297.0	169.6	428.8	59.7	243.5	197.2	257.9	21.5	404.6	491.0	145.2	27.6	63.6	223.6	237.0	261.1	137.5	306.1	195.7	552.4	263.0	208.1	157.8	182.1	187.9	288.1	219.9	136.6	273.9	390.1	159.3	182.5	121.2	328.6
GALNT7	GALNAC-T7	ENSG00000109586	"Polypeptide N-acetylgalactosaminyltransferase 7"	Q86SF2	4	173168811-173323967	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 143.4;Inhibitory neurons: 172.0;Intestinal goblet cells: 126.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064243, HPA065317"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		6200000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"	Nucleoplasm	"HPA064243: AB_2685223, HPA065317: AB_2685465"	"unprognostic (1.81e-1)"	"unprognostic (2.11e-1)"	"prognostic favorable (4.53e-4)"	"unprognostic (1.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (6.86e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (7.65e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.66e-3)"	"unprognostic (3.05e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.34e-3)"	"unprognostic (5.97e-2)"	6.4	6.4	6.4	16.3	8.8	11.5	23.3	34.2	8.3	25.1	3.5	47.8	29.1	16.9	7.0	14.9	9.8	15.6	5.9	6.6	7.8	7.8	2.9	9.6	12.2	12.6	8.3	11.2	22.2	8.7	5.2	13.0	11.7	39.7	52.8	22.4	27.4	8.1	1.4	3.9	33.7	16.7	10.1	11.0	65.7	11.9	8.4	60.0	13.5	3.9	9.8	17.0	5.9	16.0	71.1	37.2	35.0	11.2	18.6	27.1	50.3	18.1	20.5	16.7	23.0	11.5	109.9	39.4	13.3	16.6	45.2	59.2	15.0	32.0	22.7	154.3	29.1	47.8	72.2	0.4	12.2	71.6	32.8	17.5	28.3	37.6	18.9	63.4	112.3	28.2	32.6	59.3	86.0	23.5	52.7	39.4	34.8	70.2	24.0	52.1	32.4	10.2	123.2	32.8	28.2	21.5	8.5	50.4	25.4	45.3	20.2	21.0	135.6	11.9	52.3	0.6	40.0	17.2	0.2	20.8	48.6	42.3	43.6	13.2	14.3	18.9	5.1	7.5	7.2	6.2	5.7	5.3	12.4	3.3	4.4	3.3	21.3	7.5	8.0	5.0	9.2	6.4	6.4	8.8	34.2	8.3	6.6	7.8	12.6	8.3	11.7	10.1	8.4	16.0	10.0	6.4	38.0	72.8	12.1	1.8	9.0	12.3	4.0	47.9	41.1	19.8	9.6	8.6	36.0	20.2	2.1	1.4	16.4	143.4	0.0	14.4	2.5	28.3	13.3	11.3	22.8	12.0	74.4	48.9	3.7	12.1	102.4	52.9	24.1	14.8	12.1	0.2	10.3	10.1	172.0	126.8	24.4	17.9	6.2	4.2	9.3	17.2	8.8	62.8	16.3	8.1	5.2	71.4	54.1	39.9	50.0	5.3	6.6	52.8	63.7	10.0	17.4	25.5	13.1	16.1	11.7	3.8	5.5	14.9	1.1	0.8	9.9	13.1	48.6	19.4
GDI1	"FLJ41411, GDIL, MRX41, MRX48, OPHN2, RABGDIA, XAP-4"	ENSG00000203879	"GDP dissociation inhibitor 1"	P31150	X	154436913-154443467	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 438.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012979, HPA049290, HPA057668"	Enhanced		Approved	Cytosol		NA	NA		31000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 58: T-cells - T-cell receptor"	Cytosol		"CAB012979: AB_2533970, HPA049290: AB_2680700, HPA057668: AB_2683498"	"prognostic unfavorable (6.84e-4)"	"unprognostic (1.13e-2)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.98e-3)"	"unprognostic (3.86e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.70e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.72e-1)"	77.3	85.9	351.5	54.9	381.7	41.2	67.4	309.6	438.5	99.7	214.0	91.8	36.7	92.2	46.2	57.5	94.6	47.3	99.1	391.8	349.9	74.4	53.9	90.1	53.9	344.5	312.7	120.0	54.7	63.4	176.0	60.4	349.5	74.9	41.7	130.9	49.7	69.5	62.9	61.6	67.5	78.9	311.4	89.4	68.5	54.1	330.6	58.7	63.0	70.8	51.1	89.2	81.2	366.2	100.2	88.9	195.9	164.6	77.7	91.4	64.5	149.6	91.1	140.4	146.0	52.6	51.1	79.5	149.3	139.4	213.2	79.7	172.7	83.9	96.5	147.5	93.8	25.0	142.6	35.5	113.5	24.6	90.5	94.7	101.3	163.4	99.6	154.6	92.4	95.7	31.1	120.5	169.4	99.2	77.9	62.1	53.0	106.1	168.8	77.6	51.6	45.0	98.8	46.5	272.5	210.3	67.6	86.1	109.0	150.3	50.9	42.5	110.4	131.9	116.8	138.4	212.0	182.1	202.0	128.3	140.7	54.5	162.5	23.7	8.4	26.9	12.1	12.6	18.0	9.9	13.0	12.0	7.0	10.1	10.0	10.1	30.0	8.7	21.3	12.1	16.2	7.3	351.5	381.7	309.6	438.5	391.8	349.9	344.5	312.7	349.5	311.4	330.6	366.2	39.3	16.0	27.4	30.3	35.9	27.1	24.8	48.3	33.6	71.3	24.1	25.7	62.6	24.3	29.0	27.6	25.0	22.7	27.0	31.4	31.3	39.4	2.9	33.1	41.1	35.3	90.8	9.2	48.8	31.3	39.3	37.5	37.8	34.3	33.7	29.7	30.4	17.7	36.3	60.6	43.2	24.8	65.1	35.9	40.9	6.0	37.6	35.5	17.8	22.5	59.0	37.7	19.6	33.2	46.4	50.2	25.9	39.9	35.7	27.4	24.3	25.5	46.8	37.1	52.6	29.5	49.8	33.9	66.6	20.7	30.3	49.5	43.2	22.0	15.0	26.2
GID8	"bA305P22.1, C20orf11, FLJ20602, TWA1"	ENSG00000101193	"GID complex subunit 8 homolog"	Q9NWU2	20	62938147-62948475	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049929, HPA055047"	Approved		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Cell Junctions"	"HPA049929: AB_2680957, HPA055047: AB_2682682"	"unprognostic (1.35e-1)"	"unprognostic (4.06e-2)"	"unprognostic (5.90e-2)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (1.19e-1)"	"unprognostic (8.25e-2)"	"unprognostic (3.88e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (3.22e-4)"	"unprognostic (3.97e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.87e-2)"	12.5	13.3	18.8	13.5	18.3	39.2	17.1	18.7	18.3	19.1	16.7	16.6	13.8	16.3	16.8	41.8	20.1	11.1	14.2	19.2	18.6	17.2	24.7	12.7	20.7	17.8	18.4	26.3	20.4	19.0	15.9	13.0	17.4	16.2	14.3	13.0	17.1	14.8	14.8	30.5	15.5	12.5	18.8	16.9	18.1	13.7	19.2	25.3	18.4	13.2	23.1	15.6	22.5	18.3	39.9	25.0	36.6	33.2	29.5	23.1	35.8	21.8	18.2	61.1	27.5	121.4	37.9	49.9	36.5	28.4	25.1	45.2	33.9	45.3	36.9	13.4	16.6	46.5	32.8	58.6	23.2	54.5	37.7	25.6	49.4	26.4	30.4	22.2	30.1	32.5	36.3	21.0	21.3	56.0	65.3	48.4	37.0	66.1	37.0	51.1	68.8	29.9	22.5	55.4	38.0	31.0	51.5	49.9	32.8	27.0	69.5	51.9	30.6	36.4	45.4	28.8	29.9	21.9	27.0	51.2	24.6	26.2	23.5	5.3	9.5	15.4	9.8	8.3	11.6	7.4	10.4	11.1	8.9	8.2	11.2	12.7	13.5	12.3	7.7	6.7	9.9	8.1	18.8	18.3	18.7	18.3	19.2	18.6	17.8	18.4	17.4	18.8	19.2	18.3	33.5	19.2	27.4	11.4	42.7	51.6	46.9	76.6	50.1	23.1	56.4	53.0	30.9	52.9	46.5	40.5	6.2	101.7	48.6	57.3	41.1	44.7	19.1	46.4	27.4	37.7	45.0	71.1	17.7	40.4	105.1	35.1	27.0	40.1	26.6	24.4	46.4	77.7	51.8	16.8	15.0	50.1	50.8	47.9	46.4	19.4	32.9	42.9	24.9	11.2	62.1	28.3	51.5	11.6	14.4	40.8	39.2	42.2	44.0	68.2	55.7	42.5	38.8	16.5	13.1	34.1	30.7	49.1	57.9	82.1	79.8	156.9	45.8	21.6	52.1	71.7
GLIPR2	"C9orf19, GAPR-1"	ENSG00000122694	"GLI pathogenesis related 2"	Q9H4G4	9	36136536-36163913	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 188.5;Langerhans cells: 203.6;Macrophages: 117.6;monocytes: 203.0;NK-cells: 180.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 71.6;HDLM-2: 72.9;TIME: 127.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029478	Approved		Uncertain	Vesicles,Microtubules		NA	NA		19000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Microtubules	"HPA029478: AB_10670038"	"unprognostic (1.57e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.21e-1)"	"unprognostic (5.87e-2)"	"prognostic unfavorable (6.54e-7)"	"unprognostic (6.57e-3)"	"unprognostic (4.94e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.43e-2)"	38.5	20.9	17.6	52.7	22.8	73.8	32.4	21.0	22.6	45.9	14.1	73.7	14.7	77.8	15.1	18.6	36.9	24.1	24.2	17.2	19.3	8.8	6.9	62.6	29.9	24.8	22.1	13.3	5.6	2.5	4.9	8.8	22.3	38.3	33.1	2.7	15.3	39.3	7.7	12.2	32.2	63.8	22.8	41.3	25.3	3.4	26.7	18.7	15.8	11.1	19.2	38.8	27.4	27.6	3.7	2.9	20.9	22.3	71.6	33.3	2.4	32.9	20.0	7.8	14.1	1.3	0.3	0.2	10.2	30.9	19.7	0.2	7.9	1.1	4.7	72.9	6.4	8.8	6.2	0.4	27.9	5.7	28.3	23.4	1.0	44.5	7.8	14.0	62.5	22.6	0.4	5.0	17.4	7.9	27.9	15.2	20.1	0.3	10.7	18.9	44.1	1.0	1.6	1.8	5.6	11.3	4.4	2.2	3.6	42.2	2.3	24.0	127.3	10.7	24.8	9.6	28.0	7.8	2.2	12.7	11.0	35.0	2.5	268.6	360.9	540.3	168.4	162.5	89.1	24.4	114.3	108.2	208.3	24.5	47.0	74.7	657.0	125.5	124.9	18.5	132.2	414.0	17.6	22.8	21.0	22.6	17.2	19.3	24.8	22.1	22.3	22.8	26.7	27.6	11.9	3.2	25.4	4.6	22.3	13.4	2.5	14.7	1.8	0.3	46.9	19.0	2.6	2.8	30.9	5.5	0.0	3.8	66.9	14.7	0.0	21.2	0.7	1.8	33.9	13.3	8.4	58.7	1.1	1.3	3.3	54.3	11.7	2.1	52.6	1.9	16.1	0.9	188.5	0.0	0.8	42.4	14.2	83.2	203.6	2.3	18.0	117.6	62.2	2.8	203.0	21.4	180.2	3.0	28.6	5.2	16.1	25.9	22.8	16.0	4.0	1.1	64.3	0.5	46.0	44.7	43.2	0.9	6.4	0.9	10.2	3.4	75.5	10.9	45.3	3.3
GMEB1	"P96PIF, PIF96"	ENSG00000162419	"Glucocorticoid modulatory element binding protein 1"	Q9Y692	1	28668778-28719353	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044811, HPA052975"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA044811: AB_10959666, HPA052975: AB_2682003"	"unprognostic (1.52e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.49e-2)"	"prognostic favorable (1.94e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (8.91e-7)"	"unprognostic (1.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.38e-2)"	"unprognostic (8.41e-2)"	"unprognostic (4.79e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-2)"	4.7	3.0	2.3	5.7	2.2	13.6	4.3	5.9	3.1	5.1	3.1	4.4	2.9	4.9	3.0	5.2	4.4	4.2	3.1	2.5	1.9	3.6	3.4	4.3	6.7	2.5	2.2	5.6	4.1	3.3	3.7	5.7	2.5	3.5	4.4	5.6	3.4	3.1	5.3	5.0	4.4	4.8	1.9	5.5	4.1	6.0	2.6	10.6	3.5	4.4	8.0	4.3	4.4	3.1	12.1	8.5	14.1	12.9	4.6	8.5	10.0	12.5	9.0	7.9	11.7	2.7	9.4	22.1	6.5	11.7	4.7	4.6	12.7	9.7	10.2	25.4	7.9	20.4	8.9	5.2	6.9	17.1	10.2	6.8	6.8	19.2	12.3	6.9	11.1	10.8	12.6	17.1	9.6	10.5	10.7	5.7	18.9	8.0	5.7	7.2	9.7	10.3	6.0	9.6	10.4	8.6	12.1	8.0	8.1	9.4	6.1	8.7	11.2	5.4	13.1	9.3	17.0	7.6	13.8	12.1	6.6	15.8	8.7	8.1	5.4	9.9	6.7	7.0	5.1	4.0	6.5	7.9	6.3	6.0	5.3	5.5	7.6	7.5	9.0	4.6	6.0	4.6	2.3	2.2	5.9	3.1	2.5	1.9	2.5	2.2	2.5	1.9	2.6	3.1	12.9	6.4	20.0	3.9	20.5	17.0	19.9	8.6	8.6	23.6	9.0	10.2	4.0	10.0	11.0	14.7	12.5	14.1	17.7	12.7	5.9	10.9	13.3	10.1	12.5	13.2	7.8	26.7	7.0	11.1	16.6	10.0	9.2	16.3	28.5	12.8	16.8	6.1	10.7	25.2	5.9	13.1	10.2	13.4	7.9	2.8	9.6	12.2	1.8	4.7	14.8	17.5	29.9	5.0	9.2	11.5	14.1	7.9	11.5	12.4	8.5	5.7	7.1	24.7	19.7	18.3	13.0	34.8	28.6	8.3	16.8	32.3	19.5	13.2	11.0	19.6
GMFG		ENSG00000130755	"Glia maturation factor gamma"	O60234	19	39328353-39342372	"Plasma proteins, Predicted intracellular proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 577.4;lymphoid tissue: 460.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 304.3;Hofbauer cells: 467.5;Kupffer cells: 523.4;Langerhans cells: 343.2;Macrophages: 409.6;monocytes: 409.4;NK-cells: 423.3;T-cells: 370.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 356.7;HMC-1: 602.6;JURKAT: 464.5;Karpas-707: 494.4;NB-4: 361.6;REH: 409.8;THP-1: 641.5;U-937: 482.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002954	Uncertain	Approved	Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		810000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA002954: AB_1078997"	"unprognostic (1.22e-2)"	"prognostic favorable (7.35e-4)"	"unprognostic (2.37e-2)"	"unprognostic (1.21e-3)"	"unprognostic (9.93e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (9.11e-6)"	"unprognostic (3.01e-1)"	"unprognostic (8.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.27e-3)"	111.6	26.3	27.1	188.6	27.4	577.4	71.3	26.9	41.6	26.0	29.3	45.6	33.8	20.7	19.6	19.7	29.0	60.8	25.1	27.9	29.1	36.8	65.9	117.7	299.5	30.7	30.1	9.2	14.4	15.6	10.8	102.4	30.5	18.5	53.2	2.0	18.9	15.0	11.4	16.2	75.0	47.8	29.1	325.3	41.5	7.4	28.6	460.7	37.6	23.6	262.7	93.5	18.3	32.6	1.4	0.0	2.0	0.4	0.0	0.0	0.7	1.1	0.3	0.3	0.2	0.3	33.1	309.6	2.4	0.3	0.1	1.5	0.0	0.7	1.2	99.7	0.5	329.7	0.4	3.5	5.1	356.7	602.6	0.7	0.6	0.5	0.8	0.8	19.2	464.5	12.3	494.4	2.4	0.0	316.6	361.6	0.6	0.1	0.2	409.8	3.2	196.8	0.5	40.9	0.8	0.5	1.3	1.9	2.1	0.6	0.8	641.5	175.7	0.2	3.2	0.8	1.1	26.9	107.3	340.0	1.7	482.4	2.7	4389.0	1574.5	3622.3	720.9	1447.6	773.8	812.5	1058.2	894.4	1139.9	742.7	1044.5	858.2	5262.9	908.0	1686.2	459.6	1840.4	2617.7	27.1	27.4	26.9	41.6	27.9	29.1	30.7	30.1	30.5	29.1	28.6	32.6	304.3	28.9	97.6	0.0	211.7	18.6	4.4	0.3	2.8	0.0	4.2	9.4	3.2	11.5	17.3	0.0	0.0	3.6	273.5	0.9	0.0	1.1	11.8	0.6	2.2	176.4	0.0	119.4	0.5	0.7	4.0	18.2	9.7	0.8	238.0	0.3	272.4	11.8	467.5	0.0	0.4	0.3	2.0	523.4	343.2	30.4	1.8	409.6	74.7	1.9	409.4	0.7	423.3	0.5	0.3	0.3	0.0	0.4	216.8	1.1	0.3	4.6	8.9	0.3	46.0	4.2	26.4	8.6	3.3	1.4	14.8	5.5	370.6	2.3	1.1	4.1
GPR160	"GPCR1, GPCR150"	ENSG00000173890	"G protein-coupled receptor 160"	Q9UJ42	3	170037995-170085392	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 107.9;parathyroid gland: 216.6"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 194.8;Proximal enterocytes: 362.1;Proximal tubular cells: 151.4;Rod photoreceptor cells: 153.2;Undifferentiated cells: 199.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 123.9;SK-BR-3: 95.8;THP-1: 197.2;U-266/70: 206.2;U-266/84: 127.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA006970	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA006970: AB_1849275"	"unprognostic (1.70e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.21e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (5.71e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (4.93e-7)"	"unprognostic (1.40e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (3.61e-4)"	12.2	1.7	0.7	15.9	1.0	107.9	22.5	1.0	1.6	11.2	0.9	72.0	73.8	5.8	57.9	2.9	5.4	18.6	1.0	0.6	0.7	59.8	4.1	15.0	27.9	1.4	0.9	0.6	18.4	216.6	1.4	4.1	1.1	26.7	72.6	104.7	19.3	6.3	1.3	1.2	98.6	4.4	0.8	25.2	43.0	5.2	0.9	9.5	6.7	2.7	30.4	26.8	1.0	1.2	64.2	1.5	0.3	0.5	0.3	0.4	15.6	0.4	0.5	0.4	1.9	11.7	8.1	29.4	12.9	0.6	4.0	0.7	8.8	0.5	1.0	45.9	17.7	19.1	1.0	24.3	0.2	38.2	24.8	0.2	0.9	2.0	2.3	2.8	1.4	13.7	6.4	73.9	0.4	41.5	2.9	8.4	10.3	39.1	2.4	5.3	1.1	123.9	32.3	86.8	6.1	1.8	0.8	95.8	4.5	8.2	55.9	197.2	1.9	0.2	0.4	7.1	4.8	206.2	127.9	51.4	0.8	40.3	2.8	2.9	1.1	9.3	0.5	0.4	1.0	8.0	1.0	0.4	2.4	12.3	3.0	1.1	11.3	0.4	0.2	3.2	0.3	1.2	0.7	1.0	1.0	1.6	0.6	0.7	1.4	0.9	1.1	0.8	0.9	1.2	35.2	9.6	51.1	0.7	25.9	0.4	3.2	4.1	0.0	9.5	48.5	18.3	1.0	28.6	22.7	62.5	39.6	3.1	11.6	88.9	54.8	10.3	33.7	20.6	4.4	8.7	194.8	0.4	1.5	72.0	21.1	1.0	50.0	54.0	1.3	0.1	20.0	0.9	7.4	15.2	0.6	133.9	18.3	11.7	11.2	36.3	0.6	17.0	28.4	7.5	62.3	16.6	0.0	1.0	0.9	60.3	118.6	0.4	56.8	25.4	362.1	151.4	27.9	153.2	0.0	0.8	1.4	7.4	13.1	0.9	0.9	27.2	4.2	1.2	199.7	35.5
GSK3A		ENSG00000105723	"Glycogen synthase kinase 3 alpha"	P49840	19	42226225-42242625	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism, Neurogenesis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Signal transduction inhibitor, Transferase"	"Alzheimer disease, Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004422, HPA028423"	Approved		Approved	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"CAB004422: AB_627680, HPA028423: AB_10612116"	"unprognostic (5.46e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.02e-4)"	"unprognostic (1.35e-1)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (3.80e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.77e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.22e-2)"	"unprognostic (8.22e-3)"	30.6	43.3	37.5	22.1	44.0	30.7	29.4	33.6	90.2	34.5	13.7	39.4	40.9	38.1	21.7	40.2	31.8	18.7	45.8	47.0	30.9	39.2	30.4	30.4	23.7	39.1	30.9	34.5	29.6	34.4	32.1	19.9	37.6	33.3	21.1	32.6	31.7	25.9	79.2	42.9	37.1	23.0	20.5	31.2	35.4	30.6	38.2	32.9	29.6	42.0	22.7	37.7	33.0	49.5	57.0	102.1	54.3	53.2	30.3	29.5	25.9	42.7	36.1	49.6	46.0	39.0	39.6	41.0	39.6	33.9	44.8	25.6	49.5	51.3	38.5	33.8	74.5	41.5	41.3	42.7	42.7	51.7	54.0	27.2	45.8	41.9	47.7	44.8	46.5	34.7	73.9	63.0	41.1	80.0	87.7	39.0	42.8	84.5	40.0	58.4	33.8	30.4	43.4	76.1	63.7	67.5	52.8	71.6	36.6	42.8	39.5	69.5	40.6	52.0	40.9	31.0	71.9	65.8	82.8	38.7	66.4	49.8	58.2	0.9	0.5	1.4	0.5	0.8	0.9	0.3	0.3	0.7	0.2	0.2	0.2	0.8	1.7	0.3	0.4	0.6	0.5	0.7	37.5	44.0	33.6	90.2	47.0	30.9	39.1	30.9	37.6	20.5	38.2	49.5	45.6	6.4	16.2	5.2	16.4	24.6	17.7	7.3	14.8	40.8	35.0	39.2	12.9	17.2	7.9	16.5	62.6	23.4	31.4	42.3	3.9	15.2	8.6	19.6	21.5	26.6	23.4	28.6	15.1	17.2	25.3	21.3	16.8	25.0	2.5	27.2	18.2	13.9	20.3	60.6	14.9	29.7	6.1	21.3	15.4	14.6	17.7	25.2	16.0	8.4	14.4	41.8	21.6	11.1	12.2	24.2	24.3	16.6	12.6	29.0	45.0	16.0	5.9	47.0	6.6	50.4	27.4	16.4	19.4	20.2	28.1	44.1	20.6	42.6	28.8	30.1
GSTO2		ENSG00000065621	"Glutathione S-transferase omega 2"	Q9H4Y5	10	104268873-104304950	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 35.9"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 133.1;Early spermatids: 314.6;Late spermatids: 442.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 16.9;CAPAN-2: 17.1;hTCEpi: 16.2;hTERT-HME1: 18.3;OE19: 22.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA048141	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"			"HPA048141: AB_2680281"	"unprognostic (5.77e-2)"	"unprognostic (6.69e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.11e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.42e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (7.10e-7)"	"unprognostic (4.56e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.47e-1)"	0.5	3.5	5.0	0.3	5.7	2.0	5.2	3.4	5.3	4.3	0.4	4.4	2.8	2.2	4.9	11.8	4.3	1.2	0.6	4.4	4.1	14.0	2.8	2.4	0.3	2.2	2.5	5.4	16.7	5.0	14.6	1.0	2.6	8.3	3.1	6.0	7.5	3.2	1.4	14.8	3.5	1.2	1.1	0.5	10.9	35.9	4.3	2.2	7.0	1.3	0.7	3.8	7.5	5.3	10.2	1.4	0.5	0.6	0.6	1.3	1.4	9.6	16.9	4.7	4.9	0.6	17.1	1.6	4.0	0.8	0.5	10.7	0.5	5.3	1.2	1.1	3.2	0.5	3.1	2.4	2.1	0.7	0.7	1.7	16.2	0.3	18.3	1.3	0.8	1.7	1.5	2.9	1.3	12.3	0.1	0.5	1.7	22.1	1.1	0.5	0.7	0.3	4.6	6.5	0.6	1.1	3.3	2.4	2.9	0.8	12.6	0.3	2.4	1.5	5.1	0.6	0.5	2.8	6.4	0.4	1.5	0.8	0.5	0.2	0.1	0.7	0.5	0.2	0.3	0.3	0.5	0.3	0.0	0.5	0.7	0.4	1.7	1.0	0.1	0.3	1.2	0.2	5.0	5.7	3.4	5.3	4.4	4.1	2.2	2.5	2.6	1.1	4.3	5.3	3.6	3.2	21.0	13.1	1.3	34.2	62.1	94.5	50.1	19.0	61.7	78.2	3.0	21.5	46.4	40.5	16.7	14.4	3.8	12.8	133.1	30.6	314.6	26.9	7.6	5.4	54.2	3.6	33.9	63.3	9.9	4.7	31.6	37.6	2.5	3.3	15.7	3.6	1.8	0.0	28.7	34.0	50.8	1.6	3.7	442.8	2.8	2.7	17.8	1.9	2.1	11.1	1.0	24.1	20.1	31.6	29.1	9.8	0.9	25.6	27.1	43.8	31.2	23.0	6.6	3.1	7.4	22.0	8.9	46.0	47.3	6.7	4.3	11.6	40.7	58.0
GTDC1	"FLJ11753, Hmat-Xa"	ENSG00000121964	"Glycosyltransferase like domain containing 1"	Q4AE62	2	143938068-144332568	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 330.7;Inhibitory neurons: 188.0;Microglial cells: 130.2;Oligodendrocyte precursor cells: 196.6;Oligodendrocytes: 399.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036694			Approved	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA036694: AB_10671709"	"unprognostic (1.44e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.00e-3)"	"unprognostic (3.36e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.81e-7)"	"unprognostic (8.01e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.22e-3)"	"unprognostic (6.96e-2)"	"prognostic unfavorable (6.60e-4)"	"unprognostic (2.44e-1)"	"unprognostic (8.23e-2)"	"unprognostic (6.31e-3)"	"unprognostic (1.89e-1)"	15.2	12.6	15.9	7.5	18.0	14.2	9.4	11.7	21.1	11.8	4.2	7.1	4.2	6.7	9.4	7.4	5.8	10.1	15.7	17.3	14.3	9.6	6.7	7.8	11.0	15.4	14.7	12.0	7.2	7.4	4.2	9.5	15.4	6.1	6.7	7.7	6.1	5.8	10.0	5.1	4.8	5.9	17.2	13.5	5.2	12.2	14.3	8.7	10.5	11.3	11.6	9.5	5.5	24.1	6.9	2.8	20.0	3.7	20.1	18.4	6.0	4.7	11.9	10.3	14.2	3.1	6.3	14.8	3.3	8.5	6.6	1.9	4.0	7.1	21.9	19.2	4.7	23.0	2.6	3.3	8.3	9.4	12.0	12.8	17.1	11.1	16.2	7.0	14.9	6.1	4.2	16.8	23.7	3.2	2.5	10.3	5.7	5.3	4.5	7.0	10.4	4.0	11.4	14.0	10.2	7.9	9.1	7.7	9.3	12.4	5.1	10.5	9.2	11.4	8.3	5.1	6.0	10.6	0.0	8.5	6.6	6.2	15.6	2.3	2.6	7.9	5.5	2.4	11.8	4.3	3.6	9.3	2.1	3.5	0.8	5.9	11.3	8.5	2.7	0.7	5.1	3.6	15.9	18.0	11.7	21.1	17.3	14.3	15.4	14.7	15.4	17.2	14.3	24.1	7.7	9.6	23.2	82.3	11.2	7.1	4.4	6.4	4.0	20.4	5.2	5.0	18.5	4.3	14.9	5.5	4.2	4.1	13.6	6.1	5.9	4.5	9.9	3.3	11.4	9.6	4.2	9.4	330.7	10.5	5.2	16.0	4.6	5.6	17.7	15.5	20.3	3.8	10.2	18.5	188.0	3.2	4.1	18.3	11.8	7.7	12.8	16.4	5.4	130.2	11.6	10.8	18.6	196.6	399.6	9.4	4.0	13.9	8.6	4.2	2.6	7.7	13.4	3.9	13.1	25.2	17.0	5.4	23.5	4.9	4.7	4.2	19.7	14.8	3.7	8.7
GTF2B	TFIIB	ENSG00000137947	"General transcription factor IIB"	Q00403	1	88852633-88891944	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061626	Supported		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear bodies"		"HPA061626: AB_2684570"	"prognostic favorable (4.81e-4)"	"unprognostic (5.21e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.06e-3)"	"unprognostic (3.74e-2)"	25.3	26.4	14.8	18.8	15.7	62.2	28.3	16.4	24.0	22.9	17.7	22.6	17.9	21.8	30.3	26.3	22.7	23.8	15.7	15.5	16.5	22.9	32.6	22.0	28.9	15.5	15.9	26.3	23.3	22.7	20.3	25.2	15.7	18.1	23.1	17.9	22.9	16.3	23.1	28.3	23.9	20.7	16.2	28.7	23.0	16.3	15.1	40.2	21.2	18.5	31.3	31.5	23.7	17.0	40.0	13.6	34.6	18.8	49.8	34.4	42.9	32.1	39.4	44.1	46.4	17.9	24.3	45.5	37.8	28.0	53.3	22.0	36.8	32.1	38.3	42.8	34.3	48.6	21.2	32.1	31.9	56.8	28.7	30.0	32.1	38.2	21.7	33.4	25.1	41.1	43.1	33.6	47.0	12.6	54.9	46.7	28.8	35.4	29.3	34.4	46.8	34.2	47.0	47.2	26.7	22.4	28.5	35.4	57.8	30.7	15.9	51.1	22.3	19.2	24.0	35.0	38.8	35.1	29.9	62.6	12.8	48.8	16.7	91.2	49.3	82.1	45.9	57.1	53.2	57.8	52.1	50.5	62.5	48.2	62.9	53.9	99.7	54.9	60.4	40.5	70.1	50.9	14.8	15.7	16.4	24.0	15.5	16.5	15.5	15.9	15.7	16.2	15.1	17.0	106.6	6.4	29.7	13.7	114.9	46.3	75.4	63.3	58.6	14.6	39.7	104.9	12.3	21.5	45.6	11.0	2.1	74.0	122.3	39.1	39.2	49.2	22.9	53.9	28.4	30.3	20.3	51.1	22.7	38.6	60.0	53.0	41.8	29.8	48.9	30.2	16.8	17.6	40.5	18.5	21.4	30.5	52.9	32.3	42.5	7.9	36.4	93.4	28.4	22.5	40.3	30.7	33.0	18.1	25.2	49.9	70.5	29.3	74.3	27.8	26.9	47.4	55.2	18.5	13.1	86.6	65.0	24.2	29.0	40.1	50.0	150.1	122.8	34.5	22.7	79.4
H3-3B	"H3.3B, H3F3B"	ENSG00000132475	"H3.3 histone B"	P84243	17	75776434-75785893	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 4220.9"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 1321.3;Cytotrophoblasts: 1625.3;dendritic cells: 844.9;Extravillous trophoblasts: 1626.9;Hofbauer cells: 1908.9;Syncytiotrophoblasts: 3503.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 21089.7"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 21089.7"	"Low cell line specificity"	"Detected in all"											"CAB037166, CAB037187, CAB037221, HPA042570"	Supported		Enhanced	Nucleoplasm		NA	Yes			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB037166: AB_2115285, CAB037187: AB_477069, CAB037221: AB_477076, HPA042570: AB_2678056"	"unprognostic (1.66e-1)"	"unprognostic (8.42e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.43e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.26e-3)"	"unprognostic (9.20e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.99e-1)"	607.2	369.9	223.8	532.5	262.6	4220.9	628.9	264.4	288.8	741.2	186.6	415.4	329.9	507.4	180.3	798.6	585.7	467.9	312.8	210.7	226.0	438.3	380.2	553.2	509.1	268.7	241.9	1166.0	578.0	341.1	357.5	427.1	242.8	348.2	223.1	299.8	519.2	237.1	332.5	1153.2	407.5	322.9	253.7	449.9	393.0	654.3	246.0	464.0	500.7	155.6	296.2	545.3	675.2	316.1	1386.5	1194.2	490.0	486.1	273.3	424.9	675.1	636.7	557.1	764.8	609.3	1290.7	952.6	683.6	593.1	373.2	539.5	530.0	390.5	881.0	432.0	375.9	883.0	612.8	668.2	1112.0	615.7	1029.2	755.0	467.3	534.2	785.6	1004.7	339.3	582.5	437.8	885.6	1193.0	399.4	2015.3	1492.3	859.5	394.8	442.8	1322.8	1091.7	894.2	746.6	607.3	803.5	988.1	1096.0	645.8	933.7	1402.2	259.3	734.2	1091.3	549.1	1359.7	1205.2	595.2	1721.1	1431.3	932.2	843.5	720.5	967.6	761.1	7991.0	3667.6	10060.5	2613.4	3365.8	2482.2	3199.5	2474.2	2478.9	3218.1	2813.7	2635.4	2173.4	21089.7	3240.7	3199.0	3294.6	2999.0	9615.0	223.8	262.6	264.4	288.8	210.7	226.0	268.7	241.9	242.8	253.7	246.0	316.1	1321.3	0.0	0.0	0.0	294.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	398.6	0.0	0.0	0.0	0.0	1625.3	844.9	0.0	0.0	0.0	0.0	0.0	0.0	172.3	0.0	0.0	0.0	0.0	1626.9	485.1	0.0	0.0	0.0	0.0	0.0	0.0	1908.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	257.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	314.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	377.9	0.0	0.0	0.0	0.0	3503.3	211.7	0.0	0.0	0.0
HBP1		ENSG00000105856	"HMG-box transcription factor 1"	O60381	7	107168961-107202522	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 332.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020225, CAB032824"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear speckles"		"CAB032824: AB_2114615, HPA020225: "	"unprognostic (9.00e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.43e-1)"	"unprognostic (4.79e-2)"	"unprognostic (7.49e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.50e-1)"	"prognostic favorable (7.70e-5)"	"unprognostic (7.39e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.69e-2)"	"unprognostic (5.26e-2)"	58.4	49.8	13.2	15.0	18.3	49.0	52.4	17.1	14.8	50.1	15.2	45.9	16.3	53.1	20.0	54.4	40.0	19.9	39.8	13.0	14.7	26.7	37.8	40.1	17.3	19.2	16.1	51.1	34.9	29.0	24.2	24.6	19.2	35.4	17.8	16.5	46.6	22.5	86.4	70.9	34.9	22.1	15.0	34.0	38.0	57.1	14.9	23.6	36.8	39.6	19.9	43.4	51.5	25.7	9.0	10.1	18.8	12.2	38.7	36.1	8.8	15.6	35.1	11.2	19.6	3.6	23.5	8.7	20.4	21.8	23.3	11.4	7.7	9.7	13.9	6.5	7.0	6.0	16.7	6.9	22.1	4.3	17.3	42.3	28.3	10.9	13.3	37.7	37.0	8.8	11.3	21.2	14.5	14.8	7.3	13.6	11.8	12.8	11.5	6.9	13.8	22.4	19.9	11.1	7.3	22.0	18.4	26.7	25.9	25.9	8.3	13.2	35.8	14.7	11.4	22.7	4.7	24.6	31.9	9.0	14.4	9.2	15.3	142.1	59.5	80.0	37.5	61.7	35.8	35.6	39.5	36.5	40.3	34.6	45.2	38.5	146.2	53.8	64.1	20.5	55.6	91.8	13.2	18.3	17.1	14.8	13.0	14.7	19.2	16.1	19.2	15.0	14.9	25.7	67.9	22.4	39.7	37.2	72.9	108.2	77.6	56.2	91.6	29.7	83.1	54.7	22.1	31.5	51.6	33.1	8.4	46.1	95.5	56.1	45.0	50.5	175.9	56.8	45.8	51.8	54.2	59.5	32.6	32.3	26.1	76.8	50.4	93.3	50.7	25.7	35.3	36.8	28.9	42.1	35.2	41.3	85.5	49.8	81.8	332.7	54.0	67.8	74.7	49.6	46.3	33.4	37.0	40.2	91.4	33.7	46.6	57.9	70.2	82.8	55.1	45.3	37.6	29.2	46.0	91.4	70.0	53.0	38.0	55.3	133.0	210.4	94.8	42.6	28.1	89.9
HLA-E		ENSG00000204592	"Major histocompatibility complex, class I, E"	P13747	6	30489509-30494194	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 2347.3;Hepatic stellate cells: 1647.8;NK-cells: 1874.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebral cortex: 109.5"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 212.3;U-266/70: 284.8"									"CAB024589, HPA031454"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA		100000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"CAB024589: AB_324025, HPA031454: AB_2673891"	"unprognostic (1.14e-2)"	"unprognostic (1.38e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.47e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (2.90e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.42e-3)"	724.7	217.2	9.6	173.7	10.0	410.3	578.9	10.9	109.5	360.1	7.3	329.4	0.6	313.5	119.3	330.9	336.5	186.1	356.0	7.7	13.1	375.2	332.8	1144.6	336.3	16.6	22.7	213.2	156.6	95.8	121.8	117.3	16.1	251.2	116.8	12.4	252.5	93.0	179.2	518.3	428.9	89.0	10.0	1007.2	259.5	41.1	11.7	86.0	381.9	0.0	137.5	295.0	366.3	14.2	100.7	16.7	6.8	57.0	212.3	166.4	0.9	0.0	0.0	0.1	0.3	40.0	189.1	65.6	98.7	92.7	148.3	121.6	12.8	53.1	0.0	67.6	32.7	78.6	18.7	0.0	0.0	0.2	38.3	135.4	94.4	67.7	0.0	0.0	0.2	34.6	9.8	0.9	54.5	0.2	0.3	0.8	0.5	32.0	0.0	20.6	0.2	97.4	82.7	58.4	0.3	4.8	63.3	56.9	0.3	1.2	0.0	132.7	102.0	60.7	0.1	0.5	14.7	284.8	171.6	29.4	0.3	62.1	149.2	1140.0	335.4	1153.0	723.3	550.2	602.2	449.1	539.9	709.2	158.5	450.3	531.5	547.8	1916.1	512.9	648.0	138.3	611.7	1441.6	9.6	10.0	10.9	109.5	7.7	13.1	16.6	22.7	16.1	10.0	11.7	14.2	2347.3	310.9	411.0	8.1	950.6	484.6	386.6	284.2	183.8	2.7	238.7	204.0	108.3	231.6	270.0	123.2	6.2	88.2	1304.6	603.0	17.6	484.9	5.0	157.7	157.9	1554.7	216.2	172.3	0.1	677.2	277.0	402.8	233.4	325.6	531.6	59.2	1647.8	120.1	700.6	5.0	0.1	545.3	248.2	1220.4	512.2	11.0	132.0	821.6	466.0	105.9	740.5	100.2	1874.4	2.0	0.5	682.2	559.1	76.3	716.6	436.9	473.9	79.9	214.7	9.5	177.5	535.1	350.1	10.6	7.0	170.0	426.5	359.0	1162.1	196.5	285.0	544.4
HLA-G		ENSG00000204632	"Major histocompatibility complex, class I, G"	P17693	6	29826967-29831125	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins"	Immunity		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"pituitary gland: 13.8;placenta: 11.1"	"Cell type enriched"	"Detected in many"	45	"Extravillous trophoblasts: 1850.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"											CAB016158	Enhanced				"Secreted to blood"	NA	NA	32800000	67000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 28: Placenta - Pregnancy"		"Cluster 38: Extravillous trophoblasts - Unknown function"			"CAB016158: AB_627938"	"unprognostic (1.13e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.40e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.51e-1)"	"prognostic favorable (3.91e-5)"	"unprognostic (6.34e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.03e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.19e-3)"	0.4	0.3	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.8	0.6	0.2	0.0	0.3	0.3	0.1	0.4	0.0	0.0	0.7	0.4	2.7	0.0	0.0	0.0	0.2	1.2	0.0	13.8	11.1	0.0	0.3	0.0	0.0	0.6	0.0	0.2	0.4	0.7	0.0	0.0	1.3	0.7	2.7	0.0	0.4	0.6	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.9	1.4	0.8	0.6	1.0	0.7	0.6	0.9	0.4	0.5	0.5	1.3	2.1	0.8	0.6	0.1	1.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.6	0.0	1.2	22.8	7.3	7.1	1.2	0.0	0.2	0.0	0.8	4.3	1.8	0.0	0.0	10.7	2.7	28.1	0.0	4.5	20.1	0.9	1.3	8.8	17.5	2.7	0.0	5.6	1850.2	5.5	1.5	2.6	0.0	0.7	6.4	1.2	25.5	0.0	0.0	34.3	2.0	8.1	27.3	13.0	2.5	4.8	12.4	0.0	1.4	0.0	3.1	0.0	0.0	24.9	19.9	2.6	0.9	14.3	0.2	0.3	0.6	0.0	0.0	4.8	3.8	5.9	2.8	0.1	35.2	40.5	6.8	1.9	18.2	15.0
HNRNPH2	"FTP3, hnRNPH', HNRPH', HNRPH2"	ENSG00000126945	"Heterogeneous nuclear ribonucleoprotein H2"	P55795	X	101408222-101414133	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 302.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000914, HPA001359, CAB004436, HPA016884"	Supported		Enhanced	Nucleoplasm		NA	NA		640000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"CAB004436: AB_627737, HPA000914: AB_2666143, HPA001359: AB_1079076, HPA016884: AB_1856444"	"unprognostic (1.00e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.88e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.99e-1)"	"prognostic favorable (7.37e-4)"	"unprognostic (8.09e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.66e-1)"	"unprognostic (6.68e-2)"	60.1	70.3	53.5	63.0	57.7	78.0	72.3	53.6	69.6	59.2	58.4	57.2	60.1	61.6	66.1	55.5	55.2	48.7	59.1	57.4	56.8	79.0	77.7	57.4	58.3	56.1	55.5	53.0	42.7	124.0	52.8	71.8	55.6	63.1	60.9	79.4	45.6	72.7	90.4	63.8	59.7	68.7	55.7	59.5	49.0	25.6	55.0	73.0	63.1	77.8	73.2	71.9	47.2	59.8	105.0	72.1	137.8	83.2	119.4	104.0	66.0	87.3	123.5	82.0	166.6	62.1	91.9	107.9	86.6	125.5	112.3	93.8	160.6	122.5	111.9	104.9	78.0	80.1	173.7	84.8	102.2	100.4	74.7	106.1	111.0	80.8	79.3	98.5	113.5	58.1	82.9	150.6	126.8	136.9	83.3	88.7	86.6	171.7	69.7	76.9	146.2	105.1	177.8	140.7	63.1	114.6	130.0	61.3	104.5	97.3	78.9	94.7	122.0	45.0	81.4	129.7	36.2	49.8	76.9	75.0	93.2	114.6	57.5	138.8	104.6	165.1	59.2	112.3	62.9	56.7	56.6	59.3	99.4	54.5	58.7	61.3	247.6	79.5	114.5	41.9	57.4	92.2	53.5	57.7	53.6	69.6	57.4	56.8	56.1	55.5	55.6	55.7	55.0	59.8	46.3	28.9	61.2	0.0	47.7	70.9	94.1	119.0	21.1	40.5	42.6	24.9	48.1	45.8	88.5	90.1	12.5	137.7	37.5	52.0	99.7	99.1	3.2	41.4	35.6	56.1	60.6	41.0	0.0	73.4	65.0	49.0	28.1	44.6	82.4	26.2	52.1	85.3	84.3	16.8	0.0	45.7	83.4	75.4	75.8	6.1	55.3	66.0	69.4	0.0	97.8	44.1	55.6	0.0	0.0	64.5	65.8	59.0	24.6	45.3	58.4	146.2	75.0	34.1	78.9	57.2	64.6	17.6	33.1	28.2	72.0	302.5	42.0	44.3	46.0	64.5
HSD17B11	"17-BETA-HSD11, 17-BETA-HSDXI, DHRS8, PAN1B, RetSDR2, SDR16C2"	ENSG00000198189	"Hydroxysteroid 17-beta dehydrogenase 11"	Q8NBQ5	4	87336515-87391188	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 288.6;liver: 241.6"	"Cell type enhanced"	"Detected in all"		"Paneth cells: 498.6;Proximal enterocytes: 1134.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 768.7"	"Group enriched"	"Detected in all"	4	"granulocytes: 768.7;monocytes: 202.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 295.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021608	Enhanced		Supported	"Lipid droplets"	"Intracellular and membrane"	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	"Lipid droplets"		"HPA021608: AB_1847660"	"unprognostic (4.53e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.14e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.65e-3)"	"unprognostic (5.53e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.04e-2)"	56.0	64.1	15.0	33.0	15.7	109.9	45.5	19.7	18.6	44.0	18.8	139.6	216.7	57.5	28.2	21.5	44.2	107.7	21.0	15.6	18.4	75.9	241.6	104.4	41.5	20.1	17.5	60.6	54.5	10.9	13.1	47.2	18.9	25.5	145.8	8.2	14.8	34.2	12.1	14.5	288.6	49.4	19.3	42.7	36.6	10.1	16.7	36.3	19.3	26.3	34.9	41.8	33.5	22.8	1.0	45.4	22.2	56.1	66.5	92.4	31.2	23.4	39.3	16.1	29.9	38.2	295.2	0.0	45.8	26.2	14.8	0.9	65.6	5.2	18.0	72.1	13.8	63.3	22.9	131.0	37.6	114.8	114.0	65.3	1.7	22.5	7.4	51.3	31.5	27.4	67.9	32.7	30.1	1.8	24.0	144.8	37.8	146.7	7.6	63.2	20.4	77.7	45.5	70.0	7.2	69.3	47.5	1.6	87.0	28.2	0.1	112.7	24.9	11.0	47.9	43.1	13.0	15.0	6.6	7.1	20.1	80.6	77.0	591.1	202.0	442.9	62.5	142.7	74.8	57.1	62.6	64.6	108.2	47.6	55.8	64.2	768.7	82.3	125.8	36.8	77.4	171.6	15.0	15.7	19.7	18.6	15.6	18.4	20.1	17.5	18.9	19.3	16.7	22.8	169.0	314.1	179.5	13.4	89.0	28.0	77.0	16.0	10.8	1.8	5.0	6.2	5.3	368.9	83.7	44.1	2.1	30.6	63.1	356.8	25.4	53.9	1.2	9.0	28.1	101.8	93.7	68.8	16.8	58.6	59.7	77.3	28.1	18.8	100.1	34.1	112.5	337.3	129.1	18.5	14.7	180.8	18.3	220.4	176.2	5.1	104.1	139.1	67.6	43.1	197.3	36.3	113.3	16.6	19.0	65.9	498.6	59.5	60.8	39.5	1134.9	173.6	62.2	3.9	72.3	77.9	43.0	2.7	15.4	10.4	21.5	14.9	93.8	65.4	281.0	93.9
HTATIP2	"CC3, FLJ26963, SDR44U1, TIP30"	ENSG00000109854	"HIV-1 Tat interactive protein 2"	Q9BUP3	11	20363685-20383782	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Apoptosis, Differentiation, Host-virus interaction"	"Developmental protein, Oxidoreductase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 269.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 283.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006417, HPA024321"	Approved		Supported	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA006417: AB_1079091, HPA024321: AB_1851288"	"unprognostic (8.05e-3)"	"unprognostic (2.13e-1)"	"unprognostic (9.31e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.79e-3)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (1.20e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.93e-2)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (8.01e-4)"	"unprognostic (1.20e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-1)"	30.0	57.5	29.6	32.3	35.9	18.6	29.6	33.2	46.1	24.2	34.7	88.4	135.9	13.8	31.4	50.0	13.5	44.8	21.2	29.2	31.3	32.6	97.8	39.1	28.5	34.1	31.7	16.2	26.7	27.8	39.9	28.5	34.6	22.4	80.7	1.9	35.0	20.6	46.2	36.0	121.4	14.4	32.3	38.6	75.4	21.4	32.3	20.2	51.3	21.3	27.4	37.7	35.4	45.8	109.6	177.5	3.9	0.2	52.5	39.4	38.7	46.4	45.8	35.3	41.8	103.2	93.8	24.8	93.1	58.3	136.6	149.7	0.0	28.2	33.9	283.9	21.4	30.8	170.1	0.2	125.3	11.3	139.6	57.3	196.0	28.7	44.5	0.0	102.2	0.0	76.8	31.6	66.3	102.0	0.4	7.0	56.5	193.2	87.1	23.2	0.3	89.8	48.1	60.1	47.2	0.5	150.9	59.1	73.6	18.0	123.7	57.0	125.4	25.1	54.8	51.0	1.2	33.5	44.7	0.6	0.4	76.9	111.4	233.4	133.3	171.1	64.3	126.4	73.4	65.9	74.1	69.2	76.9	76.4	63.9	62.7	304.1	64.5	135.2	23.2	140.9	116.7	29.6	35.9	33.2	46.1	29.2	31.3	34.1	31.7	34.6	32.3	32.3	45.8	49.2	25.6	9.6	3.9	28.0	36.3	60.0	74.2	67.2	1.0	32.9	26.7	11.6	102.9	43.7	47.8	0.0	53.7	16.7	175.6	31.3	91.4	51.1	19.3	6.1	29.5	24.1	28.8	12.9	72.3	118.0	23.8	49.5	34.5	22.9	22.7	33.2	77.5	82.8	3.3	9.1	100.3	105.8	54.0	27.6	59.5	19.9	61.3	44.4	8.4	114.6	9.5	39.1	3.5	40.2	94.7	157.3	9.4	21.4	65.2	269.7	69.0	37.4	1.7	13.1	19.2	28.5	45.5	21.5	87.2	42.1	61.6	33.4	13.2	87.8	62.7
ICAM3	"CD50, CDW50, ICAM-R"	ENSG00000076662	"Intercellular adhesion molecule 3"	P32942	19	10333776-10339661	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 206.5;liver: 73.2;lymphoid tissue: 85.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 151.9;dendritic cells: 164.6;Hepatocytes: 168.8;NK-cells: 313.1;Plasma cells: 137.2;T-cells: 183.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1948.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 1948.5"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 324.6;NB-4: 222.3;RPMI-8226: 257.6;U-266/84: 188.8;U-937: 179.0"					"Not detected"	"Not detected"			"CAB002498, HPA049820"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"		NA	NA		390000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Mitochondria	"Nucleoplasm, Nuclear membrane"	"CAB002498: AB_563593, HPA049820: AB_2680897"	"unprognostic (6.85e-4)"	"unprognostic (5.28e-3)"	"unprognostic (3.09e-3)"	"unprognostic (1.57e-2)"	"unprognostic (5.34e-3)"	"unprognostic (5.79e-6)"	"unprognostic (5.05e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.73e-3)"	"unprognostic (7.93e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.62e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.84e-1)"	18.9	7.4	4.8	50.4	4.6	206.5	10.0	4.5	6.4	4.9	4.4	16.1	15.1	3.6	2.8	7.6	6.2	9.0	18.1	4.5	4.6	11.9	73.2	16.0	72.2	4.9	5.0	2.9	15.2	2.9	1.0	4.6	5.0	6.8	11.0	0.9	15.2	2.9	18.0	4.3	28.1	4.4	5.2	85.8	19.5	2.1	5.2	48.6	6.8	11.9	50.6	14.1	4.4	4.6	12.4	5.8	4.2	13.1	6.8	5.3	7.3	7.5	5.1	5.9	5.2	5.3	8.1	0.2	24.9	6.2	0.1	5.4	0.2	5.5	2.0	106.2	3.7	23.8	5.4	22.6	3.4	96.7	102.1	4.8	4.4	7.0	2.6	6.4	2.9	57.1	13.0	324.6	6.9	24.0	13.9	222.3	3.2	31.7	38.3	11.1	2.7	257.6	6.2	11.2	1.3	5.6	6.5	20.4	17.3	1.9	17.7	23.9	4.6	28.0	3.0	31.2	7.6	20.7	188.8	37.3	20.2	179.0	22.1	193.6	395.4	872.4	362.7	287.8	436.2	280.1	343.0	331.7	327.5	271.7	301.5	283.9	1948.5	380.1	417.4	52.9	436.3	614.5	4.8	4.6	4.5	6.4	4.5	4.6	4.9	5.0	5.0	5.2	5.2	4.6	22.6	3.2	29.7	0.7	151.9	8.2	6.5	7.0	10.2	0.3	23.1	20.6	0.1	21.5	9.8	5.5	0.0	12.0	164.6	49.1	62.6	16.9	7.7	10.7	9.4	19.2	5.4	37.4	0.2	35.4	24.7	10.2	16.8	9.9	30.4	5.5	31.1	168.8	24.0	1.7	0.1	33.2	4.1	70.0	50.4	10.0	6.2	52.9	55.2	1.0	127.7	6.4	313.1	0.0	0.1	23.2	43.8	4.1	137.2	12.3	79.9	54.4	9.0	1.2	0.0	7.3	10.7	5.7	0.7	8.3	8.4	4.7	183.3	5.4	36.4	10.2
IDS	"ID2S, SIDS"	ENSG00000010404	"Iduronate 2-sulfatase"	P22304	X	149476988-149521096	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 323.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"amygdala: 194.3;basal ganglia: 212.9;cerebral cortex: 323.4;hippocampal formation: 320.5;white matter: 109.4"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA078003	Approved				"Intracellular and membrane"	NA	NA		17000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 24: Non-specific - Transcription regulation"			"HPA078003: "	"unprognostic (9.88e-2)"	"unprognostic (1.10e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.52e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.76e-3)"	"unprognostic (3.61e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.87e-1)"	32.7	43.3	194.3	29.5	212.9	47.6	27.9	0.0	323.4	37.5	0.0	35.7	21.1	35.1	43.5	26.1	35.7	26.3	42.2	320.5	25.7	22.7	15.8	40.5	31.0	9.7	9.4	45.4	23.3	57.0	67.8	16.3	3.1	29.4	20.8	48.6	24.7	41.0	25.1	37.1	27.9	30.5	0.2	34.1	23.0	6.1	32.3	17.2	27.2	38.9	36.0	32.8	31.5	109.4	46.4	50.7	19.6	12.7	22.1	40.9	9.2	26.6	67.8	23.3	43.9	10.2	32.7	110.0	69.6	38.3	49.1	22.6	21.3	40.5	30.1	40.8	17.7	11.5	14.7	5.7	17.8	18.8	101.3	21.4	19.6	50.9	33.1	95.5	37.8	20.2	5.7	76.6	34.7	57.9	19.6	9.3	17.5	28.8	34.3	12.4	19.4	20.7	27.8	10.5	28.9	67.6	9.8	22.1	32.0	33.2	6.9	7.9	44.3	29.9	31.3	50.1	70.8	54.5	47.3	79.3	138.0	44.3	22.1	117.5	56.9	171.7	70.9	63.0	53.2	35.2	43.1	54.0	48.7	27.0	28.4	42.9	261.1	37.2	73.9	36.8	74.0	63.0	194.3	212.9	0.0	323.4	320.5	25.7	9.7	9.4	3.1	0.2	32.3	109.4	53.7	99.3	64.4	55.8	150.9	33.1	60.6	44.0	20.5	178.3	43.2	43.8	44.1	27.1	58.9	82.8	45.9	34.2	158.5	66.9	21.5	50.2	1.3	59.8	36.8	44.7	168.4	19.6	232.3	74.0	25.7	78.3	31.1	49.5	226.2	25.5	60.3	33.0	44.0	222.1	243.7	29.0	73.2	94.8	109.8	3.7	72.7	98.4	51.6	63.7	120.9	55.0	146.2	39.2	95.8	85.0	50.3	89.5	98.8	71.3	74.6	22.3	112.4	59.5	59.2	68.1	65.2	3.5	6.6	22.2	43.8	143.0	183.9	16.4	17.1	96.9
IFRD1	"PC4, TIS7"	ENSG00000006652	"Interferon related developmental regulator 1"	O00458	7	112422887-112481017	"Predicted intracellular proteins, Predicted membrane proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"eosinophil: 64.2;neutrophil: 112.3"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 112.3"	"Low cell line specificity"	"Detected in all"											"HPA024122, HPA072413"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA024122: AB_1851452, HPA072413: "	"unprognostic (2.29e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.48e-2)"	"prognostic favorable (5.45e-4)"	"unprognostic (6.41e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.50e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.89e-1)"	"unprognostic (4.70e-2)"	35.2	24.6	11.2	6.5	14.4	57.7	32.3	13.2	16.2	23.0	31.7	30.3	8.1	20.8	4.8	24.0	25.4	4.6	30.9	13.9	19.0	21.3	27.3	40.1	3.9	11.0	13.2	31.3	102.9	9.8	31.2	7.9	13.0	28.1	5.5	13.4	25.7	6.4	58.9	21.9	22.2	10.2	11.7	19.9	38.3	24.5	13.1	4.5	25.6	3.1	3.9	24.1	25.8	19.6	22.1	26.8	25.9	21.7	44.4	28.2	25.0	23.8	26.6	36.0	29.6	42.7	21.1	12.2	52.9	18.8	64.6	15.0	21.5	29.2	46.9	17.1	31.7	13.8	46.1	37.9	61.5	19.9	9.5	24.7	43.4	39.7	47.1	18.9	18.3	22.2	46.5	17.4	14.2	35.7	24.1	20.1	51.8	26.9	30.1	24.6	9.2	22.9	6.0	6.1	37.9	18.9	28.0	15.5	61.2	57.7	9.8	15.2	12.6	45.8	10.4	35.0	68.5	27.2	34.8	37.1	12.9	43.6	63.8	19.8	7.6	64.2	7.2	6.5	6.2	8.7	7.7	7.9	6.6	7.2	6.8	7.0	112.3	8.0	6.4	4.6	8.6	5.2	11.2	14.4	13.2	16.2	13.9	19.0	11.0	13.2	13.0	11.7	13.1	19.6	179.3	32.1	31.4	39.2	110.6	197.3	159.3	55.6	259.6	50.3	141.7	142.6	60.6	37.1	55.0	18.4	89.6	66.5	130.9	276.0	17.6	49.6	43.9	123.2	159.7	96.8	138.2	24.6	36.1	56.5	84.2	135.5	162.6	190.1	74.4	51.3	52.8	21.7	126.1	21.9	24.4	183.5	54.9	96.9	153.4	10.1	36.7	141.8	103.2	44.0	55.8	32.4	20.6	24.1	42.6	55.1	287.8	41.0	104.6	143.9	226.9	13.3	34.1	86.8	39.5	138.9	172.7	25.5	14.5	135.1	126.0	151.7	129.8	53.4	180.0	154.4
IL16	"FLJ16806, FLJ42735, HsT19289, IL-16, LCF, prIL-16"	ENSG00000172349	"Interleukin 16"	Q14005	15	81159575-81314058	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, Host-virus interaction, Transcription, Transcription regulation"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 135.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 135.3;dendritic cells: 78.1;Kupffer cells: 59.2;Langerhans cells: 94.4;NK-cells: 121.5;Plasma cells: 55.6;T-cells: 76.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 57.3"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 27.7;HEL: 29.4;HMC-1: 50.6;RPMI-8226: 51.0;U-266/70: 60.3;U-698: 25.8;U-937: 35.1"	"Group enriched"	"Detected in all"	11	"cerebellum: 54.5;hippocampal formation: 27.0"	"Region enriched"	"Detected in many"	12	"cerebellum: 48.8"	"CAB005247, HPA018467, HPA048861"	Enhanced		Supported	"Nuclear speckles,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	208000	7300	"Cluster 5: Granulocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear speckles"	"Plasma membrane, Cytosol"	"CAB005247: AB_2124730, HPA018467: AB_1851642, HPA048861: "	"unprognostic (8.23e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.97e-2)"	"unprognostic (9.61e-4)"	"unprognostic (2.01e-1)"	"unprognostic (5.26e-4)"	"unprognostic (2.63e-2)"	"unprognostic (6.72e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.29e-1)"	18.9	6.3	3.5	63.3	3.0	62.1	15.5	57.3	4.1	9.6	13.8	14.4	11.3	9.9	7.7	7.4	17.8	16.2	5.9	2.9	5.7	3.2	9.7	23.7	132.6	5.9	5.7	6.1	2.6	2.3	2.1	9.0	10.5	5.8	16.8	0.5	11.2	4.5	3.3	12.0	39.9	9.8	5.8	86.2	15.6	4.2	5.2	130.4	6.9	8.5	135.3	18.9	10.4	7.6	0.0	0.0	0.0	0.1	17.5	7.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	27.7	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.4	0.0	29.4	0.0	0.0	0.9	21.0	50.6	0.9	0.0	0.1	0.6	0.0	0.4	3.5	3.2	10.7	0.1	0.0	1.7	22.2	0.0	0.1	0.0	0.1	0.1	51.0	0.0	0.2	0.1	0.1	0.1	0.0	9.9	0.0	0.0	4.6	0.2	0.3	0.2	1.0	0.0	60.3	5.5	25.8	1.8	35.1	1.5	252.8	116.2	321.3	164.5	142.7	185.9	166.0	170.6	180.6	150.9	157.2	224.9	185.6	282.5	213.2	149.1	113.7	197.0	338.0	3.5	3.0	57.3	4.1	2.9	5.7	5.9	5.7	10.5	5.8	5.2	7.6	9.4	3.2	6.6	0.0	135.3	8.2	0.2	0.8	1.2	0.2	0.8	1.4	2.7	8.6	1.9	1.8	0.0	0.3	78.1	0.3	0.0	0.1	1.4	3.1	6.6	7.5	0.0	20.2	3.4	0.2	0.3	15.9	1.1	0.7	27.1	0.0	26.7	9.2	19.0	0.0	4.9	0.3	0.0	59.2	94.4	1.4	10.8	33.1	28.4	18.7	30.2	0.3	121.5	0.0	0.3	0.0	1.2	18.0	55.6	0.1	0.1	0.4	7.7	0.7	6.6	1.1	3.2	2.1	7.5	1.2	3.7	0.4	76.3	0.2	0.7	0.2
IRF2		ENSG00000168310	"Interferon regulatory factor 2"	P14316	4	184387729-184474550	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 163.6;Karpas-707: 165.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030813, CAB032306, HPA057327"	Supported		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Cell Junctions, Cytosol"	"CAB032306: AB_2249157, HPA030813: AB_10600718, HPA057327: AB_2683410"	"prognostic favorable (6.95e-5)"	"unprognostic (1.69e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.48e-2)"	"unprognostic (4.05e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.90e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (6.87e-3)"	"unprognostic (8.55e-3)"	"unprognostic (5.25e-2)"	"prognostic favorable (8.34e-5)"	"unprognostic (1.31e-3)"	25.1	30.1	18.2	47.8	23.4	18.0	21.9	22.1	19.3	25.6	21.4	27.8	31.1	21.8	22.7	26.7	25.3	24.9	19.5	17.5	21.9	18.5	37.4	27.6	62.5	25.3	22.1	28.1	14.8	20.2	12.3	28.9	25.2	20.6	28.7	9.3	29.1	21.2	28.1	19.4	33.3	23.2	21.7	54.9	31.5	6.1	23.5	49.8	21.7	23.8	52.2	35.6	22.5	29.6	20.3	14.9	17.5	12.0	37.4	37.9	10.5	14.4	44.8	34.8	36.0	4.2	37.9	12.2	7.4	21.7	28.4	18.3	12.0	27.4	22.1	163.6	6.6	34.4	7.9	26.8	37.1	21.1	27.7	41.2	24.8	19.8	50.1	29.8	26.7	14.5	6.9	165.3	14.6	14.1	40.6	25.8	4.0	18.5	10.7	52.7	6.9	55.1	26.6	30.4	7.5	11.6	20.4	16.8	31.3	7.3	13.0	18.9	22.0	9.9	10.7	11.3	12.8	47.3	40.6	11.0	20.9	20.3	17.8	106.7	95.7	175.8	76.4	126.3	77.9	104.9	74.5	82.2	79.6	107.7	78.8	78.8	407.6	94.8	145.7	20.2	111.7	100.3	18.2	23.4	22.1	19.3	17.5	21.9	25.3	22.1	25.2	21.7	23.5	29.6	58.9	38.5	24.5	53.5	68.9	49.1	50.5	60.4	45.5	13.1	25.8	27.3	21.9	27.1	36.0	25.8	6.2	31.3	48.8	40.3	37.2	30.9	0.2	53.4	40.2	42.9	30.6	62.7	23.8	30.1	16.2	35.8	34.1	63.2	26.6	23.1	38.2	37.6	48.5	20.2	27.8	29.5	44.7	90.3	53.5	3.0	37.3	65.9	19.6	41.2	144.0	23.4	70.0	43.7	77.1	28.7	38.9	53.0	63.4	72.9	42.1	46.1	58.7	8.4	39.5	25.4	44.8	0.6	2.4	49.5	44.5	26.7	56.3	37.7	22.8	70.9
IRS2		ENSG00000185950	"Insulin receptor substrate 2"	Q9Y4H2	13	109752695-109786583	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Transducer	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 51.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.3"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 38.1;LHCN-M2: 36.9;SH-SY5Y: 40.2;THP-1: 62.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016944, HPA054664"	Approved		Supported	Aggresome,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol	Aggresome	"CAB016944: , HPA054664: AB_2682563"	"unprognostic (2.87e-3)"	"unprognostic (5.73e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.28e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.34e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.09e-2)"	"unprognostic (6.21e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.24e-1)"	26.2	16.5	22.2	5.9	21.8	51.3	18.9	12.1	28.4	10.7	3.9	11.3	4.4	13.0	6.3	4.2	7.7	4.0	13.0	32.2	22.9	3.5	22.1	11.1	2.3	29.4	24.5	18.6	4.3	3.6	19.1	6.7	24.8	13.3	3.4	6.0	11.6	6.1	21.4	15.5	6.0	4.7	13.6	5.4	7.8	3.0	25.2	2.3	5.5	7.7	2.2	7.1	8.6	20.1	5.8	6.6	4.2	0.0	34.5	6.9	2.3	6.3	7.4	3.8	3.1	0.6	7.0	0.0	3.9	4.5	5.4	2.6	2.2	5.6	4.7	2.3	29.5	2.8	9.3	0.0	34.8	10.7	3.3	14.5	29.6	1.1	38.1	24.5	1.4	0.5	1.9	0.0	36.9	3.0	0.1	31.1	4.5	3.2	1.4	13.1	3.8	2.8	10.6	1.5	6.1	40.2	3.3	0.1	27.2	3.5	0.8	62.8	0.1	7.8	0.0	0.5	8.5	0.0	3.1	2.1	5.8	10.2	13.7	1.5	0.6	0.9	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.1	3.3	0.0	0.2	0.0	0.2	0.1	22.2	21.8	12.1	28.4	32.2	22.9	29.4	24.5	24.8	13.6	25.2	20.1	13.7	32.1	33.8	53.8	31.1	113.9	48.0	100.2	81.4	25.8	68.9	98.4	72.3	60.1	79.5	31.3	114.7	20.3	40.0	71.2	5.9	36.4	47.6	81.6	110.6	13.4	122.6	34.5	51.3	3.1	11.1	52.0	28.1	188.5	25.3	25.8	20.0	142.9	24.1	25.2	42.2	42.0	52.9	143.5	24.4	12.3	37.3	131.2	129.9	29.0	59.3	32.4	17.5	46.3	34.8	30.8	44.4	20.3	7.9	76.8	77.3	3.9	40.3	30.6	26.3	57.1	44.0	21.2	10.2	74.6	126.2	30.6	37.5	63.1	42.7	53.6
ISCU	"hnifU, ISU2, NIFUN"	ENSG00000136003	"Iron-sulfur cluster assembly enzyme"	Q9H1K1	12	108562582-108569368	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 1430.2;Late spermatids: 969.5;Proximal tubular cells: 1315.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB006329, HPA038602, HPA057592"	Approved		Supported	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"CAB006329: AB_425907, HPA038602: AB_2676109, HPA057592: AB_2683478"	"unprognostic (1.72e-1)"	"prognostic favorable (4.90e-7)"	"unprognostic (1.53e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.69e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.49e-2)"	"prognostic favorable (2.73e-7)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-3)"	"prognostic favorable (6.12e-4)"	174.8	387.6	186.3	89.8	187.5	98.2	166.8	209.9	216.8	174.4	222.2	222.9	88.8	170.2	148.8	91.2	142.5	106.5	507.1	186.2	223.0	341.3	119.9	138.3	138.9	223.4	192.5	169.2	106.2	286.0	228.9	111.1	214.4	150.5	112.0	58.9	123.7	196.1	422.3	111.6	142.7	122.2	187.0	163.9	169.2	123.2	188.0	151.6	184.4	381.5	138.3	179.0	133.4	177.0	47.5	113.8	78.9	47.3	277.4	211.6	191.7	92.8	152.2	69.7	65.7	84.9	66.0	47.4	77.9	128.5	74.6	67.5	76.2	106.8	62.5	147.2	82.0	51.8	60.7	190.6	161.5	124.4	59.0	206.6	234.3	75.4	149.3	176.8	107.7	100.7	98.3	148.8	147.8	102.9	98.1	225.4	76.4	70.9	165.7	64.0	52.5	205.3	204.5	134.6	67.4	62.4	67.5	39.7	108.7	98.3	102.2	99.4	92.3	70.3	59.0	56.8	47.8	175.9	207.8	146.3	109.5	91.8	72.4	478.2	182.1	567.9	224.5	200.5	269.2	564.4	292.6	292.7	128.4	516.7	366.2	305.0	554.2	207.5	239.3	225.2	334.2	400.8	186.3	187.5	209.9	216.8	186.2	223.0	223.4	192.5	214.4	187.0	188.0	177.0	129.8	76.9	158.9	19.9	206.3	98.1	148.6	227.0	98.4	46.2	137.5	212.3	674.1	145.8	148.6	233.6	10.4	453.7	142.2	120.1	1430.2	154.3	433.2	78.1	76.5	140.8	75.0	165.5	52.6	149.8	164.0	165.5	64.2	37.1	116.5	89.1	126.0	112.3	263.0	45.4	53.7	117.6	193.3	140.1	110.2	969.5	202.0	129.9	249.1	23.4	502.4	167.9	163.7	14.6	26.0	141.3	96.3	308.4	299.4	171.8	235.9	1315.1	160.4	45.8	223.5	97.4	158.1	294.5	242.1	92.6	93.1	475.2	153.6	154.2	139.8	177.7
ISY1	"fSAP33, KIAA1160"	ENSG00000240682	"ISY1 splicing factor homolog"	Q9ULR0	3	129127415-129161063	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA006312, HPA016995"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 14: REH - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear speckles"		"HPA006312: AB_1079734, HPA016995: AB_1852387"	"unprognostic (2.20e-2)"	"prognostic favorable (2.46e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.19e-1)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (7.25e-4)"	"unprognostic (4.08e-1)"	"unprognostic (5.94e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.34e-2)"	"unprognostic (2.23e-3)"	"unprognostic (2.49e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.54e-2)"	18.7	13.7	9.1	19.0	9.0	51.6	17.0	9.8	9.6	20.2	7.5	21.6	15.4	19.5	15.1	22.2	15.5	17.4	21.4	8.8	9.1	15.0	10.8	14.1	32.0	9.2	9.3	19.7	15.8	11.2	8.8	22.1	8.9	13.3	16.9	10.4	15.0	12.3	34.9	20.3	16.2	20.3	8.2	18.2	14.9	12.4	8.8	22.7	14.9	21.3	30.1	18.3	19.4	8.9	53.7	20.5	29.6	41.6	35.1	36.4	34.5	39.3	35.0	46.1	44.2	40.6	39.3	67.3	41.3	32.6	40.0	44.8	56.3	31.8	64.9	65.0	26.5	78.0	35.2	32.8	32.7	121.2	53.4	22.9	21.7	40.6	62.3	28.7	37.7	43.2	57.1	33.5	25.2	54.2	73.8	67.1	32.3	55.9	31.3	64.9	67.3	47.5	17.3	33.5	46.8	35.3	72.7	15.7	41.9	16.0	30.3	99.1	45.2	33.5	33.4	49.8	41.6	40.1	26.1	131.9	30.8	69.4	39.0	79.8	57.6	94.2	54.8	56.4	61.4	56.1	55.8	58.7	62.8	50.7	61.0	55.0	90.7	84.8	51.2	54.5	73.5	56.5	9.1	9.0	9.8	9.6	8.8	9.1	9.2	9.3	8.9	8.2	8.8	8.9	26.5	25.6	23.4	0.0	27.4	27.4	16.5	21.3	20.5	19.7	17.0	15.6	19.7	21.5	21.8	9.2	22.9	44.1	38.5	15.8	23.5	26.7	2.8	11.9	23.0	25.3	9.0	29.0	0.0	28.0	41.2	21.8	12.8	21.0	45.6	25.8	26.0	12.3	34.8	20.2	0.0	16.7	16.2	21.1	25.6	1.8	16.1	23.9	10.6	0.0	43.7	20.7	46.4	0.0	0.0	24.4	15.3	16.1	24.1	17.4	18.8	23.2	14.8	19.0	19.7	18.8	20.9	57.4	42.6	20.0	35.8	45.8	32.9	18.7	20.5	16.9
ITM2B	"BRI, BRI2, BRICD2B, E25B, E3-16"	ENSG00000136156	"Integral membrane protein 2B"	Q9Y287	13	48232612-48270357	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Amyloidosis, Deafness, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 4375.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 4375.2"	"Cell line enhanced"	"Detected in all"		"HMC-1: 731.2;RPTEC TERT1: 1718.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029292, HPA071992"	Enhanced		Enhanced	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		5800000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus, Vesicles"		"HPA029292: AB_10601917, HPA071992: AB_2686480"	"unprognostic (4.66e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.41e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.88e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.87e-2)"	"prognostic favorable (3.73e-5)"	"unprognostic (4.38e-2)"	"unprognostic (4.09e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.22e-1)"	510.2	367.4	286.9	172.5	301.0	125.6	323.8	328.6	489.0	416.1	406.6	260.1	289.2	388.8	1171.8	399.9	305.4	257.5	381.0	320.1	339.2	1306.3	391.2	376.1	236.7	334.9	308.0	507.2	179.6	233.7	290.5	573.8	304.4	312.5	191.4	174.4	408.7	386.2	164.7	399.6	287.4	232.5	373.6	435.2	312.8	121.4	308.8	188.3	386.1	206.2	187.4	305.1	402.2	394.8	67.6	51.8	73.1	116.3	348.5	254.5	119.2	215.0	202.2	87.5	100.6	29.1	248.3	16.6	168.8	121.6	48.5	214.1	61.3	107.0	107.4	69.9	147.3	137.9	29.0	99.0	138.5	140.6	731.2	113.4	149.1	45.1	62.0	375.7	131.2	78.3	24.5	90.9	174.8	29.6	200.4	310.1	266.0	116.5	103.6	100.1	100.5	73.6	1718.9	268.6	26.2	119.5	154.5	110.2	111.0	306.0	74.0	119.4	180.5	62.9	73.8	95.7	85.4	72.9	59.6	2.5	78.0	75.3	155.3	3091.4	864.5	2737.9	387.4	661.3	512.5	235.3	523.1	476.4	428.9	245.3	551.3	466.8	4375.2	356.5	692.7	196.2	563.4	1723.5	286.9	301.0	328.6	489.0	320.1	339.2	334.9	308.0	304.4	373.6	308.8	394.8	1380.0	695.5	300.4	174.6	408.6	862.4	1661.1	2606.2	1006.2	653.1	460.1	573.5	384.8	722.0	1121.9	1991.8	187.7	1164.3	448.2	754.2	545.9	910.2	23.6	751.8	802.2	1166.2	283.3	307.0	114.2	682.9	2362.8	1334.0	302.8	1177.2	578.0	421.2	1319.7	557.3	2117.8	353.3	142.6	503.2	1129.1	1569.8	900.6	76.7	1867.0	1381.5	681.3	252.0	1415.7	1634.9	425.3	174.4	237.9	515.7	788.3	2011.6	445.4	922.5	1259.3	2748.9	795.6	219.4	1222.7	602.4	1022.9	143.6	256.4	1384.6	1149.6	1471.5	723.2	665.5	440.9	1613.4
JDP2	JUNDM2	ENSG00000140044	"Jun dimerization protein 2"	Q8WYK2	14	75427716-75474111	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 70.7;Kupffer cells: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 11.8;granulocytes: 7.7;monocytes: 13.2"	"Cell line enhanced"	"Detected in many"		"HHSteC: 167.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059511	Supported		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nuclear speckles"		"HPA059511: AB_2684046"	"unprognostic (3.19e-2)"	"unprognostic (5.58e-2)"	"prognostic unfavorable (8.58e-5)"	"unprognostic (1.64e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.30e-3)"	53.5	20.0	23.2	29.3	22.0	78.6	40.2	22.8	28.2	31.6	22.0	31.6	22.5	22.7	3.7	25.4	28.5	27.7	39.1	23.5	24.2	18.9	20.5	47.2	13.1	24.6	22.9	21.6	23.1	8.1	17.3	17.5	22.6	21.8	11.3	16.4	24.2	15.0	21.9	29.1	30.1	20.9	22.6	66.8	23.3	4.7	25.4	4.8	25.1	16.7	10.6	25.3	31.6	21.8	15.5	13.5	2.5	26.8	81.5	60.2	90.5	47.5	51.0	30.4	38.1	33.0	13.5	12.4	23.5	90.7	5.6	59.5	16.7	16.2	13.1	16.7	1.9	17.0	26.0	11.9	167.1	24.1	1.3	106.5	95.2	12.4	30.6	11.9	1.5	13.8	2.2	23.0	27.7	76.4	1.4	39.8	9.1	30.4	8.7	8.2	0.3	34.0	14.8	8.6	2.1	10.4	48.9	69.4	55.1	29.7	66.4	52.1	6.2	38.1	57.5	2.4	7.0	18.7	6.0	28.8	11.5	90.0	19.1	0.1	4.5	4.4	0.0	8.1	0.0	11.8	0.2	0.0	2.4	5.1	0.0	0.0	7.7	0.1	13.2	2.1	0.2	1.4	23.2	22.0	22.8	28.2	23.5	24.2	24.6	22.9	22.6	22.6	25.4	21.8	70.7	12.8	33.5	26.8	9.9	16.4	6.0	5.8	19.9	21.8	26.2	18.2	17.7	12.8	8.1	9.2	10.4	1.4	1.2	20.0	0.0	2.4	0.3	21.6	18.4	21.2	5.4	0.8	18.9	6.6	5.6	49.5	10.2	23.9	2.5	10.1	10.4	8.5	9.7	8.4	20.8	14.9	4.1	87.7	25.7	1.5	18.0	47.3	12.4	14.0	13.8	38.6	2.1	18.1	3.0	8.5	8.2	16.6	9.8	2.6	17.7	3.0	7.4	31.1	6.6	47.2	19.5	0.1	0.9	19.7	8.9	0.3	2.2	5.3	8.7	11.5
JPT1	"ARM2, HN1, HN1A"	ENSG00000189159	"Jupiter microtubule associated homolog 1"	Q9UK76	17	75135248-75168281	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 406.9"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 371.3;Exocrine glandular cells: 437.2;Extravillous trophoblasts: 1344.2;monocytes: 375.7;Pancreatic endocrine cells: 1434.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 767.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA059729	Approved		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"		NA	NA		40000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA059729: AB_2684114"	"unprognostic (1.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-3)"	"unprognostic (3.57e-3)"	"unprognostic (6.71e-2)"	"unprognostic (2.51e-3)"	"prognostic unfavorable (1.58e-7)"	"unprognostic (3.58e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (1.25e-3)"	"unprognostic (8.24e-2)"	"prognostic unfavorable (1.77e-7)"	"unprognostic (1.83e-1)"	"unprognostic (8.99e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.51e-1)"	26.1	74.9	44.0	87.5	43.7	83.5	21.3	49.4	54.7	44.1	31.0	140.1	119.2	18.0	7.3	225.1	15.5	63.7	23.3	44.3	54.4	72.2	49.1	49.3	87.6	38.6	42.8	13.4	22.6	6.7	24.3	66.3	49.3	28.3	70.4	17.0	62.1	27.8	96.1	40.7	141.6	23.4	34.3	100.5	134.2	406.9	53.1	88.0	16.1	24.3	91.5	93.9	75.7	36.3	775.3	743.0	371.8	384.7	75.5	75.2	309.5	391.8	111.5	364.6	278.0	614.8	449.1	210.1	247.4	303.0	401.7	446.5	344.3	481.9	278.5	215.7	438.3	336.1	275.2	624.8	177.5	256.3	318.3	117.1	218.4	307.3	308.7	107.1	672.2	388.7	197.3	431.3	335.4	561.4	845.0	248.7	216.9	627.8	979.0	520.8	447.5	326.8	392.7	479.1	465.4	373.8	553.8	293.3	213.4	393.8	786.0	154.9	395.1	214.3	615.7	305.0	469.0	165.9	298.1	332.5	186.9	233.4	254.4	241.7	127.0	372.6	79.6	187.8	57.2	102.3	109.3	96.8	100.7	57.2	51.6	76.1	767.6	74.5	206.7	67.4	202.6	118.4	44.0	43.7	49.4	54.7	44.3	54.4	38.6	42.8	49.3	34.3	53.1	36.3	61.6	25.6	18.1	0.0	36.2	0.0	0.0	0.0	0.0	0.0	81.8	133.2	0.0	0.0	18.0	246.5	0.0	137.6	171.2	0.0	99.7	371.3	0.0	113.2	79.7	32.9	0.0	0.0	0.0	437.2	1344.2	40.4	0.0	194.0	7.6	179.6	0.0	0.0	319.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	102.5	0.0	0.0	375.7	0.0	0.0	0.0	0.0	1434.1	0.0	0.0	13.9	0.0	0.0	203.3	16.8	0.0	0.0	0.0	76.2	0.0	0.0	0.0	0.0	96.9	73.9	95.0	0.0	0.0
KBTBD2	"BKLHD1, DKFZP566C134"	ENSG00000170852	"Kelch repeat and BTB domain containing 2"	Q8IY47	7	32868172-32894131	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021133	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA021133: AB_1852093"	"unprognostic (1.01e-1)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (3.17e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (5.69e-4)"	"unprognostic (3.96e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.80e-3)"	"unprognostic (5.05e-1)"	"unprognostic (6.79e-3)"	"unprognostic (3.81e-3)"	"unprognostic (1.42e-2)"	"unprognostic (8.69e-2)"	"unprognostic (2.96e-1)"	26.4	16.4	23.0	21.7	25.2	54.6	20.9	27.3	24.9	17.2	21.4	16.9	15.9	20.8	10.7	16.1	15.6	25.2	20.3	21.0	24.8	15.3	21.5	22.5	25.6	27.2	25.8	16.4	11.8	17.1	15.0	25.8	27.2	16.3	19.6	25.9	14.4	15.0	57.6	16.3	17.6	23.6	26.3	27.0	14.8	18.1	26.5	30.5	18.6	40.3	24.0	22.0	17.3	28.8	38.3	18.8	47.5	23.5	28.1	28.0	17.1	33.4	33.9	31.2	37.6	18.7	28.6	31.9	22.6	34.7	52.3	27.5	24.5	26.2	39.2	12.6	17.6	27.1	30.6	24.4	28.9	29.3	34.2	30.1	26.9	34.0	32.9	28.9	34.9	28.6	50.3	46.2	46.4	31.4	24.3	47.9	38.6	26.5	17.7	23.4	41.6	26.7	27.6	22.3	24.9	46.4	21.5	29.1	38.6	39.6	20.7	49.5	30.5	29.6	38.7	28.3	46.5	37.5	39.3	57.6	28.8	34.9	77.0	14.5	6.4	21.4	10.9	12.2	9.2	7.1	5.4	9.7	5.6	9.8	4.2	6.9	39.2	10.7	14.6	2.9	7.6	4.1	23.0	25.2	27.3	24.9	21.0	24.8	27.2	25.8	27.2	26.3	26.5	28.8	67.2	28.9	23.9	24.5	27.0	40.4	15.7	13.4	44.3	14.6	20.4	15.6	18.4	20.0	22.1	1.8	10.4	6.9	41.4	18.1	0.0	11.8	7.7	21.6	23.1	48.7	14.9	25.2	21.0	12.2	8.7	22.2	17.9	33.8	43.7	20.4	36.8	14.6	13.3	8.4	20.5	14.0	4.1	24.6	23.1	6.2	13.1	32.5	24.9	34.7	13.0	8.7	15.5	29.7	36.8	16.8	10.3	6.0	25.2	17.1	10.5	5.1	7.3	8.9	19.7	26.4	21.1	19.1	8.8	25.9	36.1	7.5	28.4	10.8	11.4	18.5
KCTD13	"FKSG86, PDIP1, POLDIP1"	ENSG00000174943	"Potassium channel tetramerization domain containing 13"	Q8WZ19	16	29905012-29926236	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Autism, Autism spectrum disorder, Disease variant, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 37.5;testis: 36.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043524	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA043524: AB_2678528"	"unprognostic (6.97e-2)"	"unprognostic (9.06e-3)"	"prognostic unfavorable (8.54e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.97e-2)"	"prognostic favorable (9.05e-4)"	"unprognostic (3.92e-3)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (1.16e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.49e-3)"	6.0	7.5	27.3	7.8	28.7	8.5	5.4	17.6	37.5	5.0	17.4	6.3	7.3	5.1	9.9	5.9	8.3	7.8	4.4	36.9	24.5	3.9	3.5	4.5	9.8	19.5	21.3	7.5	7.5	7.9	3.6	4.5	19.6	6.7	6.5	9.4	6.5	8.0	2.7	12.2	7.0	5.2	20.5	7.6	5.8	36.3	23.0	9.6	5.7	2.4	7.1	6.0	2.7	28.8	9.7	12.4	6.2	15.5	10.0	8.1	12.5	5.8	7.2	5.7	8.9	3.5	12.6	17.4	11.3	8.5	9.6	14.4	6.8	5.5	4.4	26.5	17.0	3.7	7.1	6.0	13.7	9.2	15.9	10.2	15.3	11.6	8.7	6.1	4.7	19.9	9.1	14.8	7.9	28.1	18.7	14.2	3.6	5.0	6.0	13.9	4.5	9.0	7.8	9.1	15.5	15.4	2.4	7.0	31.7	5.8	10.1	7.2	10.0	5.0	5.1	15.3	10.6	12.4	5.3	3.9	12.0	10.4	14.4	7.2	3.3	8.0	2.9	2.6	3.0	3.0	5.4	5.0	3.5	2.4	5.0	4.7	11.1	3.1	4.4	3.8	4.4	1.9	27.3	28.7	17.6	37.5	36.9	24.5	19.5	21.3	19.6	20.5	23.0	28.8	7.1	0.0	9.7	20.9	10.6	6.0	5.7	10.4	12.5	9.9	8.5	8.0	3.4	5.7	5.8	0.0	8.4	5.3	7.9	5.2	3.9	6.9	17.9	9.1	6.8	4.7	7.7	3.0	15.4	4.2	5.1	6.5	4.6	8.7	2.5	10.9	6.4	2.4	7.6	5.0	20.5	7.2	10.2	4.4	5.6	9.0	6.2	6.3	8.8	12.2	5.7	5.0	11.3	17.6	28.9	11.0	7.4	6.4	3.6	8.7	6.5	2.9	6.3	6.5	0.0	5.0	7.8	20.6	26.5	12.4	9.1	6.7	10.6	5.8	6.1	7.0
KLF2	LKLF	ENSG00000127528	"Kruppel like factor 2"	Q9Y5W3	19	16324826-16328685	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 1043.3;B-cells: 691.8;dendritic cells: 542.9;Endothelial cells: 511.8;Gastric mucus-secreting cells: 561.7;NK-cells: 466.5;Plasma cells: 806.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 26.8;TIME: 67.8;U-266/70: 45.6;U-266/84: 49.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055964	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA055964: AB_2682989"	"unprognostic (3.22e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.04e-1)"	"unprognostic (7.91e-3)"	"prognostic favorable (8.55e-4)"	"unprognostic (1.74e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.76e-3)"	"unprognostic (7.80e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.50e-1)"	"unprognostic (7.56e-2)"	153.7	27.1	25.0	61.6	23.2	90.0	108.4	15.4	18.5	59.2	10.9	55.2	9.6	61.5	2.5	32.2	105.9	14.7	118.4	13.6	17.9	41.6	13.4	110.8	45.4	27.3	34.1	152.6	12.5	5.6	28.8	22.4	24.2	41.8	5.0	0.6	35.7	6.8	52.0	65.5	44.6	19.5	14.1	70.9	73.1	18.3	27.9	13.0	53.5	20.5	8.3	86.9	63.8	15.5	7.5	1.8	0.1	1.6	0.4	1.0	2.9	16.6	1.8	5.5	1.8	0.1	24.0	0.7	3.7	6.7	0.9	2.5	0.5	0.0	1.5	0.6	2.0	0.0	1.4	0.2	4.2	0.0	12.1	1.2	0.2	1.4	0.3	7.1	10.9	14.7	0.5	15.4	2.4	0.4	1.5	3.2	0.2	7.3	2.2	0.5	4.3	26.8	0.2	0.3	0.5	0.2	0.9	12.3	10.4	0.1	0.5	8.6	67.8	12.9	9.4	1.0	23.8	45.6	49.3	1.6	5.7	0.0	5.8	63.2	8.3	25.1	42.7	32.9	34.9	44.7	56.6	43.9	3.3	47.5	53.5	44.4	79.5	28.7	29.1	0.6	59.4	20.5	25.0	23.2	15.4	18.5	13.6	17.9	27.3	34.1	24.2	14.1	27.9	15.5	1043.3	35.3	60.0	1.0	691.8	23.8	25.9	7.4	30.1	5.8	69.6	51.8	47.9	31.5	9.0	3.7	8.4	4.5	542.9	151.7	0.0	10.3	2.3	53.8	31.1	511.8	46.4	35.0	0.8	6.0	7.6	350.6	561.7	20.4	33.6	8.1	393.3	10.6	91.3	0.0	1.9	110.5	2.0	242.4	58.5	6.3	89.5	272.9	64.0	48.7	74.1	7.6	466.5	0.5	0.3	64.3	61.3	73.0	806.5	10.7	4.8	1.9	18.2	8.8	65.7	460.9	235.3	0.8	2.9	22.1	26.3	6.6	417.8	57.9	33.7	12.9
KMT5B	"CGI-85, SUV420H1"	ENSG00000110066	"Lysine methyltransferase 5B"	Q4FZB7	11	68154863-68213828	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 128.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063648			Supported	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA063648: AB_2685073"	"unprognostic (5.82e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.36e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (9.30e-4)"	18.6	16.5	16.3	15.7	17.5	28.5	27.5	26.2	17.6	20.2	17.3	22.3	22.8	26.2	19.0	17.2	18.2	15.0	15.9	15.8	17.2	19.7	22.4	18.1	19.2	16.1	16.3	22.4	22.8	20.6	15.6	22.3	15.6	22.0	21.6	33.4	23.4	16.3	16.9	21.7	21.8	20.7	14.8	17.2	20.7	20.7	16.1	27.0	31.0	16.7	20.4	16.5	17.6	21.3	25.3	18.8	37.6	24.5	8.6	21.4	40.8	17.7	12.3	21.7	12.8	59.7	39.6	20.5	30.2	24.4	21.4	13.0	26.2	20.6	31.6	23.2	15.1	19.4	21.9	24.7	31.0	27.7	25.6	21.3	41.6	26.2	27.3	20.0	21.8	20.3	29.3	23.4	18.7	52.2	19.6	28.9	40.4	50.4	13.9	31.9	29.4	55.4	16.2	24.2	32.7	39.1	27.5	27.4	128.7	20.3	35.1	17.9	23.1	29.2	38.9	22.5	18.4	29.5	13.8	43.0	18.4	17.3	31.8	10.0	3.7	16.5	4.4	5.2	3.1	3.2	4.6	5.4	3.5	3.8	5.3	4.8	10.9	9.6	5.3	5.4	4.1	2.8	16.3	17.5	26.2	17.6	15.8	17.2	16.1	16.3	15.6	14.8	16.1	21.3	39.8	60.9	61.3	0.0	32.9	0.0	42.3	0.0	50.7	50.0	45.8	34.7	0.0	25.8	25.4	25.8	12.5	27.4	37.6	32.6	21.5	27.9	22.0	42.6	46.3	31.7	25.5	31.4	0.0	32.7	29.6	26.3	37.2	44.3	22.7	40.7	30.0	37.7	17.9	63.9	0.0	26.6	0.0	32.4	0.0	21.0	28.0	27.7	0.0	0.0	38.2	29.6	43.3	0.0	0.0	37.1	25.7	31.6	34.8	43.7	36.4	22.7	32.1	39.6	32.9	44.8	28.6	45.8	58.9	38.0	0.0	51.7	30.7	31.8	25.1	53.6
LAMTOR4	C7orf59	ENSG00000188186	"Late endosomal/lysosomal adaptor, MAPK and MTOR activator 4"	Q0VGL1	7	100148907-100155944	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 3294.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020998	Enhanced		Supported	Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA020998: AB_1845762"	"prognostic favorable (2.48e-4)"	"prognostic favorable (6.08e-4)"	"unprognostic (1.29e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.21e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.42e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.68e-2)"	145.5	144.7	207.2	92.8	215.4	194.6	143.4	221.1	260.4	148.0	204.4	180.6	89.4	116.7	65.9	117.5	123.1	97.7	167.4	205.7	212.3	188.5	139.1	128.0	159.0	222.1	211.3	142.7	124.2	126.7	162.7	68.1	213.3	160.8	105.8	39.9	116.8	76.2	137.5	478.7	151.0	69.0	217.6	251.9	162.2	86.6	215.8	104.8	133.8	106.0	85.5	145.8	126.7	224.1	105.9	250.9	130.2	165.4	135.2	154.9	105.7	62.1	151.0	113.1	138.9	116.9	165.7	169.1	204.7	94.2	205.7	108.9	124.0	160.0	48.1	172.4	353.2	135.2	245.0	205.4	127.4	106.4	187.1	187.3	155.4	118.5	145.6	125.7	174.9	155.3	129.9	264.4	156.1	501.0	104.0	424.7	138.7	291.1	199.9	107.4	107.1	302.8	129.1	126.9	91.6	169.0	114.3	265.8	211.3	99.0	107.1	207.0	118.3	107.1	158.6	223.7	101.7	159.1	231.2	324.2	171.0	293.5	155.9	1033.3	843.2	3121.0	299.6	795.1	251.1	541.8	377.5	312.8	570.0	475.4	381.8	307.2	3294.2	310.1	756.2	482.6	453.0	893.6	207.2	215.4	221.1	260.4	205.7	212.3	222.1	211.3	213.3	217.6	215.8	224.1	181.8	93.0	150.7	18.9	195.8	274.9	194.0	282.0	167.9	65.3	240.8	277.2	176.6	143.0	172.9	218.8	12.5	258.4	199.9	819.7	534.1	167.3	40.0	152.9	125.8	186.7	299.3	99.3	12.0	326.2	196.5	175.6	146.3	131.4	183.2	120.9	239.1	246.3	531.1	58.9	13.6	423.9	252.3	497.4	351.7	46.6	146.3	365.2	434.0	13.1	411.0	229.9	298.6	11.6	26.2	204.2	867.4	120.4	133.0	169.5	511.6	557.5	194.8	67.0	144.7	142.1	196.9	88.1	101.2	151.3	662.9	201.4	195.9	150.8	511.8	219.0
LENG1		ENSG00000105617	"Leukocyte receptor cluster member 1"	Q96BZ8	19	54155161-54159721	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 98.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 4.0;HaCaT: 5.7;HDLM-2: 3.6;HSkMC: 2.1;LHCN-M2: 3.1;U-87 MG: 4.1;WM-115: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043541	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Plasma membrane"	Nucleoplasm	"HPA043541: AB_10961190"	"unprognostic (8.75e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.73e-2)"	"unprognostic (6.42e-2)"	"unprognostic (5.22e-2)"	"prognostic favorable (8.12e-4)"	"unprognostic (7.51e-2)"	"prognostic favorable (3.72e-4)"	"unprognostic (2.21e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.14e-2)"	8.2	8.9	0.2	0.0	0.3	0.1	8.1	0.5	0.3	9.3	0.0	9.4	0.0	8.8	0.2	6.6	9.5	0.0	12.0	0.1	0.2	9.1	8.3	7.1	0.0	0.3	0.3	10.3	10.1	0.1	8.6	0.0	0.9	8.8	0.2	0.2	7.2	0.1	15.2	7.4	8.4	0.0	0.3	11.2	10.0	14.7	0.3	0.1	8.3	0.0	0.1	9.5	7.5	0.5	0.0	0.0	4.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.1	0.0	0.1	3.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	3.1	0.0	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.0	2.2	0.0	0.6	1.1	0.4	0.5	0.6	0.4	0.9	0.7	0.5	0.6	0.6	0.5	0.8	0.7	0.0	0.4	0.4	0.1	0.2	0.3	0.5	0.3	0.1	0.2	0.3	0.3	0.9	0.3	0.3	0.5	28.8	19.2	8.8	2.3	31.4	20.6	22.1	28.6	11.4	10.1	15.2	14.5	7.8	17.2	17.6	18.4	0.0	27.5	30.9	33.7	23.5	21.5	98.8	23.6	18.6	24.2	27.0	17.7	1.1	28.4	14.6	18.3	10.7	17.6	54.6	15.3	29.3	17.0	30.6	6.7	1.2	27.2	34.6	21.8	23.9	15.6	22.4	22.3	21.4	0.0	26.9	19.4	51.5	1.5	4.7	26.1	28.0	15.1	18.0	15.6	35.9	38.2	26.4	15.6	39.5	14.5	24.8	37.3	31.2	10.8	21.5	42.8	38.7	21.3	18.8	16.7
LIMK2		ENSG00000182541	"LIM domain kinase 2"	P53671	22	31212239-31280080	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 115.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"eosinophil: 40.0;neutrophil: 96.9"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 96.9"	"Cell line enhanced"	"Detected in all"		"BEWO: 135.5;hTCEpi: 251.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008183, CAB019313, HPA053882"	Approved		Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 5: Granulocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"CAB019313: , HPA008183: AB_1079252, HPA053882: AB_2682291"	"unprognostic (1.79e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.42e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (4.57e-6)"	"unprognostic (4.48e-2)"	"unprognostic (1.48e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.37e-1)"	20.1	14.4	25.5	39.8	27.3	53.8	30.9	25.8	22.1	26.4	32.6	34.0	21.2	17.0	7.7	71.8	34.2	21.3	14.3	20.8	27.7	27.7	33.0	46.8	23.2	37.8	34.2	21.6	28.8	27.0	21.9	48.0	32.8	36.7	34.7	25.5	50.7	19.1	18.8	71.5	29.3	15.9	32.7	37.5	30.0	19.2	33.6	21.3	42.0	9.2	17.8	25.7	45.3	33.1	26.6	4.4	17.9	10.0	7.6	8.8	135.5	17.2	8.0	16.9	14.2	22.7	12.2	25.8	29.9	26.0	8.1	52.6	20.9	90.3	10.6	19.1	22.8	18.8	21.1	24.7	11.4	35.1	33.1	14.3	251.5	13.7	41.0	114.5	43.6	20.6	10.7	18.2	23.3	20.9	21.5	12.0	16.7	68.3	6.7	28.1	30.0	14.3	19.6	62.3	22.8	20.4	13.0	82.1	35.1	54.8	68.7	13.9	26.6	15.1	23.5	8.3	16.3	10.0	16.2	22.4	9.6	16.4	6.6	5.8	5.1	40.0	3.1	3.5	5.9	2.0	5.7	4.3	1.9	2.4	5.6	4.4	96.9	6.7	1.4	4.4	15.2	4.4	25.5	27.3	25.8	22.1	20.8	27.7	37.8	34.2	32.8	32.7	33.6	33.1	19.5	32.1	17.9	16.3	5.2	35.9	37.7	24.8	59.2	9.4	18.0	23.2	25.1	10.0	32.6	5.5	20.9	69.8	15.3	39.3	3.9	13.0	1.4	49.6	19.2	22.4	13.2	10.3	6.4	45.0	52.4	7.6	48.9	41.6	23.5	8.6	14.3	7.1	18.2	3.3	11.3	42.8	18.3	8.9	8.2	1.6	4.4	13.8	3.6	16.9	5.4	16.6	2.1	2.5	15.5	25.9	21.2	4.5	6.2	27.1	12.0	10.5	36.3	22.8	19.7	7.5	17.2	15.6	18.4	46.1	39.1	115.5	9.3	7.1	51.7	29.9
LIN37	"F25965, lin-37, ZK418.4"	ENSG00000267796	"Lin-37 DREAM MuvB core complex component"	Q96GY3	19	35748361-35754519	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043253, HPA047809"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA043253: AB_2678391, HPA047809: AB_2680162"	"unprognostic (7.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.45e-3)"	"unprognostic (7.77e-3)"	"unprognostic (5.85e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.56e-1)"	"prognostic favorable (1.67e-4)"	"unprognostic (9.88e-3)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (2.53e-2)"	"unprognostic (8.89e-2)"	"unprognostic (4.35e-1)"	"unprognostic (5.14e-2)"	10.1	9.9	21.5	6.7	22.2	9.7	9.1	22.5	26.9	13.0	18.9	11.1	9.2	11.2	7.7	7.0	10.8	6.9	12.6	21.6	22.4	7.4	7.6	7.5	9.6	21.1	21.4	15.9	8.5	9.2	11.0	11.7	21.6	8.9	5.0	8.6	7.9	8.4	15.7	10.4	7.9	8.2	20.5	8.6	7.9	9.0	22.2	9.7	7.8	12.7	7.5	9.5	8.9	21.7	13.7	29.7	11.4	15.5	18.4	14.4	12.0	14.4	15.7	22.8	24.6	9.8	6.3	7.8	16.3	17.1	15.3	6.9	8.2	12.1	8.8	26.5	11.6	10.0	14.6	15.0	42.2	8.0	22.6	13.4	22.1	20.4	34.9	15.0	16.9	20.8	10.4	15.1	16.5	27.6	13.3	11.0	3.2	22.4	12.9	5.9	7.5	8.4	15.1	6.4	9.8	11.2	13.5	26.7	12.5	9.1	11.1	17.0	16.4	17.2	10.1	16.8	18.3	22.3	19.0	7.3	18.3	12.0	12.9	16.8	7.9	26.4	18.3	8.6	17.2	19.6	19.8	21.4	9.0	18.8	20.6	18.7	32.0	18.4	8.1	18.8	22.2	13.7	21.5	22.2	22.5	26.9	21.6	22.4	21.1	21.4	21.6	20.5	22.2	21.7	2.0	0.0	1.1	2.9	5.0	3.8	0.7	2.5	8.0	1.5	2.2	1.4	0.1	1.5	0.8	3.7	2.1	4.2	1.9	2.8	3.9	1.5	5.5	1.0	1.0	2.0	1.2	4.8	5.9	1.2	3.4	3.3	5.6	0.7	4.5	1.0	1.1	1.0	1.9	1.7	5.6	0.7	2.0	3.1	4.4	5.8	4.1	3.2	5.4	0.0	2.6	1.0	3.1	3.5	4.3	2.8	2.8	3.4	7.3	0.7	9.8	3.2	1.3	2.4	6.6	1.5	3.0	9.2	2.3	6.4	5.4	11.5	5.6	1.0	1.3	0.3
LIN7A	"LIN-7A, MALS-1, TIP-33, VELI1"	ENSG00000111052	"Lin-7 homolog A, crumbs cell polarity complex component"	O14910	12	80792520-80937934	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.9;retina: 26.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 77.3;Early spermatids: 107.2;Excitatory neurons: 135.5;Inhibitory neurons: 93.1;Late spermatids: 76.9;Spermatocytes: 61.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 8.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 18.8;eosinophil: 15.8;neutrophil: 29.8"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 29.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 21.3;ASC TERT1: 31.4;HAP1: 25.2;HDLM-2: 29.6;HL-60: 29.1;NB-4: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071562	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA071562: AB_2732181"	"unprognostic (7.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.52e-3)"	"unprognostic (3.04e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.46e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.41e-1)"	"prognostic favorable (1.63e-11)"	"unprognostic (5.01e-5)"	"unprognostic (7.79e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.69e-2)"	5.0	3.1	5.5	2.4	6.5	27.9	5.4	22.2	8.0	7.9	1.0	1.9	0.5	8.5	0.5	0.9	3.7	4.0	6.3	6.4	6.0	8.7	17.7	5.1	2.6	1.9	6.9	3.7	0.5	0.9	6.0	5.3	3.1	1.8	0.6	26.6	0.8	0.7	1.0	0.7	2.1	4.6	2.3	4.6	1.1	7.1	6.9	0.7	4.2	2.5	1.2	3.9	4.6	3.6	0.0	0.6	5.0	0.0	21.3	31.4	0.0	12.8	5.9	5.1	1.1	9.9	0.0	0.0	0.0	4.9	0.1	0.0	25.2	0.0	1.5	29.6	7.8	0.0	0.2	15.6	2.6	29.1	0.2	7.8	0.0	0.5	0.5	1.2	4.1	0.0	0.0	0.0	2.3	0.3	0.0	27.0	4.7	0.3	0.1	0.0	18.7	0.0	2.9	4.1	10.2	0.0	0.0	0.0	0.1	0.3	1.1	15.5	0.0	4.0	1.5	2.1	0.1	4.4	0.0	0.0	0.4	0.0	0.2	18.8	5.2	15.8	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	29.8	0.0	0.2	0.0	0.1	1.2	5.5	6.5	22.2	8.0	6.4	6.0	1.9	6.9	3.1	2.3	6.9	3.6	4.8	22.4	5.8	18.6	0.0	0.8	4.8	0.0	0.0	77.3	10.8	3.4	22.8	8.6	0.6	25.8	2.1	0.4	0.2	0.3	9.8	1.3	107.2	1.9	8.9	1.9	1.8	0.4	135.5	0.2	0.1	4.9	0.0	3.5	0.0	0.1	1.8	21.5	2.5	30.3	93.1	0.5	0.0	5.2	0.7	76.9	4.7	4.2	0.0	9.4	6.5	42.6	0.0	23.1	2.7	0.0	1.2	1.5	0.4	2.0	20.1	26.5	0.7	11.2	13.1	5.0	19.2	61.3	1.3	0.0	0.4	0.7	0.6	3.5	1.1	1.8
LYPLA2	APT-2	ENSG00000011009	"Lysophospholipase 2"	O95372	1	23791145-23795539	"Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063151			Uncertain	Nucleoplasm,Cytosol		NA	NA		110000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Nucleoplasm	"HPA063151: "	"unprognostic (8.84e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.81e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (5.84e-5)"	"unprognostic (3.06e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.40e-1)"	"prognostic favorable (4.99e-4)"	"unprognostic (6.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.24e-1)"	32.6	41.1	31.3	33.3	33.2	55.2	33.4	31.1	43.9	33.1	82.4	48.9	49.6	28.2	13.7	76.2	43.2	32.3	40.9	40.4	31.3	79.5	82.2	40.8	43.5	31.1	32.3	28.4	43.7	77.2	35.0	37.1	30.2	45.2	29.4	15.7	51.2	24.7	43.4	51.3	51.3	20.1	30.6	61.1	47.7	23.4	33.0	42.8	39.0	25.2	33.2	46.3	40.3	28.2	80.3	54.2	61.0	70.6	30.4	37.0	83.7	50.8	49.4	50.0	42.6	75.2	130.1	45.8	67.7	49.4	34.9	78.2	45.7	141.2	19.8	88.4	67.9	58.1	87.1	127.5	49.8	54.0	72.5	48.1	85.3	74.9	27.5	61.9	118.8	52.6	84.2	45.4	55.0	89.4	67.3	90.0	120.3	72.6	76.6	78.9	35.0	79.1	122.6	64.6	87.2	149.4	57.7	87.0	88.5	43.5	71.7	58.6	98.6	46.5	61.2	56.7	43.2	116.4	104.1	62.6	74.3	125.1	58.5	82.7	95.3	125.0	105.8	96.0	87.1	62.9	89.1	93.9	77.9	67.9	75.6	80.0	113.2	83.5	80.2	58.8	88.7	113.6	31.3	33.2	31.1	43.9	40.4	31.3	31.1	32.3	30.2	30.6	33.0	28.2	21.3	9.6	27.3	6.2	27.7	38.9	31.0	80.0	23.3	34.1	36.9	35.4	16.1	35.8	36.5	36.8	18.8	118.7	29.9	105.0	68.4	105.8	15.5	44.9	13.7	33.8	44.3	26.9	5.1	112.8	108.8	19.1	40.8	27.5	36.8	23.1	21.0	35.0	69.3	23.5	5.7	53.5	52.9	17.2	23.3	13.4	10.5	27.6	19.6	4.7	62.1	30.2	46.4	7.5	5.2	130.2	71.9	6.4	20.8	33.3	77.1	92.2	57.6	26.0	26.3	8.6	23.3	8.0	19.1	33.1	41.5	115.9	36.2	64.0	56.6	42.4
MAEA	"EMP, GID9, HLC-10, p44EMLP"	ENSG00000090316	"Macrophage erythroblast attacher, E3 ubiquitin ligase"	Q7L5Y9	4	1289887-1340147	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Erythrocyte maturation, Ubl conjugation pathway"	"Actin-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036886, HPA058185"	Approved		Enhanced	Nucleoplasm		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA036886: , HPA058185: AB_2683633"	"unprognostic (2.70e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.03e-2)"	"prognostic favorable (5.34e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.50e-1)"	"unprognostic (6.94e-3)"	"unprognostic (4.65e-3)"	"prognostic favorable (1.90e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.51e-2)"	28.5	44.2	21.9	23.5	21.3	18.3	28.8	19.8	24.0	32.6	25.9	39.7	33.5	34.4	10.9	46.7	29.2	17.5	38.6	21.1	27.2	40.9	32.3	24.0	24.3	25.7	23.0	34.9	35.4	30.7	38.9	17.2	26.3	29.2	14.2	8.8	35.7	21.5	37.1	41.2	35.7	14.9	18.1	40.0	37.1	26.8	23.2	20.7	33.9	19.2	15.7	30.7	33.5	20.0	58.1	66.9	47.6	47.7	31.5	31.1	61.4	57.4	30.6	47.1	42.2	70.5	73.5	52.5	43.6	42.4	85.5	42.0	46.1	72.2	19.1	42.4	52.2	49.2	74.1	68.1	37.1	55.8	50.9	38.8	38.6	37.8	23.6	31.8	38.0	50.4	70.4	41.6	41.3	61.5	84.2	86.5	62.2	63.4	72.9	81.0	38.1	47.8	50.3	68.2	84.7	57.8	51.1	39.3	41.5	26.3	71.5	48.4	52.8	85.9	36.0	39.0	96.1	50.5	83.4	58.1	59.0	51.3	48.2	74.9	49.9	70.9	59.2	52.6	83.5	47.6	47.1	56.4	47.1	38.1	41.4	42.5	117.9	45.5	77.3	33.0	59.8	59.1	21.9	21.3	19.8	24.0	21.1	27.2	25.7	23.0	26.3	18.1	23.2	20.0	22.0	19.2	25.0	28.4	21.6	18.7	15.7	33.9	8.0	28.1	22.5	25.3	35.5	14.3	24.3	16.5	20.9	48.2	29.7	41.2	46.9	43.4	8.0	21.9	25.2	24.4	20.4	26.3	19.6	30.3	46.4	25.0	25.5	25.0	10.8	30.4	19.6	15.0	39.6	21.9	23.2	33.1	30.5	29.2	15.9	9.8	35.4	23.2	28.4	14.0	46.3	22.3	28.8	22.6	20.0	40.3	31.3	37.2	23.5	22.7	30.4	36.4	17.9	19.1	13.1	24.9	27.9	36.6	44.0	19.3	19.9	95.2	29.7	59.6	38.1	21.8
MARF1	"KIAA0430, LKAP, LMKB, PPP1R34"	ENSG00000166783	"Meiosis regulator and mRNA stability factor 1"	Q9Y4F3	16	15594387-15643154	"Predicted intracellular proteins"	"Differentiation, Meiosis, Oogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 28.7;Breast glandular cells: 26.3;Endometrial stromal cells: 27.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017992	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus, Vesicles"		"HPA017992: AB_1852921"	"unprognostic (2.33e-1)"	"unprognostic (6.44e-3)"	"unprognostic (8.84e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.35e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.93e-2)"	"unprognostic (8.44e-3)"	"unprognostic (1.35e-1)"	"unprognostic (6.94e-3)"	"unprognostic (3.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.74e-2)"	"unprognostic (7.94e-2)"	10.5	7.1	2.1	10.8	5.2	9.7	9.4	1.5	6.6	10.0	3.7	16.0	10.4	12.8	1.0	12.3	13.7	12.5	9.2	4.5	3.4	13.5	8.3	9.3	14.6	3.6	4.5	18.2	12.9	12.3	5.9	9.4	2.6	10.4	12.1	8.4	14.4	13.7	18.3	10.5	11.2	12.0	0.0	12.1	10.1	4.9	4.4	12.7	14.8	15.2	22.0	12.1	8.8	4.5	8.3	9.4	15.0	8.2	12.1	22.4	7.2	9.6	12.4	8.2	13.5	2.7	6.2	29.8	17.0	12.3	6.7	5.6	7.7	12.4	13.6	11.6	5.0	13.1	12.3	10.4	13.4	15.7	10.5	13.4	13.4	15.3	15.5	16.9	19.5	12.8	12.6	13.3	15.6	7.7	13.9	2.6	5.6	7.1	7.2	19.5	22.0	5.9	7.1	6.4	9.1	10.8	7.7	8.9	14.3	6.7	9.2	13.2	19.7	11.2	5.5	11.6	6.3	12.3	12.9	15.9	12.4	9.6	16.4	2.5	0.7	4.6	1.1	1.2	0.7	4.1	1.7	1.3	0.8	5.2	1.9	1.4	7.1	0.9	1.8	0.3	1.7	0.9	2.1	5.2	1.5	6.6	4.5	3.4	3.6	4.5	2.6	0.0	4.4	4.5	21.4	22.4	28.7	0.0	10.7	0.0	0.0	0.0	0.0	0.0	26.3	19.8	0.0	0.0	18.6	23.9	0.0	5.7	14.7	0.0	15.6	10.4	0.0	17.8	27.5	8.4	0.0	0.0	0.0	14.2	5.9	7.7	0.0	20.0	11.4	23.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	7.2	0.0	0.0	0.0	0.0	13.7	0.0	0.0	6.8	0.0	0.0	19.0	17.5	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	7.7	7.8	17.9	0.0	0.0
MBD1	"CXXC3, PCM1"	ENSG00000141644	"Methyl-CpG binding domain protein 1"	Q9UIS9	18	50266882-50281774	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 97.4;Spermatocytes: 136.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009017, CAB036003, HPA068850"	Approved		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Vesicles"		"CAB009017: AB_2095559, CAB036003: , HPA068850: AB_2732121"	"unprognostic (2.12e-2)"	"unprognostic (5.05e-2)"	"unprognostic (6.88e-2)"	"unprognostic (5.01e-3)"	"unprognostic (9.20e-2)"	"unprognostic (6.85e-2)"	"prognostic unfavorable (5.08e-6)"	"unprognostic (5.91e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.96e-3)"	"prognostic unfavorable (1.70e-6)"	"unprognostic (7.06e-3)"	"unprognostic (7.70e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.31e-1)"	28.5	39.8	23.9	26.2	25.9	44.2	29.1	24.8	28.2	32.3	19.3	35.7	24.8	32.1	20.5	39.2	31.6	19.6	35.7	26.7	22.2	32.5	35.7	29.9	30.2	23.1	22.0	34.8	34.5	32.4	42.8	24.6	21.1	33.0	17.7	24.0	30.5	23.5	51.0	43.4	33.7	20.4	19.5	41.0	33.6	88.1	23.1	29.6	35.4	28.6	24.2	35.3	32.2	25.6	30.9	28.6	31.5	35.9	33.2	26.9	33.9	36.2	41.4	49.2	37.7	21.6	23.9	48.5	25.8	35.3	28.8	54.4	36.3	63.4	28.4	54.7	23.2	30.6	43.8	23.1	63.9	74.8	62.1	31.5	100.4	56.2	127.2	31.1	40.9	47.4	39.3	73.8	38.3	28.5	63.3	38.9	29.8	16.1	22.7	57.8	23.3	53.2	24.4	13.8	41.5	39.5	27.0	25.5	33.2	25.4	32.4	67.4	44.7	53.0	24.1	17.3	37.2	135.8	62.2	51.6	34.3	56.8	49.0	16.0	11.2	22.7	15.3	9.7	14.6	11.6	13.5	12.9	11.2	11.4	13.8	11.4	14.5	14.3	7.8	10.2	13.8	12.6	23.9	25.9	24.8	28.2	26.7	22.2	23.1	22.0	21.1	19.5	23.1	25.6	17.7	9.6	24.6	19.6	20.1	22.7	13.9	18.2	23.3	15.1	16.5	14.5	28.1	14.3	20.5	16.5	18.8	31.1	25.0	24.5	13.7	15.7	85.1	17.1	16.1	17.6	13.1	9.7	20.4	13.8	24.2	16.5	28.1	17.3	8.8	17.7	13.9	18.1	18.7	15.2	17.3	19.5	24.4	15.8	11.1	97.4	15.5	17.5	16.0	9.4	15.7	17.4	14.4	12.1	16.4	21.1	24.5	19.2	34.6	14.4	21.3	9.7	16.9	20.3	13.1	14.8	18.9	136.0	32.5	21.6	29.3	51.4	20.0	28.1	18.6	17.0
MBP		ENSG00000197971	"Myelin basic protein"	P02686	18	76978827-77133683	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Autoimmune encephalomyelitis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	142	"brain: 30812.9;choroid plexus: 9144.9"	"Cell type enriched"	"Detected in many"	11	"Oligodendrocytes: 2895.5"	"Group enriched"	"Detected in all"	9	"glioma: 47.5;melanoma: 20.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 99.3;SK-MEL-30: 204.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002300, HPA049222, HPA064368"	Enhanced	Supported	Approved	"Plasma membrane"		NA	NA		54000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"CAB002300: AB_563893, HPA049222: AB_2680679, HPA064368: AB_2685247"	"unprognostic (9.36e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.31e-1)"	"unprognostic (9.87e-2)"	"unprognostic (2.90e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.95e-1)"	"prognostic favorable (4.48e-12)"	"unprognostic (2.90e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.03e-2)"	27.3	7.1	15448.6	20.9	21296.6	43.0	20.9	19749.8	26916.8	17.3	9144.9	19.0	18.6	13.2	7.9	20.5	31.5	17.2	24.1	12696.6	16271.8	28.7	23.5	20.0	26.9	30812.9	22193.8	22.3	22.8	47.5	26.7	4.7	25986.2	15.3	16.9	7.5	22.0	13.0	140.8	28.7	20.7	8.7	23219.4	28.0	17.5	6.1	19406.0	12.5	22.2	81.6	27.8	19.0	20.2	30044.2	26.1	22.4	0.2	0.8	35.8	53.1	8.5	0.6	0.6	0.8	0.6	3.2	39.2	15.9	4.4	1.7	0.2	49.9	3.8	22.1	0.7	60.7	5.3	10.4	3.9	5.2	22.5	99.3	65.3	7.7	18.4	19.8	30.3	16.4	6.5	37.9	0.0	3.6	0.0	3.2	4.1	50.6	2.2	15.6	18.1	1.5	0.4	35.9	34.5	34.3	1.8	0.3	3.2	0.0	204.7	6.1	0.6	60.5	0.1	0.2	0.5	0.2	2.8	0.1	0.5	16.9	5.8	62.0	2.5	21.7	8.5	32.4	21.6	8.1	13.1	5.9	15.4	28.1	9.2	5.1	9.1	17.0	39.5	28.0	8.1	11.9	14.9	11.6	15448.6	21296.6	19749.8	26916.8	12696.6	16271.8	30812.9	22193.8	25986.2	23219.4	19406.0	30044.2	5.5	48.1	39.5	10.7	86.8	118.8	61.1	28.1	84.2	52.8	24.2	22.7	45.0	35.8	50.3	103.0	2.1	0.7	221.8	48.7	41.1	43.7	5.9	159.8	11.2	9.4	49.8	68.8	32.4	35.8	0.8	36.2	59.1	161.1	71.5	2.1	10.0	30.2	44.4	1.7	47.1	51.4	44.7	78.3	123.1	6.3	28.3	98.2	92.5	45.0	84.4	25.7	247.2	124.7	2895.5	60.4	25.5	14.3	45.3	117.6	37.5	36.0	54.0	6.1	0.0	88.7	8.4	7.7	1.1	75.6	154.7	0.7	151.6	0.0	42.1	103.7
MCTP2	"FLJ11175, FLJ33303"	ENSG00000140563	"Multiple C2 and transmembrane domain containing 2"	Q6DN12	15	94231538-94483952	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 72.8;NK-cells: 97.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 6.8"	"Immune cell enhanced"	"Detected in many"		"neutrophil: 32.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 20.8;HMC-1: 16.4;U-698: 22.4;U-87 MG: 24.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA051176, HPA070541"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA051176: AB_2681373, HPA070541: AB_2686277"	"unprognostic (1.70e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (7.15e-4)"	"unprognostic (3.57e-2)"	"unprognostic (2.66e-3)"	"unprognostic (3.45e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (2.18e-5)"	"unprognostic (5.87e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.76e-3)"	"unprognostic (9.41e-2)"	4.1	3.8	1.0	6.6	1.8	18.0	2.9	0.0	6.8	5.4	0.8	10.6	6.9	1.8	8.6	3.9	4.1	4.5	0.6	1.1	2.8	2.3	1.5	8.7	6.1	0.0	0.3	1.6	5.7	3.5	7.3	19.3	1.0	5.4	12.2	2.6	5.9	4.1	0.1	3.6	6.4	1.6	0.0	21.1	4.7	1.0	1.3	3.0	5.5	0.4	6.2	6.6	3.7	0.6	3.6	0.0	0.1	0.0	0.0	0.0	2.5	1.9	1.1	0.3	0.1	2.4	4.4	10.3	0.5	0.1	0.1	8.0	0.1	6.6	0.0	2.1	0.8	20.8	2.9	1.2	1.4	4.4	16.4	1.1	7.8	0.1	8.2	0.0	0.0	3.6	0.8	5.9	0.0	0.0	2.0	11.4	0.8	3.6	3.7	4.7	0.1	4.0	0.5	10.7	1.9	0.4	0.2	3.4	1.3	0.8	0.0	0.3	0.2	0.1	1.7	0.0	0.0	12.0	0.3	22.4	24.1	11.1	1.2	6.6	0.8	12.1	6.1	0.2	3.0	3.5	1.7	2.8	0.0	3.6	0.7	2.7	32.1	10.9	0.9	0.3	0.1	1.9	1.0	1.8	0.0	6.8	1.1	2.8	0.0	0.3	1.0	0.0	1.3	0.6	1.1	3.2	18.6	1.0	38.9	4.2	12.9	8.6	22.8	15.6	3.8	4.3	1.1	7.2	13.2	3.7	0.0	17.0	72.8	39.4	0.0	3.4	4.0	6.5	3.4	1.8	15.6	35.7	15.6	4.7	7.3	7.8	5.6	6.6	36.2	0.3	1.4	1.4	9.6	0.0	10.3	43.8	8.2	8.7	2.1	4.8	0.3	11.1	1.8	25.3	4.7	0.1	97.9	0.0	0.7	4.2	24.6	0.0	45.8	14.2	18.1	1.9	8.7	0.6	0.0	2.5	1.6	3.4	2.5	15.0	2.3	24.5	26.6	0.5	21.5	19.6
MED11	"HSPC296, MGC88387"	ENSG00000161920	"Mediator complex subunit 11"	Q9P086	17	4731428-4733608	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056669	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nuclear bodies"		"HPA056669: AB_2683204"	"unprognostic (4.01e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.91e-2)"	"prognostic favorable (1.86e-5)"	"unprognostic (8.24e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.82e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.61e-2)"	20.5	41.3	28.6	22.5	32.0	11.2	20.3	32.3	33.8	21.1	28.2	25.4	27.2	18.9	25.3	29.2	24.4	19.0	29.5	28.2	30.5	32.7	38.6	22.9	28.5	31.9	31.2	16.8	29.0	35.6	19.1	16.4	31.6	23.3	23.4	17.2	26.6	19.5	39.0	27.2	26.5	16.9	30.4	34.5	30.6	16.2	31.3	25.3	22.4	32.9	26.5	22.3	21.3	35.3	26.2	73.5	26.9	27.8	28.6	34.6	20.7	18.4	30.8	26.4	33.0	25.6	19.7	35.7	18.9	22.3	17.2	38.8	27.1	51.9	20.5	42.5	63.1	17.8	42.6	40.6	17.7	12.9	20.7	30.1	35.6	28.3	17.3	28.2	30.3	36.4	18.1	26.5	23.4	37.6	24.8	16.8	16.0	39.3	23.6	24.5	19.7	23.3	54.3	27.5	10.9	18.1	23.7	31.5	18.5	22.0	28.4	15.1	18.1	14.1	14.1	27.4	29.3	12.5	11.8	14.2	24.4	22.0	18.8	49.1	31.0	79.3	41.6	45.6	45.4	62.8	40.8	41.8	31.0	61.9	48.3	53.1	136.3	40.9	68.0	49.8	33.7	38.5	28.6	32.0	32.3	33.8	28.2	30.5	31.9	31.2	31.6	30.4	31.3	35.3	12.5	6.4	23.5	7.8	31.5	12.2	28.8	42.6	19.4	22.1	20.0	17.8	15.1	32.9	32.3	14.7	10.4	45.4	34.3	32.8	64.6	37.0	1.2	35.1	24.8	15.8	10.8	13.5	5.5	35.3	34.2	17.3	28.5	25.0	29.1	9.3	22.5	29.4	33.8	30.3	7.2	30.9	48.8	31.5	21.1	3.8	17.4	25.5	10.6	5.6	44.6	20.9	50.4	5.0	14.6	22.4	51.1	13.9	18.8	22.9	66.4	99.5	36.9	26.6	19.7	16.5	18.2	56.6	49.9	31.3	18.8	25.0	27.3	33.8	29.7	28.6
MED28	"DKFZP434N185, EG1, magicin"	ENSG00000118579	"Mediator complex subunit 28"	Q9H204	4	17614641-17634105	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Actin-binding, Activator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035900, HPA035901"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA035900: AB_10673223, HPA035901: AB_2674853"	"unprognostic (1.14e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.08e-3)"	"unprognostic (8.22e-3)"	"unprognostic (3.90e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.27e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.30e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.07e-3)"	6.9	5.6	8.8	7.5	9.3	12.2	9.2	9.4	8.8	12.2	8.8	9.8	5.9	11.5	9.7	7.9	10.6	5.2	6.4	8.4	9.4	7.7	6.2	9.7	10.8	9.4	8.8	14.8	7.3	6.6	10.3	8.5	8.4	9.1	6.9	11.7	9.2	7.3	12.6	10.2	9.6	7.2	8.6	10.2	8.7	6.0	9.6	11.2	9.8	5.9	11.1	9.1	9.9	11.9	4.6	2.9	23.2	11.7	10.0	7.8	9.4	6.5	7.7	8.6	7.8	8.1	10.9	12.6	4.5	6.0	7.6	4.5	14.1	7.0	8.6	5.0	7.0	22.2	10.1	12.3	7.0	15.7	10.7	7.6	9.6	5.4	4.5	9.0	7.5	18.0	20.0	11.3	7.7	4.5	23.3	27.0	16.1	9.1	4.8	17.8	8.5	5.9	8.2	6.8	16.6	8.3	5.7	4.9	5.7	13.6	9.3	16.0	9.4	5.6	3.9	4.0	6.2	8.4	4.0	16.1	5.1	14.9	6.1	5.2	6.6	6.5	4.5	5.2	4.4	5.5	4.9	4.2	6.4	5.6	6.4	5.0	9.0	5.5	4.4	4.4	4.2	7.5	8.8	9.3	9.4	8.8	8.4	9.4	9.4	8.8	8.4	8.6	9.6	11.9	45.7	19.2	27.6	4.9	67.6	92.2	114.0	86.2	46.1	42.6	54.9	65.8	19.5	38.6	55.2	22.0	16.7	114.5	69.9	25.9	84.1	61.6	11.6	31.2	47.3	63.9	44.3	93.2	5.1	53.8	167.8	57.9	19.4	35.5	59.1	78.4	52.5	31.5	93.9	33.7	5.8	41.2	65.1	74.1	103.0	20.4	56.5	61.7	60.5	5.6	115.4	58.9	94.7	9.5	8.9	57.2	47.4	47.0	33.0	110.2	33.6	58.8	40.6	35.1	32.9	50.5	74.7	76.0	100.5	46.0	93.5	134.6	61.3	62.7	47.5	104.6
MFSD14A	"DKFZP564L0864, HIAT1"	ENSG00000156875	"Major facilitator superfamily domain containing 14A"	Q96MC6	1	100038095-100083377	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 131.4"	"Group enriched"	"Detected in many"	5	"Early spermatids: 303.1;Late spermatids: 373.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA073127, HPA073681"	Approved		Approved	Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"HPA073127: , HPA073681: AB_2686625"	"unprognostic (1.37e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (2.16e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.15e-2)"	29.1	28.5	18.1	26.2	21.1	90.3	27.4	21.2	24.7	25.9	20.8	26.8	19.6	35.3	26.0	29.0	26.6	25.2	19.6	18.2	21.1	29.7	29.5	28.8	28.4	23.3	20.2	30.5	31.5	131.4	18.7	34.1	22.1	33.4	21.8	19.6	23.0	31.4	15.0	24.9	19.6	35.5	21.9	28.4	22.4	35.3	20.0	31.1	27.9	20.1	29.2	33.5	24.0	25.7	54.3	22.2	48.9	25.4	56.0	52.8	41.3	38.9	65.9	51.5	59.9	18.9	37.0	40.5	61.7	50.6	34.1	51.0	44.0	42.8	49.2	35.6	34.8	40.1	32.8	28.6	49.4	65.0	50.2	43.3	64.1	45.5	57.9	45.3	40.2	45.1	49.8	77.2	48.1	16.0	49.3	38.1	56.4	26.2	32.4	34.1	59.6	39.8	54.8	46.9	50.7	45.2	43.8	63.0	66.6	30.9	24.6	65.3	44.5	42.3	29.6	44.9	40.9	72.8	82.4	56.0	46.1	46.6	18.6	80.1	56.0	54.6	49.5	51.4	55.9	46.2	49.6	54.4	55.2	38.8	54.8	51.5	94.8	59.9	45.2	25.6	60.3	72.0	18.1	21.1	21.2	24.7	18.2	21.1	23.3	20.2	22.1	21.9	20.0	25.7	4.5	6.4	11.5	0.0	33.5	0.0	47.5	0.0	43.3	17.8	3.4	1.5	0.0	27.1	3.7	3.7	10.4	37.5	7.8	6.5	1.9	10.1	303.1	1.0	1.7	20.8	13.3	35.8	0.0	7.2	33.5	19.5	18.3	1.5	2.5	0.6	19.6	17.1	23.1	13.5	0.0	9.4	0.0	26.4	0.0	373.8	22.7	15.8	0.0	0.0	22.2	25.1	33.0	0.0	0.0	6.5	17.1	30.5	41.9	56.3	8.1	1.1	5.8	11.6	13.1	25.6	12.8	28.2	22.5	43.4	0.0	58.3	33.7	0.4	9.6	52.3
MFSD8	"CLN7, MGC33302"	ENSG00000164073	"Major facilitator superfamily domain containing 8"	Q8NHS3	4	127917799-127966034	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044802	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	Vesicles	Nucleoplasm	"HPA044802: AB_10963221"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.69e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.61e-3)"	"unprognostic (3.14e-1)"	"prognostic favorable (2.21e-4)"	4.6	5.7	1.3	6.8	1.3	2.6	6.9	1.9	1.6	6.2	1.1	6.8	10.0	5.6	3.9	5.4	5.5	4.8	3.8	1.1	1.7	6.4	10.0	4.8	5.4	1.4	1.3	6.8	8.1	9.1	7.1	5.9	1.5	5.5	8.2	4.6	5.8	4.4	3.7	5.9	7.6	5.8	1.1	7.3	6.4	3.9	0.8	5.2	7.0	4.4	7.9	5.3	5.9	2.2	10.9	7.3	9.5	4.6	7.2	6.9	7.0	8.3	10.3	10.2	10.5	5.2	14.3	5.2	14.5	14.3	14.8	7.8	10.2	7.4	14.4	10.8	7.9	5.7	9.1	8.0	9.4	6.0	6.6	8.3	2.7	8.6	7.7	5.0	10.6	6.6	9.5	5.9	14.6	8.9	5.0	1.9	1.7	11.8	5.2	5.3	0.6	4.7	7.5	13.9	8.5	2.9	9.0	12.0	3.5	6.4	5.6	5.1	6.7	2.9	3.1	10.7	7.8	12.5	22.1	9.6	10.3	5.3	8.8	1.9	1.6	2.8	2.5	2.4	2.4	2.5	2.7	2.2	1.6	1.1	2.4	2.6	2.5	2.4	3.7	2.2	3.4	1.2	1.3	1.3	1.9	1.6	1.1	1.7	1.4	1.3	1.5	1.1	0.8	2.2	9.5	12.8	14.1	17.0	18.8	3.2	4.9	8.5	10.2	17.2	8.1	5.3	3.0	5.7	14.0	16.5	20.9	12.5	17.9	7.2	1.9	8.5	10.4	7.7	7.2	7.2	4.2	3.8	32.1	7.0	7.3	8.6	11.7	8.2	12.7	18.4	8.9	10.1	7.6	11.8	34.9	6.8	10.2	8.5	3.3	14.7	9.3	6.5	3.6	27.2	10.5	8.6	20.6	20.6	24.6	7.8	9.5	9.4	19.9	5.4	11.1	6.3	12.1	24.9	6.6	5.8	6.6	12.6	8.4	8.9	5.7	22.0	13.7	11.4	7.3	4.8
MLF2	NTN4	ENSG00000089693	"Myeloid leukemia factor 2"	Q15773	12	6747996-6767475	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010811, HPA010859"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	Yes			"Cluster 5: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA010811: AB_1079389, HPA010859: AB_1079388"	"unprognostic (1.65e-1)"	"unprognostic (6.55e-2)"	"unprognostic (4.42e-1)"	"unprognostic (9.88e-3)"	"unprognostic (1.76e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.83e-2)"	"unprognostic (4.72e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.63e-1)"	121.0	199.0	214.6	67.9	225.7	123.8	109.8	206.5	243.7	119.8	215.4	161.8	106.3	148.5	85.2	168.6	120.6	68.1	181.8	234.6	219.0	163.3	298.7	107.0	66.2	208.0	205.8	116.3	111.0	158.2	145.1	79.4	205.8	142.7	74.1	78.2	131.6	96.3	192.8	144.6	117.8	93.0	205.4	101.5	135.9	97.6	211.1	78.3	114.1	129.2	71.2	135.2	117.5	223.6	222.0	354.3	179.1	294.4	159.3	157.9	283.1	216.6	230.6	318.8	286.9	353.8	195.5	163.1	55.0	265.5	228.1	173.5	220.1	295.3	220.0	274.9	239.3	115.3	174.0	200.7	176.0	128.9	143.0	151.7	240.8	255.2	209.8	257.4	140.7	152.0	152.5	61.8	247.8	320.7	165.7	197.9	554.2	236.1	141.2	102.5	160.2	134.0	310.8	247.7	111.2	224.8	188.8	303.6	203.4	385.8	89.8	186.4	133.7	191.4	279.3	213.5	299.9	80.9	98.2	208.9	259.0	102.2	231.2	259.6	120.3	461.0	82.0	109.9	80.9	85.6	63.7	78.3	134.0	97.6	66.2	75.3	528.0	76.6	129.2	231.6	69.7	115.3	214.6	225.7	206.5	243.7	234.6	219.0	208.0	205.8	205.8	205.4	211.1	223.6	106.3	38.5	30.9	19.2	77.9	136.5	149.3	230.2	261.2	110.2	157.7	156.3	71.9	92.9	108.7	110.3	41.7	264.3	92.4	120.6	279.7	169.9	12.1	64.6	70.7	86.4	100.7	74.9	36.2	125.9	213.7	100.6	91.7	74.9	84.9	84.1	71.0	168.6	147.7	80.8	32.7	138.6	197.4	57.8	70.6	13.3	114.0	78.9	103.2	13.1	138.9	142.7	39.1	19.1	23.5	153.8	124.7	107.2	108.2	202.6	219.6	324.7	58.6	63.5	52.6	77.1	131.8	96.6	80.8	193.1	125.6	427.6	70.2	138.3	145.0	174.6
MPPE1	"Cdc1, PGAP5"	ENSG00000154889	"Metallophosphoesterase 1"	Q53F39	18	11882622-11908366	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, GPI-anchor biosynthesis, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 100.8;neutrophil: 293.9"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 293.9"	"Cell line enhanced"	"Detected in all"		"OE19: 65.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012639	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Golgi apparatus"		"HPA012639: AB_1854088"	"unprognostic (9.23e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.51e-1)"	"unprognostic (7.92e-3)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (1.00e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.61e-1)"	"prognostic favorable (6.45e-7)"	"unprognostic (1.26e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.79e-2)"	"unprognostic (6.15e-2)"	14.9	13.1	11.3	20.0	11.7	28.3	15.4	11.0	11.9	16.1	11.7	21.5	17.7	17.0	20.6	17.2	16.4	21.8	18.6	10.9	11.9	28.8	23.8	25.6	16.0	12.6	11.8	12.7	31.8	20.1	15.0	14.1	12.5	16.3	21.4	15.9	15.0	19.0	23.5	29.0	20.3	15.8	10.6	15.9	22.8	8.5	12.1	16.0	47.1	11.7	14.7	14.9	13.7	13.1	7.8	11.1	8.4	19.9	22.9	26.7	7.9	18.6	26.0	10.6	16.5	20.8	21.6	15.8	39.2	17.6	10.7	8.6	5.8	10.1	9.9	17.7	10.4	4.6	22.9	4.9	31.9	20.3	30.9	40.1	13.3	9.4	6.6	15.7	6.5	13.9	5.8	14.5	17.8	18.1	15.1	13.6	5.6	65.9	3.1	6.0	5.4	18.8	17.2	11.9	11.8	6.7	17.1	13.5	16.0	9.3	9.8	25.9	13.5	21.4	8.3	20.5	10.3	22.6	21.5	19.7	15.8	10.4	21.5	20.6	42.9	100.8	24.8	34.5	18.1	17.9	15.2	23.9	37.3	21.7	18.5	23.8	293.9	29.2	24.6	29.6	27.0	31.8	11.3	11.7	11.0	11.9	10.9	11.9	12.6	11.8	12.5	10.6	12.1	13.1	19.3	57.7	33.0	13.4	24.5	18.0	16.2	20.7	12.5	17.4	14.6	11.6	2.4	24.3	23.1	22.0	12.5	27.9	35.7	43.9	21.5	30.5	20.5	17.9	14.8	15.5	9.6	13.3	20.9	41.9	32.5	16.6	29.6	22.6	27.8	23.5	15.7	27.6	25.4	8.4	21.4	23.4	14.2	33.2	25.7	36.0	12.8	24.8	19.6	20.6	24.2	23.3	52.5	12.5	24.4	36.3	18.4	15.1	16.0	10.1	36.3	27.0	26.7	20.5	13.1	17.2	13.9	7.0	8.7	21.8	20.0	16.7	33.7	16.4	16.1	22.0
MRPL45	MGC11321	ENSG00000278845	"Mitochondrial ribosomal protein L45"		17	38297023-38323217	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebral cortex: 8.4"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AF22: 35.7;Daudi: 80.9;K-562: 57.0;REH: 43.2;RPMI-8226: 34.4;RT4: 33.9;U-266/84: 52.1;U-698: 56.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023373, HPA023385"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	Mitochondria		"HPA023373: AB_1854114, HPA023385: AB_1854115"	"unprognostic (8.56e-3)"	"unprognostic (4.09e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.01e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.13e-2)"	24.0	26.7	1.5	2.2	1.9	1.9	24.1	1.6	8.4	21.1	2.2	24.6	0.0	21.4	0.0	25.3	19.8	4.0	32.1	1.6	1.6	26.0	30.7	15.2	8.0	1.7	1.6	28.3	36.8	9.0	13.1	1.7	1.7	18.0	5.7	1.3	22.4	0.0	61.8	26.5	19.6	0.7	1.5	16.3	30.0	9.5	1.6	2.6	18.2	0.0	6.9	22.1	20.1	1.6	0.0	0.5	35.7	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	26.8	80.9	0.2	0.0	24.2	0.5	0.2	0.0	0.1	0.0	0.3	31.1	0.0	2.1	12.7	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.0	0.0	57.0	0.0	0.2	0.0	23.1	0.0	0.3	0.1	0.0	43.2	0.2	34.4	0.0	33.9	0.1	0.2	0.2	0.6	0.2	0.1	0.1	0.2	0.5	15.1	0.1	0.0	0.3	23.2	52.1	56.9	0.1	0.0	0.4	0.6	6.7	2.2	5.3	8.2	6.4	7.6	7.7	4.1	11.3	6.8	9.8	6.6	0.2	9.8	2.3	4.8	6.6	6.3	1.5	1.9	1.6	8.4	1.6	1.6	1.7	1.6	1.7	1.5	1.6	1.6	20.4	12.8	12.1	6.8	23.8	30.2	39.3	54.6	42.7	10.9	41.3	37.7	46.5	32.9	23.9	25.8	8.4	69.3	16.3	11.3	60.7	41.5	18.3	21.6	25.6	26.9	16.3	45.9	10.4	37.5	67.7	25.1	24.5	21.1	23.5	31.4	22.5	30.4	42.6	16.8	12.0	27.4	34.6	39.1	21.1	15.0	20.8	22.2	19.6	1.9	43.8	13.0	22.6	7.5	9.2	29.6	15.5	16.6	23.7	28.8	32.0	64.0	21.6	11.1	6.6	28.4	25.2	30.6	18.0	31.9	32.4	71.1	19.3	42.6	41.8	33.3
MSRB1	"SelR, SelX, SepR, SEPX1"	ENSG00000198736	"Methionine sulfoxide reductase B1"	Q9NZV6	16	1938229-1943293	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 234.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 275.6;monocytes: 178.7;Proximal tubular cells: 496.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 1414.9;neutrophil: 3051.8"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 3051.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008650, HPA043463, HPA069557"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"CAB008650: AB_1619225, HPA043463: AB_2678489, HPA069557: AB_2686153"	"unprognostic (3.93e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.90e-2)"	"unprognostic (5.29e-2)"	"unprognostic (3.60e-1)"	"unprognostic (4.27e-2)"	"unprognostic (8.46e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.59e-3)"	28.1	15.1	26.2	31.8	27.3	96.3	21.3	27.8	28.4	17.5	25.8	36.7	29.4	29.5	11.2	45.3	33.5	23.2	47.3	25.6	26.8	80.3	234.2	30.4	17.7	29.3	28.0	16.4	149.6	14.8	14.5	13.2	27.1	32.0	17.4	2.7	16.5	29.2	76.0	31.1	27.5	36.8	27.5	67.0	33.3	17.7	28.5	13.7	12.5	93.6	12.2	40.8	20.1	27.1	23.6	59.1	21.3	50.4	39.9	17.0	36.4	27.8	36.0	41.2	35.6	96.2	25.5	22.7	90.6	33.5	36.0	37.9	36.3	25.2	12.8	127.7	41.1	17.5	20.5	154.9	36.1	49.3	40.3	32.0	21.9	29.6	6.0	12.9	41.9	28.8	28.2	12.3	22.3	131.2	28.2	82.7	29.2	42.7	33.5	40.3	29.3	106.0	66.0	37.2	20.5	26.9	32.3	35.6	17.3	13.9	38.7	87.9	24.8	12.3	33.7	24.3	16.7	32.0	53.4	42.4	12.5	47.4	22.0	493.5	412.0	1414.9	31.9	194.8	32.2	28.0	26.5	26.7	171.2	28.3	20.5	22.7	3051.8	42.2	182.9	73.2	45.9	226.7	26.2	27.3	27.8	28.4	25.6	26.8	29.3	28.0	27.1	27.5	28.5	27.1	24.9	9.6	13.4	3.9	10.0	6.5	9.1	21.5	8.0	6.5	27.9	21.3	36.1	32.9	14.9	33.1	4.2	33.3	12.3	69.1	93.9	65.9	5.9	23.9	13.4	15.4	60.3	21.5	0.8	111.2	121.4	13.7	11.7	17.0	4.5	12.2	20.7	275.6	63.5	8.4	1.2	38.6	34.6	59.2	21.2	13.9	9.3	37.9	16.0	2.8	178.7	22.5	25.7	1.5	2.9	66.0	62.8	23.0	13.0	16.3	97.3	496.8	37.9	4.2	0.0	8.1	22.8	28.9	8.7	11.1	9.5	38.6	10.6	14.8	33.5	21.9
MTMR3	"FYVE-DSP1, KIAA0371, ZFYVE10"	ENSG00000100330	"Myotubularin related protein 3"	Q13615	22	29883169-30030868	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 81.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 111.3;Inhibitory neurons: 78.3;Microglial cells: 90.9;Oligodendrocyte precursor cells: 96.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034515, HPA034516, HPA061399"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Cytosol	"HPA034515: AB_10669726, HPA034516: AB_10669727, HPA061399: "	"unprognostic (4.39e-3)"	"unprognostic (7.84e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.25e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.42e-1)"	"unprognostic (4.39e-1)"	"unprognostic (8.33e-4)"	"unprognostic (1.28e-1)"	"unprognostic (5.35e-4)"	"unprognostic (7.96e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.49e-1)"	"unprognostic (8.38e-2)"	17.8	18.4	18.5	13.0	19.4	81.6	17.0	21.2	18.6	18.9	17.0	15.5	11.1	16.0	12.8	22.4	16.4	12.5	13.9	20.8	19.3	11.7	10.8	20.7	11.5	19.2	19.8	20.4	16.5	18.3	17.0	15.0	17.3	16.0	12.7	21.2	17.2	11.3	36.7	25.5	14.5	14.8	18.6	21.7	15.7	26.2	21.6	16.2	17.2	30.0	13.9	15.1	19.4	16.6	13.4	11.7	17.0	18.3	16.7	12.1	12.8	12.2	17.4	15.7	18.2	10.0	7.9	10.2	7.6	22.1	12.4	16.0	18.5	14.3	16.6	21.0	15.4	18.6	10.6	10.1	15.3	15.9	45.0	12.8	22.9	14.9	26.9	14.7	15.3	10.7	11.6	17.5	10.3	16.2	10.7	11.1	6.5	13.7	7.5	12.5	23.3	10.4	14.1	24.3	19.2	13.1	22.1	19.7	11.7	14.1	11.2	15.3	16.8	25.3	16.7	5.5	8.3	14.7	11.1	9.3	11.0	7.5	11.8	8.3	7.4	11.2	3.2	4.9	4.0	2.3	2.5	3.4	4.1	2.4	3.1	2.7	17.8	4.1	5.4	1.5	2.9	4.3	18.5	19.4	21.2	18.6	20.8	19.3	19.2	19.8	17.3	18.6	21.6	16.6	15.9	3.2	14.8	111.3	13.3	16.7	9.8	11.5	14.8	0.0	13.7	11.0	4.2	10.0	17.7	12.9	0.0	13.6	10.4	21.5	1.9	9.5	14.0	16.8	14.9	10.6	12.5	21.0	61.2	8.8	7.0	12.6	31.6	24.5	7.6	14.7	13.9	10.1	10.9	0.0	78.3	9.2	46.8	20.6	11.7	16.7	13.7	20.8	14.2	90.9	22.3	0.0	12.3	96.5	73.2	12.3	11.1	11.3	13.0	14.6	12.2	7.3	16.4	0.0	6.6	15.3	11.0	26.8	28.0	18.1	13.8	13.7	13.0	8.9	11.5	21.2
MYLIP	"IDOL, MIR"	ENSG00000007944	"Myosin regulatory light chain interacting protein"	Q8WY64	6	16129086-16148248	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 352.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 57.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 7: Non-specific - Mitochondria"				"unprognostic (1.54e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.79e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.11e-2)"	"prognostic favorable (6.44e-6)"	"unprognostic (2.75e-2)"	"unprognostic (2.67e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.03e-2)"	"prognostic favorable (3.67e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (4.11e-5)"	37.0	18.9	12.8	12.8	20.0	92.1	30.2	12.5	16.4	42.2	13.6	24.3	12.9	40.3	30.6	18.1	32.6	21.3	14.2	13.4	13.3	21.6	4.9	29.5	22.8	13.7	14.3	35.8	15.5	24.6	8.2	63.4	12.0	16.4	16.5	4.7	25.7	23.1	41.1	25.7	24.5	28.4	12.3	30.8	22.7	15.0	15.7	15.2	50.2	22.8	15.4	25.0	24.7	22.4	3.4	6.0	2.8	3.3	28.3	6.9	7.3	2.4	5.4	5.4	12.0	18.4	3.3	16.0	11.5	3.9	4.0	8.2	13.0	4.4	4.9	5.2	12.8	10.2	7.1	3.8	4.1	7.4	10.0	11.5	5.5	2.6	2.2	2.8	12.5	3.4	29.8	18.6	2.1	12.6	0.2	40.6	8.0	8.4	5.7	3.5	12.9	57.9	6.7	40.0	13.5	6.2	2.9	31.2	17.1	23.9	5.8	18.8	3.5	2.6	6.2	2.2	6.1	16.0	7.5	8.1	1.6	20.9	9.0	6.1	1.5	7.8	5.8	1.8	5.4	4.2	3.7	4.1	1.1	3.3	4.0	3.9	9.4	2.6	1.5	0.5	2.3	1.2	12.8	20.0	12.5	16.4	13.4	13.3	13.7	14.3	12.0	12.3	15.7	22.4	102.6	22.4	50.2	5.5	67.7	98.0	38.9	8.8	126.3	9.3	67.6	117.0	90.7	50.1	17.7	22.0	0.0	134.2	78.5	49.5	9.8	22.1	47.5	82.7	56.2	70.9	84.3	52.6	17.1	18.4	80.0	79.6	54.0	77.7	35.5	35.1	41.4	1.4	32.0	11.8	8.4	41.1	10.2	61.7	121.2	20.2	38.5	56.0	80.0	7.5	27.3	16.9	56.7	3.0	55.3	7.6	32.4	61.7	30.2	28.1	27.8	21.1	25.7	7.8	138.1	90.8	96.7	53.0	22.6	100.9	84.0	352.3	103.8	3.9	45.4	35.1
NARF	"DKFZp434G0420, FLJ10067, IOP2"	ENSG00000141562	"Nuclear prelamin A recognition factor"	Q9UHQ1	17	82458180-82490537	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 292.6;Late spermatids: 474.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053006			Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	Nucleoli	"HPA053006: AB_2682013"	"unprognostic (1.84e-1)"	"prognostic favorable (1.15e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.14e-1)"	"unprognostic (6.52e-2)"	"unprognostic (6.62e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.42e-3)"	"unprognostic (3.80e-3)"	"prognostic unfavorable (1.48e-10)"	"unprognostic (3.57e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.83e-2)"	19.2	18.0	17.2	12.4	18.5	32.9	17.4	19.5	21.7	15.8	16.1	23.4	10.3	14.5	5.8	21.5	16.1	7.7	38.7	17.7	16.8	19.6	23.1	15.1	10.7	17.8	17.0	16.9	20.6	6.6	18.7	7.4	17.8	17.0	6.5	11.5	18.4	8.2	49.2	25.1	19.1	7.1	15.8	28.7	23.3	59.1	16.9	14.6	16.5	25.9	8.9	19.9	16.3	19.1	21.2	23.3	32.8	50.6	15.2	14.3	18.2	13.1	12.7	21.2	21.2	23.6	8.4	14.0	13.6	9.8	23.8	18.6	23.8	15.5	14.2	15.3	55.7	29.0	30.4	27.7	13.1	30.9	50.6	21.9	26.4	16.5	5.7	20.7	39.2	44.9	67.5	9.6	9.2	18.1	51.2	49.8	13.7	16.3	44.1	42.6	34.3	21.6	9.7	23.3	40.1	55.9	32.1	21.3	38.8	20.7	18.4	23.2	21.7	26.4	22.4	22.4	21.7	94.1	38.4	30.1	24.3	20.6	15.9	94.5	33.0	96.2	34.2	30.0	38.1	38.2	33.1	33.7	32.0	40.9	37.7	31.2	156.0	53.7	23.9	26.2	44.1	38.6	17.2	18.5	19.5	21.7	17.7	16.8	17.8	17.0	17.8	15.8	16.9	19.1	45.2	12.8	23.2	25.1	50.7	37.3	32.9	55.4	28.5	38.1	30.4	30.1	43.2	21.5	40.0	5.5	54.2	32.4	87.9	38.5	39.2	53.3	194.2	46.2	23.3	53.1	56.9	292.6	30.6	66.7	57.7	30.1	80.5	25.3	52.7	24.4	45.7	18.5	34.3	50.5	31.6	32.4	95.6	23.8	35.3	474.5	25.1	39.3	62.2	15.0	56.7	24.2	72.1	12.5	20.8	65.7	29.6	18.0	89.9	23.7	41.9	22.1	61.6	37.3	13.1	36.9	36.0	152.5	87.6	20.7	35.4	30.6	57.4	28.4	36.3	30.2
NCF1	"NCF1A, NOXO2, p47phox, SH3PXD1A"	ENSG00000158517	"Neutrophil cytosolic factor 1"	P14598	7	74773962-74789376	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Chronic granulomatous disease, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 86.4;lymphoid tissue: 97.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 293.0;dendritic cells: 157.3;Kupffer cells: 119.9;Macrophages: 153.4;monocytes: 329.9;Plasma cells: 205.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 1165.0;classical monocyte: 673.5;eosinophil: 1467.3;neutrophil: 2128.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 2128.0;monocytes: 673.5"	"Group enriched"	"Detected in some"	5	"Daudi: 96.2;HMC-1: 130.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004524, HPA047836, HPA052095"	Enhanced					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"			"CAB004524: AB_627987, HPA047836: AB_2680173, HPA052095: AB_2681721"	"unprognostic (4.93e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.25e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.55e-3)"	"unprognostic (7.60e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.23e-3)"	"unprognostic (9.99e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.77e-3)"	"unprognostic (3.16e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.09e-1)"	7.5	3.8	1.9	38.7	2.2	86.4	2.7	4.6	2.9	1.7	0.9	7.2	7.6	1.3	0.5	3.3	3.2	5.5	3.0	2.8	2.0	2.9	5.0	17.7	56.8	5.0	3.4	1.1	1.5	0.7	1.2	5.0	4.5	2.1	4.5	1.6	4.2	1.4	1.5	1.8	26.6	4.0	2.4	97.5	6.6	0.8	2.3	7.5	2.6	4.8	37.5	7.6	1.8	6.6	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.1	96.2	0.1	0.0	0.0	0.4	0.0	0.4	0.0	0.5	0.6	2.9	1.4	0.9	0.0	0.8	130.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.9	0.0	0.0	0.1	16.8	0.3	0.0	0.0	1.6	0.0	3.4	0.2	0.4	0.0	0.1	0.0	0.1	0.1	0.1	0.0	20.6	0.2	0.1	0.3	0.2	0.0	0.6	0.3	16.5	0.2	8.1	0.2	1165.0	673.5	1467.3	4.2	242.3	9.8	257.0	10.0	6.7	77.7	276.6	15.4	9.4	2128.0	10.7	60.2	280.9	11.1	514.1	1.9	2.2	4.6	2.9	2.8	2.0	5.0	3.4	4.5	2.4	2.3	6.6	5.0	0.0	2.8	0.0	293.0	3.1	1.1	29.6	5.2	0.2	3.1	3.2	0.6	4.3	10.9	3.7	0.0	0.6	157.3	0.0	0.0	1.3	8.7	0.8	1.0	3.6	0.0	6.1	0.0	0.6	12.2	1.5	10.2	2.5	14.5	0.1	3.9	3.6	39.3	3.3	0.1	0.3	2.0	119.9	23.4	6.4	0.0	153.4	10.6	1.0	329.9	0.3	10.3	0.0	0.1	1.2	4.2	0.4	205.7	1.0	0.4	1.9	17.6	0.5	0.0	1.4	1.5	0.2	0.7	5.0	1.7	4.5	63.6	0.1	0.3	2.2
NCF4	"p40phox, SH3PXD4"	ENSG00000100365	"Neutrophil cytosolic factor 4"	Q15080	22	36860988-36878017	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Chronic granulomatous disease, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 180.2;lymphoid tissue: 162.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 70.9;granulocytes: 74.1;Hofbauer cells: 198.4;Kupffer cells: 85.3;Langerhans cells: 55.8;Macrophages: 85.7;Plasma cells: 68.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 657.3;eosinophil: 750.1;neutrophil: 1235.8"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 1235.8"	"Cell line enhanced"	"Detected in some"		"HEL: 78.3;HMC-1: 396.0;NB-4: 148.7;REH: 76.5;RPMI-8226: 144.0;THP-1: 137.9;U-937: 76.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB010146, HPA036156, HPA057975"	Enhanced		Enhanced	Cytosol		NA	NA		7800	"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Cytosol		"CAB010146: AB_627989, HPA036156: AB_2674974, HPA057975: AB_2683568"	"unprognostic (3.27e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.78e-3)"	"unprognostic (4.20e-2)"	"unprognostic (3.69e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (7.06e-8)"	"unprognostic (3.60e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.42e-1)"	29.5	14.4	4.8	43.1	5.0	180.2	12.7	4.9	7.5	4.6	6.4	19.2	11.7	4.5	1.0	7.2	13.9	13.0	9.4	4.9	5.4	8.9	10.1	45.1	39.8	6.8	5.9	3.3	4.1	1.4	5.3	24.3	6.4	7.4	11.8	0.1	10.7	4.5	3.6	4.9	42.6	10.5	5.8	162.3	9.3	1.8	8.6	12.9	8.1	7.1	33.5	18.7	7.2	7.1	1.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	28.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.6	0.0	78.3	0.0	0.0	0.0	12.8	396.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	26.8	0.0	0.8	0.0	148.7	0.0	0.0	0.0	76.5	0.0	144.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	137.9	0.0	0.0	0.2	0.1	0.2	0.5	0.1	23.7	0.1	76.8	0.1	657.3	184.6	750.1	2.3	92.5	9.8	108.2	32.0	6.9	86.1	85.9	1.9	2.1	1235.8	4.4	62.0	100.7	96.3	106.3	4.8	5.0	4.9	7.5	4.9	5.4	6.8	5.9	6.4	5.8	8.6	7.1	1.5	3.2	18.7	0.0	70.9	2.8	2.2	1.3	0.6	0.0	3.1	2.5	2.1	0.0	5.8	1.8	0.0	3.2	21.1	1.3	0.0	0.6	0.2	0.2	0.1	3.6	0.0	28.8	0.0	3.1	16.0	1.8	2.0	0.4	74.1	0.0	1.4	0.7	198.4	0.0	0.0	0.5	2.0	85.3	55.8	1.0	0.6	85.7	14.2	3.7	38.5	0.0	3.1	0.0	0.1	0.9	22.5	0.0	68.2	0.3	0.2	0.2	0.9	0.3	0.0	0.5	1.6	0.0	0.4	0.5	2.3	13.0	17.5	0.7	1.7	4.3
NCOA1	"bHLHe74, F-SRC-1, KAT13A, NCoA-1, RIP160, SRC1"	ENSG00000084676	"Nuclear receptor coactivator 1"	Q15788	2	24491914-24770702	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 467.5;Excitatory neurons: 313.0;Inhibitory neurons: 421.8;Microglial cells: 341.9;Oligodendrocyte precursor cells: 459.4;Oligodendrocytes: 305.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 81.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019402, HPA070213, HPA070520"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Plasma membrane, Cytosol"	"CAB019402: AB_2196189, HPA070213: AB_2686235, HPA070520: AB_2686276"	"unprognostic (2.73e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.46e-2)"	"unprognostic (9.89e-3)"	"unprognostic (7.60e-2)"	"unprognostic (2.36e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.15e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.92e-2)"	16.6	15.1	24.0	13.3	25.4	17.3	17.3	24.6	28.2	18.6	13.6	15.9	20.9	19.0	12.8	17.6	15.7	14.0	15.3	29.6	19.5	18.9	15.0	16.0	15.3	17.7	19.2	26.6	17.4	30.0	16.6	17.1	16.0	15.2	16.6	47.3	16.0	20.2	33.4	15.7	18.9	19.0	19.5	16.3	12.5	19.9	21.8	26.1	11.8	36.1	16.3	14.9	15.5	22.3	14.1	10.3	17.7	9.2	19.2	17.3	26.9	7.4	14.7	9.1	8.1	9.6	5.9	10.2	3.1	13.5	17.4	3.4	10.7	6.3	9.8	48.6	15.5	36.5	4.1	4.1	12.0	16.9	29.1	27.9	9.4	8.8	7.1	11.3	9.4	12.9	22.6	16.5	14.0	9.4	15.1	6.0	8.5	8.2	6.8	11.8	81.5	5.1	9.9	18.9	16.2	12.8	17.1	10.2	7.4	9.3	12.3	8.6	10.2	15.2	11.9	10.5	7.5	18.8	17.5	17.2	8.6	10.5	7.7	10.6	3.3	7.0	3.4	2.6	3.8	1.6	3.0	3.8	2.5	2.4	2.9	3.5	13.8	3.5	2.9	5.2	3.7	2.0	24.0	25.4	24.6	28.2	29.6	19.5	17.7	19.2	16.0	19.5	21.8	22.3	41.0	38.5	31.5	467.5	16.7	30.5	11.6	7.8	14.2	96.5	32.3	26.7	41.9	17.2	22.8	14.7	52.1	13.1	47.0	39.0	7.9	16.5	29.7	14.6	37.6	34.9	25.2	29.9	313.0	26.6	18.1	39.8	19.9	28.4	20.2	52.9	36.8	22.8	17.9	62.2	421.8	20.7	20.3	29.8	30.3	7.4	47.2	37.7	19.6	341.9	34.7	66.7	78.2	459.4	305.8	20.1	33.5	43.2	14.3	15.7	30.4	12.5	16.9	71.6	39.5	116.9	34.4	37.7	37.6	16.6	31.0	5.3	33.4	27.2	24.1	21.7
NCOA4	"ARA70, DKFZp762E1112, ELE1, PTC3, RFG"	ENSG00000266412	"Nuclear receptor coactivator 4"	Q13772	10	46005088-46030623	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 476.2;Macrophages: 316.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 251.9;granulocytes: 839.6;monocytes: 363.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051260, HPA065208"	Uncertain		Approved	"Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoli	"Golgi apparatus, Cytosol"	"HPA051260: AB_2681412, HPA065208: AB_2685432"	"unprognostic (4.23e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.82e-1)"	"prognostic favorable (3.26e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.80e-1)"	"unprognostic (9.34e-2)"	"unprognostic (4.67e-2)"	"unprognostic (5.22e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.04e-2)"	"prognostic favorable (8.04e-6)"	"unprognostic (1.35e-1)"	"unprognostic (4.71e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.78e-1)"	117.1	67.8	45.6	91.5	52.5	189.5	96.9	56.1	50.9	85.1	50.7	110.3	249.7	70.2	74.6	110.3	62.6	87.8	156.8	40.6	55.8	159.7	372.9	108.3	102.6	52.4	53.5	65.5	64.6	97.9	25.2	131.3	53.6	132.2	115.7	33.7	79.2	78.7	163.5	71.1	155.9	98.3	52.6	148.1	90.3	43.6	51.6	124.4	87.0	193.6	150.3	104.6	46.8	60.0	142.7	58.5	68.0	70.4	176.9	159.4	170.3	128.3	204.8	122.1	119.6	91.0	102.3	161.2	149.2	211.2	69.1	141.8	72.6	142.3	137.1	114.4	74.1	108.4	74.3	263.5	124.0	279.9	229.7	156.1	139.2	104.2	175.7	131.6	185.5	79.5	119.7	93.5	171.9	64.0	136.1	104.3	41.4	110.2	34.8	79.5	99.3	96.7	148.9	119.4	68.2	46.1	128.9	146.2	131.5	133.5	105.7	135.3	171.6	75.8	89.9	81.3	87.5	69.3	79.1	156.9	94.6	231.2	41.2	692.1	363.6	611.8	78.9	223.6	86.2	57.6	73.3	74.9	251.9	53.8	78.2	66.4	839.6	119.0	275.3	77.4	92.8	559.4	45.6	52.5	56.1	50.9	40.6	55.8	52.4	53.5	53.6	52.6	51.6	60.0	44.5	51.3	95.2	13.4	44.6	49.5	39.3	126.2	50.7	14.3	49.6	38.5	161.3	45.8	96.2	44.1	29.2	104.7	58.2	108.8	80.3	45.3	105.4	45.1	37.7	52.9	26.9	476.2	17.4	51.8	107.2	45.3	42.3	56.9	195.2	28.2	55.3	166.7	181.4	20.2	20.5	45.4	59.0	254.5	74.2	72.4	37.3	316.1	51.6	16.9	158.4	38.2	44.3	18.6	22.9	47.8	63.9	47.4	37.6	62.0	162.5	128.8	59.7	13.0	13.1	36.7	46.7	24.5	16.5	71.9	56.7	158.2	41.3	60.7	71.3	52.0
NDEL1	"MITAP1, NDE1L1, NDE2, NUDEL"	ENSG00000166579	"NudE neurodevelopment protein 1 like 1"	Q9GZM8	17	8413131-8490411	"Predicted intracellular proteins"	"Differentiation, Neurogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 134.5;Suprabasal keratinocytes: 136.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	5	"granulocytes: 175.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017916	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"			"HPA017916: AB_1854337"	"unprognostic (6.34e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.35e-3)"	"unprognostic (6.98e-3)"	"unprognostic (1.70e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.77e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.95e-3)"	"unprognostic (4.66e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.73e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.63e-3)"	42.8	60.3	18.2	37.0	23.1	109.8	33.2	19.4	26.2	36.6	17.6	30.9	18.4	29.2	20.3	54.7	32.1	40.7	30.0	23.8	20.9	19.8	43.9	44.4	23.2	18.0	19.2	46.6	27.8	18.0	35.0	39.9	20.9	25.5	23.1	25.3	32.5	22.3	43.6	91.3	24.8	26.7	15.3	29.0	25.8	26.4	20.6	24.4	23.2	31.1	26.8	37.8	39.8	23.5	41.9	36.6	34.2	29.4	50.9	61.9	28.1	87.2	72.6	61.4	64.0	32.0	22.2	24.0	28.9	97.1	34.8	47.7	30.9	34.6	62.9	40.1	50.1	48.0	59.8	38.7	54.5	18.4	98.4	41.2	66.7	52.8	60.0	44.7	49.8	37.0	29.0	27.6	54.1	17.9	27.2	15.7	14.9	26.2	20.4	28.2	26.9	19.8	27.7	23.6	16.2	17.8	52.9	25.4	29.4	36.0	17.3	12.6	65.6	48.7	18.4	45.4	48.4	19.3	42.5	19.3	61.0	27.4	50.3	85.5	28.3	98.2	35.1	27.6	37.0	25.5	31.3	34.8	23.9	26.1	30.4	27.9	175.0	32.8	24.7	20.6	36.5	36.3	18.2	23.1	19.4	26.2	23.8	20.9	18.0	19.2	20.9	15.3	20.6	23.5	48.4	12.8	20.9	12.1	33.8	79.0	55.3	18.3	27.3	13.9	24.1	20.4	17.5	12.8	18.1	12.9	20.9	18.9	39.7	36.8	9.8	13.6	86.8	34.8	21.5	26.4	4.2	37.5	27.0	12.2	37.1	26.4	47.9	63.5	80.5	13.3	18.5	12.8	14.1	8.4	22.0	37.1	20.3	13.2	74.0	134.5	12.8	40.8	32.0	18.7	13.2	8.8	19.6	14.6	19.6	24.0	42.6	14.7	38.2	36.0	21.8	5.8	11.3	14.1	6.6	24.7	40.1	8.3	10.0	25.0	136.7	57.3	40.1	11.8	17.6	73.4
NFKB2	"LYT-10, NF-kB2, p105, p49/p100, p52"	ENSG00000077150	"Nuclear factor kappa B subunit 2"	Q00653	10	102394110-102402524	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 122.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 168.0;Karpas-707: 157.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008422, CAB022098, HPA023900"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol	Nucleoplasm	"CAB022098: , HPA008422: AB_1854434, HPA023900: AB_1854435"	"unprognostic (1.10e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (1.53e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.38e-3)"	"unprognostic (3.98e-2)"	"prognostic favorable (8.45e-5)"	"unprognostic (4.04e-1)"	"unprognostic (8.34e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (6.69e-12)"	"unprognostic (2.37e-3)"	"unprognostic (1.63e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.56e-1)"	26.5	21.0	7.6	44.4	7.4	69.3	19.6	7.1	9.2	22.9	8.5	39.1	15.5	21.6	2.3	17.7	20.4	18.5	20.6	7.2	7.2	34.6	28.2	41.0	40.7	8.5	7.5	21.4	24.1	6.1	10.8	14.7	8.0	29.0	6.8	1.1	21.3	9.1	18.4	20.0	26.5	12.2	7.5	50.6	22.7	10.0	8.4	16.9	20.1	7.6	25.7	37.0	19.1	8.0	67.9	48.6	7.7	31.7	11.1	16.6	19.3	18.5	61.0	19.6	25.9	28.6	55.2	32.9	43.5	11.9	48.8	40.9	20.5	28.2	6.8	168.0	11.2	7.0	11.7	15.9	30.1	5.1	45.5	22.0	14.6	34.1	32.3	26.5	7.8	16.1	7.6	157.8	7.4	26.4	7.1	22.7	10.3	15.7	16.6	16.8	24.5	27.0	34.3	22.1	1.7	8.2	16.2	36.7	26.3	7.2	29.3	16.4	21.2	19.0	28.9	25.4	47.0	113.1	105.0	32.6	31.1	14.8	10.9	0.0	1.3	0.0	0.7	0.9	0.7	2.6	0.8	0.7	0.7	2.1	0.8	0.8	5.6	0.8	2.1	0.6	1.1	0.5	7.6	7.4	7.1	9.2	7.2	7.2	8.5	7.5	8.0	7.5	8.4	8.0	20.8	9.6	8.8	3.3	88.3	43.5	59.3	41.2	34.7	2.2	17.1	14.5	3.1	25.8	29.9	18.4	16.7	6.3	39.0	33.3	5.9	33.2	1.1	33.7	14.4	26.1	16.3	0.4	0.1	21.0	15.8	26.0	80.0	52.0	71.8	5.5	11.7	3.7	20.9	0.0	0.1	30.4	22.4	19.4	122.9	1.7	7.5	52.5	30.2	1.9	75.1	3.9	12.3	1.5	0.7	44.9	37.4	4.9	49.1	49.3	33.2	8.6	19.9	5.3	0.0	36.4	43.6	4.7	11.1	17.5	44.6	23.1	54.6	8.8	17.9	45.6
NINJ1	NIN1	ENSG00000131669	"Ninjurin 1"	Q92982	9	93121496-93134251	"Predicted membrane proteins"	"Angiogenesis, Cell adhesion, Cytolysis, Inflammatory response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 286.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 539.9;Langerhans cells: 741.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1668.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 1668.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 197.5;MCF7: 191.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045063	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 41: Macrophages - Immune response"			"HPA045063: AB_10964133"	"unprognostic (1.23e-2)"	"unprognostic (8.25e-3)"	"unprognostic (3.64e-3)"	"unprognostic (1.40e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.29e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.82e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.74e-2)"	"unprognostic (9.45e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.40e-3)"	"unprognostic (7.46e-3)"	60.9	129.8	51.0	39.9	48.9	286.9	53.0	47.9	58.7	47.6	50.2	60.1	27.0	36.5	20.2	25.7	47.6	39.2	64.0	44.2	51.9	100.4	118.0	65.0	41.5	54.5	53.2	35.9	35.0	137.7	59.2	66.6	53.3	58.9	16.5	6.1	77.3	56.2	38.0	80.4	37.6	36.0	57.6	89.9	42.5	37.6	57.2	30.5	71.4	30.0	19.6	100.5	37.9	59.2	45.0	68.2	13.2	30.0	47.4	19.1	51.6	30.2	85.9	43.5	26.7	29.5	15.5	0.6	15.0	29.7	47.6	44.8	14.7	84.6	9.4	103.3	28.7	6.8	17.2	197.5	163.7	4.8	13.8	62.5	80.9	41.1	22.5	132.4	41.3	16.3	5.0	49.6	9.9	191.1	13.9	13.8	18.7	51.9	53.0	24.6	10.3	79.0	35.0	18.6	4.3	18.4	67.3	105.4	41.9	22.0	81.9	31.3	31.1	15.8	44.6	33.2	22.9	26.2	11.4	1.0	48.2	14.8	12.1	152.9	313.3	824.9	69.8	315.4	94.5	7.8	65.0	59.3	75.9	2.4	76.5	55.1	1668.9	44.7	355.8	10.7	73.8	219.1	51.0	48.9	47.9	58.7	44.2	51.9	54.5	53.2	53.3	57.6	57.2	59.2	15.7	28.9	41.6	6.5	24.3	114.6	75.8	273.0	130.3	1.8	117.8	96.6	31.6	62.9	80.7	40.5	0.0	128.3	45.8	19.4	129.1	95.2	3.9	22.9	20.9	46.9	18.0	3.0	3.4	101.7	78.3	64.9	20.9	24.5	47.0	13.8	23.6	48.5	539.9	1.7	3.9	21.3	111.9	176.9	741.7	21.1	42.0	278.1	147.7	18.7	214.9	76.1	33.0	3.0	1.7	68.7	23.7	72.6	32.5	60.3	75.5	240.6	18.8	3.8	13.1	45.7	53.3	0.9	11.4	36.3	135.7	73.3	54.7	4.5	19.7	76.9
NRDC	"hNRD1, hNRD2, NRD1"	ENSG00000078618	"Nardilysin convertase"	O43847	1	51789191-51878937	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 267.3"	"Group enriched"	"Detected in many"	9	"Early spermatids: 597.7;Late spermatids: 1672.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053661			Approved	Nucleoplasm		NA	NA		58000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA053661: AB_2682221"	"unprognostic (1.22e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (5.49e-6)"	"unprognostic (1.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (2.12e-9)"	"unprognostic (2.75e-1)"	"unprognostic (2.35e-2)"	"unprognostic (9.54e-2)"	"unprognostic (5.53e-3)"	48.2	36.8	33.3	48.2	33.9	48.5	34.2	33.6	42.3	31.1	37.2	32.5	32.3	31.1	20.2	40.4	29.7	31.0	58.5	34.4	35.5	26.5	55.7	34.3	43.8	35.2	34.6	32.6	40.1	60.9	32.8	40.2	37.8	38.6	35.3	48.1	28.7	30.5	267.3	51.4	31.4	38.4	33.6	40.9	35.2	95.6	36.5	54.9	33.1	182.0	46.7	36.5	28.4	38.1	166.8	91.0	94.2	133.4	98.9	145.5	106.8	165.6	143.9	116.6	123.5	65.6	65.3	108.3	84.7	128.4	157.6	95.1	136.5	127.9	156.2	127.7	66.1	129.5	125.4	62.9	97.9	114.4	95.4	117.2	102.1	169.7	160.0	105.0	125.7	113.1	174.7	71.7	153.4	62.9	105.0	45.2	161.5	71.8	97.4	101.6	106.4	122.6	92.8	94.7	86.5	65.2	148.0	124.8	94.5	185.7	79.3	152.5	102.4	103.8	94.2	114.2	146.0	103.9	168.4	100.1	120.8	146.6	120.1	44.5	33.8	50.0	23.2	35.1	23.3	23.2	21.5	26.0	33.7	15.6	20.9	22.7	67.8	29.8	28.3	27.5	26.9	33.1	33.3	33.9	33.6	42.3	34.4	35.5	35.2	34.6	37.8	33.6	36.5	38.1	43.5	35.3	69.0	0.0	58.9	0.0	46.3	0.0	38.7	73.3	38.2	31.0	0.0	28.6	34.7	27.6	81.3	56.8	94.3	11.1	31.3	48.1	597.7	63.1	78.8	39.4	18.2	85.8	0.0	64.0	45.5	40.1	56.6	55.4	35.3	74.6	30.4	59.9	44.3	62.2	0.0	19.5	0.0	44.6	0.0	1672.1	66.2	72.5	0.0	0.0	70.3	45.9	55.6	0.0	0.0	57.6	13.7	59.0	126.1	41.9	30.1	19.6	59.0	71.8	59.2	64.5	38.2	39.0	28.1	57.7	0.0	82.5	52.8	65.9	21.6	42.3
NRF1	"ALPHA-PAL, EWG"	ENSG00000106459	"Nuclear respiratory factor 1"	Q16656	7	129611720-129757082	"Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Astrocytes: 127.0;Excitatory neurons: 115.4;Inhibitory neurons: 109.4;Microglial cells: 75.9;Oligodendrocyte precursor cells: 143.2;Oligodendrocytes: 122.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029329	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA029329: AB_10601240"	"unprognostic (2.80e-2)"	"unprognostic (2.20e-3)"	"unprognostic (4.51e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.20e-3)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.99e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.52e-2)"	"unprognostic (4.20e-1)"	"unprognostic (2.06e-3)"	8.3	5.6	9.2	7.9	9.9	16.7	7.9	13.3	11.1	10.8	11.5	8.8	6.4	9.9	6.4	7.2	12.8	5.5	9.4	9.3	10.7	9.0	6.1	8.0	12.3	11.1	10.6	16.6	7.3	8.5	7.7	7.0	10.1	8.0	6.8	12.7	7.5	6.2	15.6	9.3	8.3	7.7	9.1	10.3	6.7	5.6	10.2	18.0	9.7	8.8	11.1	8.7	8.0	13.0	15.9	12.8	18.1	15.9	10.7	8.5	14.4	10.9	11.2	16.3	12.6	15.6	10.4	18.3	7.8	12.3	10.2	11.9	19.7	11.0	16.5	17.5	14.1	15.1	11.0	10.3	7.8	18.7	14.5	7.3	10.2	16.1	15.5	9.4	12.1	17.4	18.6	13.7	10.1	14.5	36.9	17.6	16.9	14.5	11.3	23.2	14.6	16.2	9.2	11.5	15.6	17.1	16.4	16.8	11.0	14.7	10.5	17.4	9.4	9.2	12.6	10.8	20.3	14.7	15.7	32.0	9.7	17.0	18.1	5.6	4.2	10.6	8.2	5.2	9.8	5.5	6.3	7.7	5.5	5.9	6.8	6.0	8.8	5.0	5.8	3.6	7.2	5.8	9.2	9.9	13.3	11.1	9.3	10.7	11.1	10.6	10.1	9.1	10.2	13.0	6.8	3.2	6.5	127.0	15.8	6.6	3.2	3.4	4.6	10.8	5.4	5.1	6.2	2.8	4.8	3.7	10.4	2.8	11.3	5.5	0.0	2.3	0.4	8.9	6.4	7.1	6.7	3.0	115.4	3.6	4.1	6.0	7.1	5.7	5.1	6.9	7.1	4.1	3.1	10.1	109.4	5.3	4.1	7.7	9.5	1.9	5.3	5.4	5.4	75.9	4.0	6.4	12.3	143.2	122.3	3.0	10.2	4.5	14.2	6.8	3.7	2.3	13.1	11.2	6.6	10.0	6.4	9.0	6.6	6.2	7.7	3.4	13.8	2.3	4.2	5.4
NSFL1C	"dJ776F14.1, p47, UBX1, UBXD10, UBXN2C"	ENSG00000088833	"NSFL1 cofactor"	Q9UNZ2	20	1442162-1473842	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047108, HPA050628"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		1900000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA047108: AB_2679935, HPA050628: AB_2681194"	"unprognostic (7.55e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.97e-2)"	"unprognostic (6.90e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.44e-2)"	"unprognostic (7.50e-3)"	22.8	37.7	38.3	13.5	39.5	27.8	21.5	37.0	45.9	23.2	41.6	23.0	14.9	22.5	26.8	28.5	26.1	13.5	29.1	39.7	38.6	21.4	26.3	18.0	15.2	39.0	39.0	25.7	15.5	23.9	14.1	21.1	39.8	20.9	18.4	22.6	19.3	26.4	69.0	36.6	17.6	22.9	36.4	19.8	18.0	14.8	38.6	21.0	20.0	43.3	18.6	22.4	21.6	39.7	55.6	64.4	35.9	32.0	30.5	31.4	28.7	21.0	41.8	57.7	41.3	53.9	43.1	31.6	16.6	47.8	47.2	50.4	25.9	70.3	40.8	12.3	25.1	29.8	10.3	61.4	33.8	30.7	16.4	23.5	33.3	55.3	20.3	30.8	46.8	23.4	42.5	26.5	36.2	29.1	31.4	54.7	40.7	42.5	65.4	14.7	41.1	29.8	68.6	37.1	20.5	23.4	29.6	59.8	26.7	18.8	36.5	22.0	37.8	38.7	29.4	23.9	40.2	21.9	41.8	24.7	28.9	43.0	29.3	31.4	21.3	80.3	20.0	26.6	19.7	35.0	21.2	19.5	29.7	36.0	23.4	20.7	69.1	16.7	28.1	23.1	28.2	25.5	38.3	39.5	37.0	45.9	39.7	38.6	39.0	39.0	39.8	36.4	38.6	39.7	34.6	22.4	23.2	17.3	36.1	89.2	63.5	106.3	44.3	60.2	28.6	26.0	35.4	24.3	57.8	31.3	22.9	150.7	29.7	68.2	56.7	104.7	23.0	51.0	29.6	44.3	43.6	41.0	24.0	94.5	146.0	41.1	30.5	54.9	40.5	49.1	31.1	42.2	81.1	70.7	24.8	42.5	61.1	43.7	43.6	38.8	39.1	43.8	42.7	14.0	52.9	61.7	32.0	17.6	31.2	123.4	65.7	46.3	41.8	76.0	66.4	73.8	43.2	44.5	78.9	44.2	64.7	106.1	103.2	55.1	75.7	151.6	31.6	48.9	44.0	88.5
NT5C2	"cN-II, GMP, NT5B, PNT5, SPG45, SPG65"	ENSG00000076685	"5'-nucleotidase, cytosolic II"	P49902	10	103087185-103277605	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	"Allosteric enzyme, Hydrolase"	"Cancer-related genes, Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 141.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003751	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA003751: AB_1854664"	"unprognostic (8.18e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.87e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.41e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.93e-3)"	"unprognostic (6.20e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.70e-2)"	"unprognostic (6.40e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.50e-1)"	24.6	27.0	25.0	19.0	27.2	29.7	23.0	27.3	28.5	37.6	36.8	27.3	9.9	18.8	17.3	67.1	26.5	16.4	28.5	25.2	28.8	32.5	27.8	30.8	18.3	26.9	29.5	32.4	22.0	21.7	34.0	17.9	27.2	32.4	16.7	47.3	46.4	18.4	51.6	19.9	20.4	13.4	26.4	32.8	22.3	30.8	27.2	28.6	55.4	18.1	24.5	33.3	42.7	28.6	148.4	52.5	32.6	67.5	27.2	33.2	18.2	66.0	64.7	29.9	32.4	34.6	91.7	49.2	47.7	45.6	27.6	62.8	23.4	33.8	38.3	40.3	21.6	38.7	21.1	39.6	48.5	64.2	21.0	50.4	34.1	28.0	24.8	57.5	25.6	19.4	29.4	36.4	54.5	73.8	53.7	64.6	34.6	43.2	68.6	102.6	30.0	19.6	43.3	72.5	10.0	24.9	35.8	25.9	50.3	33.7	39.2	38.1	30.5	20.5	24.8	39.7	51.7	32.9	71.6	85.5	23.9	64.6	7.8	29.5	16.5	31.3	10.0	18.8	10.3	8.9	8.4	8.7	14.7	5.2	6.7	8.0	27.4	14.4	23.0	9.6	9.3	10.5	25.0	27.2	27.3	28.5	25.2	28.8	26.9	29.5	27.2	26.4	27.2	28.6	16.2	83.3	34.9	141.7	17.2	7.4	29.0	26.9	5.7	24.4	13.9	13.6	2.6	18.6	60.4	27.6	45.9	19.4	23.3	48.7	11.7	28.5	103.7	29.5	17.1	19.8	11.5	12.4	79.8	26.0	11.7	17.5	25.5	46.2	8.8	18.2	13.9	17.4	19.9	47.1	83.6	17.6	18.3	29.8	14.2	61.9	24.8	27.1	26.6	78.7	25.9	85.5	16.5	70.4	107.5	57.9	23.1	13.5	21.0	35.7	11.7	15.3	44.1	59.1	32.9	22.9	21.7	25.3	20.5	22.9	7.5	35.0	16.6	15.8	18.0	80.5
NUDT16L1	"SDOS, TIRR"	ENSG00000168101	"Nudix hydrolase 16 like 1"	Q9BRJ7	16	4693694-4695859	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044186, HPA063605"	Approved		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Cytosol"		"HPA044186: AB_10968571, HPA063605: AB_2685058"	"unprognostic (1.35e-2)"	"unprognostic (1.70e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.14e-1)"	"prognostic favorable (2.79e-4)"	"unprognostic (2.51e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.12e-3)"	"unprognostic (6.81e-2)"	"prognostic favorable (1.02e-6)"	"unprognostic (2.78e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.08e-2)"	"unprognostic (6.81e-3)"	19.7	46.4	43.1	12.0	44.8	22.2	21.5	43.6	52.5	23.1	45.6	28.5	21.7	21.4	15.3	28.9	23.4	8.4	58.2	44.1	42.0	43.4	64.1	17.2	17.9	45.3	43.2	22.7	24.6	20.4	39.9	8.0	41.9	34.8	11.9	14.5	26.6	14.7	25.0	25.2	29.2	8.5	43.3	33.7	30.1	22.8	44.3	18.2	30.8	16.9	13.1	22.7	21.8	45.7	14.7	23.8	21.2	28.7	15.7	12.1	19.4	17.2	12.9	20.4	12.8	26.9	11.6	15.2	24.4	20.7	10.3	16.8	23.1	23.4	9.5	22.6	38.9	16.8	21.1	32.8	17.0	24.4	19.2	18.7	21.3	17.2	10.7	13.9	15.1	22.6	31.2	18.5	20.1	57.3	36.8	36.0	33.6	24.4	27.0	50.9	22.4	24.2	24.8	18.0	41.8	31.5	25.1	25.9	11.7	16.5	38.4	56.4	20.0	16.7	25.3	39.8	15.9	32.1	20.5	26.1	10.4	32.3	34.8	56.6	54.3	96.2	52.6	48.2	63.1	60.7	63.4	62.8	50.2	65.3	74.0	63.5	68.2	63.9	53.5	83.6	78.3	98.1	43.1	44.8	43.6	52.5	44.1	42.0	45.3	43.2	41.9	43.3	44.3	45.7	23.3	16.0	22.4	14.4	32.6	14.0	19.7	37.4	27.9	52.1	36.0	36.2	52.6	24.3	28.0	42.3	10.4	53.8	43.6	47.7	109.5	28.7	5.2	28.7	33.6	21.4	43.1	23.1	10.2	30.9	31.8	24.0	30.5	29.0	27.9	31.7	17.9	41.8	40.9	47.1	11.8	51.7	89.5	18.3	18.7	8.7	31.4	20.8	30.2	3.7	43.3	83.5	34.0	9.5	15.0	30.0	48.5	50.0	33.0	17.9	77.8	98.2	20.1	58.3	46.0	14.2	22.8	14.8	34.7	24.9	16.6	49.1	43.6	58.0	51.4	17.6
NUP210L		ENSG00000143552	"Nucleoporin 210 like"	Q5VU65	1	153992685-154155116	"Cancer-related genes, Metabolic proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 26.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 20.3;Inhibitory neurons: 8.4;Late spermatids: 8.5;Oligodendrocytes: 19.2;Spermatocytes: 28.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	47	"MCF7: 15.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047195, HPA064245, HPA066707"	Enhanced		Approved	"Nuclear bodies"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear bodies"		"HPA047195: AB_2679980, HPA064245: AB_2685224, HPA066707: AB_2685706"	"unprognostic (2.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.72e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.45e-2)"	"unprognostic (5.57e-2)"	"unprognostic (4.51e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.35e-10)"	"unprognostic (4.20e-2)"	"unprognostic (3.78e-2)"	"unprognostic (7.45e-2)"	"unprognostic (4.09e-2)"	0.1	0.0	0.2	0.0	0.7	0.1	0.0	2.4	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.3	0.1	0.0	0.1	0.0	0.7	0.6	0.1	0.1	0.0	0.3	0.0	0.8	0.1	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.2	0.3	0.0	0.0	26.6	0.5	0.0	0.2	0.0	0.0	0.3	0.0	2.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	15.8	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.2	0.7	2.4	0.9	0.4	0.3	0.7	0.6	0.8	0.3	0.5	2.3	0.6	0.0	0.0	6.2	0.5	0.3	0.1	0.1	0.0	0.0	0.3	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	20.3	0.7	0.6	0.9	0.0	0.4	7.0	0.2	0.1	0.5	0.0	1.5	0.0	0.1	0.0	0.0	0.2	0.0	8.4	0.1	0.0	0.0	0.6	8.5	0.9	0.8	0.0	2.8	0.0	0.0	0.0	4.5	19.2	0.0	0.0	1.2	1.7	0.1	0.0	0.1	0.1	0.0	6.6	1.8	0.3	28.2	5.1	0.3	0.6	0.0	0.4	0.1	0.1	0.3
NUP50	NPAP60L	ENSG00000093000	"Nucleoporin 50"	Q9UKX7	22	45163925-45188017	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047162, HPA048328"	Enhanced		Enhanced	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA047162: AB_2679963, HPA048328: AB_2680360"	"unprognostic (2.64e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.46e-3)"	"unprognostic (5.83e-3)"	"unprognostic (4.94e-2)"	"unprognostic (4.94e-2)"	"unprognostic (7.22e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.97e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (1.43e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.63e-2)"	14.1	14.8	8.6	23.3	9.9	54.4	13.5	11.9	12.1	14.3	11.2	18.7	16.6	10.1	18.7	20.5	18.1	14.3	7.2	10.7	10.2	13.7	23.5	14.6	33.7	8.1	8.3	13.9	15.9	15.8	6.7	15.5	7.8	12.2	16.7	10.9	11.7	13.4	7.8	19.0	16.3	11.4	8.0	25.5	24.2	29.8	9.2	46.6	15.2	12.7	35.3	19.3	12.3	9.7	75.8	35.5	67.1	43.7	31.0	31.8	70.9	61.9	41.1	46.9	47.1	77.6	32.9	82.7	28.1	41.0	35.1	52.0	83.4	50.5	67.3	44.3	87.4	72.6	54.8	47.7	32.2	193.7	73.7	38.8	34.1	60.1	45.2	22.7	52.4	71.4	76.5	84.3	49.0	50.8	88.2	50.5	50.4	50.0	36.3	91.8	40.7	58.0	37.0	72.5	41.7	40.4	61.5	37.9	74.0	50.9	23.6	50.3	48.3	99.1	88.6	51.6	52.7	58.4	51.3	119.0	37.1	49.2	70.4	55.1	39.1	80.5	20.3	40.2	27.8	19.5	24.5	23.5	25.5	18.1	28.4	19.6	92.7	30.6	24.2	13.9	25.8	34.2	8.6	9.9	11.9	12.1	10.7	10.2	8.1	8.3	7.8	8.0	9.2	9.7	42.7	9.6	27.9	6.2	32.7	85.5	51.9	26.4	48.3	14.6	26.2	16.3	10.8	22.8	29.6	33.1	12.5	22.6	47.5	34.2	13.7	18.9	46.3	56.3	34.7	29.7	17.4	72.4	16.4	20.9	39.8	21.8	59.1	47.3	34.7	23.9	33.2	38.5	28.1	13.5	15.3	24.4	20.3	47.5	32.8	83.3	14.6	33.4	24.9	11.2	56.9	11.1	42.2	11.6	12.5	29.8	33.5	13.9	49.0	60.8	16.9	22.8	50.0	16.3	26.3	15.9	17.1	45.9	44.3	60.6	89.4	56.6	47.1	23.5	26.3	95.3
OASL	"OASL1, p59OASL, TRIP14"	ENSG00000135114	"2'-5'-oligoadenylate synthetase like"	Q15646	12	121017763-121039242	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 35.7;stomach 1: 22.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 54.1;Distal enterocytes: 82.3;Gastric mucus-secreting cells: 97.9;Paneth cells: 71.4;T-cells: 43.9;Urothelial cells: 96.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 132.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 126.9;BJ hTERT+ SV40 Large T+ RasG12V: 66.2;GAMG: 35.3;hTEC/SVTERT24-B: 50.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001474	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA001474: AB_1079518"	"unprognostic (2.39e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.62e-2)"	"unprognostic (6.22e-2)"	"unprognostic (5.93e-3)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (4.61e-1)"	"prognostic unfavorable (3.70e-9)"	"unprognostic (2.52e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.17e-2)"	2.3	0.8	0.7	4.2	0.8	35.7	2.4	0.7	0.8	3.3	0.6	7.5	2.7	0.5	0.5	4.0	0.7	3.6	1.1	0.6	0.5	2.3	11.8	11.9	3.6	1.4	0.7	0.4	0.7	0.1	0.6	1.4	1.4	0.5	3.4	0.2	4.1	0.4	0.4	0.9	2.0	1.3	3.3	5.3	22.3	2.1	1.1	3.3	1.1	0.6	1.7	7.8	1.4	0.9	2.6	0.6	0.2	0.9	1.0	1.6	0.1	0.2	0.9	126.9	66.2	0.3	13.0	0.6	4.0	0.1	35.3	6.4	0.1	0.9	7.2	25.2	0.1	0.1	13.8	0.0	0.7	0.2	1.8	0.8	0.6	50.7	0.1	0.3	0.3	1.0	0.1	5.3	1.1	1.7	0.1	3.1	0.1	4.5	3.7	0.1	0.2	1.4	0.1	13.7	0.1	0.2	1.1	0.6	18.5	0.1	0.4	1.7	0.1	0.7	1.2	2.1	0.2	4.9	10.1	0.3	19.9	1.3	0.4	12.3	29.6	65.8	53.1	32.5	14.3	2.5	36.2	62.1	8.9	0.8	9.9	38.5	132.8	20.3	23.5	0.5	27.8	33.2	0.7	0.8	0.7	0.8	0.6	0.5	1.4	0.7	1.4	3.3	1.1	0.9	28.6	0.0	4.2	0.7	4.6	2.2	5.0	2.7	1.8	0.0	3.3	4.7	0.6	1.5	3.9	0.0	0.0	0.2	54.1	82.3	0.0	2.5	6.6	2.0	0.6	4.5	1.8	0.8	0.2	3.8	1.3	2.4	97.9	2.8	11.4	1.0	2.2	4.5	12.6	0.0	0.2	30.7	4.1	3.1	7.2	3.4	0.3	16.7	0.0	1.0	6.0	0.0	9.2	0.0	0.0	12.7	71.4	0.0	14.3	2.2	2.4	0.3	3.8	0.0	0.0	0.7	2.8	2.4	0.1	14.6	1.0	0.1	43.9	0.2	5.1	96.3
OSER1	"C20orf111, dJ1183I21.1, HSPC207, Osr1, Perit1"	ENSG00000132823	"Oxidative stress responsive serine rich 1"	Q9NX31	20	44195939-44210771	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 842.5;Late spermatids: 2257.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045125	Approved		Approved	"Nucleoli,Nucleoli rim,Nuclear speckles"		NA	Yes			"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli, Nucleoli rim, Nuclear speckles"		"HPA045125: AB_10961629"	"unprognostic (2.77e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.22e-1)"	"prognostic unfavorable (2.58e-5)"	"unprognostic (1.18e-1)"	"unprognostic (6.07e-2)"	"unprognostic (8.44e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.78e-2)"	"unprognostic (8.01e-3)"	"unprognostic (9.87e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.06e-1)"	43.4	26.6	22.0	22.3	23.2	128.5	42.3	24.7	26.8	37.2	21.9	39.2	27.2	35.1	30.7	46.2	34.9	23.6	37.5	21.9	24.1	35.7	38.1	36.0	27.7	25.0	23.7	42.5	23.5	29.4	24.3	25.2	24.4	36.7	24.7	25.1	36.9	21.5	110.1	51.8	37.3	25.7	24.1	40.1	32.9	116.3	23.8	25.3	37.7	61.1	32.5	44.6	39.2	27.8	50.6	37.1	28.9	22.6	75.2	54.6	32.7	45.0	69.6	71.0	64.1	93.9	54.7	49.1	44.3	43.3	96.1	73.9	31.8	42.7	59.3	16.2	20.1	16.1	99.8	66.8	41.6	27.6	26.8	64.5	72.3	47.1	86.1	38.7	32.8	30.6	24.9	64.9	40.2	75.8	22.5	35.9	25.7	46.5	39.3	32.8	46.4	35.0	37.3	34.7	28.2	27.5	64.2	90.5	62.2	33.9	45.1	25.6	27.8	60.6	45.3	35.8	39.7	44.3	49.1	48.4	42.6	20.6	31.1	264.8	68.4	119.5	50.0	68.3	54.1	120.1	57.1	49.7	60.7	115.2	67.7	61.8	306.7	67.7	100.2	39.7	73.8	91.5	22.0	23.2	24.7	26.8	21.9	24.1	25.0	23.7	24.4	24.1	23.8	27.8	51.2	19.2	21.0	14.4	70.0	259.4	137.6	95.4	101.3	10.3	69.1	75.2	38.7	18.6	61.3	12.9	4.2	40.4	48.6	58.6	37.2	45.1	842.5	94.7	48.0	36.8	49.5	25.0	9.0	36.4	38.2	48.6	37.2	175.1	33.0	22.9	18.5	27.9	43.4	11.8	9.0	34.6	65.1	30.6	111.1	2257.1	40.7	55.2	76.5	5.6	84.2	31.0	30.9	5.0	12.5	49.3	87.7	35.3	40.6	91.4	68.1	33.5	36.9	14.8	19.7	47.0	45.6	194.8	71.7	50.4	198.5	173.6	55.2	22.3	47.5	119.4
PADI2	"KIAA0994, PDI2"	ENSG00000117115	"Peptidyl arginine deiminase 2"	Q9Y2J8	1	17066761-17119451	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 240.6;skeletal muscle: 311.8;tongue: 492.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 95.9;Distal enterocytes: 178.7;Intestinal goblet cells: 77.3;Oligodendrocytes: 117.1;Paneth cells: 72.3"	"Cancer enhanced"	"Detected in many"		"glioma: 24.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 43.3;neutrophil: 100.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 100.6"	"Cell line enhanced"	"Detected in some"		"A549: 11.6;RPTEC TERT1: 33.1;SK-BR-3: 50.7;T-47d: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047735	Enhanced					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA047735: AB_2680139"	"unprognostic (2.61e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.74e-3)"	"unprognostic (2.78e-3)"	"unprognostic (3.28e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.91e-3)"	2.1	0.9	85.9	9.3	161.5	23.7	41.1	164.3	103.9	3.3	33.5	89.8	1.4	0.8	0.6	6.1	2.7	1.6	0.6	82.2	165.1	12.7	0.7	4.4	1.0	205.8	167.0	0.2	1.5	2.1	3.7	1.4	212.0	2.6	92.3	50.5	44.4	1.6	311.8	9.6	8.4	5.8	189.3	13.4	2.2	0.8	144.3	2.1	0.6	492.3	1.3	2.5	1.0	240.6	0.0	11.6	0.1	0.0	0.0	0.0	0.7	0.3	0.0	0.1	0.1	0.1	4.9	0.2	1.5	0.5	0.1	1.6	0.4	0.1	0.3	0.0	0.8	0.5	0.0	0.0	0.0	0.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.9	3.8	0.6	1.4	1.6	3.9	0.0	0.0	0.0	0.4	33.1	0.0	2.1	0.2	0.0	50.7	0.0	2.7	13.9	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.9	0.0	1.3	16.2	43.3	0.0	0.9	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	100.6	0.0	0.2	0.4	0.0	6.4	85.9	161.5	164.3	103.9	82.2	165.1	205.8	167.0	212.0	189.3	144.3	240.6	0.2	0.0	1.3	28.4	1.0	0.3	0.4	0.6	0.0	2.2	31.2	32.5	0.4	0.0	3.3	1.8	95.9	0.2	0.7	178.7	11.7	0.6	6.1	0.0	0.0	8.2	3.6	0.0	1.5	0.0	0.5	0.6	0.0	0.1	17.1	0.5	0.7	0.0	7.2	0.0	1.4	77.3	2.0	4.8	25.8	10.3	0.3	9.2	28.4	15.9	33.8	33.6	0.0	13.6	117.1	0.0	72.3	0.7	0.4	0.5	15.0	0.3	0.2	29.6	0.0	5.6	1.3	0.2	0.4	0.0	0.4	0.1	0.4	0.0	51.8	0.2
PADI4	"PAD, PADI5, PDI4, PDI5"	ENSG00000159339	"Peptidyl arginine deiminase 4"	Q9UM07	1	17308195-17364004	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"bone marrow: 105.1;lymphoid tissue: 29.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 8.3;granulocytes: 12.6;Macrophages: 14.6;monocytes: 22.3;NK-cells: 20.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"basophil: 79.9;classical monocyte: 71.3;eosinophil: 97.5;neutrophil: 183.0"	"Group enriched"	"Detected in all"	9	"granulocytes: 183.0;monocytes: 71.3"	"Cell line enhanced"	"Detected in some"		"HEL: 1.2;RPMI-8226: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA017007, HPA042825"	Enhanced					NA	NA		29000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA017007: AB_1854921, HPA042825: AB_2678189"	"unprognostic (1.70e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.91e-2)"	"unprognostic (8.49e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.80e-1)"	1.8	0.1	0.2	0.7	0.4	105.1	0.3	0.2	0.8	0.1	0.2	0.1	0.1	0.1	0.0	0.4	1.0	0.4	1.1	0.3	0.2	0.5	1.7	7.9	0.3	0.3	0.1	0.1	0.3	0.0	0.2	0.5	0.3	0.2	0.0	0.0	0.2	0.0	0.2	0.2	0.2	0.4	0.0	29.9	0.4	0.1	0.1	1.6	0.3	0.3	0.2	0.7	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	79.9	71.3	97.5	0.4	5.7	0.2	1.1	0.5	0.7	13.9	1.8	2.6	4.5	183.0	4.5	1.8	6.2	0.4	35.8	0.2	0.4	0.2	0.8	0.3	0.2	0.3	0.1	0.3	0.0	0.1	0.4	0.0	0.0	3.7	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.6	0.0	0.6	0.6	0.0	0.0	12.6	0.1	0.0	0.4	0.2	0.0	0.4	0.0	0.0	3.3	0.4	0.2	0.0	14.6	0.0	0.0	22.3	0.0	20.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	4.0	0.0	0.0	0.1	2.3	0.1	0.0	0.0
PAIP2	PAIP2A	ENSG00000120727	"Poly(A) binding protein interacting protein 2"	Q9BPZ3	5	139341587-139369720	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 834.4;Late spermatids: 2779.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035945, CAB037212, HPA056766"	Approved		Supported	Vesicles		NA	NA		21000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"CAB037212: AB_1841072, HPA035945: AB_10672996, HPA056766: AB_2683231"	"unprognostic (1.07e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.86e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.80e-3)"	"unprognostic (7.70e-3)"	"unprognostic (8.91e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.01e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.36e-1)"	"unprognostic (6.92e-2)"	103.3	148.6	107.9	77.2	107.9	115.7	90.3	120.0	149.6	77.3	119.9	79.1	44.2	94.1	85.6	68.8	91.6	66.5	173.1	107.8	118.9	104.7	114.2	73.1	109.0	119.5	114.0	112.3	64.2	88.9	96.2	93.7	123.8	84.3	53.9	168.9	92.1	82.4	169.6	48.2	50.0	83.1	119.1	92.1	58.1	169.0	110.0	147.4	74.6	161.9	107.7	81.4	54.3	138.9	91.9	102.7	196.2	118.5	144.0	81.3	95.6	81.9	113.6	104.7	163.6	138.5	86.7	160.7	170.8	62.3	120.1	88.9	173.5	112.5	137.4	155.7	136.4	148.5	145.7	125.8	93.0	92.8	105.4	93.2	92.4	78.5	88.8	112.9	108.7	173.3	143.7	138.6	95.8	121.1	254.3	227.3	118.9	130.5	74.6	140.0	248.1	177.2	84.0	163.2	90.9	165.2	121.2	110.7	251.2	245.4	214.4	192.6	66.9	55.9	67.9	61.3	67.3	200.0	262.6	167.8	98.2	161.6	58.9	569.5	292.2	735.8	286.2	329.3	317.0	378.7	314.7	330.4	292.0	337.7	364.4	356.5	800.5	347.5	380.6	298.7	449.5	577.2	107.9	107.9	120.0	149.6	107.8	118.9	119.5	114.0	123.8	119.1	110.0	138.9	154.8	73.7	87.5	26.4	173.8	159.8	164.3	168.2	79.1	102.4	108.2	98.0	59.7	97.2	100.9	99.3	58.4	198.6	253.1	74.0	170.2	126.4	834.4	228.6	109.2	126.9	97.0	190.0	40.6	115.1	134.1	129.5	38.7	109.0	109.0	108.2	123.1	103.8	142.3	97.6	46.6	57.7	120.1	142.2	196.1	2779.9	160.9	170.6	135.2	29.0	239.2	158.5	247.2	29.7	59.9	122.5	64.7	155.3	146.8	232.8	62.1	256.2	149.4	93.6	170.9	87.7	180.3	432.3	238.1	57.0	208.3	479.7	191.3	145.8	59.5	178.3
PAK2	"PAK65, PAKgamma"	ENSG00000180370	"P21 (RAC1) activated kinase 2"	Q13177	3	196739857-196832647	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Growth regulation, Host-virus interaction"	"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB007794	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		1700000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Vesicles"		"CAB007794: AB_562363"	"unprognostic (1.03e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.85e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.36e-4)"	"prognostic unfavorable (9.58e-4)"	"unprognostic (1.30e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.39e-1)"	31.8	18.1	21.2	34.6	24.9	28.1	19.5	25.0	21.7	21.1	19.8	25.6	23.0	21.9	16.0	26.5	20.5	23.8	24.0	19.5	24.6	22.1	33.8	26.3	40.9	26.7	23.4	19.8	18.5	32.6	8.4	33.3	27.7	20.1	26.6	17.4	14.5	18.9	28.3	16.6	22.5	27.0	24.8	43.5	20.9	15.1	23.0	45.1	19.7	25.9	39.4	34.1	16.0	34.1	140.7	49.1	67.6	49.8	47.1	61.9	100.0	69.1	57.0	73.7	66.8	117.5	70.1	89.4	192.7	70.8	75.1	70.2	72.5	66.2	113.6	39.9	35.2	132.2	52.1	92.5	95.0	130.2	122.0	49.6	53.1	66.2	139.2	78.1	74.3	97.3	65.0	107.5	72.9	146.7	124.8	67.2	40.5	74.7	73.4	112.4	38.6	80.9	64.8	96.7	39.6	44.7	92.8	64.7	52.7	51.9	227.0	92.6	76.9	60.9	33.6	64.3	103.1	72.5	138.9	216.4	50.4	127.6	59.1	37.3	20.0	48.0	10.9	23.2	14.7	11.2	12.7	12.6	25.4	11.3	9.1	10.9	47.6	12.2	21.2	9.3	20.7	14.9	21.2	24.9	25.0	21.7	19.5	24.6	26.7	23.4	27.7	24.8	23.0	34.1	164.9	80.1	40.2	37.9	142.8	97.4	89.2	41.8	96.2	42.6	59.7	47.5	59.3	62.9	45.1	82.8	52.1	50.3	135.1	69.6	33.2	71.5	57.1	107.9	112.6	104.0	44.9	72.3	32.2	59.0	101.4	68.9	58.1	96.1	148.8	70.9	66.0	138.6	104.3	55.5	38.9	46.4	57.0	160.5	115.9	75.5	60.9	169.6	33.8	46.9	183.2	63.7	140.1	37.2	61.3	100.4	52.1	45.5	100.0	149.4	58.2	85.2	76.4	45.0	39.5	86.0	75.9	24.5	43.0	103.2	86.2	34.9	139.1	96.3	51.0	124.1
PARP16	"ARTD15, C15orf30, FLJ20509, FLJ25281, pART15"	ENSG00000138617	"Poly(ADP-ribose) polymerase family member 16"	Q8N5Y8	15	65234460-65300618	"Metabolic proteins, Predicted membrane proteins"	"Unfolded protein response"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 33.0;Spermatogonia: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017081	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA017081: AB_10963218"	"unprognostic (1.17e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.82e-2)"	"unprognostic (6.37e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.41e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.61e-2)"	6.6	9.8	5.0	4.7	4.8	6.0	8.8	7.0	5.6	12.6	4.4	10.2	6.2	8.7	5.1	7.5	9.7	4.3	4.9	4.9	4.9	6.2	13.2	5.1	7.0	4.8	4.8	11.9	7.5	8.2	5.5	6.0	4.9	8.4	6.4	5.1	7.2	6.2	3.8	8.1	7.1	6.8	4.7	6.5	7.9	4.8	4.9	10.0	6.4	3.9	8.2	10.0	9.1	5.1	6.0	6.3	6.5	10.4	5.3	4.9	2.8	2.8	7.1	7.0	7.3	4.5	5.4	18.9	7.3	3.5	15.3	9.4	30.3	3.7	5.0	7.3	11.3	3.1	6.5	6.3	9.1	8.7	5.6	6.1	6.0	2.0	7.2	10.6	6.4	17.9	7.6	7.1	5.9	6.8	19.0	8.8	2.8	29.7	8.2	33.5	11.8	14.3	5.0	5.3	10.8	7.2	8.3	7.5	6.8	5.1	8.7	7.5	2.7	8.5	6.5	4.7	3.9	13.3	16.5	24.2	7.0	12.5	4.2	19.9	3.9	12.2	12.6	6.0	14.0	8.5	11.9	12.8	5.2	11.1	14.7	10.9	15.0	12.5	6.5	4.4	10.8	6.9	5.0	4.8	7.0	5.6	4.9	4.9	4.8	4.8	4.9	4.7	4.9	5.1	3.7	3.2	3.1	10.1	9.6	5.2	6.0	3.9	9.6	12.1	5.0	4.7	4.1	7.2	3.4	3.7	0.0	12.5	9.1	3.4	0.0	5.8	0.8	1.5	4.7	4.5	1.8	3.0	14.0	9.1	5.7	7.0	11.7	2.7	0.0	6.5	2.9	6.0	3.8	3.3	18.3	4.9	4.1	2.5	1.7	1.9	9.9	4.3	3.6	11.2	4.3	7.3	9.2	10.6	13.4	5.3	2.5	7.9	9.8	3.2	7.1	4.0	2.6	33.0	6.6	4.3	4.5	1.6	28.6	4.6	4.3	5.5	9.0	6.3	5.4	3.0
PCIF1	"bA465L10.1, C20orf67, CAPAM, PPP1R121"	ENSG00000100982	"Phosphorylated CTD interacting factor 1"	Q9H4Z3	20	45934683-45948023	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049517	Enhanced		Supported	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Microtubules, Cytokinetic bridge"	"HPA049517: AB_2680801"	"unprognostic (5.42e-3)"	"unprognostic (7.76e-2)"	"unprognostic (7.69e-2)"	"prognostic unfavorable (8.86e-4)"	"unprognostic (1.39e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.50e-6)"	"unprognostic (1.01e-1)"	"unprognostic (4.44e-2)"	"unprognostic (9.14e-3)"	"unprognostic (1.24e-1)"	28.7	28.0	20.7	18.6	23.0	33.9	28.7	30.2	24.2	36.1	17.6	30.7	16.5	39.7	10.8	24.4	35.3	16.3	31.9	20.4	20.2	23.4	19.5	28.2	27.3	22.7	21.6	41.7	29.5	22.8	26.0	17.0	22.1	26.2	11.7	15.9	23.6	21.3	41.7	36.7	27.2	21.3	20.9	34.7	25.4	18.1	21.7	34.4	32.0	27.6	19.6	28.6	29.3	24.9	21.2	29.0	22.0	27.2	15.3	18.2	24.2	8.3	25.1	24.9	24.2	49.3	27.7	22.7	27.4	22.6	28.7	23.4	15.8	29.0	10.8	14.1	11.4	29.1	23.1	33.4	28.2	26.4	28.1	25.5	29.9	15.3	24.5	22.3	21.0	37.1	20.8	30.9	17.9	44.6	52.3	48.3	7.8	25.5	24.9	32.2	20.4	28.0	20.1	21.8	30.2	30.0	31.5	29.5	16.1	11.6	31.0	30.7	18.1	30.7	24.1	27.3	16.8	35.4	22.1	21.0	37.7	23.8	18.2	75.5	47.5	80.2	54.5	47.2	43.0	51.6	47.3	50.2	50.3	56.2	48.6	43.0	74.6	74.3	48.0	40.4	54.4	64.0	20.7	23.0	30.2	24.2	20.4	20.2	22.7	21.6	22.1	20.9	21.7	24.9	19.7	3.2	14.2	4.6	33.7	8.7	26.4	7.9	26.2	9.9	17.0	19.7	21.9	20.0	7.1	11.0	2.1	19.5	32.4	14.6	15.6	21.4	9.6	13.3	10.7	16.1	26.5	25.4	2.5	38.6	22.6	15.4	17.3	13.5	14.5	14.9	9.7	12.4	16.9	13.5	3.6	14.0	4.1	16.0	8.7	8.1	11.5	21.5	17.8	1.0	24.9	12.0	33.0	3.0	3.9	28.3	13.1	12.8	35.5	25.4	14.8	23.2	11.0	13.4	0.0	20.2	19.3	14.4	11.9	23.8	10.7	27.8	30.8	15.1	12.0	38.8
PCYT1A	"CT, CTPCT, PCYT1"	ENSG00000161217	"Phosphate cytidylyltransferase 1, choline, alpha"	P49585	3	196214222-196287957	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"	"Cone-rod dystrophy, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 215.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035428	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA035428: AB_10602045"	"unprognostic (8.58e-3)"	"unprognostic (2.63e-1)"	"unprognostic (8.45e-2)"	"unprognostic (8.61e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (8.65e-5)"	"unprognostic (8.52e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.47e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.41e-2)"	31.4	24.4	15.2	30.0	16.0	45.3	21.0	16.6	15.8	16.7	17.8	25.7	60.3	19.1	13.9	31.0	15.6	20.7	46.4	15.5	21.1	18.3	20.7	22.5	22.9	18.8	18.0	15.8	16.8	22.7	12.9	20.1	18.5	16.6	22.9	14.4	19.3	18.6	73.8	43.0	49.1	23.0	17.5	25.9	24.2	22.4	18.1	18.1	17.2	42.1	26.8	21.0	19.8	17.1	92.6	36.6	25.8	37.2	52.2	53.9	37.0	68.2	47.1	59.2	51.8	92.3	32.8	23.9	215.2	78.1	60.2	71.4	40.5	52.1	50.4	42.1	28.6	68.6	40.6	39.5	45.2	34.3	56.7	47.4	40.0	55.9	39.6	35.4	63.0	21.0	38.3	53.3	58.1	79.6	19.9	17.3	21.4	55.7	53.0	34.5	31.0	37.5	35.7	53.6	25.4	18.3	44.5	79.5	44.2	32.8	114.1	37.2	88.5	45.5	25.2	61.8	92.7	45.8	101.1	44.1	69.6	43.8	56.9	9.6	9.2	10.4	8.8	9.3	7.5	7.2	6.5	9.7	9.1	6.3	4.2	6.3	21.0	9.4	11.0	5.9	14.9	5.2	15.2	16.0	16.6	15.8	15.5	21.1	18.8	18.0	18.5	17.5	18.1	17.1	24.7	16.0	25.7	15.3	19.9	14.5	9.4	19.7	14.2	15.9	14.1	9.4	70.1	20.0	17.5	14.7	25.0	11.9	27.3	36.4	13.7	24.8	76.3	17.8	22.9	23.2	22.1	12.2	20.4	22.9	17.7	17.0	23.4	15.6	20.8	16.1	26.7	35.6	37.4	8.4	22.7	24.2	6.1	34.6	27.1	67.6	19.9	33.9	19.6	20.6	39.4	13.1	39.1	16.1	17.6	24.6	21.1	28.2	27.2	12.0	67.2	23.2	33.9	12.8	26.3	15.0	19.0	46.0	13.2	30.0	21.5	18.6	25.6	25.5	23.8	12.2
PDK1		ENSG00000152256	"Pyruvate dehydrogenase kinase 1"	Q15118	2	172555373-172608669	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 130.4;Plasma cells: 144.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 8.6;granulocytes: 25.2;T-cells: 21.2"	"Cell line enhanced"	"Detected in all"		"U-266/70: 71.8;U-87 MG: 72.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017554, HPA027376"	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB017554: AB_2161138, HPA027376: AB_1855139"	"unprognostic (2.14e-1)"	"prognostic unfavorable (7.30e-5)"	"unprognostic (1.21e-1)"	"unprognostic (3.94e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.69e-3)"	"unprognostic (6.44e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (1.10e-8)"	"unprognostic (1.82e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.56e-2)"	"unprognostic (5.34e-2)"	7.7	16.0	2.5	11.6	3.0	15.8	10.1	5.6	5.3	5.5	2.7	16.7	16.5	4.0	3.1	8.5	3.6	6.0	28.1	3.1	2.1	4.8	11.2	4.2	13.1	2.7	6.7	12.2	6.9	4.3	3.8	6.4	3.2	4.7	13.3	27.1	10.2	5.0	9.0	18.1	9.1	4.4	1.3	10.5	13.6	12.2	5.0	8.3	3.9	7.6	19.1	11.0	7.6	2.5	34.0	1.4	8.4	21.0	3.4	5.1	12.1	29.1	23.4	14.3	30.4	8.6	7.1	32.1	15.8	9.1	11.9	14.5	5.8	18.2	45.5	6.6	11.7	39.3	7.1	10.2	6.2	19.6	14.0	6.6	6.4	10.0	16.6	19.8	7.7	16.7	8.5	21.5	19.2	3.5	12.5	24.5	20.8	6.9	9.2	13.1	13.8	52.5	7.4	10.8	15.7	18.0	7.6	8.8	11.1	7.0	5.6	8.0	9.2	22.7	7.4	12.0	7.9	71.8	44.8	26.9	72.6	14.0	4.6	19.6	3.4	25.2	3.7	2.3	4.2	7.3	5.9	4.0	3.5	8.6	21.2	13.5	12.7	2.2	3.2	0.6	12.2	9.2	2.5	3.0	5.6	5.3	3.1	2.1	2.7	6.7	3.2	1.3	5.0	2.5	9.2	3.2	5.0	12.1	33.7	50.1	5.1	15.8	4.6	29.4	7.0	4.7	35.5	2.8	7.0	3.7	47.9	10.2	9.9	11.9	5.9	8.7	130.4	6.4	7.2	9.6	7.8	4.2	35.4	3.7	13.2	8.5	9.7	12.1	5.7	13.3	19.6	20.2	10.2	55.5	32.7	6.6	12.2	12.0	15.2	43.8	3.4	12.9	30.2	30.9	11.4	7.4	10.3	12.1	14.8	9.6	17.5	3.8	144.8	7.2	6.7	1.9	5.0	18.5	6.6	4.6	11.6	9.6	10.4	8.9	43.3	4.1	17.3	5.3	7.0	6.1
PDK3		ENSG00000067992	"Pyruvate dehydrogenase kinase 3"	Q15120	X	24465270-24550466	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 71.6;Excitatory neurons: 92.8;Inhibitory neurons: 78.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046583, HPA072492"	Approved		Supported	Nucleoli,Mitochondria		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 6: T47d - Mammary gland"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	Nucleoli	"HPA046583: AB_2679707, HPA072492: AB_2686526"	"unprognostic (5.41e-3)"	"unprognostic (5.43e-3)"	"unprognostic (5.35e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.05e-3)"	"unprognostic (5.38e-2)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (1.51e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.28e-2)"	"unprognostic (9.43e-3)"	4.4	2.0	4.4	5.6	6.2	8.9	8.8	1.4	7.5	3.5	2.5	6.1	8.2	2.8	10.9	3.9	5.9	3.2	7.4	13.2	4.7	8.8	4.7	5.0	7.9	2.6	4.2	4.8	2.9	6.7	5.8	4.1	2.4	4.6	5.3	6.0	11.1	2.9	1.4	6.8	8.3	4.5	0.9	7.7	6.9	11.6	9.1	6.3	2.3	1.8	8.0	4.2	4.1	4.2	11.5	5.2	4.2	8.0	0.2	0.0	5.0	3.4	2.4	4.1	6.9	0.5	13.9	10.4	2.3	0.8	11.6	2.1	12.3	8.4	10.4	9.7	6.0	5.3	6.1	3.3	1.4	4.6	5.8	0.9	3.6	1.1	1.2	0.5	6.8	10.9	0.9	16.5	0.5	20.9	9.4	6.0	8.1	12.2	5.6	5.0	8.0	17.3	4.1	21.4	2.6	4.0	17.9	8.0	5.5	7.3	9.6	1.9	0.1	3.3	3.6	5.8	4.2	11.0	8.9	12.9	8.7	7.7	6.4	13.3	15.4	37.9	11.8	19.6	16.5	7.5	9.1	10.3	12.2	7.3	7.6	8.6	57.6	13.3	18.8	3.5	8.3	12.4	4.4	6.2	1.4	7.5	13.2	4.7	2.6	4.2	2.4	0.9	9.1	4.2	3.9	3.2	2.0	19.6	15.2	4.6	9.5	13.5	30.1	3.5	11.1	8.1	6.6	1.5	5.2	1.8	0.0	5.5	16.6	4.2	3.9	4.3	71.6	2.1	2.9	3.8	4.2	14.3	92.8	5.1	32.1	4.9	5.6	2.8	5.7	4.9	5.3	5.3	15.0	8.4	78.0	2.9	10.2	19.8	7.4	35.9	3.7	17.4	16.0	35.6	10.3	3.7	25.7	19.6	14.0	2.1	0.3	5.7	19.0	5.9	13.3	14.2	2.4	3.5	0.0	2.0	10.6	10.2	8.3	6.8	4.4	17.8	18.2	9.7	4.1	8.4
PDZD8	"bA129M16.2, FLJ34427, PDZK8"	ENSG00000165650	"PDZ domain containing 8"	Q8NEN9	10	117277274-117375440	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 73.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 208.7;Late spermatids: 477.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEL: 124.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015716, HPA051610"	Uncertain		Approved	"Nucleoli fibrillar center,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli fibrillar center"	"Plasma membrane"	"HPA015716: AB_1855162, HPA051610: AB_2681549"	"unprognostic (1.12e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.65e-3)"	"unprognostic (2.75e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.10e-2)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (1.90e-2)"	"unprognostic (5.37e-3)"	"unprognostic (7.60e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.01e-2)"	7.1	7.0	8.9	4.7	12.1	73.0	4.7	15.7	8.6	7.9	17.9	9.3	14.0	9.1	14.1	10.8	6.8	9.7	5.1	8.1	11.8	13.1	15.8	6.0	3.2	11.9	13.8	8.9	14.1	28.3	4.2	5.4	12.2	6.4	11.2	14.1	12.9	10.6	4.9	5.5	10.6	6.9	11.3	3.7	10.4	13.2	12.5	5.8	6.8	5.8	3.6	6.6	5.8	13.2	12.6	21.1	7.6	14.7	12.8	11.4	4.3	11.9	10.2	5.2	4.2	10.7	16.4	14.7	10.5	18.1	6.0	18.4	13.4	12.6	10.3	9.4	11.8	124.3	8.6	10.6	9.4	52.4	11.2	11.2	14.7	9.5	27.9	19.3	9.3	12.1	11.5	15.0	13.0	5.1	10.2	6.7	6.0	6.6	18.8	8.2	29.2	6.4	15.5	9.0	6.0	9.6	12.6	5.4	9.7	6.9	3.7	7.6	15.1	8.6	9.4	15.8	20.5	8.0	7.2	10.5	10.8	23.6	7.7	1.4	0.5	2.6	0.9	0.5	0.9	0.3	0.7	0.7	0.7	0.4	0.5	0.7	2.3	1.2	0.9	0.5	0.3	0.2	8.9	12.1	15.7	8.6	8.1	11.8	11.9	13.8	12.2	11.3	12.5	13.2	22.1	12.8	30.7	32.3	13.7	29.7	24.4	10.3	24.5	31.9	16.4	17.0	19.8	40.0	21.0	18.4	22.9	9.8	36.1	26.9	9.8	31.9	208.7	78.3	46.7	24.0	33.7	82.0	49.2	81.9	7.2	27.3	48.4	111.2	44.2	14.6	18.9	58.6	7.5	32.0	61.0	38.8	10.2	16.0	31.8	477.6	23.6	25.2	23.2	30.0	15.5	29.0	23.7	51.8	56.4	57.6	23.1	28.6	28.1	41.1	27.0	26.5	28.5	45.0	26.3	46.3	24.5	25.8	29.1	36.3	32.4	6.7	28.4	90.8	50.2	44.6
PGAP2	"CWH43-N, FRAG1, MRT17, MRT21"	ENSG00000148985	"Post-GPI attachment to proteins 2"	Q9UHJ9	11	3797724-3826371	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"GPI-anchor biosynthesis"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"epididymis: 216.2"	"Group enriched"	"Detected in all"	4	"Cytotrophoblasts: 74.9;Early spermatids: 147.6;Late spermatids: 296.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063099	Approved		Approved	Microtubules		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Microtubules		"HPA063099: AB_2684940"	"unprognostic (1.94e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.18e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.44e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.66e-3)"	"unprognostic (4.13e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.67e-2)"	8.9	14.9	16.4	6.4	17.5	9.5	11.5	15.9	18.2	13.7	17.0	13.9	18.4	8.3	216.2	34.9	19.2	7.6	21.7	16.6	16.3	13.9	30.9	16.2	10.4	17.8	16.6	11.2	28.9	17.6	15.1	14.2	17.2	16.7	13.3	9.2	18.4	33.4	11.4	48.0	16.0	7.6	16.3	11.3	14.1	28.5	17.3	13.1	19.4	9.5	13.5	10.9	18.8	20.9	27.1	36.3	17.2	15.8	15.2	28.9	27.3	10.9	9.4	15.6	14.2	31.1	46.6	29.0	12.3	8.0	9.4	44.1	27.6	30.2	15.5	35.5	30.9	17.7	14.7	38.4	10.7	23.0	22.0	22.8	41.9	11.6	39.3	10.2	18.0	38.4	38.4	41.8	16.6	39.9	28.0	19.3	32.4	56.7	21.5	44.0	2.0	27.8	30.0	31.6	22.7	22.5	19.7	52.0	12.3	20.1	43.2	9.6	16.5	9.9	9.2	23.8	6.8	26.2	31.3	21.6	12.9	15.3	19.1	3.0	6.4	5.9	9.1	9.2	11.0	11.4	13.2	11.3	9.7	12.7	17.3	11.8	18.2	10.7	9.2	6.6	13.3	8.8	16.4	17.5	15.9	18.2	16.6	16.3	17.8	16.6	17.2	16.3	17.3	20.9	8.4	12.8	10.6	7.5	10.6	31.7	15.1	23.3	33.6	14.1	19.2	18.0	13.7	11.5	13.0	12.9	22.9	74.9	5.2	11.4	1.9	15.6	147.6	11.7	6.6	9.0	3.0	13.2	15.4	21.3	18.4	7.6	10.2	14.7	8.8	13.4	3.6	14.6	16.0	3.3	19.1	10.5	10.2	5.0	8.0	296.8	8.7	5.5	5.4	4.7	8.9	9.3	8.2	10.6	23.0	14.2	9.3	6.8	12.2	9.1	39.8	10.2	15.2	9.5	6.6	11.0	7.2	17.7	21.6	31.1	28.6	29.3	9.4	11.8	20.1	13.0
PHF5A	"bK223H9.2, INI, MGC1346, Rds3, SAP14b, SF3b14b, SF3B7"	ENSG00000100410	"PHD finger protein 5A"	Q7RTV0	22	41459717-41468692	"Predicted intracellular proteins, Transcription factors"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028885	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA028885: AB_10602079"	"unprognostic (4.38e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (3.02e-8)"	"unprognostic (3.39e-3)"	"unprognostic (3.97e-3)"	"unprognostic (4.46e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.12e-1)"	"unprognostic (5.25e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.91e-2)"	26.0	21.1	26.5	23.0	29.7	58.2	27.7	30.0	30.6	23.3	28.9	25.1	22.7	22.9	26.0	29.0	22.8	19.6	20.9	26.7	28.5	25.5	30.9	20.1	35.5	28.9	28.5	20.7	26.2	25.1	21.5	25.6	29.7	19.7	28.8	24.5	21.0	19.1	35.8	27.7	22.4	22.6	28.8	26.4	26.0	18.8	28.2	52.2	19.7	29.0	41.9	30.6	23.7	33.9	80.5	56.8	95.0	62.8	68.7	51.7	65.9	80.1	65.5	102.9	86.4	78.4	46.5	115.4	45.7	60.1	72.1	60.7	130.2	95.3	115.6	71.7	136.5	71.8	86.9	92.2	71.9	190.3	54.9	50.4	72.9	81.3	100.5	41.7	73.8	80.6	97.5	71.8	74.9	107.5	154.8	124.3	96.1	220.8	82.2	115.4	84.9	81.5	68.6	63.1	46.6	38.9	87.9	57.4	90.0	66.6	45.9	96.8	50.7	54.0	95.6	44.1	97.9	58.9	112.3	194.9	52.2	82.6	59.0	32.8	47.0	57.9	36.0	45.2	47.2	47.6	41.1	45.6	49.2	42.6	40.2	39.5	55.6	47.6	44.1	41.7	47.8	59.3	26.5	29.7	30.0	30.6	26.7	28.5	28.9	28.5	29.7	28.8	28.2	33.9	36.4	22.4	13.9	2.3	52.3	77.2	78.1	81.1	58.1	24.6	35.1	35.4	10.6	41.5	33.5	11.0	4.2	93.0	42.3	27.2	46.9	58.5	14.7	26.6	20.7	43.7	15.0	56.1	3.5	56.2	115.0	36.2	20.4	25.5	33.7	20.9	37.5	24.7	58.7	13.5	3.7	32.1	63.1	38.8	55.9	9.1	42.3	37.3	33.8	2.8	67.5	47.3	59.8	5.5	8.2	64.5	32.5	41.8	41.6	84.4	41.1	42.1	24.3	28.2	98.6	32.3	38.6	63.5	88.1	59.0	91.6	109.2	42.3	20.2	41.9	95.7
PHKA2	"PHK, PYK"	ENSG00000044446	"Phosphorylase kinase regulatory subunit alpha 2"	P46019	X	18892298-18984114	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	Calmodulin-binding	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 42.7;Hepatocytes: 57.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002912	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA002912: AB_10961321"	"unprognostic (3.90e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.25e-5)"	"unprognostic (2.07e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.82e-1)"	"prognostic favorable (7.68e-4)"	"unprognostic (7.51e-2)"	"prognostic unfavorable (1.55e-5)"	"unprognostic (2.05e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.16e-2)"	"prognostic favorable (2.96e-5)"	12.7	9.6	4.6	6.8	6.3	15.0	7.6	6.6	5.5	9.0	6.9	6.8	12.5	10.5	6.5	6.3	9.9	8.1	12.6	5.6	5.4	6.7	34.3	6.4	7.7	6.9	5.6	16.8	15.2	8.1	12.8	10.5	6.7	9.7	6.5	10.6	9.5	7.1	7.8	8.8	10.1	6.2	5.5	9.3	8.6	9.7	6.0	12.6	10.1	14.3	7.4	6.2	8.1	7.3	11.3	10.6	6.1	10.2	8.2	7.5	16.6	4.9	4.1	7.1	7.7	11.3	7.3	13.3	3.6	6.4	11.2	10.3	11.0	12.8	7.6	6.5	11.2	15.9	17.6	13.8	5.8	15.2	19.7	12.6	8.3	8.7	12.5	11.8	7.4	13.8	5.3	8.0	5.0	12.0	16.0	25.2	7.5	5.2	11.2	12.4	12.5	14.9	4.6	5.0	5.2	8.0	14.8	15.3	6.8	20.3	18.9	8.8	13.2	9.6	5.3	10.3	7.6	7.6	6.7	10.1	5.4	8.1	5.2	4.3	3.2	7.2	2.0	3.8	2.1	1.6	1.7	1.5	2.1	1.7	1.9	1.9	5.4	3.0	2.5	1.1	2.3	1.9	4.6	6.3	6.6	5.5	5.6	5.4	6.9	5.6	6.7	5.5	6.0	7.3	6.1	9.6	12.9	27.7	5.7	6.5	5.4	6.0	8.6	11.1	8.0	7.4	20.1	12.8	5.1	9.2	10.4	16.8	3.4	9.6	0.0	7.5	7.2	6.4	11.8	7.3	4.2	14.5	15.2	5.1	17.5	5.3	4.1	7.2	1.3	42.7	20.3	57.4	8.0	5.0	19.9	7.4	4.1	18.9	3.8	5.3	7.5	10.5	5.4	13.1	8.3	17.0	7.2	16.6	16.9	6.3	12.6	7.9	7.4	6.9	12.4	4.8	4.1	13.3	0.0	7.4	5.9	7.9	7.9	8.6	4.7	10.5	7.4	12.1	10.7	3.6
PHOSPHO1		ENSG00000173868	"Phosphoethanolamine/phosphocholine phosphatase 1"	Q8TCT1	17	49223366-49230787	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Mineral balance"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 103.0"	"Cell type enriched"	"Detected in some"	6	"Late spermatids: 1499.6"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	160	"eosinophil: 171.1;neutrophil: 426.7"	"Lineage enriched"	"Detected in many"	228	"granulocytes: 426.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.7;EFO-21: 3.2;HDLM-2: 4.1;SuSa: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA065025			Approved	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Actin filaments"	"Plasma membrane"	"HPA065025: AB_2732727"	"unprognostic (1.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (7.53e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.57e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.04e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.87e-1)"	2.5	1.3	1.5	3.4	3.4	19.0	0.5	6.3	3.9	0.4	0.6	0.7	2.9	0.7	0.2	1.0	1.3	2.2	1.8	1.8	7.3	1.3	1.0	2.3	1.6	8.8	6.2	0.3	1.2	0.2	0.6	6.4	7.4	0.8	0.0	0.7	1.2	0.3	3.4	1.3	3.0	0.4	6.9	14.2	0.9	103.0	5.5	0.3	0.7	3.2	0.2	0.9	0.5	6.1	0.0	1.0	0.0	0.8	0.1	0.1	0.0	0.2	0.2	0.0	0.1	1.5	0.0	5.7	3.2	0.0	2.1	0.0	0.9	0.3	0.1	4.1	0.1	0.7	0.7	0.2	0.0	0.0	0.6	0.2	0.0	0.3	0.0	0.4	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.2	0.7	1.2	2.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	5.4	0.1	0.1	2.2	0.3	1.7	1.1	0.0	0.1	0.2	0.3	1.5	2.0	0.1	0.2	0.6	171.1	0.4	1.5	0.3	0.1	0.1	0.2	0.4	0.0	0.0	0.2	426.7	0.5	1.8	0.0	0.1	1.1	1.5	3.4	6.3	3.9	1.8	7.3	8.8	6.2	7.4	6.9	5.5	6.1	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.2	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	10.1	0.3	0.0	0.0	0.0	205.8	0.0	0.0	1.4	0.0	8.6	0.7	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.4	0.0	2.6	0.0	1.4	0.0	0.0	0.3	0.0	1499.6	7.8	0.6	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	11.2	4.5	0.0	0.0	237.6	0.1	0.0	0.1	0.1
PIAS1	"DDXBP1, GBP, GU/RH-II, ZMIZ3"	ENSG00000033800	"Protein inhibitor of activated STAT 1"	O75925	15	68054309-68198603	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 248.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005743, CAB012304"	Supported		Approved	Microtubules		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Microtubules		"CAB012304: AB_777265, HPA005743: "	"unprognostic (1.36e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.10e-3)"	"unprognostic (6.93e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.28e-2)"	10.2	10.2	5.6	14.1	7.0	23.2	11.7	11.9	9.4	15.3	5.7	12.0	12.0	14.7	13.9	15.1	14.0	12.7	11.5	7.6	8.3	10.8	9.7	14.9	18.2	4.8	4.9	22.7	11.3	12.5	6.5	12.9	4.9	15.5	11.1	21.3	10.4	17.7	12.4	12.6	12.3	13.6	4.7	15.3	12.7	20.6	6.9	24.9	18.8	16.3	17.6	14.1	10.8	7.0	13.1	17.6	27.9	13.6	16.4	16.8	8.4	19.6	19.8	21.1	23.6	14.7	19.2	24.6	13.1	16.5	13.5	35.5	41.5	10.7	22.7	14.2	15.5	29.6	17.3	16.3	10.7	29.0	23.0	15.2	30.5	13.7	12.4	16.2	15.1	14.1	20.7	18.3	16.3	10.7	24.1	15.0	15.8	14.4	9.9	21.2	26.8	24.1	13.8	16.4	23.3	9.8	13.1	12.1	13.4	25.4	10.7	26.9	13.5	18.3	19.3	10.6	14.6	13.6	19.2	26.2	11.4	30.2	13.7	33.8	31.4	41.9	18.7	23.9	19.3	20.8	18.7	19.8	30.7	19.5	22.3	19.6	70.8	19.2	25.7	16.7	21.5	27.3	5.6	7.0	11.9	9.4	7.6	8.3	4.8	4.9	4.9	4.7	6.9	7.0	38.7	109.0	58.4	106.7	91.5	38.0	58.2	29.4	132.1	72.2	30.3	25.1	28.3	45.8	35.9	12.9	106.3	35.5	61.3	35.2	21.5	32.5	67.1	23.5	48.2	42.0	27.6	41.0	165.7	22.6	20.4	37.5	43.8	27.2	56.3	30.6	40.0	34.9	45.8	48.8	136.6	30.2	14.2	102.4	38.8	33.4	123.6	62.6	21.4	248.3	104.9	57.8	56.7	120.1	126.2	25.5	25.0	113.6	59.3	48.3	38.1	20.0	25.0	64.8	32.9	47.7	31.6	66.7	45.4	51.1	33.0	36.0	67.6	22.6	22.4	64.5
PLCG2		ENSG00000197943	"Phospholipase C gamma 2"	P16885	16	81739097-81962685	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 706.3;choroid plexus: 347.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 187.0;Bipolar cells: 224.8;Muller glia cells: 221.7;Rod photoreceptor cells: 196.2"	"Cancer enhanced"	"Detected in all"		"renal cancer: 9.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 183.3;HMC-1: 84.2;REH: 75.1;U-698: 403.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004280, HPA020099, HPA020100"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		8200	"Cluster 5: Granulocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Vesicles, Cytosol"	Nucleoplasm	"CAB004280: AB_628120, HPA020099: AB_1855324, HPA020100: AB_1855325"	"unprognostic (2.86e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (6.71e-4)"	"unprognostic (6.23e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.58e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.71e-2)"	"prognostic favorable (4.88e-4)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.40e-3)"	9.0	4.2	69.4	33.0	141.3	30.3	8.5	706.3	105.2	5.0	347.5	8.6	17.3	8.6	22.5	4.6	5.5	13.4	4.3	40.1	122.6	23.4	14.3	9.4	66.8	301.3	122.7	1.6	3.9	2.8	1.2	8.2	207.3	2.8	7.0	0.5	7.1	3.4	1.9	4.0	19.4	8.8	241.5	34.8	8.7	2.0	283.3	10.0	6.9	3.6	72.0	10.1	3.9	437.2	1.4	3.2	0.6	2.9	0.2	0.2	4.0	0.3	0.4	2.3	0.8	0.9	8.1	183.3	30.1	0.2	7.4	4.2	4.0	0.5	1.4	1.4	2.1	22.1	0.4	0.3	1.2	22.3	84.2	0.3	1.8	1.3	1.0	0.3	4.2	8.1	2.5	15.0	0.4	5.7	2.6	55.5	3.1	2.3	1.3	75.1	0.1	23.7	0.5	3.9	1.4	0.4	5.0	1.6	1.5	3.9	3.3	67.7	1.1	0.4	3.2	0.4	0.6	35.2	61.4	403.4	0.3	30.0	1.6	9.4	12.1	76.2	1.9	16.1	0.9	51.1	0.6	2.9	10.7	49.6	0.8	1.9	65.7	41.3	36.8	7.0	0.5	6.9	69.4	141.3	706.3	105.2	40.1	122.6	301.3	122.7	207.3	241.5	283.3	437.2	187.0	12.8	54.0	0.0	138.3	2.9	1.6	2.3	1.8	224.8	139.5	113.0	7.2	28.6	13.1	16.5	104.3	13.6	94.0	0.4	13.7	2.6	20.5	65.5	88.0	61.7	21.5	23.2	0.7	0.0	2.2	30.6	16.8	86.6	40.4	29.0	37.1	43.2	27.7	101.0	0.8	2.7	65.1	47.4	9.4	30.7	11.1	46.7	8.8	95.5	21.8	221.7	47.4	2.0	1.3	0.1	9.8	4.9	138.6	3.5	5.5	5.9	6.9	196.2	6.6	28.0	51.9	4.8	2.9	3.0	2.3	11.1	48.2	8.7	1.9	6.5
PLEKHG3	"ARHGEF43, KIAA0599"	ENSG00000126822	"Pleckstrin homology and RhoGEF domain containing G3"	A1L390	14	64704102-64750249	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 179.2"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 90.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 24.0;NK-cells: 9.4;T-cells: 16.2"	"Cell line enhanced"	"Detected in many"		"A-431: 78.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063455, HPA065323, HPA073702, HPA074734"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Centrosome,Cytosol"		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"	"Nucleoplasm, Cytokinetic bridge, Centrosome"	"HPA063455: AB_2685015, HPA065323: AB_2685467, HPA073702: AB_2732238, HPA074734: AB_2732265"	"unprognostic (8.71e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.22e-2)"	"unprognostic (7.21e-2)"	"unprognostic (5.53e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.34e-3)"	"unprognostic (3.63e-1)"	"unprognostic (3.54e-2)"	"prognostic favorable (7.39e-8)"	"unprognostic (2.29e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.67e-3)"	25.2	3.5	44.0	10.7	92.5	16.3	23.4	47.2	74.1	33.9	53.0	39.0	13.0	67.5	5.0	45.8	38.1	22.6	17.2	44.5	46.7	36.0	36.3	14.3	5.6	65.8	66.3	33.8	33.0	17.0	6.8	29.3	60.9	24.2	15.5	2.9	29.2	37.5	9.7	44.9	13.2	26.4	37.9	26.6	22.3	5.7	74.1	4.6	23.7	7.4	4.9	32.2	39.1	179.2	78.4	36.5	29.8	45.3	3.1	0.0	49.0	8.7	10.4	13.8	11.0	38.9	34.3	0.0	15.3	8.6	4.8	74.6	20.3	69.7	4.7	0.2	16.7	35.1	48.3	9.2	4.0	1.3	16.1	3.9	39.6	2.9	24.4	22.9	9.1	0.3	0.0	0.4	4.6	37.5	0.1	32.0	10.0	21.2	37.0	0.4	14.7	5.5	37.0	58.0	9.9	18.0	17.7	26.7	25.1	27.5	29.0	8.0	16.6	6.0	59.8	0.3	12.3	0.1	0.2	0.1	0.6	3.7	10.7	9.0	3.0	18.2	16.2	1.5	11.1	0.0	5.0	7.3	1.0	0.0	0.5	3.6	24.0	9.4	1.0	0.0	1.7	5.3	44.0	92.5	47.2	74.1	44.5	46.7	65.8	66.3	60.9	37.9	74.1	179.2	3.1	3.2	6.2	15.0	0.7	19.4	19.4	15.1	21.6	5.5	16.0	9.8	7.8	12.8	6.0	47.8	0.0	7.9	14.5	24.7	11.7	26.7	0.9	18.6	18.5	4.0	34.7	0.4	1.0	20.6	9.5	7.4	14.3	23.6	1.3	1.9	3.6	10.1	5.5	0.0	3.2	26.9	18.3	6.5	8.0	1.5	7.5	2.7	5.4	6.5	4.6	9.1	45.3	10.6	90.9	35.3	16.7	25.6	2.8	16.1	2.3	9.5	4.0	0.8	26.3	5.1	25.3	0.2	1.6	25.6	21.5	2.6	9.0	10.5	13.2	32.2
POR	"CYPOR, FLJ26468"	ENSG00000127948	"Cytochrome p450 oxidoreductase"	P16435	7	75899200-75986855	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Congenital adrenal hyperplasia, Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 313.3"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 489.2;Proximal enterocytes: 274.2;Theca cells: 647.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 328.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004372, HPA010136"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		12000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Vesicles"	Cytosol	"CAB004372: AB_627391, HPA010136: AB_1079657"	"unprognostic (1.89e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.81e-3)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (8.54e-4)"	"unprognostic (1.65e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.94e-2)"	"unprognostic (9.89e-2)"	53.4	197.4	19.9	32.1	20.7	17.9	44.7	14.1	18.6	42.0	15.5	35.9	105.2	32.1	29.4	53.6	50.2	37.0	43.3	20.7	30.2	38.1	313.3	55.0	19.9	22.2	24.5	52.2	44.5	77.6	71.4	46.3	20.9	31.8	21.9	12.7	29.9	113.1	56.2	43.8	92.4	28.2	16.9	43.8	41.5	25.5	34.7	38.0	131.3	68.1	23.2	36.6	42.3	15.3	59.6	133.0	57.0	106.3	212.9	79.8	98.0	24.4	79.3	44.7	62.3	100.7	257.0	56.1	21.9	53.1	151.8	28.3	76.0	38.4	19.6	48.1	57.9	26.0	36.9	189.4	146.5	26.2	45.5	163.9	47.4	59.2	43.2	36.3	42.3	27.1	79.1	24.0	40.8	90.9	29.0	49.4	71.7	92.9	74.8	41.0	37.6	61.1	50.0	72.8	59.3	57.4	65.4	328.4	91.0	32.6	94.0	44.2	38.6	41.7	45.8	63.6	48.7	23.8	38.3	39.0	59.3	39.8	54.9	65.9	42.6	60.4	20.6	39.6	17.1	11.0	17.5	19.4	45.6	11.2	17.1	14.7	53.8	25.9	30.2	12.5	19.3	36.6	19.9	20.7	14.1	18.6	20.7	30.2	22.2	24.5	20.9	16.9	34.7	15.3	34.3	38.5	39.7	23.2	17.1	17.1	29.4	172.3	13.1	31.4	20.5	14.0	10.9	54.3	201.4	73.5	12.5	99.9	26.0	97.7	1.9	65.0	27.6	62.1	28.0	27.1	19.8	11.8	10.1	29.4	95.0	40.1	67.8	46.6	24.7	121.4	32.2	489.2	67.8	15.2	17.1	41.7	124.1	35.2	16.1	9.5	75.8	47.3	12.4	11.2	20.5	25.9	12.3	11.6	8.8	27.9	102.0	112.5	17.0	20.7	274.2	31.7	178.6	23.0	65.7	32.7	46.9	21.3	30.8	18.2	14.6	193.2	25.4	647.6	44.5	45.9
PPIG	"CARS-Cyp, SCAF10, SRCyp"	ENSG00000138398	"Peptidylprolyl isomerase G"	Q13427	2	169584342-169641406	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021788, HPA057469"	Supported		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"	Cytosol	"HPA021788: AB_1847408, HPA057469: AB_2683445"	"unprognostic (2.70e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.04e-3)"	"unprognostic (4.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.55e-3)"	"unprognostic (3.66e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.15e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (5.23e-2)"	"unprognostic (3.29e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.39e-2)"	26.0	23.2	23.1	28.4	22.1	54.2	27.5	28.8	58.6	27.6	22.9	26.3	26.6	28.8	31.5	27.5	23.6	22.0	25.6	21.5	29.9	29.2	47.1	24.7	36.9	24.6	25.6	26.5	21.2	32.6	25.8	28.0	24.3	27.9	26.0	29.3	26.5	22.9	27.6	25.4	29.7	21.7	22.9	32.3	27.4	20.1	23.7	36.1	29.9	26.2	35.4	26.3	26.5	25.9	56.4	25.5	70.8	35.9	35.4	42.5	63.7	58.9	42.3	45.0	45.9	66.3	58.9	94.8	52.5	44.1	55.5	50.5	56.6	48.4	65.6	68.0	45.7	129.9	36.7	88.3	34.4	136.8	58.9	36.6	54.0	58.5	64.6	40.6	50.4	53.5	142.7	76.2	49.5	43.5	101.0	81.9	100.8	45.3	25.1	90.7	71.7	90.5	53.9	81.2	60.5	41.2	63.4	47.2	68.9	52.9	44.2	78.7	52.7	53.9	43.7	38.4	52.6	41.1	65.3	126.8	38.5	68.1	54.1	31.9	22.5	36.7	22.8	25.1	26.7	32.9	30.9	29.2	18.2	38.4	33.4	27.6	40.4	21.1	31.4	30.0	26.8	17.0	23.1	22.1	28.8	58.6	21.5	29.9	24.6	25.6	24.3	22.9	23.7	25.9	159.7	221.2	175.1	53.5	188.8	151.4	191.4	185.9	101.3	204.6	120.8	156.1	148.4	107.2	169.5	93.8	54.2	170.0	160.1	91.6	80.3	103.1	11.0	104.6	142.3	141.1	104.8	163.5	82.4	103.3	177.0	142.4	66.8	126.3	179.1	115.8	121.7	181.2	151.7	220.4	81.8	135.8	116.0	130.3	126.5	15.6	142.0	129.6	110.3	46.9	152.4	137.6	133.9	53.8	69.7	93.9	118.0	146.7	130.1	161.8	121.1	113.8	132.2	109.1	164.3	150.2	193.9	276.4	183.8	108.3	172.8	205.5	166.7	147.1	149.9	167.7
PPP1R2	"IPP2, PPP1R2A"	ENSG00000184203	"Protein phosphatase 1 regulatory inhibitor subunit 2"	P41236	3	195514428-195543386	"Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 431.9;Spermatocytes: 354.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 142.1;U-266/70: 224.2"	"Low region specificity"	"Detected in all"							"HPA043729, HPA059420"			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA043729: AB_2678639, HPA059420: AB_2684009"	"unprognostic (1.85e-2)"	"unprognostic (3.71e-3)"	"unprognostic (6.26e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.92e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.73e-2)"	"unprognostic (8.32e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.74e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.13e-1)"	18.3	15.0	15.4	21.3	16.2	68.1	22.6	12.9	16.9	18.0	16.5	22.8	25.8	21.2	25.2	22.4	18.3	19.7	24.7	16.6	21.0	21.0	15.0	17.4	29.1	15.1	15.4	13.9	13.5	16.8	15.6	17.5	17.2	20.9	19.8	16.0	16.9	19.1	85.8	17.2	22.3	21.6	14.3	21.5	17.7	29.2	15.2	28.2	23.1	56.2	25.2	21.1	18.2	15.0	43.8	9.8	14.7	17.0	24.1	25.8	29.1	25.8	36.6	26.4	22.6	142.1	18.0	17.3	99.2	31.1	27.8	18.1	15.1	25.6	32.1	33.0	30.3	18.6	14.0	47.5	37.2	20.5	18.8	31.4	19.4	19.7	39.6	20.8	23.0	17.1	14.7	33.4	23.4	32.3	34.4	22.9	15.6	49.2	42.1	16.6	25.6	50.4	31.8	32.1	34.9	20.0	31.6	33.1	46.5	27.0	52.5	19.9	27.9	16.9	19.3	28.8	36.7	224.2	105.7	79.5	23.9	37.0	33.3	120.6	64.7	257.5	71.8	68.2	98.2	100.3	149.3	99.1	68.8	95.8	178.6	122.8	152.3	94.2	69.0	103.5	168.4	129.2	15.4	16.2	12.9	16.9	16.6	21.0	15.1	15.4	17.2	14.3	15.2	15.0	106.9	22.4	47.8	13.1	165.7	94.2	138.6	70.1	89.4	51.5	80.6	61.5	53.5	38.6	56.3	22.0	58.4	67.7	148.2	48.6	125.2	69.5	431.9	119.5	65.0	99.6	57.4	33.6	30.8	66.3	43.0	62.5	45.3	67.9	111.0	26.7	51.0	27.1	61.0	52.2	41.7	48.5	69.2	73.3	170.6	243.8	51.6	103.4	97.8	25.3	120.9	50.5	74.2	23.1	19.1	74.5	65.1	63.6	188.4	123.0	77.3	106.0	80.3	91.1	26.3	48.7	71.1	354.3	92.4	88.2	77.6	103.2	230.1	58.0	54.7	186.2
PRKD2	"DKFZP586E0820, HSPC187, PKD2"	ENSG00000105287	"Protein kinase D2"	Q9BZL6	19	46674275-46717127	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Cell adhesion, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-266/84: 149.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021490, HPA056727"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA021490: AB_1855708, HPA056727: AB_2683217"	"unprognostic (3.01e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.06e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.79e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.21e-3)"	"unprognostic (8.89e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.04e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.34e-2)"	"prognostic favorable (9.15e-4)"	29.0	11.5	7.2	23.6	7.3	29.4	29.3	5.4	7.7	26.6	12.5	20.3	17.1	21.8	4.7	27.5	24.1	11.2	13.8	6.1	6.0	19.2	13.8	34.3	31.1	10.0	6.3	21.8	19.1	8.3	24.0	11.1	6.8	23.9	7.1	4.4	24.7	10.0	8.0	46.8	29.9	6.0	6.0	54.3	20.3	6.6	7.7	25.6	28.9	4.8	21.2	19.5	26.9	6.6	19.6	34.5	12.8	16.6	7.3	6.4	15.1	11.5	13.2	19.6	19.7	19.7	21.0	22.3	16.3	13.2	13.2	27.5	9.5	26.0	5.9	19.8	17.5	25.9	11.5	10.2	12.8	21.2	34.7	11.0	15.8	12.7	9.8	12.8	30.1	21.5	14.6	35.4	7.0	23.8	32.7	53.1	9.7	27.4	17.4	25.8	5.8	37.5	11.4	32.7	7.7	22.4	18.8	18.8	4.6	10.6	11.6	7.5	17.6	8.7	18.8	7.1	10.0	31.8	149.1	13.5	8.5	17.7	11.0	0.6	0.7	2.6	3.9	0.7	3.3	4.3	3.9	4.3	0.3	4.1	3.3	3.3	5.3	2.2	0.5	0.0	2.9	1.5	7.2	7.3	5.4	7.7	6.1	6.0	10.0	6.3	6.8	6.0	7.7	6.6	37.8	9.6	9.9	5.9	46.5	22.0	32.0	13.2	22.8	6.4	13.9	11.3	17.2	12.8	13.0	9.2	0.0	13.8	17.5	43.6	7.9	18.6	1.2	15.3	6.7	37.2	21.6	4.0	6.5	28.2	13.8	9.6	23.4	15.0	14.5	14.1	37.1	8.5	9.0	1.7	2.8	21.7	4.1	12.3	11.4	3.1	11.8	8.3	12.4	11.2	9.3	6.5	42.2	4.0	3.1	29.5	35.1	6.8	47.0	22.9	34.1	9.3	15.6	4.4	13.1	6.1	7.6	2.9	17.9	21.2	26.7	29.7	31.9	6.6	15.3	30.2
PRKRIP1	"C114, FLJ13902, KRBOX3"	ENSG00000128563	"PRKR interacting protein 1"	Q9H875	7	102363872-102426676	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051146	Uncertain		Supported	"Actin filaments,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Actin filaments"	Cytosol	"HPA051146: AB_2681361"	"unprognostic (4.78e-3)"	"unprognostic (7.23e-3)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (8.25e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.15e-2)"	"unprognostic (1.99e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.61e-3)"	"unprognostic (9.79e-3)"	"prognostic unfavorable (4.39e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.88e-1)"	"prognostic favorable (1.94e-4)"	12.6	16.2	15.1	7.2	15.2	16.5	12.8	18.4	17.9	15.4	14.3	14.1	8.6	13.7	3.5	11.7	14.2	5.7	10.1	15.1	17.0	16.1	12.1	9.7	12.5	16.0	15.4	14.7	11.6	11.6	15.4	7.0	15.5	15.5	3.7	4.2	12.1	6.8	12.2	18.6	12.4	5.0	14.8	18.3	13.5	19.0	15.4	12.1	14.5	7.4	7.7	13.6	13.1	16.0	17.0	12.4	11.8	17.3	5.4	7.7	17.6	13.1	9.0	21.1	17.8	20.3	14.7	17.6	20.3	11.2	15.0	19.2	9.0	12.9	10.7	20.1	19.1	7.3	12.3	11.9	13.3	10.3	10.3	5.5	12.4	16.2	10.9	11.3	10.7	19.9	21.1	26.3	13.1	33.7	34.4	46.7	18.3	15.1	14.7	24.8	11.5	27.5	11.3	7.2	13.5	25.9	19.5	29.2	20.1	11.8	15.1	20.0	12.7	21.6	26.0	23.3	20.5	36.0	26.7	31.6	18.3	18.4	29.4	3.8	10.1	18.3	11.5	10.0	10.7	14.0	11.5	12.9	7.8	13.0	14.2	12.4	20.7	12.9	13.6	14.1	9.6	10.0	15.1	15.2	18.4	17.9	15.1	17.0	16.0	15.4	15.5	14.8	15.4	16.0	23.4	32.1	21.8	0.0	31.4	13.4	19.0	14.8	20.5	23.1	21.1	19.3	23.8	14.3	23.0	16.5	31.3	27.5	31.7	13.7	31.3	24.8	77.8	29.6	26.0	21.4	16.3	21.8	0.0	25.1	26.7	21.3	16.3	32.0	22.8	27.1	15.0	14.1	27.6	23.5	0.0	13.8	8.2	13.8	16.9	92.5	17.1	19.2	12.4	0.0	22.1	25.3	20.6	0.0	0.0	29.5	9.8	16.6	28.6	22.4	14.6	26.6	27.1	21.5	32.9	29.2	27.0	88.4	47.6	20.8	17.6	41.9	30.4	24.2	12.0	19.4
PRUNE1	"DRES-17, H-PRUNE, HTCD37, PRUNE"	ENSG00000143363	"Prune exopolyphosphatase 1"	Q86TP1	1	151008420-151035713	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Mental retardation, Neurodegeneration, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 13.0;Breast glandular cells: 9.8;Breast myoepithelial cells: 8.9;Collecting duct cells: 11.0;Granulosa cells: 8.9;Proximal tubular cells: 8.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 169.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028411	Uncertain		Supported	Cytosol		NA	NA		41000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA028411: AB_10603229"	"unprognostic (6.24e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (6.91e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.12e-3)"	"unprognostic (7.05e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (3.48e-4)"	"unprognostic (2.18e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.36e-1)"	10.1	9.5	12.2	7.7	12.1	4.4	14.9	16.1	15.1	15.0	12.4	14.8	12.5	14.8	15.6	12.4	16.0	9.2	33.4	12.4	12.6	18.8	14.3	10.8	10.8	12.0	12.5	17.2	10.7	20.9	12.6	7.1	11.9	12.2	14.5	10.8	13.2	14.4	29.4	11.5	12.0	14.1	11.9	11.2	11.2	18.3	12.8	16.2	32.5	21.4	12.6	13.7	11.9	13.5	11.0	11.6	20.2	19.3	24.3	6.6	10.9	5.1	11.2	18.7	16.4	14.1	13.0	22.2	21.7	6.9	5.5	15.5	19.9	13.4	14.6	24.5	22.6	26.6	11.8	20.4	13.5	17.5	13.0	8.4	24.7	10.2	9.5	15.4	9.2	29.4	21.1	18.3	8.9	26.2	27.2	14.1	18.7	39.7	15.0	24.2	12.8	21.5	13.4	14.9	28.7	23.5	17.5	23.5	16.1	28.3	32.6	25.7	6.3	6.6	7.8	7.5	8.1	44.1	40.0	169.1	6.5	13.0	16.9	19.1	8.1	17.8	16.4	7.8	19.8	14.4	18.1	18.6	11.9	15.4	21.7	17.5	18.6	18.8	12.2	6.4	18.5	22.3	12.2	12.1	16.1	15.1	12.4	12.6	12.0	12.5	11.9	11.9	12.8	13.5	4.5	6.4	13.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	9.8	8.9	0.0	0.0	3.1	11.0	0.0	4.1	3.2	0.0	0.0	6.0	0.0	4.3	7.8	2.1	0.0	0.0	0.0	5.7	4.8	2.5	0.0	6.4	0.0	8.9	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	5.6	0.0	0.0	1.0	0.0	0.0	8.9	2.9	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	5.1	2.8	4.8	0.0	0.0
PTAR1		ENSG00000188647	"Protein prenyltransferase alpha subunit repeat containing 1"	Q7Z6K3	9	69709522-69760011	"Predicted intracellular proteins"		"Prenyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021248	Uncertain		Approved	"Centriolar satellite,Rods & Rings"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Centriolar satellite"	"Rods & Rings"	"HPA021248: AB_1855872"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.47e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.16e-1)"	"unprognostic (6.99e-2)"	"prognostic favorable (4.65e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.79e-1)"	9.7	6.6	11.8	9.7	9.8	33.8	12.8	9.5	10.9	10.9	11.3	10.6	6.9	11.2	7.4	8.3	9.7	8.0	8.9	10.3	8.6	14.1	13.3	11.3	11.6	12.5	12.0	12.6	11.0	15.4	6.7	9.8	9.2	7.2	12.8	21.4	10.4	5.7	14.4	10.0	10.6	8.4	8.5	11.3	7.6	9.6	16.1	20.1	10.0	11.7	8.9	9.2	10.8	13.5	11.8	11.9	18.7	9.1	16.4	21.2	10.4	27.2	17.5	8.1	8.9	3.8	7.7	12.2	12.5	20.9	8.1	18.0	39.4	10.2	19.3	11.1	10.7	18.8	24.3	10.8	18.0	16.7	16.2	14.1	9.4	14.4	22.7	16.9	14.6	19.9	11.7	24.7	23.3	3.2	14.5	6.5	24.9	12.2	9.9	13.1	29.6	9.2	23.4	10.3	13.7	17.2	16.6	8.0	15.5	17.4	5.5	8.3	27.3	22.3	20.4	18.5	22.3	17.2	18.2	7.4	15.0	16.1	41.6	5.6	2.3	4.2	2.8	3.3	2.6	1.9	2.5	2.2	2.0	1.6	2.8	2.9	7.3	2.9	2.0	1.1	4.3	1.4	11.8	9.8	9.5	10.9	10.3	8.6	12.5	12.0	9.2	8.5	16.1	13.5	26.0	35.3	21.6	104.8	26.3	16.7	19.4	17.7	21.6	29.1	21.1	18.5	19.1	40.0	17.9	33.1	81.3	20.1	28.5	29.2	15.6	13.3	19.2	17.0	24.8	24.5	11.4	23.8	21.7	7.7	14.6	21.6	12.2	16.8	17.7	28.7	20.0	32.6	12.7	33.7	33.0	28.6	36.7	31.1	18.3	22.1	31.1	22.9	32.0	51.5	28.6	31.8	26.8	82.0	62.2	12.5	21.3	23.0	22.1	23.2	14.7	41.4	18.8	56.2	26.3	26.1	21.1	57.0	10.3	19.5	15.3	9.6	26.0	21.6	22.2	25.5
PUM2	"KIAA0235, PUMH2"	ENSG00000055917	"Pumilio RNA binding family member 2"	Q8TB72	2	20248691-20352234	"Predicted intracellular proteins"	"Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030316, HPA049670"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA030316: AB_10610289, HPA049670: AB_2680845"	"unprognostic (2.41e-1)"	"unprognostic (8.77e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.49e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.87e-2)"	27.6	29.8	29.7	33.4	31.7	33.4	41.7	42.5	32.7	36.2	32.4	36.5	34.4	36.3	32.8	39.2	29.7	27.1	33.1	31.1	30.9	36.8	43.1	33.2	48.6	26.0	29.3	44.6	27.4	41.4	8.3	40.3	26.1	37.3	37.0	66.8	33.0	33.1	21.5	47.2	35.6	32.3	29.1	42.6	35.8	24.9	31.6	70.5	57.6	32.6	47.6	38.0	18.3	37.6	72.4	50.0	65.3	46.1	40.2	40.5	65.9	49.2	53.6	48.4	42.2	43.5	33.0	96.3	11.0	44.9	58.2	38.9	61.4	35.6	71.2	87.0	38.2	105.0	35.3	62.2	43.4	107.2	93.3	29.7	79.7	42.1	77.4	45.5	53.1	57.1	75.0	82.9	57.3	35.5	93.6	65.9	55.8	68.3	31.5	80.6	110.9	73.8	45.0	68.1	55.9	76.6	42.2	58.3	48.1	43.4	33.0	61.5	52.5	58.6	58.5	38.3	64.6	93.3	123.0	181.8	35.3	75.8	51.4	11.5	4.0	5.8	6.0	5.2	7.1	4.8	6.7	7.5	4.2	5.3	7.3	6.0	11.6	7.7	7.3	3.7	5.8	3.7	29.7	31.7	42.5	32.7	31.1	30.9	26.0	29.3	26.1	29.1	31.6	37.6	43.6	35.3	51.6	89.5	57.6	79.7	32.2	26.4	74.0	94.6	46.9	30.5	46.5	32.9	33.8	47.8	62.6	36.3	43.6	44.0	11.7	16.6	10.1	33.9	35.6	45.0	34.6	41.0	134.7	15.5	16.9	36.5	43.8	45.9	20.3	53.0	41.4	56.3	29.1	58.9	153.5	43.2	38.7	70.7	44.2	5.8	34.2	44.9	32.0	144.3	42.7	26.8	43.3	155.3	186.0	22.6	28.1	26.4	54.7	57.8	33.9	29.7	39.5	72.3	32.9	40.5	47.6	16.8	16.6	75.2	106.3	52.0	50.1	31.2	40.2	56.6
RAB1B		ENSG00000174903	"RAB1B, member RAS oncogene family"	Q9H0U4	11	66268590-66277492	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB010225, HPA056141"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	"Endoplasmic reticulum"	"CAB010225: AB_2284660, HPA056141: AB_2683051"	"unprognostic (6.07e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.09e-5)"	"unprognostic (2.41e-2)"	"unprognostic (9.45e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.85e-2)"	127.1	129.7	121.7	84.0	117.4	91.1	120.9	117.7	137.7	113.7	106.2	129.3	112.5	111.2	82.3	180.9	105.7	83.0	146.7	117.5	116.8	127.2	126.4	116.5	90.3	122.7	121.0	103.5	96.1	132.9	112.6	88.4	119.3	140.6	90.3	46.5	128.0	105.1	233.2	147.6	112.9	86.9	119.3	125.3	125.5	79.9	124.2	105.5	111.5	152.8	86.1	113.6	119.2	118.9	226.5	248.0	126.2	166.1	205.6	150.9	113.8	182.7	212.8	232.2	163.4	141.4	223.7	91.7	235.7	263.1	172.1	209.0	140.7	253.9	125.9	190.3	128.0	144.7	156.0	124.2	135.0	124.3	258.2	158.7	212.4	199.6	102.4	163.2	221.1	144.9	153.1	158.8	223.6	434.5	219.1	197.1	131.5	196.1	230.8	133.0	101.8	237.2	234.7	204.5	122.9	137.1	132.7	319.2	133.7	91.4	487.5	141.6	228.1	221.4	152.9	267.9	164.9	89.9	77.9	121.5	251.2	104.3	207.8	173.1	199.8	329.3	227.5	211.9	171.7	109.8	135.5	188.1	163.0	130.2	115.3	140.6	420.5	203.5	243.9	188.3	165.5	375.6	121.7	117.4	117.7	137.7	117.5	116.8	122.7	121.0	119.3	119.3	124.2	118.9	56.3	38.5	59.6	7.8	41.7	33.6	31.4	42.4	53.5	22.0	55.0	53.1	1.1	40.0	47.9	36.8	29.2	56.2	50.8	137.1	50.9	49.3	13.4	41.3	38.6	50.6	54.0	27.1	7.2	71.3	84.2	36.5	58.1	44.9	53.8	24.6	48.9	47.8	54.2	16.8	8.0	85.0	36.7	55.2	26.4	27.2	35.8	51.4	24.9	5.6	47.7	37.8	43.3	5.5	13.1	71.6	80.6	42.2	61.0	41.4	79.6	49.5	36.0	18.2	39.5	36.2	39.7	23.8	17.4	64.5	42.1	80.2	57.4	28.1	64.9	43.5
RAB5B		ENSG00000111540	"RAB5B, member RAS oncogene family"	P61020	12	55973913-55996683	"Predicted intracellular proteins, RAS pathway related proteins"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB010224, HPA068337"	Approved		Supported	Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles		"CAB010224: AB_2175453, HPA068337: AB_2685974"	"prognostic unfavorable (2.24e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.66e-3)"	"unprognostic (2.09e-1)"	"unprognostic (8.42e-2)"	"unprognostic (9.16e-3)"	"unprognostic (3.09e-1)"	"unprognostic (3.13e-1)"	"unprognostic (8.31e-3)"	"unprognostic (8.64e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.49e-1)"	50.9	54.4	95.4	39.4	102.3	35.0	68.2	106.2	96.8	76.8	76.5	72.2	52.4	73.8	92.4	99.8	75.7	55.8	87.2	93.1	99.5	70.1	68.8	72.9	44.5	103.5	105.6	85.4	47.9	112.1	31.4	63.4	106.0	74.6	80.6	72.9	61.7	94.6	100.6	92.4	50.4	79.9	103.6	48.1	67.0	57.1	99.9	64.0	64.6	127.6	76.0	65.6	69.6	112.9	62.3	39.1	80.2	59.4	128.5	115.9	72.1	56.1	102.3	68.3	57.5	67.5	76.7	34.7	65.5	107.6	50.3	44.8	51.4	77.8	63.3	44.1	39.5	39.3	53.1	38.6	94.5	33.2	61.6	94.9	142.7	64.2	54.2	153.0	87.0	42.2	36.2	99.3	87.3	42.3	42.6	51.9	35.8	51.5	35.2	36.5	49.9	45.1	128.2	100.7	40.0	35.6	73.1	72.4	89.0	88.3	104.6	102.5	72.3	44.5	32.5	32.8	22.2	56.4	46.9	21.8	71.5	30.7	38.4	18.5	10.1	32.6	11.1	9.3	10.3	8.9	9.0	9.9	8.0	6.9	10.2	8.0	27.4	7.6	10.6	8.0	7.6	8.9	95.4	102.3	106.2	96.8	93.1	99.5	103.5	105.6	106.0	103.6	99.9	112.9	24.4	57.7	37.1	13.1	26.7	51.7	26.5	34.0	35.3	33.3	54.4	38.2	53.2	55.8	34.0	42.3	52.1	44.0	29.1	88.1	35.2	49.4	11.1	24.1	22.8	30.8	38.9	29.8	21.4	37.1	42.8	33.1	37.2	33.9	19.7	34.1	42.1	86.0	31.1	16.8	23.4	51.1	16.2	46.4	52.3	27.7	53.4	25.4	35.6	11.2	64.7	41.6	32.0	11.1	26.3	71.3	44.4	59.5	27.1	57.0	44.7	35.9	23.9	31.6	59.2	31.9	33.2	36.8	25.6	64.7	89.2	88.0	25.0	23.4	42.7	65.8
RAC2	EN-7	ENSG00000128340	"Rac family small GTPase 2"	P15153	22	37225270-37244448	"Disease related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 411.9;lymphoid tissue: 387.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 329.0;dendritic cells: 381.4;granulocytes: 520.5;NK-cells: 717.9;Plasma cells: 287.8;T-cells: 419.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 522.5;HL-60: 734.5;HMC-1: 1427.9;Karpas-707: 684.5;U-87 MG: 618.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022946, HPA047820"	Enhanced					NA	Yes		3300000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB022946: , HPA047820: AB_2680167"	"prognostic favorable (1.03e-5)"	"unprognostic (2.91e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.82e-3)"	"unprognostic (6.74e-2)"	"unprognostic (7.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (5.00e-2)"	"unprognostic (8.52e-3)"	"unprognostic (2.65e-1)"	"unprognostic (7.65e-2)"	"unprognostic (3.81e-1)"	"prognostic unfavorable (1.06e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.50e-2)"	24.7	8.4	3.6	207.2	3.8	411.9	11.4	3.9	8.0	12.2	4.4	34.8	35.3	10.1	4.7	15.9	11.7	37.1	6.5	3.8	4.7	10.9	19.3	63.4	387.9	6.5	5.3	5.5	5.3	2.1	3.4	12.4	7.1	10.9	33.9	0.4	21.5	8.3	4.9	7.6	96.9	19.6	5.2	299.9	42.7	3.5	6.1	323.9	9.5	7.2	309.1	54.0	9.9	7.2	136.6	0.2	0.0	0.0	14.3	130.5	0.6	17.9	41.1	14.2	28.8	0.3	44.8	167.4	19.8	52.9	0.8	33.3	1.0	231.6	15.6	522.5	0.6	209.6	3.6	0.6	35.8	734.5	1427.9	96.4	32.3	25.1	84.3	0.9	239.7	159.1	50.5	684.5	1.9	0.2	218.9	291.2	2.8	13.1	87.2	72.3	0.7	193.8	22.6	0.1	2.0	0.6	0.9	23.0	2.7	0.8	9.7	391.8	258.7	0.6	23.5	1.0	2.0	307.0	171.4	176.6	618.6	316.5	35.1	1319.9	519.8	1602.2	972.1	695.5	731.5	761.7	768.6	858.9	494.0	672.8	584.3	759.8	1336.4	972.2	879.5	728.7	1163.4	1566.2	3.6	3.8	3.9	8.0	3.8	4.7	6.5	5.3	7.1	5.2	6.1	7.2	4.4	16.0	47.7	0.0	329.0	5.4	2.2	26.0	16.5	0.0	8.6	9.5	1.1	2.8	12.6	1.8	0.0	0.8	381.4	3.4	0.0	13.6	0.2	1.1	0.8	5.6	4.2	109.7	0.4	2.2	1.5	9.2	33.6	1.0	520.5	0.3	13.6	3.4	150.8	0.0	0.1	6.3	0.0	129.9	63.9	0.9	0.3	147.9	30.2	3.7	125.9	0.0	717.9	0.5	0.0	18.2	18.1	0.0	287.8	0.5	0.6	1.5	4.4	0.0	13.1	2.4	4.5	0.0	1.0	5.1	4.0	2.9	419.6	3.7	11.2	3.6
RASGEF1A	"CG4853, FLJ37817"	ENSG00000198915	"RasGEF domain family member 1A"	Q8N9B8	10	43194535-43267065	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.6;brain: 19.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 22.1;Inhibitory neurons: 16.3;NK-cells: 8.2;Spermatogonia: 7.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"K-562: 17.2;SCLC-21H: 15.6;SK-BR-3: 14.1;T-47d: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035593	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus"		"HPA035593: AB_10602083"	"prognostic favorable (1.86e-5)"	"unprognostic (1.85e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (4.28e-4)"	"unprognostic (1.86e-1)"	"unprognostic (3.92e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.73e-2)"	"unprognostic (8.53e-2)"	"unprognostic (9.00e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (4.11e-7)"	"unprognostic (2.88e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.83e-2)"	0.8	1.6	18.8	1.3	17.0	14.6	3.3	11.6	19.3	1.7	5.2	0.8	0.9	1.2	0.4	1.1	2.5	2.3	1.5	19.2	14.6	2.6	0.4	1.6	5.3	15.0	15.2	1.2	3.7	4.3	4.4	0.7	13.6	1.4	0.4	1.3	3.4	1.7	0.8	0.8	1.3	1.2	13.1	3.8	0.7	2.3	18.4	1.0	0.8	0.7	3.7	1.2	2.6	17.0	9.7	8.2	0.0	0.1	0.0	0.2	4.8	0.1	0.0	0.0	0.0	0.2	5.2	8.4	8.6	0.8	0.0	0.1	1.3	7.7	0.0	0.0	6.3	0.0	0.1	0.4	3.7	0.0	3.0	2.0	8.7	0.7	0.0	0.0	0.0	0.4	17.2	0.0	0.0	1.9	0.0	0.2	0.8	4.3	0.0	0.0	0.0	0.2	0.6	4.5	15.6	0.0	0.0	14.1	0.1	7.1	15.6	0.1	0.1	0.0	3.5	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	6.1	2.9	0.5	1.1	0.2	0.7	2.2	2.9	2.6	0.2	1.4	9.4	6.3	0.4	5.1	0.0	1.2	18.8	17.0	11.6	19.3	19.2	14.6	15.0	15.2	13.6	13.1	18.4	17.0	0.2	0.0	0.0	3.6	1.1	0.5	0.3	2.4	0.6	2.0	4.3	4.1	2.2	0.0	0.2	3.7	0.0	0.4	6.7	0.2	0.0	0.3	1.3	1.8	0.5	1.0	0.0	0.0	22.1	1.3	1.1	1.0	0.5	2.3	0.0	1.9	1.1	0.1	0.9	1.7	16.3	0.3	0.0	0.9	1.7	0.7	0.0	1.4	0.0	1.0	1.4	0.3	8.2	1.5	1.0	2.1	0.1	0.0	0.7	1.2	0.2	0.6	0.6	0.3	0.0	0.9	0.4	0.7	7.7	0.5	0.3	0.3	5.0	0.5	0.6	0.1
RASSF5	"Maxp1, NORE1, RAPL"	ENSG00000266094	"Ras association domain family member 5"	Q8WWW0	1	206507531-206589448	"Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 109.3;lymphoid tissue: 83.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 119.3;granulocytes: 140.0;Langerhans cells: 147.7;Macrophages: 78.0;NK-cells: 118.4;T-cells: 97.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 90.9;Karpas-707: 192.6;MOLT-4: 84.1;RPMI-8226: 218.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070480	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA070480: AB_2686271"	"unprognostic (1.92e-3)"	"prognostic favorable (1.46e-4)"	"unprognostic (1.37e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.93e-1)"	"unprognostic (5.17e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.84e-2)"	"unprognostic (9.39e-2)"	"prognostic unfavorable (1.22e-6)"	"unprognostic (3.29e-1)"	"unprognostic (5.58e-2)"	"unprognostic (4.28e-2)"	"unprognostic (6.28e-3)"	6.8	15.1	3.4	48.1	2.9	109.3	4.9	1.2	3.6	10.8	0.4	8.9	9.1	3.9	1.8	41.7	10.2	18.2	10.8	3.2	2.9	4.3	14.0	26.4	63.4	4.1	4.4	3.6	10.8	8.4	10.3	5.3	4.1	8.1	9.3	1.0	30.3	7.2	14.8	28.8	17.7	6.7	2.3	56.2	17.3	1.4	5.5	83.1	5.7	3.7	60.0	30.3	20.7	4.6	9.3	4.2	0.1	1.6	3.2	1.8	0.0	0.6	4.9	1.7	2.3	0.4	19.5	32.4	2.5	2.1	0.3	13.5	3.5	2.2	1.5	22.4	12.7	35.2	1.0	0.2	1.2	59.1	90.9	2.2	8.9	2.0	2.4	3.2	0.3	76.0	14.4	192.6	0.9	1.1	84.1	37.8	1.8	0.1	3.6	39.4	4.6	218.8	0.1	14.7	4.7	0.3	15.6	1.7	0.6	0.1	3.7	37.5	0.1	0.4	6.4	8.0	2.1	67.7	52.8	30.2	3.0	34.1	1.0	211.8	40.3	268.7	112.3	53.7	99.7	28.4	82.6	117.0	43.9	26.6	112.1	105.8	157.2	131.2	84.0	34.2	78.2	154.7	3.4	2.9	1.2	3.6	3.2	2.9	4.1	4.4	4.1	2.3	5.5	4.6	2.1	38.5	27.9	1.6	64.0	32.8	16.6	8.6	27.9	1.8	7.4	4.4	7.7	15.7	11.3	0.0	0.0	0.2	119.3	1.0	3.9	8.1	0.3	0.5	0.5	4.4	2.4	16.4	19.4	8.9	0.1	11.6	9.2	0.6	140.0	0.1	5.7	6.2	12.1	8.4	16.8	1.0	10.2	49.0	147.7	0.1	7.5	78.0	14.2	6.5	54.2	0.1	118.4	2.0	0.7	8.3	2.6	9.1	41.1	13.7	0.0	0.8	9.6	0.2	0.0	2.1	6.8	0.1	0.6	48.6	27.3	0.1	97.7	0.2	2.1	49.6
RFFL	"CARP-2, CARP2, fring, rififylin, RNF189, RNF34L"	ENSG00000092871	"Ring finger and FYVE like domain containing E3 ubiquitin protein ligase"	Q8WZ73	17	35005990-35089319	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 93.8"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 109.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 119.5;Karpas-707: 112.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008096, HPA017910, HPA019492"	Approved		Approved	Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles		"CAB008096: AB_2178607, HPA017910: AB_1856189, HPA019492: AB_1856190"	"unprognostic (2.59e-1)"	"unprognostic (2.87e-1)"	"prognostic favorable (4.92e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.73e-3)"	"unprognostic (4.34e-3)"	"unprognostic (2.31e-1)"	"unprognostic (9.26e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (2.43e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.36e-1)"	9.9	7.1	23.9	17.7	59.5	41.4	12.2	49.2	38.0	11.9	11.6	26.7	28.1	9.6	8.8	35.9	9.3	19.4	8.2	24.3	36.4	17.7	48.3	12.6	17.6	74.2	53.0	8.5	18.8	12.1	6.8	11.9	71.2	18.3	23.2	21.1	13.1	12.7	15.8	7.5	22.8	13.3	48.6	19.2	23.3	26.6	52.2	26.0	39.0	13.1	29.4	20.3	16.2	93.8	22.9	43.4	10.7	15.0	21.6	28.1	6.1	15.6	25.8	15.5	18.7	15.4	50.5	7.0	19.4	21.4	33.0	32.2	18.4	30.8	22.4	119.5	11.2	40.5	11.0	38.6	18.0	20.2	20.0	19.0	18.8	23.7	46.9	22.6	15.6	21.2	18.2	112.2	16.0	8.7	4.9	19.4	15.2	51.1	24.9	17.3	18.7	43.2	22.8	48.6	12.0	15.8	8.9	10.3	9.1	24.4	15.9	27.7	29.7	8.6	14.9	8.7	24.1	41.4	33.0	9.4	36.4	15.8	7.4	28.6	16.2	33.7	16.8	9.3	20.6	7.8	18.5	16.3	10.8	6.9	16.0	14.5	55.3	14.4	9.9	1.3	29.6	15.5	23.9	59.5	49.2	38.0	24.3	36.4	74.2	53.0	71.2	48.6	52.2	93.8	6.5	41.7	27.4	0.0	12.6	6.0	11.9	7.4	5.2	10.6	9.9	3.8	1.3	20.0	17.3	0.0	14.6	9.4	12.1	33.7	1.9	8.4	41.0	13.0	6.8	6.6	15.0	23.8	0.0	15.1	1.7	9.3	23.0	18.1	25.3	5.4	9.3	35.2	7.2	6.7	0.0	26.4	6.1	16.3	16.9	109.1	3.1	16.1	1.8	0.0	22.6	20.8	25.7	0.0	0.0	16.8	19.3	4.5	12.9	28.1	16.7	20.4	11.7	34.9	6.6	15.2	5.7	15.9	10.8	16.2	6.1	5.1	23.7	3.1	18.9	39.5
RGL2	"HKE1.5, KE1.5, RAB2L"	ENSG00000237441	"Ral guanine nucleotide dissociation stimulator like 2"	O15211	6	33291654-33298942	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 19.0;SK-MEL-30: 20.4;TIME: 22.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047039, HPA053444"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA047039: AB_2732538, HPA053444: AB_2682153"	"unprognostic (4.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (6.16e-4)"	"unprognostic (1.27e-1)"	"unprognostic (5.00e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.62e-2)"	10.4	8.7	2.6	0.6	2.8	2.3	9.1	2.7	1.6	13.0	8.9	10.0	2.2	11.0	0.0	5.4	12.5	2.0	8.9	2.1	3.7	8.9	2.5	11.4	0.8	6.0	3.0	12.9	6.9	2.7	20.7	5.6	2.5	9.5	0.6	0.1	7.5	3.0	18.5	5.7	8.0	4.0	2.5	24.2	9.9	5.4	4.0	1.0	16.0	8.5	0.2	9.3	7.4	2.2	15.7	2.8	0.2	1.0	2.1	7.2	0.0	1.5	6.0	2.4	1.5	0.2	2.5	2.7	14.0	2.8	5.4	0.3	0.6	5.8	1.4	0.9	0.6	6.5	0.0	2.8	12.9	1.8	5.3	5.4	6.0	5.0	3.6	2.6	19.0	0.0	4.0	0.1	2.4	0.0	1.9	7.9	1.6	1.0	9.7	4.4	0.4	4.1	4.8	3.5	2.9	11.8	0.1	0.0	20.4	0.0	0.0	4.9	22.6	5.1	5.1	3.0	14.8	2.8	1.9	1.6	3.4	4.1	10.4	4.3	4.2	8.8	2.0	3.1	1.7	1.6	1.3	1.5	3.3	2.1	0.7	1.1	9.6	2.4	1.1	0.4	1.3	2.8	2.6	2.8	2.7	1.6	2.1	3.7	6.0	3.0	2.5	2.5	4.0	2.2	75.5	16.0	41.5	52.2	20.6	28.4	36.5	30.3	37.0	30.4	58.8	40.4	28.7	20.0	38.6	22.0	22.9	30.4	18.4	8.4	13.7	21.2	5.1	19.9	13.6	60.8	28.6	7.8	13.0	14.5	39.0	20.1	16.3	21.1	11.4	21.4	75.7	10.7	32.3	32.0	18.2	10.8	22.4	27.0	23.4	17.4	16.8	23.0	17.8	30.9	13.4	22.5	19.6	17.6	11.1	22.4	25.5	14.7	7.8	30.5	5.6	11.7	39.9	30.9	26.3	20.4	26.9	26.2	18.9	20.0	24.3	102.2	16.5	28.3	10.0	39.2
RGL4	Rgr	ENSG00000159496	"Ral guanine nucleotide dissociation stimulator like 4"	Q8IZJ4	22	23688136-23699176	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	8	"bone marrow: 164.4"	"Group enriched"	"Detected in some"	4	"dendritic cells: 23.8;Early spermatids: 18.1;NK-cells: 52.5;T-cells: 51.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 393.6;neutrophil: 516.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 516.3"	"Group enriched"	"Detected in many"	5	"MOLT-4: 26.3;U-937: 61.0"									HPA035979	Uncertain		Approved	Centrosome	"Intracellular and membrane"	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Centrosome		"HPA035979: AB_10673227"	"unprognostic (1.48e-4)"	"unprognostic (2.75e-4)"	"unprognostic (4.44e-2)"	"unprognostic (1.11e-4)"	"unprognostic (3.10e-1)"	"unprognostic (2.93e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.11e-1)"	"unprognostic (4.25e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-3)"	3.8	3.1	0.1	7.6	0.2	164.4	0.5	2.0	0.8	0.3	0.3	1.2	4.1	3.1	0.0	1.9	0.9	4.6	2.8	0.2	0.0	1.5	1.3	4.8	11.5	0.6	0.1	3.9	3.4	0.1	0.5	1.7	1.0	1.4	1.1	10.6	4.6	0.2	3.0	5.6	4.1	0.6	0.1	19.8	2.4	3.8	0.1	8.4	3.1	0.9	8.1	3.8	0.5	1.1	1.6	0.5	5.8	2.5	0.0	0.0	2.5	1.8	0.0	0.0	0.0	1.3	1.1	1.9	0.4	0.0	1.0	2.8	0.0	0.0	0.0	2.0	3.6	0.9	2.5	0.3	0.0	3.4	3.8	0.0	0.0	0.0	0.0	2.9	0.0	2.0	2.1	3.0	0.0	1.0	26.3	3.6	0.4	0.6	0.8	9.3	2.0	1.4	0.0	1.7	1.8	2.7	1.7	3.7	0.6	3.1	1.2	2.0	2.5	3.2	1.9	2.2	1.1	5.3	0.8	1.3	1.9	61.0	1.6	98.0	2.9	393.6	57.4	20.8	59.6	6.5	74.1	66.2	5.4	5.2	104.6	93.8	516.3	35.2	84.6	0.7	114.2	37.4	0.1	0.2	2.0	0.8	0.2	0.0	0.6	0.1	1.0	0.1	0.1	1.1	0.7	0.0	4.4	0.3	5.9	0.9	0.0	0.0	0.0	0.5	0.4	0.5	0.5	1.5	1.3	0.0	2.1	0.0	23.8	0.0	0.0	2.4	18.1	0.1	0.3	0.3	0.0	8.8	0.4	1.7	0.1	0.6	2.6	0.2	1.3	0.1	0.4	0.3	0.1	1.7	0.5	0.0	0.0	1.6	0.7	2.0	0.0	3.5	1.8	0.0	2.5	0.0	52.5	0.5	0.4	2.2	0.0	0.0	3.4	0.0	0.0	0.3	0.0	2.8	0.0	0.3	0.5	5.9	0.0	0.0	0.3	0.0	51.8	0.1	0.1	0.1
RGS14		ENSG00000169220	"Regulator of G protein signaling 14"	O43566	5	177357924-177372596	"Predicted intracellular proteins"	"Cell cycle, Cell division"	"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 110.4"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 72.8;Proximal tubular cells: 113.7;Squamous epithelial cells: 95.8;Suprabasal keratinocytes: 115.1"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basal ganglia: 110.4;cerebral cortex: 67.9;hippocampal formation: 56.4"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 112.5;HMC-1: 95.4;NB-4: 44.8;RPMI-8226: 57.9"	"Group enriched"	"Detected in many"	10	"amygdala: 66.0;basal ganglia: 57.9;cerebral cortex: 46.8;hippocampal formation: 93.6;white matter: 23.8"	"Region enhanced"	"Detected in many"		"basal ganglia: 102.1"	"HPA046847, HPA061819"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Intermediate filaments"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Vesicles, Plasma membrane, Intermediate filaments"	"HPA046847: AB_2679836, HPA061819: "	"unprognostic (6.05e-3)"	"unprognostic (1.65e-2)"	"unprognostic (8.57e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (7.27e-2)"	"prognostic unfavorable (1.84e-6)"	"unprognostic (1.95e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.78e-2)"	3.5	2.8	16.0	13.9	110.4	22.4	2.9	0.0	67.9	3.1	1.8	3.7	6.3	2.3	0.4	10.0	7.7	4.3	1.3	56.4	4.5	8.5	28.7	5.5	18.1	0.0	0.4	1.1	3.7	1.5	2.4	1.4	0.1	3.5	0.9	0.0	6.2	2.1	2.6	6.1	11.0	1.8	0.1	27.7	4.9	1.9	15.2	16.3	6.1	0.9	6.6	4.1	5.0	3.2	5.4	1.1	2.3	1.4	0.1	0.0	3.7	0.2	0.0	0.5	0.6	3.7	10.4	13.3	7.3	0.4	1.3	10.6	0.2	3.8	0.0	112.5	0.5	20.7	1.0	4.7	0.9	16.3	95.4	1.8	1.1	0.6	0.7	1.4	0.6	14.9	3.5	26.5	0.2	0.4	21.7	44.8	1.7	5.4	2.8	10.2	0.3	57.9	1.5	1.6	0.4	1.9	0.4	0.4	8.8	0.0	3.5	25.2	1.1	0.2	1.9	0.0	9.7	13.9	7.1	5.8	1.6	30.3	2.4	70.6	39.9	148.8	62.4	37.9	63.0	27.7	57.9	57.8	39.8	26.6	47.4	43.1	140.0	23.6	41.2	17.6	60.9	43.9	16.0	110.4	0.0	67.9	56.4	4.5	0.0	0.4	0.1	0.1	15.2	3.2	5.3	6.4	4.4	2.6	27.3	68.8	23.9	15.4	72.8	0.7	8.9	11.8	2.3	37.1	5.6	11.0	2.1	3.9	41.4	4.2	31.3	11.4	0.6	19.5	2.0	6.5	4.8	7.4	4.6	16.7	10.4	5.4	12.2	8.1	24.7	2.8	8.2	64.0	26.1	0.0	1.5	10.0	10.2	17.0	23.3	1.5	2.8	18.2	21.4	6.5	18.1	9.9	48.4	0.5	0.3	12.8	17.2	2.2	18.0	14.1	16.8	113.7	11.7	2.0	0.0	1.6	4.6	0.1	20.3	95.8	115.1	3.3	51.2	1.1	4.4	20.0
RIT1	"MGC125864, MGC125865, RIBB, RIT, ROC1"	ENSG00000143622	"Ras like without CAAX 1"	Q92963	1	155897808-155911404	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 80.7"	"Cell type enhanced"	"Detected in all"		"Langerhans cells: 107.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053249	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"			"HPA053249: AB_2682089"	"unprognostic (1.84e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.27e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (8.64e-6)"	"unprognostic (3.80e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.19e-2)"	"unprognostic (9.22e-3)"	"unprognostic (4.82e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.33e-3)"	19.8	13.8	10.7	22.9	12.1	80.7	13.3	12.0	13.0	16.6	12.1	14.0	12.7	14.8	15.4	37.3	10.8	18.5	15.7	10.3	11.8	25.1	12.2	22.7	18.3	13.5	12.7	12.8	13.8	16.5	11.0	23.0	13.3	13.8	14.3	16.0	14.4	18.0	10.8	12.8	12.5	21.3	11.6	21.7	19.7	12.2	12.8	21.5	13.4	16.5	23.6	23.6	21.9	13.3	21.0	22.9	42.3	21.7	21.5	26.6	12.0	37.2	37.4	35.2	35.4	24.1	40.0	9.6	50.0	43.9	25.3	24.7	32.0	18.5	29.4	12.9	16.4	21.0	24.4	15.6	55.7	22.5	37.9	37.1	22.5	40.9	27.4	47.7	48.7	19.7	21.0	26.3	54.3	27.3	30.7	14.9	23.0	36.2	13.9	24.0	33.3	19.6	29.9	44.2	19.7	30.7	27.1	51.1	34.8	76.9	37.3	29.4	62.5	31.7	22.3	27.3	30.7	31.1	30.9	38.8	33.9	22.8	43.0	22.8	41.0	46.9	19.5	25.5	15.6	16.9	16.8	18.5	31.1	17.1	20.2	18.1	106.3	28.8	29.3	12.5	23.8	30.0	10.7	12.1	12.0	13.0	10.3	11.8	13.5	12.7	13.3	11.6	12.8	13.3	45.8	48.1	23.9	12.4	22.4	28.9	36.5	43.7	21.6	8.1	17.4	12.3	14.2	8.6	40.4	18.4	10.4	14.5	41.8	14.1	21.5	39.4	10.4	20.4	25.7	50.5	12.6	16.4	5.1	23.4	16.8	20.8	13.3	32.5	14.0	15.2	24.7	7.0	50.7	6.7	5.3	11.5	42.7	45.6	107.9	10.3	7.2	62.6	33.8	11.2	79.2	25.9	16.5	8.5	8.1	28.3	15.4	15.8	13.4	48.8	15.4	70.6	21.9	11.9	26.3	18.2	26.1	12.7	23.2	26.0	30.7	33.5	32.7	20.7	10.0	79.2
RNF167	DKFZP566H073	ENSG00000108523	"Ring finger protein 167"	Q9H6Y7	17	4940008-4945222	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049810	Approved		Approved	"Vesicles,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Vesicles, Cytosol"	"Mitotic spindle, Centriolar satellite"	"HPA049810: AB_2680894"	"unprognostic (1.13e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.77e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.07e-2)"	"prognostic favorable (2.03e-6)"	"unprognostic (2.16e-1)"	"prognostic favorable (4.47e-4)"	"unprognostic (7.62e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.12e-1)"	75.0	110.6	141.9	53.0	146.7	69.0	73.1	146.4	179.9	93.2	138.6	111.5	66.6	94.9	76.4	122.1	84.3	45.3	131.8	141.5	146.4	106.7	184.2	77.5	64.5	146.3	145.4	87.4	115.1	105.8	96.8	50.7	146.3	95.0	65.7	98.1	92.5	70.5	152.9	127.8	100.5	52.8	142.4	113.8	111.8	110.6	150.3	98.1	93.4	94.2	71.6	106.7	90.4	153.3	102.6	143.1	61.1	73.7	132.8	68.7	92.7	63.4	76.1	119.7	93.4	96.2	43.3	71.5	120.3	93.5	63.9	147.5	103.2	114.8	86.1	74.5	166.1	121.9	164.4	94.9	100.6	59.0	245.0	79.6	176.5	129.8	116.2	74.6	77.2	101.0	49.9	237.5	96.2	66.3	92.8	70.6	75.4	102.0	86.8	62.8	61.9	91.5	137.3	77.4	49.2	61.1	56.0	92.9	81.9	83.1	87.3	55.9	49.5	76.6	48.3	66.8	119.3	79.5	88.0	23.7	98.4	80.6	77.9	108.4	88.8	236.9	195.3	94.0	153.4	100.4	148.0	195.7	73.9	98.7	103.2	152.2	219.8	118.8	117.7	75.9	153.0	177.0	141.9	146.7	146.4	179.9	141.5	146.4	146.3	145.4	146.3	142.4	150.3	153.3	36.9	0.0	3.9	12.4	54.3	68.6	44.4	65.8	51.8	43.2	56.6	44.7	15.8	77.2	38.9	49.7	20.9	120.1	64.7	65.2	56.7	78.5	59.6	29.8	25.1	36.4	31.8	60.6	11.3	66.7	139.7	36.3	36.2	32.2	14.0	26.3	45.7	95.1	58.4	18.5	11.2	45.7	65.1	41.3	43.6	86.5	48.7	36.1	39.2	6.5	53.1	46.9	114.4	10.1	17.9	60.7	44.9	53.8	59.1	32.6	108.2	64.0	31.1	32.3	39.5	28.4	35.1	127.1	106.7	61.4	83.3	125.2	82.5	37.2	59.6	48.0
RNF44	KIAA1100	ENSG00000146083	"Ring finger protein 44"	Q7L0R7	5	176526712-176538025	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 105.1;Late spermatids: 398.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038981	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA038981: AB_10674846"	"unprognostic (1.85e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.57e-7)"	"unprognostic (1.50e-1)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (8.45e-4)"	"unprognostic (1.61e-1)"	"unprognostic (4.54e-2)"	"unprognostic (5.36e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.62e-1)"	"unprognostic (5.12e-3)"	"unprognostic (1.15e-2)"	16.7	17.8	15.9	28.9	14.0	42.7	18.1	8.6	19.3	18.3	6.1	26.3	20.2	16.3	5.4	25.9	19.1	9.1	17.0	14.2	14.4	21.7	14.6	22.0	37.7	12.5	12.0	24.9	19.5	10.3	15.7	13.1	9.9	19.5	12.6	8.4	23.2	9.3	11.8	30.5	34.6	7.8	8.5	54.7	20.4	20.2	15.0	30.9	25.1	7.5	24.2	18.0	21.1	11.4	9.3	20.9	32.7	30.6	6.4	5.3	87.6	5.3	4.6	3.5	4.5	31.9	20.2	17.7	32.0	3.0	16.0	24.8	14.8	31.8	4.0	69.0	26.1	18.9	20.1	29.8	8.1	22.1	25.0	10.3	25.1	3.9	11.7	11.4	9.8	33.8	21.4	25.9	4.8	32.1	51.6	49.3	43.4	12.1	25.5	21.0	8.6	25.8	12.0	21.4	40.1	48.8	8.0	21.7	31.2	21.5	24.0	43.9	16.0	8.8	13.1	7.1	10.0	32.6	26.3	24.1	4.3	44.7	11.7	0.0	1.5	2.9	3.0	1.8	2.2	1.9	2.3	2.5	1.0	2.3	2.2	2.7	5.3	2.1	1.6	1.1	3.1	1.8	15.9	14.0	8.6	19.3	14.2	14.4	12.5	12.0	9.9	8.5	15.0	11.4	18.3	12.8	28.6	22.9	39.0	40.3	10.5	24.4	43.3	17.1	30.7	25.4	13.3	20.0	18.2	12.9	10.4	10.5	46.6	41.7	7.9	12.3	105.1	15.3	13.7	19.9	40.7	10.1	20.5	16.2	11.7	11.1	21.4	20.2	15.8	13.7	15.7	10.5	15.3	28.6	24.7	40.7	18.3	56.5	19.6	398.5	19.9	26.8	5.4	21.5	38.4	9.2	40.2	13.0	12.2	21.2	24.3	12.4	17.0	22.2	27.1	10.8	13.9	8.5	6.6	14.1	13.0	3.6	12.0	35.0	49.6	12.0	40.3	12.9	35.7	15.3
RNPEPL1		ENSG00000142327	"Arginyl aminopeptidase like 1"	Q9HAU8	2	240565804-240581372	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 138.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036772, HPA036773"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA036772: AB_10670848, HPA036773: "	"unprognostic (3.92e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.24e-3)"	"prognostic favorable (7.43e-4)"	"prognostic unfavorable (5.06e-4)"	"unprognostic (3.72e-3)"	"unprognostic (9.10e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.10e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.31e-2)"	"unprognostic (9.86e-2)"	40.3	31.4	29.1	14.1	29.6	21.7	32.0	29.0	38.7	15.6	27.0	39.6	20.2	16.8	5.6	52.4	17.0	12.1	79.4	27.9	27.8	42.7	50.6	35.9	23.8	31.5	30.0	12.0	64.2	10.9	9.1	10.6	30.3	34.7	9.5	0.8	28.9	13.1	63.7	35.3	39.8	9.4	31.0	56.4	48.4	9.9	31.4	15.9	19.2	17.1	12.1	34.1	23.2	31.1	13.7	22.4	4.9	13.2	17.6	18.1	16.6	8.6	21.1	9.5	11.6	6.3	39.3	3.9	4.3	21.8	13.3	14.6	5.5	16.1	0.9	23.9	7.7	9.0	7.3	37.2	44.1	5.9	15.5	21.6	25.5	4.9	9.6	15.1	32.8	15.2	6.8	25.7	6.5	19.3	7.5	22.4	6.5	26.5	9.0	15.5	7.4	33.3	39.3	18.5	4.6	9.8	5.8	19.7	39.9	5.6	13.9	26.8	22.7	10.2	10.4	14.4	10.0	24.1	3.9	4.8	20.9	16.6	15.7	9.2	11.2	30.5	14.8	9.9	12.7	8.2	11.3	13.4	8.2	8.7	6.4	9.5	20.0	10.7	10.1	9.5	14.7	7.9	29.1	29.6	29.0	38.7	27.9	27.8	31.5	30.0	30.3	31.0	31.4	31.1	27.9	22.4	25.7	10.4	27.8	7.8	15.0	8.4	2.8	6.4	18.8	9.1	35.6	24.3	12.9	12.9	0.0	7.1	80.4	138.9	17.6	24.6	3.1	12.1	11.0	22.7	26.4	22.3	9.5	49.6	6.8	12.3	104.5	27.4	34.2	31.8	30.0	42.2	43.8	3.3	8.6	58.7	8.2	74.3	21.0	5.9	8.7	47.1	23.2	9.4	52.0	15.9	79.3	5.5	10.3	65.0	70.0	13.5	20.5	20.2	77.1	35.6	7.2	6.9	13.1	14.8	16.4	1.3	8.2	13.0	9.2	5.1	47.9	17.4	60.5	23.0
ROPN1L	"ASP, FLJ25776, RSPH11"	ENSG00000145491	"Rhophilin associated tail protein 1 like"	Q96C74	5	10441524-10472029	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 323.0"	"Group enriched"	"Detected in many"	5	"Early spermatids: 3125.2;Late spermatids: 3173.9;Spermatocytes: 987.8"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 9.6;ovarian cancer: 3.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	12	"basophil: 45.1;eosinophil: 55.0;neutrophil: 105.3"	"Lineage enriched"	"Detected in many"	18	"granulocytes: 105.3"	"Cell line enriched"	"Detected in some"	5	"NB-4: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039193, HPA041830"	Enhanced					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 24: NB-4 - Immune response"	"Cluster 34: Spermatids - Unknown function"			"HPA039193: AB_10673415, HPA041830: AB_2677695"	"unprognostic (2.39e-4)"	"unprognostic (1.21e-1)"	"unprognostic (3.78e-3)"	"unprognostic (6.84e-3)"	"unprognostic (3.59e-2)"	"unprognostic (2.82e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.53e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.07e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.32e-3)"	"unprognostic (7.54e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.22e-2)"	0.7	0.2	1.3	0.3	1.3	4.3	0.8	0.7	0.8	2.0	6.5	0.2	0.0	0.8	0.0	0.1	27.4	0.3	0.6	1.8	1.5	0.8	0.3	5.3	0.4	5.0	8.4	0.2	1.1	0.0	1.2	0.2	4.9	0.6	0.0	1.0	0.1	0.1	0.2	0.3	0.3	0.0	4.2	4.5	0.3	323.0	1.3	0.2	0.8	0.3	0.0	0.2	0.1	2.1	0.1	0.4	0.0	0.0	0.4	0.0	0.5	0.0	0.6	0.5	0.5	0.1	0.1	0.0	1.5	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	2.7	0.0	0.0	0.1	0.2	0.2	0.5	0.0	0.0	0.1	0.0	0.1	0.0	13.4	0.1	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.9	0.0	0.1	0.1	0.2	0.4	0.0	0.0	0.9	1.5	0.1	0.1	0.4	0.0	1.5	1.6	0.3	45.1	0.8	55.0	4.0	0.3	2.7	0.0	3.5	4.7	0.1	0.0	2.3	2.7	105.3	0.4	1.4	0.0	5.8	2.1	1.3	1.3	0.7	0.8	1.8	1.5	5.0	8.4	4.9	4.2	1.3	2.1	2.0	3.2	2.0	1.6	0.1	0.3	0.0	38.0	0.0	0.2	0.4	0.4	0.4	0.0	45.3	0.0	0.0	0.0	2.2	0.0	0.0	1.0	3125.2	311.3	2.0	4.0	0.0	0.0	5.4	0.0	0.1	0.9	0.0	3.4	1.3	0.0	7.5	0.2	0.1	3.3	4.0	0.0	38.7	0.6	0.3	3173.9	36.1	2.2	0.0	0.0	0.2	0.2	0.0	1.0	0.3	0.1	0.0	18.4	0.1	0.3	0.0	1.3	482.3	3.3	13.1	0.4	14.1	987.8	35.8	0.0	0.1	0.1	0.8	2.9	0.0	0.1
RTF2	"C20orf43, CDAO5, HSPC164, RTFDC1"	ENSG00000022277	"Replication termination factor 2"	Q9BY42	20	56468585-56519449	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 162.8;Distal tubular cells: 156.5;Proximal tubular cells: 149.9;Syncytiotrophoblasts: 182.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053986	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA053986: AB_2682333"	"unprognostic (1.65e-1)"	"unprognostic (1.94e-3)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (3.54e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (8.90e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.98e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.58e-1)"	"unprognostic (8.48e-3)"	73.8	72.7	101.4	65.9	113.3	128.5	65.7	117.4	106.7	66.2	88.3	79.2	60.5	70.6	48.9	64.2	64.8	49.2	85.9	97.2	106.7	68.7	63.8	58.1	70.7	113.7	109.6	71.1	59.3	63.0	67.8	55.4	115.0	58.2	54.2	61.3	51.2	62.2	181.4	69.6	60.8	65.4	111.1	67.8	59.3	57.0	108.4	79.2	60.6	111.1	76.2	73.8	57.5	123.5	132.8	93.3	91.1	91.3	111.1	97.9	85.9	198.5	148.1	280.0	158.5	192.6	125.2	110.4	232.0	161.5	139.7	144.9	92.4	153.8	190.7	52.6	72.9	138.9	97.4	150.8	127.9	201.3	186.6	88.1	156.5	126.0	106.9	119.7	121.3	118.1	109.6	114.3	139.1	253.9	171.6	173.0	68.8	185.2	175.9	116.3	247.2	149.5	119.1	86.1	95.1	103.1	208.2	355.0	199.0	66.7	165.0	191.7	131.5	242.2	156.0	133.0	165.1	94.6	116.1	156.9	190.7	134.7	135.1	309.4	205.4	562.3	125.6	192.8	106.2	115.7	106.4	122.5	223.6	134.0	119.7	110.6	580.4	197.4	200.5	189.6	152.2	254.1	101.4	113.3	117.4	106.7	97.2	106.7	113.7	109.6	115.0	111.1	108.4	123.5	87.2	51.3	61.2	0.0	20.9	0.0	0.0	0.0	0.0	0.0	54.1	56.9	0.0	0.0	34.0	66.2	0.0	162.8	50.9	0.0	156.5	104.5	0.0	47.8	51.2	38.8	0.0	0.0	0.0	96.3	109.5	37.3	0.0	47.7	90.8	57.9	0.0	0.0	110.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.8	0.0	0.0	92.0	0.0	0.0	0.0	0.0	101.9	0.0	0.0	5.3	0.0	0.0	149.9	34.2	0.0	0.0	0.0	37.4	0.0	0.0	0.0	0.0	182.9	26.4	89.8	0.0	0.0
SDF2		ENSG00000132581	"Stromal cell derived factor 2"	Q99470	17	28648346-28662189	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 211.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042799			Approved	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"HPA042799: AB_10794533"	"unprognostic (3.91e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.77e-3)"	"unprognostic (3.90e-2)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (2.28e-3)"	"unprognostic (3.20e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.75e-3)"	"unprognostic (6.61e-2)"	16.2	32.2	14.6	8.7	14.6	8.8	14.2	14.9	15.2	17.5	18.5	15.7	8.0	14.4	27.2	13.8	17.3	13.0	17.5	14.9	16.3	18.5	23.2	15.4	9.4	15.4	15.3	19.7	19.9	20.1	19.1	20.5	16.0	18.2	11.1	6.6	21.8	15.7	14.7	11.5	13.0	14.4	15.3	16.1	15.3	9.4	15.9	12.7	16.2	12.9	8.1	20.2	14.3	14.9	18.8	54.3	25.2	18.7	107.1	29.6	18.0	53.6	48.4	39.6	49.8	34.6	23.5	8.0	47.8	57.6	36.6	30.5	24.7	22.6	27.8	62.3	29.8	13.7	26.6	28.6	30.9	8.1	17.2	53.7	28.5	38.3	8.8	34.4	39.9	11.0	14.9	19.4	45.1	35.9	20.7	22.2	12.9	48.8	19.2	12.5	37.1	24.8	45.3	29.6	15.6	18.1	42.3	32.4	30.3	37.5	43.7	10.4	45.0	21.0	23.3	24.2	31.2	25.2	35.2	11.9	32.0	12.9	23.9	189.1	45.1	129.1	64.4	39.6	62.6	50.8	52.2	62.8	30.0	44.4	47.1	55.9	203.1	71.1	42.1	62.5	74.2	59.7	14.6	14.6	14.9	15.2	14.9	16.3	15.4	15.3	16.0	15.3	15.9	14.9	61.1	25.6	21.7	10.4	45.5	34.0	59.1	125.6	41.5	26.4	49.4	44.6	13.1	38.6	71.1	42.3	25.0	130.3	74.0	82.8	29.4	74.8	7.4	36.2	43.6	52.2	57.1	37.5	11.1	47.2	109.0	52.6	27.5	44.9	21.0	47.2	53.2	46.2	56.7	13.5	12.2	57.5	71.2	44.9	49.7	3.9	76.1	38.1	37.4	8.4	50.2	49.9	56.7	11.1	17.8	80.4	90.4	66.5	46.2	54.1	88.0	50.7	47.8	31.1	72.3	36.7	48.1	30.5	32.1	40.6	37.6	211.0	53.2	86.0	46.2	86.9
SF3B2	"Cus1, SAP145, SF3b1, SF3b145"	ENSG00000087365	"Splicing factor 3b subunit 2"	Q13435	11	66050729-66069308	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045028	Supported		Enhanced	"Nuclear speckles"		NA	NA		130000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA045028: AB_10965174"	"unprognostic (1.48e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.45e-2)"	"unprognostic (3.29e-1)"	"unprognostic (9.86e-2)"	"unprognostic (7.10e-2)"	"prognostic unfavorable (6.43e-5)"	"unprognostic (8.43e-2)"	"unprognostic (4.69e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (3.51e-5)"	"unprognostic (4.03e-2)"	"unprognostic (3.56e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.60e-2)"	116.0	96.0	117.5	80.4	127.1	144.6	109.0	119.4	139.5	123.3	125.1	97.4	70.7	111.6	95.5	96.6	112.3	55.2	94.7	117.9	120.4	107.1	112.0	104.3	99.0	124.2	118.9	136.1	137.4	88.9	137.2	80.6	121.3	99.2	77.0	96.5	91.3	73.8	108.1	116.9	98.5	80.0	121.4	113.9	102.9	145.2	124.0	109.4	115.2	54.6	114.0	108.3	104.7	136.9	226.9	177.3	189.0	178.9	184.3	163.5	153.1	168.4	210.5	234.9	176.8	149.8	188.9	212.5	185.7	186.7	249.5	202.9	263.2	177.8	208.8	170.2	143.5	223.3	164.2	245.5	187.8	229.7	171.5	137.9	174.0	242.5	287.8	171.3	172.7	180.5	215.2	348.7	191.4	309.8	257.5	343.2	196.1	166.2	163.9	235.6	162.9	299.0	192.3	186.0	147.8	218.0	165.9	175.9	257.0	136.3	217.2	147.1	156.7	206.9	178.0	229.0	194.3	267.5	337.0	270.8	229.6	151.6	191.9	152.1	96.2	167.9	135.3	117.2	131.1	106.8	120.3	128.2	98.5	110.2	116.7	116.8	130.2	116.3	160.1	78.8	131.8	147.5	117.5	127.1	119.4	139.5	117.9	120.4	124.2	118.9	121.3	121.4	124.0	136.9	86.5	128.2	131.0	18.6	144.3	111.3	148.9	165.9	129.1	94.9	69.1	65.0	68.5	98.7	141.5	66.2	89.6	195.9	131.8	114.3	92.0	172.2	278.2	119.5	103.2	104.4	82.5	113.6	19.2	214.8	183.7	117.6	95.8	92.0	120.8	119.0	80.7	72.4	124.9	107.7	19.3	112.4	130.2	103.6	115.0	78.5	120.2	103.8	65.8	10.3	195.6	122.1	155.5	12.1	28.9	158.9	96.3	130.1	198.3	136.6	101.1	108.1	214.7	109.4	78.9	106.1	153.7	220.1	172.0	103.2	99.0	186.6	145.5	118.7	122.3	130.8
SLC40A1	"FPN1, HFE4, IREG1, MTP1, SLC11A3"	ENSG00000138449	"Solute carrier family 40 member 1"	Q9NP59	2	189560590-189583758	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 489.8;Kupffer cells: 1340.2;Syncytiotrophoblasts: 2463.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 326.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 509.0;CACO-2: 123.1;HEL: 430.0;HMC-1: 110.5;T-47d: 207.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065634	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA065634: AB_2685524"	"unprognostic (1.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.22e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.43e-2)"	"unprognostic (6.44e-2)"	"prognostic favorable (8.55e-5)"	"unprognostic (4.66e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.96e-2)"	"unprognostic (4.11e-2)"	59.6	333.5	9.3	52.6	11.9	45.8	97.7	9.6	9.8	156.3	10.4	124.7	289.3	95.4	61.6	30.5	214.2	148.7	52.6	7.2	12.0	79.9	251.5	122.9	172.6	15.6	15.7	317.2	53.2	91.8	19.0	250.1	12.8	39.5	130.8	29.5	58.7	53.1	64.2	12.2	127.9	69.3	15.5	368.1	96.8	33.2	13.9	62.6	68.0	60.3	59.1	53.1	21.8	11.3	0.0	7.4	0.6	0.0	509.0	3.3	25.4	0.2	6.6	1.9	3.1	123.1	0.4	0.2	1.0	0.2	1.4	0.4	2.4	0.3	1.6	0.3	1.7	430.0	1.7	45.8	1.9	1.5	110.5	35.9	0.2	1.2	0.0	11.7	13.0	16.4	44.6	1.1	6.3	0.0	18.2	28.8	1.5	92.7	1.7	0.2	5.0	2.5	5.3	18.1	1.0	5.4	0.8	35.4	0.0	39.5	207.6	6.2	0.3	0.8	11.7	0.5	0.1	1.1	0.2	0.3	0.1	0.2	0.1	129.8	101.5	172.1	2.2	23.7	3.2	0.2	54.4	4.9	115.6	0.7	80.2	17.8	326.2	4.6	2.6	18.8	5.3	105.8	9.3	11.9	9.6	9.8	7.2	12.0	15.6	15.7	12.8	15.5	13.9	11.3	44.2	125.0	40.3	3.6	12.0	9.2	51.3	10.5	19.9	4.8	83.8	30.0	48.0	138.7	31.6	33.1	4.2	489.8	5.7	328.9	49.0	54.7	10.5	39.6	38.2	39.8	18.6	253.7	0.3	71.8	20.3	81.9	76.5	129.5	9.5	12.8	245.9	259.7	86.4	6.7	6.8	60.8	6.1	1340.2	26.8	9.2	121.2	172.7	8.8	34.7	41.7	17.5	2.1	14.6	0.2	71.5	86.2	58.6	4.1	26.2	163.0	150.0	34.4	48.4	65.7	13.7	49.1	7.4	3.9	12.5	8.1	2463.5	11.9	84.8	48.9	27.7
SMIM27	"C9orf133, TOPORS-AS1"	ENSG00000235453	"Small integral membrane protein 27"	A0A1B0GUW7	9	32551144-32568621	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 48.6;Distal tubular cells: 119.3;Proximal tubular cells: 112.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 680.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 680.4"	"Low cell line specificity"	"Detected in all"																	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"				"prognostic favorable (4.18e-5)"	"prognostic favorable (6.11e-4)"	"unprognostic (1.47e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.88e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.74e-3)"	"unprognostic (8.58e-2)"	"prognostic favorable (8.39e-4)"	"prognostic favorable (7.33e-5)"	"unprognostic (1.30e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (7.64e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.14e-3)"	10.0	19.0	22.4	9.3	23.3	17.4	10.4	25.9	28.0	9.1	21.5	11.5	9.6	8.4	13.8	8.6	8.4	3.0	17.5	22.4	24.8	18.6	9.0	9.8	12.2	23.4	22.6	8.5	19.8	13.0	24.0	4.8	23.2	10.2	4.0	18.9	11.9	6.0	28.5	11.0	10.7	4.0	23.1	16.6	12.8	41.7	22.6	17.1	11.7	13.7	8.7	9.4	8.1	26.2	13.8	7.2	13.7	12.4	5.9	17.8	7.5	6.4	10.2	5.3	10.8	1.9	3.5	10.3	10.0	10.2	9.7	5.3	9.4	6.2	7.7	20.0	21.1	50.5	22.5	17.5	13.5	13.0	8.2	13.1	9.6	5.2	12.2	15.1	12.3	33.6	7.4	25.6	9.7	10.3	22.6	52.5	17.0	13.9	14.5	11.1	6.1	18.8	12.8	7.1	10.2	12.4	16.5	6.3	8.8	16.5	5.0	11.0	6.3	3.6	9.5	4.9	6.9	28.5	23.8	38.0	22.7	7.6	3.0	116.8	47.3	332.4	79.5	51.3	107.8	122.1	114.0	93.7	41.8	129.3	135.6	117.4	680.4	93.3	54.9	56.9	129.0	62.9	22.4	23.3	25.9	28.0	22.4	24.8	23.4	22.6	23.2	23.1	22.6	26.2	22.2	28.9	30.1	0.0	13.4	0.0	0.0	0.0	0.0	0.0	38.6	48.6	0.0	0.0	9.3	29.5	0.0	26.4	27.3	0.0	119.3	20.4	0.0	43.9	18.1	8.1	0.0	0.0	0.0	32.2	12.6	6.4	0.0	29.2	25.2	15.0	0.0	0.0	27.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	6.2	0.0	0.0	0.0	0.0	22.9	0.0	0.0	5.3	0.0	0.0	112.9	29.9	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	20.0	16.7	11.2	0.0	0.0
SMTNL1	CHASM	ENSG00000214872	"Smoothelin like 1"	A8MU46	11	57542641-57550274	"Predicted intracellular proteins"		"Calmodulin-binding, Muscle protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	51	"skeletal muscle: 711.3;tongue: 192.9"	"Cell type enriched"	"Detected in some"	5	"Skeletal myocytes: 5.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"U-266/70: 1.6;U-266/84: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 37: Myocytes - Muscle contraction"				"unprognostic (1.35e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.79e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.22e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.53e-3)"	"unprognostic (4.04e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.44e-2)"	0.4	0.2	0.7	0.9	0.1	2.3	0.4	0.2	0.3	0.4	0.0	0.2	0.3	0.3	0.0	8.8	0.5	0.3	0.3	0.2	0.2	0.2	0.8	0.9	0.8	2.5	0.6	0.5	0.1	0.0	0.5	0.1	0.5	1.6	0.0	0.6	6.1	0.0	711.3	0.3	0.5	0.0	1.3	1.1	0.2	0.5	0.9	0.0	0.4	192.9	0.0	0.2	0.4	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.4	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.4	0.0	0.1	0.7	0.3	0.2	0.0	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	1.6	1.0	0.0	0.1	0.4	0.0	0.6	0.3	0.7	0.4	0.4	0.4	0.2	0.3	0.5	0.2	0.3	0.6	0.4	1.1	0.2	0.5	0.2	0.2	0.1	0.7	0.1	0.2	0.3	0.2	0.2	2.5	0.6	0.5	1.3	0.9	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.1	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SORL1	"C11orf32, gp250, LR11, LRP9, SorLA, SorLA-1"	ENSG00000137642	"Sortilin related receptor 1"	Q92673	11	121452314-121633763	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Endocytosis, Transport"	Receptor	"Alzheimer disease, Amyloidosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 79.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 387.8;Excitatory neurons: 247.4;Microglial cells: 404.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 125.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 125.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 142.8;Daudi: 68.7;OE19: 93.5;RT4: 102.1;U-698: 139.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011500, HPA031321"	Uncertain				"Secreted to blood"	NA	NA		79000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB011500: AB_443414, HPA031321: AB_2673826"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.08e-2)"	"unprognostic (9.53e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.80e-7)"	"unprognostic (2.48e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.21e-2)"	7.0	6.1	29.1	24.4	39.1	47.4	13.9	49.5	35.5	44.4	0.0	17.3	11.6	5.4	8.9	5.4	40.1	7.3	2.4	33.8	39.7	19.0	58.2	10.4	21.1	40.3	46.8	9.0	8.0	10.4	16.8	2.3	47.0	20.8	16.9	20.3	21.8	25.4	1.7	3.4	18.1	4.5	45.3	21.8	10.3	5.1	38.8	17.0	13.5	4.0	23.0	15.7	6.6	79.1	1.3	8.1	7.3	1.1	0.0	0.0	7.4	0.4	2.4	0.3	0.0	11.9	142.8	68.7	8.5	1.8	10.5	47.4	9.1	7.0	0.1	0.0	2.6	0.0	10.3	16.8	0.1	29.6	0.1	0.0	7.6	0.0	25.8	4.0	0.0	8.7	0.0	0.7	0.0	9.7	7.1	15.3	8.8	93.5	10.8	7.7	0.4	1.6	15.8	102.1	5.1	1.5	15.2	21.5	0.0	16.0	21.0	9.5	0.3	0.1	4.9	1.0	0.0	0.0	0.0	139.8	0.1	38.6	0.4	44.3	15.9	59.1	22.1	6.9	29.3	1.9	24.6	20.0	6.6	5.1	23.1	20.8	125.7	20.9	9.4	16.4	19.3	21.2	29.1	39.1	49.5	35.5	33.8	39.7	40.3	46.8	47.0	45.3	38.8	79.1	1.6	6.4	23.3	160.9	20.7	4.5	42.3	23.3	18.2	68.8	44.5	22.0	12.3	18.6	36.8	79.1	387.8	0.4	130.1	132.1	0.0	10.3	1.2	21.6	2.9	10.3	6.1	8.8	247.4	0.7	0.7	5.8	14.3	24.7	12.0	20.6	34.6	114.5	39.1	50.5	80.1	54.6	40.7	62.4	16.9	5.0	77.9	67.0	3.6	404.7	97.5	28.0	146.2	74.9	86.0	6.4	81.1	57.9	28.6	36.1	168.6	1.0	15.6	31.2	0.0	19.5	10.3	2.9	18.8	20.8	2.4	0.4	60.2	32.7	42.2	33.4
SP100		ENSG00000067066	"SP100 nuclear antigen"	P23497	2	230415942-230545606	"Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 189.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 255.0"					"Low region specificity"	"Detected in all"			"HPA016707, HPA017384"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 57: B-cells - Immune response"	"Nuclear bodies"	Nucleoplasm	"HPA016707: AB_1857398, HPA017384: AB_1857399"	"unprognostic (8.04e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.86e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.77e-2)"	"unprognostic (6.25e-3)"	"unprognostic (5.32e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (1.96e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.25e-2)"	66.3	53.1	11.0	65.5	12.3	189.2	53.8	11.3	17.9	42.4	20.7	46.1	46.1	35.1	30.8	29.4	34.9	55.9	52.9	10.9	14.0	46.0	60.9	72.4	94.3	19.6	14.3	44.3	41.1	10.5	18.3	54.5	16.7	34.9	36.1	2.5	72.7	33.0	24.3	35.7	60.4	38.7	16.2	78.8	47.9	9.2	16.5	54.2	41.0	32.1	81.6	56.1	37.1	17.1	56.9	16.9	0.8	7.5	80.8	123.2	13.3	70.3	151.0	162.4	255.0	10.6	67.9	22.9	57.0	77.0	103.0	25.9	0.8	66.6	120.7	55.2	1.9	41.8	27.9	24.0	120.0	47.3	51.4	105.6	38.8	79.8	71.4	120.2	125.1	18.9	23.9	37.9	61.7	15.9	32.0	57.6	2.4	25.6	25.6	24.4	40.7	18.2	45.9	45.3	0.4	0.7	30.0	9.5	130.3	2.8	9.1	48.3	140.3	78.7	21.4	49.4	41.8	50.3	16.0	59.8	71.6	54.8	38.1	149.7	84.4	115.8	116.3	74.9	93.9	152.0	113.0	102.4	64.6	160.5	107.5	95.3	284.6	119.8	106.0	67.0	116.0	110.1	11.0	12.3	11.3	17.9	10.9	14.0	19.6	14.3	16.7	16.2	16.5	17.1	171.9	153.8	56.6	0.3	236.6	70.7	71.2	96.5	49.5	0.6	31.2	36.7	72.3	42.9	74.4	33.1	2.1	32.9	150.6	50.5	43.0	102.9	4.7	61.6	58.3	122.7	9.0	66.9	0.6	105.5	69.4	77.9	46.4	58.9	56.8	39.3	73.5	34.5	81.0	0.0	0.7	32.5	63.1	72.9	70.9	4.8	46.6	104.1	71.2	140.5	114.3	0.2	128.8	4.5	4.8	89.7	56.9	52.6	95.6	74.2	72.8	45.4	68.4	0.8	39.5	61.2	65.9	0.8	1.1	28.4	68.2	16.1	151.5	74.0	25.2	73.7
SP110	"IFI41, IFI75"	ENSG00000135899	"SP110 nuclear body protein"	Q9HB58	2	230165186-230225729	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 53.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 141.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 99.3"					"Low region specificity"	"Detected in all"			HPA058554			Supported	Nucleoplasm		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA058554: AB_2683754"	"unprognostic (9.72e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.02e-2)"	"unprognostic (8.33e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.65e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.38e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.99e-3)"	"unprognostic (9.50e-3)"	14.0	7.3	8.4	38.5	10.3	29.8	11.8	9.4	10.8	11.6	11.5	12.6	11.9	10.5	7.9	9.2	9.6	18.0	8.1	8.1	10.3	11.9	14.8	21.0	53.7	15.3	10.9	16.5	7.9	9.7	5.3	17.5	11.6	9.6	14.0	2.0	17.0	7.6	5.7	7.8	17.6	13.4	12.1	49.8	12.9	3.1	10.9	35.7	7.4	8.4	50.1	18.9	9.3	12.3	8.3	4.4	2.7	4.7	14.2	23.6	8.3	14.8	30.8	70.3	99.3	0.2	12.7	34.5	13.8	15.8	67.0	5.1	9.0	23.0	25.7	30.5	6.0	14.9	6.2	8.9	14.5	22.1	17.1	32.7	11.8	20.8	27.4	13.2	25.3	23.6	5.3	12.1	20.6	4.9	33.0	43.5	8.6	4.2	5.1	20.1	25.4	12.8	56.2	11.1	0.5	5.7	5.7	12.7	32.7	0.9	9.6	18.5	18.8	12.9	7.9	3.2	7.5	12.9	4.6	16.2	14.4	20.6	10.7	92.2	49.7	124.4	55.2	85.8	47.8	142.8	53.5	50.5	44.1	135.8	54.1	58.7	268.6	56.9	143.4	84.4	70.7	48.5	8.4	10.3	9.4	10.8	8.1	10.3	15.3	10.9	11.6	12.1	10.9	12.3	77.8	44.8	23.8	17.3	141.7	9.9	5.2	25.7	16.5	0.4	21.6	19.3	3.7	7.2	19.6	11.0	0.0	3.8	84.0	17.0	13.7	19.9	5.2	17.2	21.3	28.6	6.7	9.7	1.1	28.5	12.7	22.8	9.2	20.1	38.0	21.2	26.4	6.2	26.9	0.0	2.1	11.4	73.2	47.4	25.8	4.2	11.8	62.3	19.6	42.2	56.7	9.7	59.8	19.6	18.2	26.0	11.6	10.1	35.7	3.5	10.7	14.4	21.0	4.9	6.6	8.6	16.2	4.8	2.3	9.8	10.1	4.7	68.8	23.5	6.1	3.0
SPATA2	"KIAA0757, PD1, PPP1R145, tamo"	ENSG00000158480	"Spermatogenesis associated 2"	Q9UM82	20	49903391-49915529	"Predicted intracellular proteins"	Necrosis	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 45.2;Late spermatids: 62.5;Spermatocytes: 41.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048581, HPA052224"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA048581: AB_2680449, HPA052224: AB_2681769"	"unprognostic (4.02e-2)"	"unprognostic (5.98e-2)"	"unprognostic (8.26e-2)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.90e-2)"	"unprognostic (3.25e-3)"	"unprognostic (8.77e-2)"	"prognostic favorable (9.08e-4)"	"unprognostic (8.33e-2)"	"unprognostic (6.45e-3)"	"unprognostic (5.99e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.57e-2)"	"unprognostic (4.38e-1)"	"prognostic unfavorable (4.53e-4)"	"unprognostic (2.52e-1)"	3.9	5.8	19.9	3.7	21.6	12.2	3.7	17.5	20.9	3.9	8.1	7.8	7.8	5.3	3.6	5.6	4.7	3.4	6.9	21.0	16.7	5.0	5.8	4.0	3.6	17.2	19.0	4.5	8.0	5.6	7.9	3.5	16.7	5.8	6.3	6.5	5.9	3.9	13.1	5.0	7.5	3.1	17.0	11.4	5.7	14.3	21.1	3.8	8.0	7.8	3.6	4.1	3.7	21.5	7.8	9.4	6.3	5.7	7.0	5.0	10.3	4.9	7.2	16.7	7.0	29.7	6.1	5.9	10.1	4.9	8.6	14.1	4.7	8.1	8.8	8.3	4.5	3.1	5.6	19.5	6.6	8.5	12.2	5.0	9.6	8.6	5.4	5.5	3.6	8.2	10.8	6.6	4.0	16.5	8.7	21.5	9.5	10.5	11.3	6.5	6.8	6.2	5.4	6.1	6.0	6.4	9.8	29.6	7.8	4.9	7.2	7.3	5.1	11.9	9.8	9.9	7.0	16.2	13.4	6.3	9.3	4.4	5.4	0.1	1.5	1.4	1.4	1.1	1.3	1.3	1.3	1.7	1.3	2.1	1.6	1.9	2.5	1.5	0.5	0.6	1.5	1.0	19.9	21.6	17.5	20.9	21.0	16.7	17.2	19.0	16.7	17.0	21.1	21.5	5.4	9.6	2.2	2.9	7.8	7.4	6.6	4.3	12.5	7.4	11.9	8.6	4.9	10.0	2.8	0.0	8.4	11.0	8.3	34.7	3.9	6.0	45.2	11.4	4.7	6.3	26.4	1.7	6.8	8.0	13.4	5.4	9.7	9.0	4.5	5.4	10.4	7.1	4.8	6.7	5.0	22.2	2.0	4.4	5.4	62.5	5.0	3.6	5.4	1.9	7.0	5.4	4.1	2.0	8.5	8.3	16.1	5.7	6.4	7.4	20.7	4.8	6.7	7.6	6.6	5.8	6.6	41.3	16.9	7.8	7.2	30.1	6.8	10.3	18.4	8.5
SPOPL	BTBD33	ENSG00000144228	"Speckle type BTB/POZ protein like"	Q6IQ16	2	138501770-138573547	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034687	Uncertain		Approved	Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA034687: AB_10670573"	"unprognostic (1.39e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.12e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.75e-2)"	"unprognostic (8.90e-2)"	"prognostic favorable (3.63e-4)"	"unprognostic (2.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.91e-3)"	7.9	5.9	6.1	9.7	8.1	14.2	12.7	6.7	8.0	6.6	4.8	8.3	7.9	8.5	3.6	6.2	6.6	7.3	5.4	5.5	6.2	8.8	9.4	7.6	11.3	7.6	9.1	10.3	5.6	7.3	4.3	6.8	7.9	9.4	8.9	9.8	11.5	8.1	4.6	8.5	8.4	7.4	7.6	11.2	9.3	3.7	7.1	4.9	8.5	8.0	9.7	8.0	6.3	9.1	13.3	4.0	7.2	7.0	5.8	9.7	13.8	9.6	7.2	5.9	7.0	14.8	10.6	14.2	9.0	8.3	5.3	5.1	9.5	8.4	12.4	11.1	7.7	9.0	9.2	23.2	6.0	10.0	12.1	6.4	12.3	11.7	10.8	12.0	9.6	3.3	3.0	19.2	10.1	12.9	1.0	9.4	6.5	9.3	6.9	5.0	12.6	8.1	9.3	18.7	8.4	10.3	14.7	13.8	7.3	8.5	7.6	10.9	9.6	9.5	8.1	12.0	14.7	27.6	21.6	10.3	15.9	9.2	8.8	0.4	1.6	2.8	0.3	1.5	0.3	1.1	0.2	0.3	2.2	1.1	0.1	0.2	5.7	0.4	1.3	0.9	0.4	0.6	6.1	8.1	6.7	8.0	5.5	6.2	7.6	9.1	7.9	7.6	7.1	9.1	16.9	12.8	13.6	25.8	25.9	55.6	11.4	7.9	13.6	9.9	38.8	13.8	13.2	15.7	20.6	3.7	4.2	6.4	15.0	20.3	7.9	10.1	1.7	11.9	10.3	12.4	19.2	5.0	55.3	13.3	7.3	12.3	17.3	11.8	8.8	12.5	8.9	13.8	8.9	18.5	67.2	19.8	18.3	31.5	37.7	2.8	17.1	33.2	12.4	48.7	27.5	9.2	9.2	63.8	54.1	21.1	12.6	15.8	11.8	19.5	11.0	16.4	16.1	16.6	6.6	18.8	18.5	10.0	18.8	10.3	44.8	6.2	10.8	4.9	12.0	21.3
SPRYD3	FLJ14800	ENSG00000167778	"SPRY domain containing 3"	Q8NCJ5	12	53064316-53079404	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039426, HPA039685"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"	"Vesicles, Plasma membrane, Actin filaments"	"HPA039426: AB_10673358, HPA039685: AB_2676623"	"unprognostic (7.73e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.05e-3)"	"unprognostic (1.52e-2)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (1.27e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.14e-2)"	"prognostic favorable (1.78e-15)"	"unprognostic (9.82e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.41e-1)"	32.2	29.2	70.6	18.4	77.9	6.4	30.2	35.6	84.2	33.6	38.1	32.8	18.9	38.1	36.2	31.7	45.1	20.4	42.4	79.9	60.4	29.5	22.1	23.6	17.4	61.7	55.1	43.5	50.0	43.3	60.7	14.0	61.5	34.5	17.0	39.3	43.9	40.6	21.2	27.0	23.4	31.6	43.8	24.3	35.8	11.5	58.0	13.7	34.6	23.1	20.6	36.5	30.7	67.9	28.4	43.0	5.6	11.5	45.4	22.4	7.3	42.6	22.2	16.1	10.1	7.4	23.8	18.6	34.2	53.5	19.2	26.0	7.6	32.9	10.5	19.4	11.3	11.5	25.5	16.9	34.0	22.3	20.1	20.2	51.6	23.1	34.9	31.6	33.5	9.3	10.4	45.3	28.5	62.3	16.3	11.7	3.2	23.1	30.8	7.1	9.5	38.4	20.6	22.3	9.4	8.9	37.3	34.6	18.1	3.0	31.8	16.7	46.4	18.1	17.9	40.9	29.0	24.7	24.1	5.4	53.8	19.5	22.4	29.9	16.7	47.5	32.7	28.9	30.9	14.6	22.4	26.9	15.5	11.3	18.8	22.7	25.8	17.0	32.8	7.4	13.5	28.9	70.6	77.9	35.6	84.2	79.9	60.4	61.7	55.1	61.5	43.8	58.0	67.9	13.4	3.2	10.1	4.9	13.3	5.7	19.5	12.0	13.1	46.4	11.3	8.8	20.4	17.2	10.4	18.4	8.4	6.2	8.8	9.1	11.7	30.4	0.9	21.2	10.9	17.1	11.5	2.1	14.4	36.5	14.6	22.9	15.8	16.1	10.1	5.1	18.9	9.1	11.8	43.7	13.5	13.8	10.2	11.7	5.7	2.7	16.1	10.3	10.6	3.7	15.0	38.5	16.5	4.5	5.6	28.6	9.3	33.1	19.1	20.8	10.7	15.6	18.2	23.8	19.7	11.1	20.0	4.5	3.9	12.0	9.5	4.2	14.9	5.1	7.9	16.4
SRGN	"PPG, PRG, PRG1"	ENSG00000122862	Serglycin	P10124	10	69088103-69104805	"Plasma proteins, Predicted secreted proteins"	"Apoptosis, Biomineralization"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"bone marrow: 8096.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 2922.2;granulocytes: 2343.1;Kupffer cells: 1789.9;Langerhans cells: 6618.2;Macrophages: 3639.1;monocytes: 3188.2;Plasma cells: 1740.9;T-cells: 2235.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 5714.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 5714.1"	"Cell line enhanced"	"Detected in many"		"HL-60: 4442.1;NB-4: 2549.7;THP-1: 4346.8;TIME: 2609.1;U-937: 3546.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000759	Enhanced		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA		100000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"HPA000759: AB_1079675"	"unprognostic (3.61e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.80e-2)"	"unprognostic (9.82e-2)"	"prognostic unfavorable (3.18e-5)"	"unprognostic (1.65e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.08e-2)"	404.6	114.9	48.8	799.8	50.5	8096.7	136.4	55.5	99.6	93.2	70.1	101.8	77.9	63.5	25.9	91.0	96.8	316.4	111.9	48.2	67.8	98.3	239.4	347.3	437.2	82.4	59.3	30.7	68.4	131.6	62.1	355.6	67.8	58.9	118.9	15.5	40.1	57.4	37.5	18.9	111.4	219.4	65.5	362.8	95.0	18.3	64.7	228.9	72.7	117.1	314.6	508.3	46.1	71.0	5.3	43.0	0.2	0.4	768.1	749.7	1.2	94.9	63.9	235.1	283.5	0.1	18.2	9.1	117.4	4.1	134.4	1.1	0.0	20.6	799.9	535.7	0.4	87.1	29.8	0.3	312.7	4442.1	914.9	306.8	1.1	641.5	39.2	223.8	1227.8	13.3	82.5	419.9	1239.9	0.2	18.7	2549.7	0.7	0.1	84.6	2.4	2.3	446.7	0.6	6.0	0.3	0.8	2.3	0.6	16.0	0.0	2.2	4346.8	2609.1	187.9	12.9	3.8	20.1	486.4	508.4	57.3	112.2	3546.9	1.2	2349.8	1105.3	2730.6	474.9	774.6	313.4	73.5	228.5	362.8	583.0	39.0	125.5	268.4	5714.1	962.8	693.6	631.9	392.6	1590.5	48.8	50.5	55.5	99.6	48.2	67.8	82.4	59.3	67.8	65.5	64.7	71.0	1081.4	112.2	198.1	0.7	592.0	175.9	12.5	38.3	8.6	1.1	16.0	28.2	21.2	21.5	57.5	33.1	0.0	10.2	2922.2	2.9	0.0	4.2	4.1	4.6	15.0	566.8	1.8	277.8	0.2	9.8	10.2	87.9	70.3	6.6	2343.1	0.4	636.1	22.1	847.1	0.0	0.5	1.7	0.0	1789.9	6618.2	8.4	7.5	3639.1	556.7	80.6	3188.2	1.4	1292.5	0.0	0.2	1.3	1.2	18.0	1740.9	12.2	0.3	4.7	45.6	5.0	72.3	22.8	97.5	0.9	2.2	8.7	141.8	14.2	2235.9	1.2	5.5	18.1
SRSF4	"SFRS4, SRP75"	ENSG00000116350	"Serine and arginine rich splicing factor 4"	Q08170	1	29147743-29181900	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050975	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 22: Epithelial cell types - Mixed function"	"Nuclear speckles"		"HPA050975: AB_2681296"	"unprognostic (3.26e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (4.26e-4)"	"prognostic unfavorable (4.30e-4)"	"unprognostic (6.25e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.75e-3)"	"unprognostic (1.60e-2)"	84.7	61.1	43.4	46.8	45.4	77.5	78.2	47.6	46.6	82.3	44.1	86.7	49.6	79.7	38.6	73.5	71.7	36.4	61.9	43.0	46.9	62.9	95.8	83.5	57.4	44.8	43.7	88.2	61.6	38.7	56.0	57.6	45.6	72.0	35.6	51.8	62.5	39.6	94.1	76.2	73.1	40.6	43.0	81.9	66.7	44.5	45.0	63.2	73.7	51.7	43.4	77.7	76.6	46.1	108.2	63.5	117.0	42.8	83.9	63.0	72.5	87.6	65.5	103.3	88.0	58.6	64.9	122.2	79.9	74.5	66.9	99.0	99.7	81.4	104.5	148.6	118.9	185.7	95.6	92.9	87.2	127.8	114.0	51.1	101.1	87.7	111.8	83.9	86.6	70.2	154.8	95.7	71.1	54.1	162.2	110.4	125.2	64.4	60.0	150.6	126.9	83.3	71.1	110.0	71.3	81.4	107.4	61.5	105.8	103.4	41.0	76.3	84.2	82.9	66.1	91.0	146.4	88.0	70.6	134.5	79.4	161.0	91.9	72.7	45.7	102.2	64.6	55.1	63.3	49.0	59.7	70.5	55.8	53.1	51.0	55.0	89.6	48.4	62.3	43.2	78.9	51.1	43.4	45.4	47.6	46.6	43.0	46.9	44.8	43.7	45.6	43.0	45.0	46.1	142.3	80.1	129.8	23.8	94.2	99.8	179.6	65.0	91.0	70.2	50.2	42.9	51.1	45.8	92.8	51.5	85.5	132.7	100.0	68.4	54.8	64.9	8.2	85.4	98.4	131.0	39.0	114.3	20.1	47.2	124.6	87.8	76.5	99.4	91.7	76.2	101.0	75.9	68.8	57.2	21.1	72.7	59.0	69.8	79.0	11.6	85.7	83.4	55.2	14.0	88.6	74.8	92.7	19.6	19.6	56.3	78.8	89.1	121.4	172.3	83.1	58.3	91.7	108.3	72.3	99.5	97.4	64.7	51.9	95.9	103.3	142.8	105.1	75.9	78.7	210.4
ST20-MTHFS		ENSG00000259332	"ST20-MTHFS readthrough"		15	79845150-79923754	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in all"		"liver: 96.6"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 1.8;Collecting duct cells: 1.8;Erythroid cells: 4.2;Gastric mucus-secreting cells: 5.1;Squamous epithelial cells: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 492.2"	"Group enriched"	"Detected in all"	4	"granulocytes: 492.2;monocytes: 133.6"	"Low cell line specificity"	"Detected in all"											HPA008067	Uncertain					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"			"HPA008067: AB_1078882"	"unprognostic (9.84e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.06e-2)"		"unprognostic (4.41e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.75e-3)"	"unprognostic (6.63e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.19e-4)"	"unprognostic (2.38e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.04e-1)"	9.9	10.2	7.3	15.2	7.5	10.1	7.8	8.2	12.0	8.5	8.9	9.5	10.9	6.7	10.0	3.8	7.3	7.7	6.5	8.1	8.4	38.6	96.6	11.0	11.8	8.2	8.8	6.0	15.0	24.0	2.4	9.7	8.4	15.5	8.7	12.2	12.8	8.5	10.5	3.8	14.6	7.5	7.4	7.7	12.0	7.6	9.1	10.3	11.1	10.1	12.8	7.2	1.5	9.1	16.2	33.1	6.6	6.5	24.0	14.2	19.1	13.9	22.1	27.4	24.6	15.7	35.9	20.1	29.6	13.1	25.6	29.7	44.2	13.6	17.3	24.8	14.6	20.5	20.4	24.3	25.2	10.5	3.7	21.1	32.2	8.1	27.0	19.5	7.9	26.7	37.6	19.7	13.0	20.9	13.7	26.2	16.3	56.3	13.5	20.4	12.4	22.0	32.5	14.8	16.2	9.8	33.3	22.6	40.8	24.3	26.6	21.0	11.4	11.7	19.9	1.2	10.9	10.8	37.0	21.9	6.4	45.4	9.7	76.4	82.3	223.6	38.9	87.1	48.2	53.1	51.3	42.9	50.8	53.7	58.9	51.0	492.2	77.5	133.6	35.5	60.6	75.7	7.3	7.5	8.2	12.0	8.1	8.4	8.2	8.8	8.4	7.4	9.1	9.1	0.0	0.0	0.5	0.0	1.6	0.1	0.0	0.5	1.8	0.0	0.0	0.0	0.0	0.0	1.4	1.8	0.0	0.4	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.0	4.2	0.1	0.0	0.2	0.8	5.1	0.2	0.0	0.1	0.0	1.5	0.3	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.0	1.3	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	4.4	0.3	1.4	1.6	0.0	0.3	0.0
STARD3	"es64, MLN64"	ENSG00000131748	"StAR related lipid transfer domain containing 3"	Q14849	17	39637090-39664201	"Cancer-related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"SK-BR-3: 260.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017021, HPA024307, HPA073948"	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Vesicles"	"Endoplasmic reticulum"	"CAB017021: , HPA024307: , HPA073948: "	"unprognostic (1.11e-1)"	"unprognostic (2.14e-2)"	"unprognostic (6.35e-2)"	"unprognostic (8.92e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (3.60e-5)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.25e-3)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (1.33e-1)"	"unprognostic (5.22e-2)"	"unprognostic (8.51e-3)"	"unprognostic (3.00e-2)"	24.8	33.4	18.3	18.8	29.1	25.4	23.4	21.6	18.9	22.3	14.9	21.5	24.1	20.4	2.7	24.1	21.5	17.2	16.3	17.9	15.4	18.9	25.8	28.8	22.3	21.1	21.3	21.3	26.5	15.2	24.0	17.1	19.0	20.1	5.2	3.2	21.2	11.3	23.9	27.0	26.7	9.2	18.7	33.1	26.5	26.2	22.5	14.8	21.4	9.5	8.8	21.0	20.1	18.5	29.3	47.6	18.6	33.5	19.9	22.9	31.2	23.1	24.9	27.1	24.3	24.0	47.6	25.2	47.7	17.8	30.8	55.4	11.3	21.0	6.3	36.2	34.5	15.2	18.8	30.1	25.9	29.6	35.5	24.5	19.0	29.8	12.6	19.0	23.4	36.4	41.0	27.4	23.5	24.7	32.2	25.6	22.2	15.3	20.6	28.5	31.4	40.1	15.0	35.7	24.9	29.1	16.1	260.8	64.0	10.8	34.1	41.7	26.3	43.2	29.5	46.5	43.6	27.5	37.8	18.7	36.2	36.8	45.1	23.7	36.3	54.4	42.7	35.5	30.7	20.8	29.6	32.7	38.3	26.1	29.1	27.8	63.6	39.6	29.3	18.7	38.5	33.8	18.3	29.1	21.6	18.9	17.9	15.4	21.1	21.3	19.0	18.7	22.5	18.5	45.8	3.2	7.5	31.0	23.2	16.6	13.0	23.4	14.2	12.6	19.9	14.6	3.4	18.6	14.8	11.0	37.5	28.5	32.9	21.0	9.8	26.5	2.7	9.7	11.7	35.8	27.5	11.1	17.3	35.4	37.2	16.2	29.6	11.0	19.0	22.2	45.0	11.9	49.8	18.5	14.8	11.6	14.2	49.0	18.5	5.3	17.1	27.7	5.4	9.4	18.5	15.8	29.9	12.1	30.2	35.9	22.9	13.2	24.3	20.2	41.5	10.3	8.3	13.2	13.1	21.8	14.4	9.3	16.2	15.9	16.9	40.0	35.2	18.6	15.1	20.1
STAU2	39K2	ENSG00000040341	"Staufen double-stranded RNA binding protein 2"	Q9NUL3	8	73420369-73747708	"Predicted intracellular proteins"	Transport	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 278.9;Inhibitory neurons: 298.3;Oligodendrocyte precursor cells: 157.8;Oligodendrocytes: 149.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 152.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019155, CAB020836"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"CAB020836: , HPA019155: AB_1857565"	"unprognostic (5.75e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.47e-2)"	"unprognostic (3.76e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.62e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.44e-3)"	"unprognostic (4.25e-2)"	20.2	22.7	24.8	15.8	30.5	24.6	17.8	35.0	39.6	15.3	5.5	17.6	14.9	18.2	19.0	35.1	16.6	24.2	70.6	34.8	22.8	29.5	25.7	17.3	19.3	25.3	25.6	18.2	16.1	29.6	12.5	17.6	25.0	20.9	18.6	34.6	20.5	20.8	110.6	15.0	20.8	23.4	16.2	16.7	16.3	16.8	20.7	35.0	22.9	110.0	22.0	20.8	14.2	35.3	34.7	40.7	63.5	34.5	35.5	25.2	19.3	30.4	27.5	27.1	35.4	15.6	36.0	55.1	31.5	23.9	24.3	27.2	44.5	29.2	39.1	56.1	21.2	74.7	19.4	25.5	18.6	28.4	25.8	18.1	21.6	23.2	15.1	55.8	54.8	48.2	50.5	24.2	36.8	22.6	152.7	22.5	31.4	57.5	26.8	44.9	29.6	46.3	57.6	38.1	24.0	40.2	16.4	43.1	27.4	46.8	51.2	33.3	43.4	26.3	46.0	26.2	22.7	39.4	41.7	51.8	29.3	42.3	22.1	24.4	18.0	42.8	28.6	17.9	21.5	15.7	19.0	24.3	18.4	17.9	16.6	21.7	30.8	44.4	22.8	25.1	26.0	12.8	24.8	30.5	35.0	39.6	34.8	22.8	25.3	25.6	25.0	16.2	20.7	35.3	20.4	9.6	31.1	120.8	22.5	10.6	15.4	16.7	8.6	29.1	24.6	11.8	75.7	21.5	40.7	20.2	41.7	18.4	27.1	22.5	43.0	22.7	22.0	18.6	11.6	26.2	29.9	14.7	278.9	21.7	10.0	20.2	21.4	25.5	20.3	21.8	38.2	58.0	16.1	28.6	298.3	17.6	18.3	24.1	16.8	32.2	9.0	22.5	16.0	129.3	16.9	26.9	43.3	157.8	149.9	17.6	16.5	9.4	20.2	10.9	102.1	37.6	27.6	22.2	0.0	15.8	21.8	12.5	13.8	22.1	19.2	12.2	21.6	20.5	16.1	18.5
STK17B	DRAK2	ENSG00000081320	"Serine/threonine kinase 17b"	O94768	2	196133583-196176503	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 376.2;lymphoid tissue: 113.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 229.3;dendritic cells: 267.7;granulocytes: 195.1;Langerhans cells: 201.3;Macrophages: 198.9;Plasma cells: 191.8;T-cells: 342.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 122.3;HMC-1: 118.9;Karpas-707: 111.6;U-698: 132.1"	"Region enriched"	"Detected in all"	5	"cerebellum: 63.4"	"Low region specificity"	"Detected in all"			HPA034858	Enhanced		Uncertain	"Plasma membrane,Cytosol"		NA	Yes			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cytosol"		"HPA034858: AB_10670981"	"unprognostic (2.14e-1)"	"unprognostic (2.45e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.63e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.75e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.72e-8)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.80e-2)"	28.2	8.9	2.1	67.0	2.9	376.2	21.5	3.7	5.3	24.2	3.3	19.1	27.8	5.4	1.8	11.9	5.8	20.4	4.6	4.1	3.3	6.5	8.5	23.6	113.3	3.1	2.0	2.2	12.7	2.1	3.0	16.7	3.2	10.5	17.5	0.4	17.0	5.7	2.4	11.2	40.1	16.8	2.2	56.9	20.1	9.5	4.0	60.9	7.2	3.5	111.1	24.4	5.2	2.9	11.0	7.5	11.2	4.2	47.7	18.1	12.4	25.7	38.4	27.7	28.5	22.8	3.9	122.3	23.1	14.8	7.3	7.4	4.7	11.1	33.4	21.8	12.7	11.6	9.1	2.2	14.2	47.0	118.9	23.1	10.9	34.3	17.7	39.2	11.5	28.5	9.1	111.6	69.4	5.9	61.6	106.0	6.3	19.9	17.2	10.1	67.5	37.4	16.3	25.6	4.2	4.2	6.6	6.4	5.4	17.2	4.3	24.3	14.0	26.8	13.1	19.3	14.7	45.5	78.9	132.1	20.2	15.9	12.1	165.1	74.3	163.1	43.7	81.3	55.4	49.2	77.0	52.8	53.0	58.6	98.6	82.4	236.7	40.8	113.1	37.7	73.8	89.3	2.1	2.9	3.7	5.3	4.1	3.3	3.1	2.0	3.2	2.2	4.0	2.9	23.3	89.8	74.0	48.3	229.3	59.9	27.1	15.1	10.8	0.9	28.9	15.2	2.6	12.8	42.5	11.0	0.0	7.9	267.7	54.0	3.9	6.6	6.8	15.3	14.1	11.3	3.0	68.8	3.4	2.8	24.0	27.2	38.2	26.5	195.1	47.4	5.3	2.4	26.1	0.0	3.1	13.9	18.3	151.1	201.3	3.6	5.6	198.9	58.7	11.2	158.0	0.6	118.4	17.6	0.7	10.9	41.6	4.5	191.8	34.3	80.7	2.5	26.9	0.3	6.6	49.7	19.7	41.1	26.3	16.4	63.4	5.1	342.5	22.6	13.2	53.8
SUDS3	"FLJ00052, SAP45, SDS3"	ENSG00000111707	"SDS3 homolog, SIN3A corepressor complex component"	Q9H7L9	12	118376555-118418033	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 271.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040402, HPA041972"	Approved		Supported	"Nuclear bodies,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear bodies, Cytosol"		"HPA040402: , HPA041972: AB_2677776"	"unprognostic (1.49e-1)"	"unprognostic (4.08e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.60e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.05e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.37e-1)"	10.8	12.3	13.3	12.0	14.2	16.9	18.7	9.6	15.2	16.6	12.1	16.5	14.3	14.9	16.0	19.9	18.1	11.7	12.8	15.8	12.9	16.1	14.0	11.9	14.7	12.7	14.6	15.0	17.3	25.3	11.6	11.5	14.1	16.2	18.3	16.3	19.2	15.7	11.3	20.1	14.1	13.7	10.6	13.7	16.2	16.4	12.2	17.9	21.7	11.9	19.5	14.4	15.2	13.2	29.4	21.9	29.4	29.4	16.1	21.1	31.5	22.5	23.2	25.8	20.4	24.1	18.6	39.8	23.5	21.8	16.0	34.3	35.3	23.8	30.3	35.3	20.9	27.7	18.4	21.6	18.4	30.9	20.5	14.6	25.0	12.8	22.7	33.5	22.2	36.9	30.8	14.1	23.9	20.2	36.7	40.2	30.5	38.8	17.0	32.9	26.4	28.3	23.7	42.7	22.9	22.7	31.9	18.7	19.9	36.7	61.1	24.9	18.7	17.5	16.6	19.7	15.5	26.2	31.4	29.2	19.4	19.4	21.4	1.8	4.3	5.9	5.0	2.8	6.1	8.8	5.4	5.7	4.7	8.4	6.4	4.4	12.6	4.3	2.8	6.8	5.5	3.9	13.3	14.2	9.6	15.2	15.8	12.9	12.7	14.6	14.1	10.6	12.2	13.2	25.5	28.9	15.9	19.6	37.8	64.7	44.7	55.0	46.1	75.4	85.6	63.0	37.5	41.5	37.1	47.8	77.2	34.6	26.9	75.1	80.3	41.5	271.9	87.6	54.4	24.6	37.3	30.3	22.4	19.3	54.5	31.5	36.7	73.2	8.2	37.5	21.0	34.1	25.0	107.7	29.1	60.2	59.0	18.2	36.1	59.4	38.5	20.8	28.4	13.1	30.5	30.0	29.9	30.2	21.6	26.4	52.6	41.0	49.1	60.5	38.3	45.7	61.9	57.3	26.3	42.8	48.5	62.6	53.4	74.1	78.7	49.1	32.9	41.6	56.8	61.9
SUPT20H	"bA421P11.4, C13orf19, FAM48A, P38IP, SPT20"	ENSG00000102710	"SPT20 homolog, SAGA complex component"	Q8NEM7	13	37009312-37059713	"Predicted intracellular proteins"	"Autophagy, Gastrulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 56.3"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 145.7;Spermatocytes: 316.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038906, HPA038907"	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli fibrillar center"		"HPA038906: AB_10673482, HPA038907: AB_10697401"	"unprognostic (4.04e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.81e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.46e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.30e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.21e-3)"	10.1	9.1	8.8	12.3	9.9	19.2	10.0	11.3	12.7	13.7	11.0	15.4	7.6	13.4	8.8	10.4	15.2	10.6	12.1	9.0	9.9	10.2	6.5	11.8	13.9	10.2	9.7	13.0	7.5	9.9	9.8	13.6	9.8	11.4	11.3	11.0	8.9	12.5	14.6	9.4	10.6	16.1	9.4	13.4	9.9	56.3	9.7	23.7	9.2	11.4	15.9	13.6	10.6	11.3	13.8	16.7	52.0	29.5	19.2	26.1	21.7	36.4	22.6	40.8	29.4	28.0	26.3	27.3	14.7	29.4	45.3	23.4	32.6	37.7	54.2	38.1	29.5	82.9	11.7	30.6	36.9	33.9	35.4	19.9	23.1	37.0	63.2	24.9	49.3	36.7	27.5	6.9	47.9	20.5	47.6	23.7	32.7	31.9	18.8	38.2	36.3	5.9	30.6	21.5	9.7	26.1	23.4	20.9	26.0	41.3	15.1	29.8	29.8	16.5	14.4	19.4	31.1	11.5	12.3	26.8	18.8	19.9	31.7	18.9	16.1	22.6	18.9	21.1	16.7	12.9	18.0	17.0	15.3	14.1	20.6	19.7	28.1	19.3	20.4	11.9	21.7	15.2	8.8	9.9	11.3	12.7	9.0	9.9	10.2	9.7	9.8	9.4	9.7	11.3	25.9	22.4	29.6	34.9	29.0	13.5	16.1	18.8	19.4	36.0	20.3	22.6	16.4	14.3	28.1	31.3	35.5	32.4	26.4	13.1	21.5	24.7	145.7	48.5	35.6	21.4	31.2	33.9	41.8	14.5	31.0	23.3	25.0	25.3	45.5	60.2	23.2	9.8	19.6	21.9	47.7	20.4	26.4	18.2	16.8	29.4	34.2	22.6	7.2	54.4	33.2	17.3	37.0	45.2	60.1	21.6	14.9	33.4	25.4	19.6	17.9	17.6	40.5	34.4	32.9	20.1	27.8	316.0	74.2	23.3	9.9	26.4	34.5	69.4	19.9	15.7
SYF2	"CBPIN, DKFZp564O2082, fSAP29, NTC31, p29"	ENSG00000117614	"SYF2 pre-mRNA splicing factor"	O95926	1	25222276-25232502	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018265, HPA070710"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear speckles"		"HPA018265: AB_10962002, HPA070710: AB_2686301"	"unprognostic (4.19e-3)"	"unprognostic (1.58e-2)"	"unprognostic (9.98e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.76e-2)"	"unprognostic (6.76e-3)"	"unprognostic (7.40e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.58e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.45e-3)"	"prognostic favorable (5.72e-4)"	75.3	56.5	37.8	42.6	38.4	147.6	66.9	39.9	48.4	70.1	39.0	71.6	55.4	59.9	72.2	49.3	63.7	40.7	50.0	36.9	41.6	64.0	48.3	46.4	63.8	39.3	38.4	104.5	59.1	67.8	35.3	57.1	40.3	50.3	59.4	29.5	52.0	51.3	89.1	58.5	57.7	47.0	39.2	55.9	61.9	26.9	38.4	77.6	59.0	57.8	76.8	63.2	60.1	41.4	54.0	22.0	54.9	45.4	85.2	109.0	42.4	56.1	91.0	52.7	47.8	13.7	73.0	46.2	75.6	68.1	39.8	47.3	47.6	43.2	76.4	76.2	39.4	52.8	56.1	41.8	86.6	75.9	54.3	79.4	118.2	54.3	75.2	100.4	76.0	61.8	42.0	74.4	75.2	19.8	77.6	104.0	71.7	78.9	32.4	51.3	46.3	78.9	86.9	28.6	47.8	69.5	49.1	44.5	160.5	47.7	38.3	91.5	61.8	45.9	40.6	87.0	46.8	86.7	83.4	48.6	67.6	77.7	45.2	185.5	82.1	222.9	79.1	98.4	95.7	140.0	102.4	99.9	70.0	125.5	108.4	102.0	337.6	111.3	121.6	67.3	129.2	92.7	37.8	38.4	39.9	48.4	36.9	41.6	39.3	38.4	40.3	39.2	38.4	41.4	160.7	128.2	112.8	6.8	176.0	159.3	123.0	238.5	111.5	74.3	134.9	174.1	108.1	147.3	151.3	189.4	83.4	195.7	203.9	211.7	246.5	158.6	78.7	153.2	125.9	137.4	111.4	117.6	10.6	174.2	130.1	121.1	59.1	166.8	232.4	120.9	154.9	131.3	126.4	58.9	10.2	166.0	181.0	231.5	155.4	32.1	214.6	155.4	108.5	3.7	251.8	95.0	217.3	6.0	12.5	154.5	221.1	164.7	83.0	109.5	322.0	273.4	151.0	90.5	164.3	139.5	142.5	98.2	108.8	88.1	171.3	280.6	176.8	95.9	171.8	147.2
SYK		ENSG00000165025	"Spleen associated tyrosine kinase"	P43405	9	90801787-90898549	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Host-virus interaction, Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 73.8;parathyroid gland: 87.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 91.3;Hofbauer cells: 73.1;Kupffer cells: 96.7;Macrophages: 95.2;Microglial cells: 114.3;monocytes: 92.5;Plasma cells: 83.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	13	"classical monocyte: 77.3;eosinophil: 83.5;intermediate monocyte: 64.0;memory B-cell: 74.5;myeloid DC: 85.1;naive B-cell: 58.4;neutrophil: 112.1;NK-cell: 30.0;non-classical monocyte: 60.2;plasmacytoid DC: 63.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 125.8;HEL: 72.8;HL-60: 101.6;HMC-1: 64.1;REH: 84.4;THP-1: 76.8;U-698: 58.8;U-937: 70.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001384, CAB007773"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		No	NA		290000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane, Cytosol"	Vesicles	"CAB007773: AB_562232, HPA001384: AB_1080144"	"unprognostic (1.01e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.78e-2)"	"unprognostic (7.20e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.55e-3)"	"unprognostic (8.77e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.41e-2)"	"unprognostic (1.06e-2)"	7.4	4.6	4.1	42.5	4.1	50.9	6.8	4.5	4.9	7.7	4.2	20.1	30.8	4.1	16.1	17.5	17.0	12.9	2.9	3.8	5.0	11.2	4.5	20.6	61.8	7.1	5.8	1.7	9.1	87.6	2.4	12.0	7.0	3.8	20.5	0.7	8.4	4.2	1.0	9.9	36.3	9.3	6.6	40.3	19.1	6.9	7.1	49.7	25.6	2.4	73.8	17.5	8.3	9.8	22.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	14.3	125.8	3.5	0.0	4.2	19.1	2.7	10.2	0.0	0.0	17.0	72.8	0.0	0.0	0.0	101.6	64.1	0.0	14.0	0.0	1.4	0.0	0.0	15.5	2.0	9.9	0.0	15.4	0.1	44.4	0.7	47.0	0.0	84.4	0.1	34.6	2.6	18.6	6.4	5.7	0.1	8.7	0.1	0.3	7.9	76.8	0.2	0.0	0.4	0.1	0.1	0.2	0.0	58.8	0.0	70.3	0.0	5.3	77.3	83.5	0.3	64.0	0.3	74.5	0.2	0.2	85.1	58.4	0.2	0.1	112.1	30.0	60.2	63.2	0.1	44.6	4.1	4.1	4.5	4.9	3.8	5.0	7.1	5.8	7.0	6.6	7.1	9.8	0.5	12.8	20.2	0.0	91.3	3.4	3.7	8.7	12.0	1.4	6.3	2.8	1.6	14.3	12.8	14.7	0.0	1.3	70.4	16.5	15.6	15.0	7.1	10.7	1.0	2.1	10.3	37.9	0.4	12.5	2.6	2.1	22.4	12.6	43.6	0.0	3.3	1.0	73.1	0.0	0.7	24.4	0.0	96.7	28.8	6.2	0.6	95.2	12.4	114.3	92.5	0.0	62.8	1.5	0.5	18.2	25.1	0.0	83.1	2.5	31.4	0.4	10.4	0.2	6.6	0.7	2.3	0.8	0.7	30.4	5.7	1.4	8.3	0.0	31.1	8.0
TACC3	"ERIC-1, ERIC1, maskin, Tacc4"	ENSG00000013810	"Transforming acidic coiled-coil containing protein 3"	Q9Y6A5	4	1712891-1745171	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 58.9;lymphoid tissue: 52.4;testis: 50.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 70.4;Hofbauer cells: 43.9;Late spermatids: 69.9;Spermatocytes: 94.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005781, HPA006050, CAB010111, HPA022039"	Enhanced		Enhanced	"Vesicles,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	Yes		11000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Mitotic spindle, Centriolar satellite, Cytosol"	Vesicles	"CAB010111: AB_628323, HPA005781: AB_1857724, HPA006050: AB_2667505, HPA022039: AB_1857725"	"unprognostic (2.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.71e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.10e-3)"	"unprognostic (4.61e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.26e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.44e-3)"	"unprognostic (9.75e-2)"	5.3	3.9	4.2	24.9	4.3	58.9	3.5	5.2	5.3	3.6	5.2	10.3	6.6	3.3	4.8	14.9	2.8	4.2	3.3	4.5	4.4	2.7	3.5	6.5	43.2	4.8	5.3	2.2	1.4	2.3	2.6	8.7	4.8	2.4	10.6	1.9	3.9	2.5	2.0	6.4	12.9	6.4	4.2	22.1	6.4	50.6	5.1	52.4	2.8	3.4	39.3	5.0	5.4	4.7	106.7	88.7	129.5	72.2	6.7	15.2	72.9	114.6	62.1	135.4	87.6	93.5	122.8	133.8	48.0	65.4	149.9	71.4	142.5	86.8	131.1	59.8	77.0	113.8	67.2	85.8	5.9	146.6	85.5	5.2	5.7	85.6	46.0	26.0	102.2	110.3	106.3	90.8	123.8	87.1	207.5	204.0	139.3	89.2	111.6	139.1	90.5	55.0	73.8	125.5	99.8	62.8	70.1	42.3	33.1	95.2	83.3	90.5	56.4	75.4	90.0	65.4	176.7	69.5	102.5	207.1	43.2	141.1	109.1	45.5	30.0	37.9	8.5	12.5	11.1	7.8	16.5	11.5	15.3	10.8	28.3	13.1	91.8	12.2	9.6	8.3	42.5	32.5	4.2	4.3	5.2	5.3	4.5	4.4	4.8	5.3	4.8	4.2	5.1	4.7	6.0	0.0	6.7	2.0	16.5	2.2	1.2	3.2	1.2	1.7	2.4	3.0	2.6	2.8	3.4	9.2	8.4	19.5	6.4	11.2	0.0	2.2	70.4	4.2	2.8	5.2	1.2	37.2	2.3	0.7	20.4	6.0	12.8	4.3	5.1	24.5	8.9	5.1	43.9	5.0	3.2	9.5	4.1	23.2	10.8	69.9	2.8	34.1	0.0	4.7	24.4	1.4	6.2	0.5	0.8	2.9	4.2	2.6	18.0	1.3	2.6	2.8	0.9	2.7	6.6	2.0	4.8	94.3	37.7	12.8	1.4	4.0	23.2	2.2	16.1	2.7
TAGAP	"ARHGAP47, FLJ32631, IDDM21"	ENSG00000164691	"T cell activation RhoGTPase activating protein"	Q8N103	6	159034468-159045152	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 146.6;lymphoid tissue: 47.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 249.5;dendritic cells: 152.3;Macrophages: 91.1;NK-cells: 86.5;Plasma cells: 272.1;T-cells: 223.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 30.1;HMC-1: 42.5;Karpas-707: 43.8;U-266/84: 20.6;U-698: 39.6;U-937: 33.4"					"Low region specificity"	"Detected in all"			"HPA031000, HPA039982"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA031000: AB_10610560, HPA039982: "	"unprognostic (9.86e-3)"	"unprognostic (7.55e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.25e-2)"	"unprognostic (3.35e-3)"	"unprognostic (8.39e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.24e-2)"	"unprognostic (7.39e-2)"	5.0	2.8	1.0	28.9	1.1	146.6	3.9	1.3	2.1	3.4	3.0	5.9	4.4	9.5	2.3	4.1	2.0	6.9	1.6	1.2	3.4	1.3	4.1	8.4	39.6	2.7	2.0	2.2	0.9	0.7	0.8	3.4	2.1	2.8	8.2	1.5	3.0	1.8	0.7	1.2	10.2	26.0	2.2	22.8	7.2	1.6	2.2	24.3	1.6	2.3	47.6	10.0	1.2	4.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	30.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	6.2	0.0	0.0	0.0	15.6	42.5	0.3	0.0	0.0	0.0	0.0	0.0	9.0	0.1	43.8	0.0	0.0	4.0	8.2	12.0	0.0	0.0	1.4	0.0	1.4	0.0	0.0	0.3	0.2	0.0	0.1	0.1	1.2	0.0	6.9	0.2	0.0	0.0	0.0	0.0	4.7	20.6	39.6	0.0	33.4	0.0	163.6	27.8	88.4	54.8	20.4	62.6	45.9	73.9	64.6	27.9	46.6	56.9	40.8	169.7	45.6	27.6	9.3	57.5	60.9	1.0	1.1	1.3	2.1	1.2	3.4	2.7	2.0	2.1	2.2	2.2	4.2	5.2	3.2	6.6	0.0	249.5	2.8	0.3	0.2	3.4	0.3	4.4	6.0	0.6	0.0	1.4	0.0	0.0	0.7	152.3	0.2	0.0	0.1	0.3	0.5	0.4	5.2	0.0	8.8	1.2	0.0	0.6	4.3	16.8	0.5	19.0	1.8	1.4	0.8	24.9	0.0	1.0	0.0	0.0	21.9	60.2	1.1	1.2	91.1	28.4	20.6	21.5	0.4	86.5	1.5	0.0	0.0	0.0	22.6	272.1	0.3	0.0	0.3	1.2	0.2	0.0	0.8	2.0	0.1	0.1	2.0	2.7	0.8	223.6	4.6	0.4	0.3
TAGLN2	"HA1756, KIAA0120"	ENSG00000158710	"Transgelin 2"	P37802	1	159918107-159925507	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 2404.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA001925	Approved		Approved	"Actin filaments,Cytosol"	"Intracellular and membrane"	NA	NA		270000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol	"Actin filaments"	"HPA001925: AB_1857756"	"prognostic unfavorable (2.06e-5)"	"unprognostic (2.56e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (7.07e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.21e-1)"	"unprognostic (3.56e-3)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (1.92e-10)"	"unprognostic (1.81e-1)"	"unprognostic (9.22e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.50e-2)"	401.9	154.7	103.7	356.0	103.2	437.3	355.4	106.3	115.0	266.6	94.9	337.4	314.3	220.5	94.9	494.0	231.9	282.6	351.1	101.1	152.7	307.9	254.4	687.7	321.1	141.7	117.6	170.9	284.7	81.0	100.0	378.2	122.9	208.5	307.9	46.1	388.7	205.2	83.4	418.2	356.3	254.4	125.2	479.7	698.8	127.0	125.9	309.6	210.2	139.6	386.4	436.1	350.0	114.9	1382.3	723.7	22.3	8.3	266.8	646.6	835.4	760.0	872.6	1635.2	799.8	786.6	1049.3	862.0	628.0	954.9	495.0	1054.3	378.1	1039.9	978.8	974.3	355.5	1140.7	651.8	50.0	322.7	808.2	1221.4	667.4	776.9	1030.4	504.3	1134.7	1029.0	260.3	494.8	578.9	586.1	563.0	378.1	601.2	619.3	947.6	1457.7	2.9	391.7	1275.3	376.6	527.7	340.7	325.6	900.7	1435.1	410.3	1190.6	756.5	814.2	1147.3	955.1	1134.4	876.9	2078.0	230.8	110.6	525.0	1238.3	541.3	603.8	1458.4	742.0	3160.6	558.9	449.7	499.9	866.5	620.0	544.6	1177.7	680.2	321.6	360.3	3746.8	817.6	356.9	1966.4	756.1	2257.9	103.7	103.2	106.3	115.0	101.1	152.7	141.7	117.6	122.9	125.2	125.9	114.9	617.1	179.5	130.5	0.3	507.8	549.1	330.6	454.3	307.9	31.6	257.0	201.8	12.8	121.5	221.4	183.9	18.8	497.4	567.6	371.0	74.3	1273.4	54.3	289.4	145.9	509.6	317.8	197.6	0.1	1206.9	2404.5	405.2	545.3	242.7	418.8	32.0	265.2	64.1	443.7	3.3	0.6	445.5	284.8	285.9	952.4	85.9	118.7	651.5	334.4	16.9	911.4	66.3	186.4	0.5	1.6	877.4	263.2	63.9	393.4	337.5	324.2	208.2	275.9	25.6	184.1	358.3	324.3	14.3	20.7	494.1	572.5	230.4	393.6	136.7	271.7	405.9
TALDO1		ENSG00000177156	"Transaldolase 1"	P37837	11	747415-765012	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pentose shunt"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 820.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 2870.4;neutrophil: 3726.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048089			Approved	Nucleoplasm,Cytosol		NA	NA		29000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm	Cytosol	"HPA048089: AB_2680260"	"unprognostic (5.29e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (9.65e-3)"	"unprognostic (2.97e-2)"	"unprognostic (4.15e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (9.78e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.97e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.16e-3)"	139.5	80.7	108.0	121.8	128.8	464.8	121.0	129.3	119.3	101.9	105.2	99.6	116.0	68.4	66.4	330.6	79.1	100.0	95.5	108.0	113.8	111.6	136.2	109.1	107.8	135.8	119.3	77.0	107.5	49.3	53.0	88.0	130.0	91.9	78.4	34.2	132.8	60.1	120.7	132.7	101.0	60.8	124.0	152.6	132.5	40.4	120.1	109.9	140.3	107.1	115.8	160.8	142.1	148.2	331.0	405.5	115.4	218.1	235.8	136.5	338.0	242.2	313.8	238.2	194.5	176.6	694.8	179.5	323.1	324.7	181.9	345.5	185.6	263.5	122.8	238.9	372.5	310.9	146.0	616.4	250.3	498.4	449.0	112.0	210.6	159.6	129.0	170.4	331.6	224.0	413.5	294.3	224.5	318.0	296.4	601.2	183.9	478.9	326.0	243.5	131.5	656.4	437.9	185.4	284.2	100.1	224.9	466.1	243.3	102.4	220.0	383.9	434.1	107.9	99.5	86.0	232.9	122.9	132.1	223.5	238.5	440.5	444.7	1456.7	1203.5	2870.4	94.1	432.7	102.3	145.5	125.7	115.5	654.2	127.2	100.9	94.9	3726.6	112.2	457.8	267.0	192.7	1066.0	108.0	128.8	129.3	119.3	108.0	113.8	135.8	119.3	130.0	124.0	120.1	148.2	90.2	141.1	117.2	10.7	91.1	73.5	199.8	354.0	61.5	50.3	113.0	122.2	46.4	100.1	253.4	150.8	14.6	419.8	83.8	151.0	250.5	230.4	82.1	156.5	85.4	85.6	101.5	507.0	13.1	272.1	427.6	97.3	144.3	216.7	161.4	86.0	93.5	149.7	418.3	50.5	11.6	186.0	268.5	271.8	169.4	21.2	117.8	352.8	140.5	7.5	820.0	142.1	84.5	10.6	54.8	257.6	200.3	104.2	129.4	361.9	197.7	309.1	232.6	61.7	72.3	59.6	115.0	143.2	140.6	257.6	83.1	526.6	86.8	77.5	215.1	342.6
TAP1	"ABCB2, D6S114E, PSF1, RING4"	ENSG00000168394	"Transporter 1, ATP binding cassette subfamily B member"	Q03518	6	32845209-32853816	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport"	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 126.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009516, HPA072354"	Approved		Approved	"Endoplasmic reticulum,Centriolar satellite"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum, Centriolar satellite"		"CAB009516: AB_2303048, HPA072354: AB_2686513"	"unprognostic (3.59e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (9.01e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.56e-2)"	"prognostic favorable (4.07e-4)"	"unprognostic (3.02e-3)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (6.58e-5)"	"unprognostic (2.07e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.21e-2)"	28.4	24.9	16.1	50.1	16.2	13.7	20.7	15.8	20.3	21.6	16.2	30.3	36.0	20.5	2.5	31.6	17.8	12.7	25.4	14.7	16.2	21.8	19.3	52.7	50.0	24.0	16.1	12.1	14.5	7.0	11.6	12.1	21.2	21.9	12.5	1.7	25.9	7.0	16.3	51.2	42.6	11.5	18.6	73.0	33.4	11.5	19.4	25.5	17.0	7.4	21.3	23.9	24.4	17.4	22.9	13.7	0.1	16.1	8.8	11.4	126.2	8.1	34.3	59.3	86.5	2.0	27.3	41.8	25.0	12.6	48.9	45.8	4.5	20.6	5.3	81.0	6.1	26.5	4.1	10.8	42.3	0.1	17.5	15.0	17.9	17.1	10.4	8.6	15.4	8.4	1.9	55.0	10.6	10.5	17.7	27.4	0.8	3.1	11.1	47.6	5.2	32.8	25.0	10.5	0.2	1.2	6.7	38.0	33.4	1.7	30.9	37.4	9.7	21.5	8.1	53.1	11.4	59.9	82.6	12.6	16.6	16.6	16.4	176.8	99.5	270.1	155.8	101.6	133.8	137.3	125.2	153.7	95.0	107.5	120.9	124.6	295.6	132.9	94.6	94.8	213.8	221.2	16.1	16.2	15.8	20.3	14.7	16.2	24.0	16.1	21.2	18.6	19.4	17.4	72.1	25.6	24.0	9.1	62.1	74.7	47.1	54.5	27.3	4.8	21.5	15.9	7.3	24.3	33.1	5.5	0.0	5.6	108.0	78.8	5.9	81.6	0.5	31.3	39.3	63.6	16.8	12.6	1.1	75.3	95.0	26.9	42.8	77.9	26.6	13.8	27.1	11.1	45.9	15.2	1.9	55.9	57.0	31.9	90.6	0.3	13.1	43.9	23.2	16.9	115.9	25.1	149.3	12.1	3.6	91.3	38.8	10.5	84.8	70.2	84.6	6.9	29.4	2.8	6.6	18.1	27.8	1.0	1.3	20.4	76.4	4.8	92.3	18.2	54.5	52.1
TAX1BP1	"CALCOCO3, TXBP151"	ENSG00000106052	"Tax1 binding protein 1"	Q86VP1	7	27739331-27844564	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024432	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	Nucleoplasm	"HPA024432: AB_1857783"	"unprognostic (1.38e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.83e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.59e-2)"	"unprognostic (6.72e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (3.69e-1)"	"prognostic favorable (2.80e-6)"	"unprognostic (1.76e-1)"	"unprognostic (4.76e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.03e-1)"	57.0	107.0	58.0	54.9	61.1	106.6	78.7	62.5	67.6	64.7	71.5	72.3	63.4	63.5	88.2	113.6	78.4	73.1	128.1	56.4	65.7	102.2	80.4	69.5	57.5	61.2	59.9	55.3	69.9	125.2	44.7	104.2	61.3	83.3	79.6	124.3	91.6	79.7	94.4	57.1	67.9	66.0	59.6	66.2	76.3	77.2	63.6	76.7	98.6	89.2	67.8	101.5	52.4	64.5	180.9	98.2	98.1	93.4	151.9	109.9	66.5	131.5	160.9	96.6	120.1	79.8	142.8	38.3	120.9	193.5	166.1	125.0	92.8	86.1	149.8	72.3	48.2	103.6	98.5	160.2	143.0	152.7	117.9	93.7	175.2	112.4	127.9	115.7	105.5	65.3	117.3	113.9	197.5	66.5	67.4	150.1	110.7	234.6	91.0	55.6	105.3	79.1	136.7	200.8	64.9	105.4	184.5	237.8	280.6	187.1	111.1	226.5	114.6	90.5	140.1	113.8	87.8	207.6	154.1	71.2	106.1	283.6	212.3	155.3	81.3	211.8	68.6	100.4	84.4	70.8	81.7	81.2	59.6	62.3	74.5	75.2	163.7	63.4	114.8	55.0	117.1	85.8	58.0	61.1	62.5	67.6	56.4	65.7	61.2	59.9	61.3	59.6	63.6	64.5	111.3	214.7	199.3	58.1	122.8	183.3	269.4	220.7	100.7	375.3	161.6	98.2	595.7	134.4	268.4	128.8	95.9	154.7	178.2	209.3	412.8	211.5	124.3	342.9	128.2	142.9	140.0	160.4	107.4	262.9	105.6	156.7	118.3	245.9	148.8	101.3	78.9	106.3	123.1	159.9	107.0	162.1	242.1	144.7	107.3	94.2	116.8	191.4	113.8	86.2	260.0	189.8	141.1	82.0	105.7	301.4	166.1	148.6	157.4	291.0	146.0	323.4	546.6	147.6	105.2	126.6	202.7	221.8	137.5	121.7	191.9	621.4	166.1	197.0	140.3	393.3
TBC1D10C	"Carabin, EPI64C, FLJ00332"	ENSG00000175463	"TBC1 domain family member 10C"	Q8IV04	11	67403915-67410089	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 40.4;intestine: 25.6;lymphoid tissue: 58.6"	"Group enriched"	"Detected in many"	4	"B-cells: 109.6;dendritic cells: 144.4;NK-cells: 284.2;T-cells: 147.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 19.0;JURKAT: 27.3;MOLT-4: 47.1;NB-4: 64.7;U-937: 24.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA069743	Enhanced		Approved	"Nuclear bodies"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear bodies"		"HPA069743: AB_2686186"	"prognostic favorable (3.83e-4)"	"prognostic favorable (4.20e-4)"	"unprognostic (9.23e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.28e-3)"	"prognostic favorable (1.86e-5)"	"unprognostic (6.22e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (4.35e-7)"	"unprognostic (1.52e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.81e-2)"	2.3	0.7	0.7	25.8	1.2	40.4	1.1	0.4	1.2	1.4	0.8	4.1	5.5	0.9	0.1	2.3	1.9	3.2	0.9	0.6	0.6	2.5	2.6	8.9	56.7	0.9	0.5	0.5	0.8	0.2	0.5	0.8	0.6	1.9	1.5	0.0	3.8	0.7	0.9	1.4	25.6	0.5	0.5	58.6	7.6	0.5	0.7	46.0	7.6	0.6	21.8	3.2	1.7	1.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	8.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	11.7	0.1	1.2	0.0	6.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	27.3	0.1	0.0	0.0	0.3	47.1	64.7	0.0	0.0	0.0	6.6	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	4.5	0.0	0.0	0.1	0.2	0.0	0.4	0.5	12.2	0.0	24.6	0.0	191.0	46.0	270.4	237.7	120.4	169.7	177.3	201.5	208.3	65.6	184.2	206.7	192.0	237.6	148.0	167.0	55.8	286.6	261.6	0.7	1.2	0.4	1.2	0.6	0.6	0.9	0.5	0.6	0.5	0.7	1.1	2.5	6.4	19.5	0.0	109.6	1.1	0.1	0.1	0.6	1.0	1.4	1.9	1.5	2.8	2.5	0.0	0.0	0.2	144.4	0.2	0.0	0.2	0.2	2.4	0.4	1.9	1.2	12.6	0.2	0.0	0.3	2.0	2.0	1.1	23.4	0.1	5.0	1.4	23.7	0.0	0.1	0.0	0.0	16.0	6.9	0.6	0.0	23.1	3.6	1.0	24.5	0.3	284.2	0.0	0.5	0.0	0.0	0.0	40.2	0.1	0.1	1.1	1.3	0.5	0.0	1.3	1.1	0.1	0.2	0.0	1.0	0.4	147.7	0.1	0.1	0.1
TBCC	CFC	ENSG00000124659	"Tubulin folding cofactor C"	Q15814	6	42744498-42746103	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035073, HPA035074"	Approved		Supported	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 21: OE19 - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA035073: AB_10602897, HPA035074: AB_2674448"	"unprognostic (7.16e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.23e-2)"	"unprognostic (8.20e-2)"	"unprognostic (6.79e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.76e-3)"	10.4	15.0	15.9	17.8	15.8	39.6	9.9	15.4	18.3	9.9	12.3	17.0	14.5	14.4	12.9	16.1	15.6	10.1	16.0	16.4	16.3	11.9	13.1	11.6	29.1	18.0	14.1	12.2	14.9	11.3	11.1	7.6	18.8	11.3	9.9	15.4	14.5	11.8	26.7	16.8	23.5	10.7	15.2	30.1	15.5	18.0	14.7	21.9	14.0	14.4	19.5	13.1	10.0	16.6	34.5	11.2	16.9	31.7	23.9	16.0	22.3	23.2	26.1	25.3	27.4	17.4	13.3	31.0	18.3	22.7	21.0	29.5	22.9	23.2	14.0	17.0	25.0	16.3	16.7	29.7	27.2	17.9	25.5	26.2	27.8	19.7	16.1	22.7	20.1	17.1	37.8	27.4	22.9	42.4	14.8	34.3	15.8	93.5	30.4	14.8	20.3	20.3	24.5	18.6	64.7	28.1	15.1	25.8	41.1	15.4	28.3	59.7	21.9	24.1	21.6	19.6	32.3	36.1	43.7	53.0	11.8	24.2	23.7	139.1	91.4	174.5	105.5	79.2	108.9	101.7	111.9	116.7	83.5	90.9	129.6	119.9	162.1	170.8	74.1	142.3	154.8	170.4	15.9	15.8	15.4	18.3	16.4	16.3	18.0	14.1	18.8	15.2	14.7	16.6	19.3	3.2	24.0	2.6	50.8	25.1	25.9	49.3	51.2	55.0	25.4	29.1	6.8	24.3	25.7	11.0	41.7	21.4	83.8	25.1	33.2	38.6	30.3	23.0	21.2	20.9	45.3	13.0	7.0	30.9	23.5	17.1	18.3	22.9	31.0	21.0	19.6	10.0	18.8	18.5	7.8	21.2	71.2	16.2	27.8	10.2	17.7	15.9	28.4	8.4	33.6	46.3	77.2	5.0	12.8	28.5	27.0	20.7	37.1	15.9	29.8	23.9	22.0	51.7	19.7	13.0	46.1	50.1	22.7	30.7	24.9	21.1	80.2	26.6	22.3	22.1
TGFBR2	"MFS2, TBR-ii, TBRII"	ENSG00000163513	"Transforming growth factor beta receptor 2"	P37173	3	30606601-30694142	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Apoptosis, Differentiation, Growth regulation"	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Cancer-related genes, Craniosynostosis, Disease variant, FDA approved drug targets, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 391.5;Endothelial cells: 236.4;Hepatic stellate cells: 478.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 313.6;ASC TERT1: 472.3;HSkMC: 430.0;LHCN-M2: 381.7;TIME: 418.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB073537			Supported	"Plasma membrane"		NA	NA		810000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"CAB073537: "	"unprognostic (1.74e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.81e-2)"	"unprognostic (8.02e-2)"	230.0	56.1	16.5	73.8	12.9	29.4	145.7	13.8	19.3	90.0	30.6	96.0	44.2	69.1	18.2	44.9	69.6	91.9	95.2	10.6	13.4	67.9	59.1	148.0	70.1	17.6	16.5	26.6	52.0	59.0	16.9	81.6	16.7	44.1	54.1	2.1	49.2	60.8	31.1	39.1	77.7	107.2	17.3	111.1	63.4	7.8	21.5	49.7	91.8	62.2	60.7	98.0	55.1	17.2	16.6	100.2	5.3	0.1	313.6	472.3	15.9	83.9	116.1	28.5	27.7	22.9	86.6	2.2	298.2	117.2	32.2	33.3	4.0	125.4	42.0	7.0	8.9	10.1	10.7	104.5	128.5	14.9	76.6	430.0	93.6	126.3	114.4	117.0	296.0	10.9	1.8	0.0	381.7	1.3	16.2	10.5	2.2	75.7	39.8	14.1	36.4	2.1	113.5	40.5	0.1	5.6	24.9	6.1	22.0	6.6	0.0	14.0	418.6	134.7	33.2	61.4	32.0	2.8	0.3	12.5	80.1	16.1	55.8	9.0	3.0	11.5	3.4	3.1	3.3	4.5	4.8	3.3	2.6	6.4	16.6	7.3	13.1	1.9	8.0	6.6	0.7	3.8	16.5	12.9	13.8	19.3	10.6	13.4	17.6	16.5	16.7	17.3	21.5	17.2	391.5	144.2	99.7	0.7	77.0	37.3	18.9	23.5	39.9	5.1	23.7	24.1	84.5	50.1	39.5	27.6	0.0	6.8	85.3	10.5	3.9	13.1	2.5	28.3	57.5	236.4	8.4	20.4	0.4	15.8	5.1	129.2	39.3	30.8	29.8	0.7	478.0	55.5	30.4	0.0	1.0	12.4	22.4	147.0	58.0	3.8	32.9	67.9	30.2	170.5	47.5	0.2	56.7	6.0	2.4	37.6	12.1	47.4	37.5	8.6	13.6	7.2	14.7	1.2	32.9	60.8	53.4	0.3	1.2	8.0	30.5	3.7	68.2	1.7	14.5	10.8
THAP6	MGC30052	ENSG00000174796	"THAP domain containing 6"	Q8TBB0	4	75513946-75550473	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA035767	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	Centrosome	Nucleoplasm	"HPA035767: AB_10696510"	"unprognostic (9.62e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.89e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.47e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.38e-2)"	9.8	11.3	6.8	12.6	12.3	12.6	15.3	14.4	10.0	10.2	8.9	9.9	12.4	16.5	12.7	9.4	10.6	9.1	14.6	7.9	11.5	9.8	12.5	9.4	15.7	11.7	9.6	14.8	8.5	12.4	9.4	9.6	11.0	13.5	11.7	21.7	13.3	10.2	15.3	16.7	13.2	10.7	7.2	12.5	11.0	23.5	10.8	9.2	15.5	13.6	12.1	9.2	8.5	21.0	8.5	6.2	13.4	9.2	14.8	14.9	6.9	19.8	10.1	10.5	10.8	7.3	20.7	11.5	10.0	6.6	11.8	8.8	12.4	8.8	12.8	14.1	8.5	8.8	10.5	9.3	20.0	12.8	9.5	12.3	16.9	11.7	18.3	16.5	5.9	14.8	16.2	25.0	11.3	10.4	11.1	8.2	6.8	12.2	5.8	11.0	14.5	8.5	9.9	6.5	10.0	10.3	9.6	12.6	11.8	11.0	14.1	10.2	6.8	17.5	11.6	20.8	9.8	22.4	12.3	11.5	11.9	9.5	14.9	17.2	8.4	12.7	9.0	7.4	12.2	8.6	10.9	8.6	7.0	10.2	12.2	9.5	18.2	6.9	8.3	5.7	13.3	6.6	6.8	12.3	14.4	10.0	7.9	11.5	11.7	9.6	11.0	7.2	10.8	21.0	11.0	12.8	11.0	21.9	19.8	8.3	14.7	12.7	14.8	20.2	13.0	10.5	17.0	18.6	11.5	22.0	31.3	10.8	13.5	8.9	15.6	8.3	131.8	13.1	13.5	8.5	12.6	12.6	11.0	6.4	8.8	16.0	8.6	8.4	10.8	18.0	9.3	9.8	7.2	16.8	15.6	12.8	6.1	14.0	6.5	23.0	14.0	9.6	7.2	13.1	11.5	13.3	8.2	18.6	35.9	8.0	11.5	11.3	17.5	11.4	16.7	15.7	20.6	18.9	0.0	10.0	13.7	56.0	16.6	12.2	6.8	7.7	18.1	15.5	7.5	7.7
TM2D3	"BLP2, FLJ22604"	ENSG00000184277	"TM2 domain containing 3"	Q9BRN9	15	101621444-101652391	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054064	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	Cytosol	"HPA054064: AB_2682366"	"unprognostic (1.41e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.40e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.78e-2)"	32.2	38.3	58.9	23.5	62.8	28.2	33.9	57.0	74.7	36.7	51.4	31.1	24.6	40.8	43.5	23.9	34.2	29.6	47.8	62.0	70.1	32.2	58.1	28.1	30.5	54.9	58.7	55.7	30.3	40.6	35.7	31.7	58.5	32.7	24.2	32.3	34.4	35.3	44.5	27.0	26.2	32.1	55.9	29.2	29.1	28.0	61.1	29.5	45.2	55.7	31.7	32.8	28.5	58.0	20.1	48.9	25.6	46.6	71.9	53.1	31.3	25.9	42.6	30.0	33.4	26.4	55.5	32.5	34.9	35.5	50.7	45.9	40.3	33.3	23.7	31.2	88.4	48.7	39.9	45.4	47.2	38.4	55.8	44.2	66.3	18.1	37.4	42.1	42.1	41.5	40.6	47.8	47.9	40.8	28.3	40.2	39.5	90.4	16.2	33.9	32.3	51.0	61.5	52.0	34.3	31.3	35.8	37.4	54.3	43.7	35.5	49.8	33.7	31.6	32.5	21.2	28.9	45.0	71.2	35.3	26.9	47.5	26.7	36.4	40.6	81.9	41.2	41.9	46.4	30.6	33.6	31.6	29.1	44.8	44.1	41.4	69.6	52.4	32.4	24.6	38.4	41.3	58.9	62.8	57.0	74.7	62.0	70.1	54.9	58.7	58.5	55.9	61.1	58.0	52.4	25.6	28.7	22.2	55.8	66.3	58.5	142.3	32.5	47.1	42.6	45.8	35.7	35.8	67.9	42.3	33.3	73.7	51.9	23.0	19.6	61.0	8.0	28.1	38.2	48.8	27.0	30.3	41.5	42.3	64.7	53.7	23.0	44.8	25.3	37.6	60.3	56.6	32.3	69.0	55.3	23.2	91.6	42.1	36.4	10.8	73.7	39.2	26.6	37.5	44.4	60.6	56.7	29.1	45.8	27.8	20.7	62.8	41.3	66.6	32.6	39.5	47.2	46.8	72.3	40.1	67.0	89.3	84.2	25.0	55.4	91.0	55.1	21.5	27.8	40.0
TMCC3	KIAA1145	ENSG00000057704	"Transmembrane and coiled-coil domain family 3"	Q9ULS5	12	94567122-94650557	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 81.2;Distal enterocytes: 98.3;Microglial cells: 70.3;Oligodendrocytes: 119.8;Paneth cells: 70.1;Urothelial cells: 83.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 46.9;neutrophil: 69.7"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 69.7"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 31.3;Karpas-707: 41.9;U-266/84: 30.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014272	Approved		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"	Vesicles	"HPA014272: AB_1858059"	"unprognostic (1.03e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (1.30e-1)"	"unprognostic (8.63e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.12e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.80e-3)"	"unprognostic (9.11e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.41e-2)"	"unprognostic (4.75e-2)"	11.7	4.5	13.6	9.4	25.8	10.0	9.6	23.1	16.5	11.6	3.9	22.5	14.9	7.7	3.1	6.1	5.7	5.3	2.3	13.2	19.6	8.1	4.1	5.3	4.4	26.9	25.9	4.7	3.2	4.6	3.4	17.8	26.7	8.3	16.4	0.9	2.8	5.4	18.4	6.1	21.0	7.9	20.8	12.2	7.3	2.0	24.8	4.0	13.3	7.0	6.3	7.5	4.8	36.3	7.8	0.4	1.9	0.0	0.7	2.7	13.6	0.0	0.0	0.5	1.9	0.0	1.7	0.2	0.1	0.0	6.8	19.1	10.7	12.9	2.6	3.5	2.6	5.1	0.8	0.0	0.5	0.0	10.2	1.7	1.7	7.2	10.1	11.3	31.3	0.0	0.2	41.9	1.0	0.4	0.0	0.4	1.0	2.7	6.5	0.0	0.6	5.1	2.0	16.4	0.2	0.8	0.2	8.0	0.4	8.8	0.0	0.4	19.0	0.0	0.2	0.1	3.4	19.4	30.1	0.3	3.9	1.6	1.7	16.4	4.3	46.9	3.3	6.0	0.3	5.4	1.2	1.9	2.5	3.1	0.0	2.2	69.7	3.3	7.8	2.8	0.0	3.1	13.6	25.8	23.1	16.5	13.2	19.6	26.9	25.9	26.7	20.8	24.8	36.3	81.2	0.0	2.7	2.9	5.7	20.6	32.7	3.2	9.6	4.4	2.1	1.3	2.0	4.3	3.2	7.3	0.0	16.0	16.3	98.3	0.0	1.9	5.8	24.5	3.6	31.9	12.0	0.0	0.6	3.8	3.2	4.8	10.2	39.8	0.0	17.1	31.8	0.6	4.1	0.0	15.0	13.0	0.0	15.0	9.2	8.3	1.8	20.3	3.6	70.3	19.0	0.1	11.3	11.6	119.8	12.9	70.1	1.2	7.8	16.8	48.1	8.9	3.0	0.3	6.6	19.7	6.1	0.0	2.2	30.4	16.2	7.1	7.7	2.5	8.2	83.3
TMEM120A	"NET29, TMPIT"	ENSG00000189077	"Transmembrane protein 120A"	Q9BXJ8	7	75986831-75994656	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 289.1;Late spermatids: 1002.1;Proximal enterocytes: 414.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 223.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"									NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (1.78e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.75e-3)"	"unprognostic (6.16e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.58e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.15e-2)"	54.4	95.0	33.9	11.0	32.7	13.9	44.4	36.9	40.6	33.1	33.2	33.7	50.6	22.6	21.6	31.8	32.0	16.6	111.9	32.3	34.4	38.9	84.7	25.0	10.1	57.6	36.1	56.1	43.2	17.4	20.0	15.6	61.5	26.5	14.8	6.1	24.7	23.3	79.3	18.5	63.4	11.0	31.2	28.2	44.3	77.1	34.7	8.0	19.4	94.4	12.0	32.9	27.3	31.8	10.3	15.3	7.7	61.7	52.1	35.1	16.9	10.0	27.8	13.7	17.2	26.8	14.3	4.8	7.6	30.4	39.1	11.8	7.6	10.3	4.7	9.0	8.5	5.2	10.6	38.2	50.6	2.1	32.6	37.5	9.2	10.1	12.2	14.3	22.4	8.7	9.8	7.9	24.5	18.5	3.3	32.6	3.5	23.7	16.3	3.5	7.8	23.6	28.2	9.3	3.8	18.0	11.4	32.5	16.7	19.1	22.7	15.4	12.8	38.1	12.0	22.1	8.6	8.5	7.0	2.2	20.7	5.3	8.9	106.6	58.0	109.5	26.4	53.7	20.0	15.8	21.7	20.5	27.2	17.9	15.1	14.8	223.0	31.2	55.2	10.7	50.9	46.5	33.9	32.7	36.9	40.6	32.3	34.4	57.6	36.1	61.5	31.2	34.7	31.8	22.4	22.4	12.3	12.7	14.1	0.0	18.1	0.0	18.8	5.6	36.2	22.2	112.7	51.5	8.6	27.6	6.2	20.9	17.6	133.9	25.4	50.3	289.1	9.8	29.3	21.4	8.4	11.4	4.1	38.9	16.2	36.0	31.1	18.1	24.6	172.6	29.3	115.6	36.1	11.8	7.2	40.5	0.0	34.2	0.0	1002.1	40.4	36.0	0.0	3.7	23.7	12.8	18.6	4.0	7.3	40.0	108.9	30.9	24.6	17.4	414.8	118.0	4.4	7.0	39.5	46.0	31.2	113.4	15.4	33.1	0.0	10.9	20.0	31.0	43.6	28.1
TMEM167B	"AD-020, C1orf119, FLJ90710"	ENSG00000215717	"Transmembrane protein 167B"	Q9NRX6	1	109090764-109096934	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"									NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"				"unprognostic (7.89e-2)"	"unprognostic (3.28e-1)"	"unprognostic (4.96e-2)"	"prognostic favorable (8.86e-4)"	"unprognostic (3.76e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.25e-1)"	31.7	35.5	29.9	24.2	30.3	53.7	33.1	30.0	34.4	32.4	29.6	27.7	23.2	30.9	31.6	24.0	25.4	25.6	35.9	30.1	30.5	33.3	33.0	28.4	26.2	29.1	30.2	29.7	25.7	45.1	15.9	33.8	29.6	36.9	29.8	31.3	30.3	27.9	21.3	28.9	23.7	30.6	31.3	28.3	32.4	23.4	30.9	25.1	41.7	25.9	27.7	27.2	16.3	33.0	36.1	6.5	23.4	32.3	47.8	47.0	20.9	54.2	49.7	30.0	27.8	13.7	13.4	24.0	30.1	55.9	17.8	17.4	15.1	24.1	43.0	37.4	11.4	22.4	8.7	18.8	53.6	43.6	36.6	38.8	64.7	27.9	46.7	40.8	26.5	30.8	28.5	33.9	33.0	22.2	33.0	28.1	17.7	31.0	33.1	20.5	37.1	19.0	38.6	22.5	16.6	17.0	26.2	38.0	53.0	20.8	23.7	32.0	25.2	30.6	30.8	67.0	26.6	34.0	20.6	23.7	51.7	44.7	65.0	38.1	20.7	35.4	13.3	23.8	19.1	14.4	17.6	17.0	19.1	13.5	17.8	17.8	45.4	17.5	30.8	11.7	17.9	19.9	29.9	30.3	30.0	34.4	30.1	30.5	29.1	30.2	29.6	31.3	30.9	33.0	29.6	32.1	31.4	10.7	30.1	30.5	29.4	25.7	16.5	30.1	28.2	17.9	34.0	22.8	28.6	18.4	12.5	42.1	38.7	20.0	19.6	26.7	19.1	16.2	25.2	30.7	20.9	25.9	11.5	30.1	44.3	32.3	23.0	27.1	32.3	21.7	27.8	21.7	39.1	25.2	12.5	25.2	24.4	36.8	42.8	17.0	28.9	38.8	26.6	6.5	56.3	36.0	24.7	12.5	16.4	29.3	19.7	25.2	16.8	39.8	25.9	29.6	19.7	30.1	0.0	21.7	26.8	28.9	28.2	26.0	35.7	63.1	32.9	20.4	19.1	51.5
TMEM222	"C1orf160, DKFZP564D0478"	ENSG00000186501	"Transmembrane protein 222"	Q9H0R3	1	27322145-27336400	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016579, HPA059374"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"	"Cell Junctions"	"HPA016579: AB_2669392, HPA059374: AB_2683995"	"unprognostic (3.65e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.29e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.83e-2)"	"unprognostic (7.80e-2)"	26.6	38.2	61.9	13.0	60.1	23.8	27.1	58.7	76.8	25.1	57.4	26.9	15.0	28.1	24.4	36.1	29.6	19.2	34.5	61.2	65.4	32.8	49.4	22.4	16.1	61.7	64.4	26.6	28.6	30.6	38.4	13.0	62.3	39.0	14.4	10.6	26.7	23.9	36.8	28.9	23.8	18.8	60.7	25.0	30.1	28.8	63.8	21.1	29.4	20.7	14.1	27.6	24.2	59.5	26.2	31.2	25.7	42.3	39.2	28.2	20.7	39.6	45.1	52.9	44.8	13.0	53.5	16.5	30.2	42.4	24.6	35.3	28.3	38.5	21.9	22.0	54.4	27.6	24.7	30.1	58.0	27.8	26.5	49.4	21.5	50.8	28.7	24.3	35.7	32.4	21.2	37.1	33.6	23.4	40.1	29.2	48.3	27.0	38.6	32.8	17.7	33.5	51.6	15.2	54.8	48.4	30.6	42.6	39.7	9.2	42.3	44.2	33.1	31.1	26.1	50.6	38.1	39.8	38.5	17.6	47.1	53.3	45.8	38.2	20.6	27.7	32.5	32.5	24.8	37.4	29.7	24.6	18.5	30.0	29.1	30.2	56.3	31.9	35.3	30.4	37.4	25.6	61.9	60.1	58.7	76.8	61.2	65.4	61.7	64.4	62.3	60.7	63.8	59.5	22.9	9.6	13.5	8.5	25.4	11.7	13.3	26.2	15.9	42.1	24.0	29.2	8.9	18.6	13.3	12.9	14.6	30.9	20.9	24.5	39.2	39.1	25.5	13.2	17.2	20.6	29.9	43.8	12.4	40.5	33.9	22.6	18.8	12.4	17.1	22.0	11.0	15.1	28.3	43.7	15.0	21.0	40.7	8.5	12.9	76.9	20.2	12.2	26.6	6.5	20.6	51.9	22.6	17.1	14.4	48.6	22.7	19.9	18.6	19.9	28.8	19.2	7.9	18.7	13.1	19.6	20.3	27.2	18.0	19.3	13.5	30.8	20.5	22.4	23.1	12.4
TMEM43	"ARVD5, DKFZp586G1919, LUMA, MGC3222"	ENSG00000170876	"Transmembrane protein 43"	Q9BTV4	3	14125015-14143680	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Cardiomyopathy, Disease variant, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 137.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA019198	Approved					NA	NA		34000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA019198: AB_1858118"	"unprognostic (3.65e-3)"	"unprognostic (2.52e-1)"	"unprognostic (4.03e-2)"	"unprognostic (4.66e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (5.77e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.19e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.18e-1)"	75.4	34.3	23.1	36.8	23.8	21.0	61.3	23.0	25.3	66.8	23.5	56.7	23.5	89.1	31.0	69.5	63.9	47.1	64.7	23.2	25.0	27.7	19.6	58.1	30.2	27.5	25.1	82.6	27.3	25.6	30.6	57.6	25.9	43.3	29.4	15.9	37.9	65.2	60.8	108.7	40.0	82.5	23.6	31.2	34.8	15.2	25.5	26.0	47.0	45.8	33.7	56.1	66.4	25.2	41.5	45.7	44.1	58.3	173.4	180.6	104.6	80.1	164.8	129.9	93.0	37.5	54.1	19.5	55.7	201.3	64.3	88.3	47.1	70.9	92.9	48.7	38.0	35.3	45.6	53.8	109.3	51.4	40.4	136.0	173.6	107.9	133.0	103.6	94.8	36.2	56.1	47.8	76.6	54.3	23.4	43.2	48.4	62.8	75.3	32.2	46.8	78.2	59.4	70.4	12.9	35.5	101.0	59.3	66.5	37.3	37.5	74.3	86.4	118.7	63.7	120.6	76.0	32.1	54.3	25.1	89.3	68.4	108.7	81.3	51.5	100.3	68.7	45.5	64.0	36.8	66.8	62.7	67.4	31.6	44.5	49.0	157.2	79.9	49.2	42.6	65.7	69.7	23.1	23.8	23.0	25.3	23.2	25.0	27.5	25.1	25.9	23.6	25.5	25.2	44.2	137.8	46.8	17.9	16.8	43.7	32.2	31.0	39.9	6.2	19.9	29.7	13.4	15.7	52.9	18.4	14.6	31.2	43.2	9.3	0.0	34.9	0.6	17.3	58.1	37.4	4.9	22.5	24.1	10.0	65.6	68.0	20.9	34.4	28.4	16.1	23.6	8.9	17.8	6.7	20.6	8.3	8.2	16.1	33.5	3.9	43.2	19.8	30.2	15.9	26.8	8.4	16.5	30.2	23.9	22.4	9.7	70.7	15.6	35.8	8.8	9.0	16.2	8.6	32.9	43.6	39.3	5.6	12.0	44.1	45.5	37.5	32.1	17.6	11.5	30.2
TMEM71	FLJ33069	ENSG00000165071	"Transmembrane protein 71"	Q6P5X7	8	132685007-132760712	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 33.5;heart muscle: 37.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 39.9;Kupffer cells: 20.7;Langerhans cells: 25.7;Macrophages: 26.2;monocytes: 25.5;NK-cells: 54.6;T-cells: 35.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebral cortex: 9.7"	"Immune cell enhanced"	"Detected in all"		"neutrophil: 269.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 269.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 12.7;HDLM-2: 54.5;Karpas-707: 11.1;U-937: 31.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA058401, HPA070655"	Uncertain		Enhanced	Mitochondria		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Mitochondria		"HPA058401: AB_2683707, HPA070655: AB_2686292"	"unprognostic (1.39e-3)"	"unprognostic (7.27e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.10e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.91e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.90e-2)"	"unprognostic (6.29e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.73e-1)"	5.6	2.0	1.0	13.1	1.3	33.5	8.5	1.0	9.7	2.5	2.2	11.3	2.2	1.3	1.1	2.8	1.9	5.5	37.1	1.1	1.8	2.6	3.9	8.2	13.2	1.6	1.3	1.0	2.4	0.7	1.1	1.8	2.1	2.0	3.4	0.5	5.7	2.2	1.6	1.1	7.3	3.6	1.1	18.4	2.8	1.0	2.4	19.2	2.0	4.6	10.6	4.6	1.9	1.6	0.4	0.0	4.9	0.0	0.0	0.0	0.0	1.3	12.7	0.5	0.9	0.0	0.0	0.1	0.6	4.1	0.1	0.0	0.0	0.3	1.5	54.5	0.0	0.0	0.0	0.0	0.3	3.6	0.0	0.1	0.0	0.1	2.0	1.4	1.0	6.7	0.0	11.1	2.4	0.0	2.9	2.2	1.2	0.0	0.4	0.1	1.8	0.8	4.8	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.1	2.1	0.5	0.9	1.2	5.7	0.1	2.9	0.0	9.0	31.6	3.7	61.9	55.9	101.6	31.3	16.1	57.9	6.6	22.8	22.2	33.7	4.7	33.9	25.1	269.0	12.9	14.7	1.1	3.0	39.0	1.0	1.3	1.0	9.7	1.1	1.8	1.6	1.3	2.1	1.1	2.4	1.6	0.5	0.0	3.0	0.0	6.9	0.9	1.0	2.5	0.6	0.0	4.2	2.7	15.9	0.0	5.5	0.0	0.0	0.0	39.9	0.1	0.0	0.0	6.5	0.1	0.3	1.5	0.0	8.8	0.5	0.0	0.0	4.1	1.1	0.2	1.3	0.0	3.3	0.2	3.2	0.0	1.3	0.2	0.0	20.7	25.7	5.1	0.0	26.2	5.4	17.8	25.5	1.9	54.6	0.0	0.1	0.1	0.0	0.0	11.3	0.1	0.0	0.4	2.9	0.0	0.0	3.7	0.8	0.0	0.6	0.4	0.3	0.3	35.9	0.1	0.0	4.5
TNFSF14	"CD258, HVEM-L, LIGHT, LTg"	ENSG00000125735	"TNF superfamily member 14"	O43557	19	6661253-6670588	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 29.0;liver: 107.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 26.3;dendritic cells: 40.5;granulocytes: 26.1;Macrophages: 20.0;NK-cells: 26.8;T-cells: 43.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 199.7"	"Group enriched"	"Detected in all"	4	"granulocytes: 199.7;T-cells: 61.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 16.9;NB-4: 4.9;THP-1: 3.1;U-937: 10.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA012700	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	41000		"Cluster 5: Granulocytes - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA012700: AB_1852870"	"unprognostic (2.78e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.35e-3)"	"unprognostic (3.82e-4)"	"unprognostic (4.51e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.23e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (6.07e-13)"	"unprognostic (1.09e-1)"	"unprognostic (9.56e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.62e-2)"	29.0	1.7	2.2	3.1	1.3	1.9	2.7	0.8	6.4	2.1	1.3	2.7	1.8	0.9	0.3	1.8	9.7	1.2	3.8	1.0	1.2	1.3	107.9	4.9	2.5	1.3	1.7	5.1	4.5	0.0	1.1	0.2	1.7	2.0	1.3	0.2	2.2	0.2	0.5	0.6	5.9	1.2	0.9	3.2	2.3	0.6	3.1	1.1	2.8	0.6	2.0	4.1	2.3	1.7	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.5	0.0	0.0	0.0	16.9	0.0	0.0	0.2	1.1	0.0	0.5	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	10.4	0.0	140.9	17.6	115.3	41.8	4.0	61.2	0.4	17.7	34.5	6.9	1.9	2.8	15.0	199.7	30.7	0.5	0.7	15.9	12.8	2.2	1.3	0.8	6.4	1.0	1.2	1.3	1.7	1.7	0.9	3.1	1.7	0.7	9.6	26.3	0.0	1.6	2.9	0.7	0.9	0.0	0.0	1.1	0.8	0.8	15.7	8.2	0.0	0.0	0.1	40.5	0.0	0.0	4.1	1.2	4.8	2.6	0.9	0.0	0.4	0.1	3.8	0.2	12.4	1.1	18.1	26.1	0.2	1.8	15.8	12.8	0.0	0.1	0.2	0.0	3.4	12.3	0.0	0.3	20.0	3.6	1.0	5.8	0.0	26.8	0.0	0.1	6.0	0.0	0.0	4.8	0.6	0.0	0.4	2.8	0.0	0.0	1.4	1.0	0.2	0.3	0.3	3.3	0.0	43.7	0.0	0.0	0.4
TOR1B	"DQ1, MGC4386"	ENSG00000136816	"Torsin family 1 member B"	O14657	9	129803157-129811281	"Predicted intracellular proteins"		"Chaperone, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA013403, HPA013697, CAB022709"	Approved		Uncertain	"Nuclear speckles,Cytosol"	"Intracellular and membrane"	NA	NA		140000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"	Cytosol	"CAB022709: , HPA013403: AB_1858195, HPA013697: AB_1858196"	"unprognostic (2.91e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.55e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.95e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.07e-3)"	"unprognostic (4.09e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.69e-3)"	11.1	10.0	8.6	13.1	8.4	14.3	8.7	12.0	8.7	8.4	9.5	20.3	11.3	9.1	7.0	10.3	7.7	13.3	8.9	8.2	9.2	8.6	18.5	11.7	11.0	8.8	8.6	7.5	12.6	11.7	7.3	14.2	8.7	11.0	22.6	5.9	10.3	9.2	10.6	11.8	14.1	12.6	8.6	9.3	11.9	10.2	9.5	10.7	10.7	9.9	9.4	15.8	8.5	8.4	11.7	26.5	10.9	29.0	53.2	39.4	25.0	40.8	26.7	27.6	27.2	22.0	26.1	8.3	25.2	40.7	43.0	46.4	11.9	16.9	28.2	30.4	12.3	7.2	21.5	15.8	22.8	13.8	31.1	22.6	29.3	39.6	19.4	20.4	24.9	21.5	25.6	18.8	26.2	32.9	19.2	21.8	22.9	54.8	20.1	7.8	18.9	25.3	21.3	12.1	15.0	17.2	26.0	30.4	16.6	19.5	43.7	13.5	22.7	51.9	24.5	62.4	35.7	13.6	53.9	7.0	28.6	17.9	36.0	8.7	13.3	20.2	12.6	16.0	13.0	4.0	10.0	11.2	6.9	4.7	7.3	7.3	16.4	8.8	10.1	4.2	10.5	9.9	8.6	8.4	12.0	8.7	8.2	9.2	8.8	8.6	8.7	8.6	9.5	8.4	9.5	9.6	2.4	6.5	11.7	6.5	5.9	7.3	12.5	2.7	6.9	5.6	5.5	5.7	6.1	5.5	4.2	10.8	16.1	15.3	0.0	9.7	13.3	5.0	6.7	8.2	19.2	3.4	13.9	13.7	17.7	10.5	17.9	5.7	4.5	4.0	9.7	13.3	12.0	6.7	15.6	16.2	4.1	5.4	5.0	15.1	4.4	12.1	3.6	4.7	12.3	4.7	16.5	14.6	10.5	12.6	6.7	5.7	14.5	10.1	10.7	3.7	9.4	2.7	19.7	6.8	13.0	22.7	5.4	10.4	5.4	15.2	12.2	4.6	10.5	11.2
TOX4	"C14orf92, KIAA0737, LCP1"	ENSG00000092203	"TOX high mobility group box family member 4"	O94842	14	21476597-21499175	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 265.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017880, HPA027551"	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Nucleoli, Vesicles"	"HPA017880: AB_1845573, HPA027551: AB_10601701"	"unprognostic (9.56e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.46e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (3.46e-4)"	"unprognostic (8.05e-3)"	"unprognostic (2.58e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.94e-1)"	"prognostic favorable (8.38e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.48e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.48e-3)"	16.7	14.6	17.3	14.1	17.6	21.4	16.3	17.9	20.1	18.0	14.8	18.5	12.6	15.4	15.1	21.1	14.7	12.2	21.9	17.5	17.7	15.0	15.7	15.9	15.1	17.1	18.7	15.9	15.8	20.4	13.6	15.5	17.5	14.7	15.2	16.1	14.8	17.4	55.5	21.5	14.8	19.7	16.8	13.7	16.9	14.3	18.3	26.1	17.1	25.8	21.3	17.4	16.0	19.5	27.1	27.4	22.7	21.5	32.1	30.6	30.3	25.3	49.6	52.7	50.3	27.0	31.6	16.2	17.5	41.5	42.0	31.5	37.4	38.8	66.8	28.6	15.1	18.1	17.7	37.8	41.5	33.6	28.7	40.0	39.8	41.7	39.4	35.9	38.0	30.1	22.6	27.4	37.9	22.8	33.4	19.3	12.8	39.5	43.2	29.7	23.7	18.6	24.5	33.4	20.9	21.5	25.0	26.3	21.3	29.8	24.8	12.6	25.0	27.2	24.9	24.1	22.5	35.1	41.7	36.9	12.8	16.4	28.7	40.9	27.4	40.0	23.1	29.2	25.0	24.0	20.5	22.2	26.0	24.9	21.3	24.4	48.6	29.2	27.5	33.7	31.7	28.9	17.3	17.6	17.9	20.1	17.5	17.7	17.1	18.7	17.5	16.8	18.3	19.5	60.0	67.3	64.0	0.0	43.3	87.3	63.9	81.3	58.1	75.0	50.4	42.0	51.8	42.9	64.4	46.0	29.2	73.5	69.3	51.0	62.6	47.3	76.1	42.6	46.9	53.4	68.9	48.8	0.0	51.4	64.1	48.4	40.8	50.4	61.4	41.4	37.9	43.1	43.8	42.1	0.0	45.4	52.9	41.3	61.6	36.5	48.7	46.1	39.2	0.0	55.3	40.4	46.4	0.0	0.0	51.4	51.9	44.0	44.4	59.0	91.4	64.0	57.4	54.5	32.9	54.1	58.6	131.9	66.8	50.5	88.8	265.8	62.0	55.5	43.8	70.0
TRIM13	"DLEU5, Leu5, RFP2, RNF77"	ENSG00000204977	"Tripartite motif containing 13"	O60858	13	49995888-50020481	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 576.8;Spermatocytes: 211.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000367	Enhanced					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA000367: AB_1856196"	"unprognostic (1.14e-1)"	"unprognostic (8.22e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.23e-3)"	"unprognostic (4.75e-3)"	"unprognostic (5.01e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.07e-1)"	"unprognostic (7.28e-3)"	"unprognostic (4.66e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.55e-2)"	18.0	13.7	12.8	14.7	18.1	65.2	21.0	21.7	14.7	17.0	10.1	18.1	12.7	16.6	14.9	26.6	17.2	12.6	16.6	11.8	14.3	22.0	14.3	20.8	20.2	15.2	14.2	19.3	15.5	20.2	15.7	14.9	15.4	20.1	20.1	15.8	19.0	13.1	24.9	27.0	18.7	14.0	13.6	20.9	15.3	79.0	15.1	24.1	15.9	24.3	23.2	15.5	18.9	24.3	10.6	12.0	41.3	32.1	22.7	35.3	18.7	17.0	24.5	13.5	9.4	16.6	23.7	38.9	5.2	18.6	12.2	16.2	18.4	22.5	16.6	15.1	16.2	38.7	9.9	18.9	25.3	37.5	21.7	25.9	32.5	12.4	20.6	34.0	30.3	32.9	21.0	12.0	27.0	9.6	31.5	58.5	37.5	24.3	9.0	37.7	1.9	11.7	28.8	17.2	16.5	26.9	15.4	15.8	24.8	29.1	17.9	46.9	28.5	13.9	12.8	11.5	9.7	8.6	7.8	28.6	6.2	16.9	19.2	24.8	17.7	28.4	19.0	15.8	24.1	46.4	25.5	25.2	22.7	45.4	22.3	20.9	35.0	27.0	23.5	34.8	30.0	14.4	12.8	18.1	21.7	14.7	11.8	14.3	15.2	14.2	15.4	13.6	15.1	24.3	34.2	25.6	29.1	20.9	47.7	27.5	37.0	48.8	21.1	24.5	24.8	19.2	20.1	22.8	39.8	27.6	20.9	33.4	31.7	24.2	19.6	25.4	576.8	21.3	25.3	29.8	44.9	20.6	30.6	20.1	16.5	26.2	15.8	15.3	38.7	34.1	20.3	15.1	18.3	11.8	29.6	27.5	30.5	21.3	62.3	83.6	25.7	24.3	17.8	35.6	27.1	14.5	28.8	45.8	57.5	20.3	22.7	29.7	13.8	34.5	21.5	32.8	51.8	54.3	19.7	25.2	29.9	211.2	25.2	29.9	33.4	32.2	29.0	21.3	28.6	31.1
TSC22D3	"DIP, DSIPI, GILZ, hDIP, TSC-22R"	ENSG00000157514	"TSC22 domain family member 3"	Q99576	X	107713221-107777342	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 1234.8;dendritic cells: 1146.4;Plasma cells: 2348.5;T-cells: 1479.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 380.5;ASC TERT1: 259.7;HHSteC: 628.0;hTCEpi: 572.7;Karpas-707: 364.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001916, CAB034364"	Approved		Approved	"Nuclear speckles,Golgi apparatus,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Nuclear speckles, Golgi apparatus"	"CAB034364: AB_2272198, HPA001916: AB_2666504"	"unprognostic (3.67e-2)"	"unprognostic (3.90e-3)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (3.49e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.73e-3)"	"unprognostic (4.40e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.25e-1)"	"unprognostic (7.47e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.37e-3)"	"unprognostic (6.41e-2)"	"unprognostic (4.14e-1)"	"unprognostic (9.64e-2)"	536.4	240.5	90.3	394.8	93.5	433.3	447.3	101.0	105.0	396.4	104.1	290.2	87.2	269.3	72.0	300.4	369.8	167.1	331.9	81.3	102.9	194.9	177.4	522.6	281.0	99.6	97.2	371.1	113.8	55.7	136.2	163.8	98.9	404.4	183.6	22.5	333.4	160.5	729.3	493.6	426.3	178.7	92.8	408.2	390.4	43.8	99.3	203.2	313.0	187.8	338.2	508.2	486.9	91.3	10.9	18.2	9.3	25.7	380.5	259.7	3.7	16.9	14.1	7.8	8.6	0.1	35.8	23.4	40.1	13.7	5.5	53.5	19.1	54.2	3.3	7.0	9.0	11.5	76.9	1.0	628.0	2.5	37.7	238.8	572.7	6.1	158.7	78.8	29.3	2.5	3.6	364.1	67.2	37.8	0.7	40.5	16.3	11.5	11.7	1.2	23.5	51.3	26.1	7.3	2.4	20.3	16.6	89.2	128.8	16.9	17.0	52.4	44.1	23.6	7.1	4.8	3.4	79.6	37.8	11.2	12.0	46.7	6.7	668.9	417.2	1653.1	649.7	524.1	484.2	584.0	740.6	641.5	399.5	559.6	686.3	643.0	2396.6	968.4	851.8	81.4	1080.9	1624.1	90.3	93.5	101.0	105.0	81.3	102.9	99.6	97.2	98.9	92.8	99.3	91.3	423.5	64.1	164.7	10.4	1234.8	110.0	82.8	129.7	435.4	52.0	97.0	47.5	31.8	70.1	106.9	47.8	0.0	3.2	1146.4	26.2	232.8	28.3	28.8	24.2	40.9	171.7	64.2	481.5	13.1	22.2	140.5	454.2	200.3	29.7	353.2	15.3	247.0	95.6	121.3	62.2	12.9	32.9	83.4	396.3	191.8	41.2	230.5	539.1	437.6	16.9	126.0	8.9	234.8	37.7	23.7	22.7	19.6	319.7	2348.5	106.5	58.6	48.6	61.0	19.1	433.9	245.4	248.3	24.1	15.3	182.6	79.1	9.9	1479.6	89.6	33.0	42.2
TSPAN16	"TM-8, TM4-B, TM4SF16"	ENSG00000130167	"Tetraspanin 16"	Q9UKR8	19	11296139-11326996	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"testis: 134.7"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 4868.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"basophil: 16.6;eosinophil: 19.1;neutrophil: 37.4"	"Lineage enriched"	"Detected in many"	17	"granulocytes: 37.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA076551	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 83: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"		"HPA076551: "	"unprognostic (1.06e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.06e-3)"		"unprognostic (1.37e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.90e-1)"	"unprognostic (8.69e-4)"	"unprognostic (8.81e-8)"	"unprognostic (1.98e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.95e-3)"	"unprognostic (2.67e-1)"	0.0	0.0	0.2	0.2	0.1	5.1	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	134.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	16.6	2.2	19.1	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	37.4	0.0	0.4	0.0	0.0	0.3	0.2	0.1	0.3	0.4	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	892.5	0.0	0.1	1.6	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.2	4868.3	15.5	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.4	20.9	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TTC32		ENSG00000183891	"Tetratricopeptide repeat domain 32"	Q5I0X7	2	19896631-19901983	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 113.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA036024	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Mitochondria	Nucleoplasm	"HPA036024: AB_10673493"	"unprognostic (2.77e-3)"	"unprognostic (5.44e-2)"	"unprognostic (8.85e-2)"	"unprognostic (8.80e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.25e-2)"	"prognostic favorable (9.44e-4)"	"unprognostic (4.46e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.92e-3)"	"unprognostic (6.22e-2)"	"prognostic unfavorable (5.45e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.27e-2)"	11.8	8.8	8.7	12.3	10.5	34.7	16.6	13.6	17.2	12.3	8.6	11.7	12.2	13.9	26.0	7.4	11.9	6.7	7.1	8.8	9.1	11.4	12.3	10.0	15.5	10.6	10.0	16.5	8.6	8.2	11.3	8.5	11.3	16.0	10.2	33.0	11.1	9.3	22.5	13.8	13.1	8.0	9.5	15.6	11.4	12.5	9.7	19.7	12.4	7.7	10.1	11.3	11.2	14.2	22.5	14.4	12.8	9.6	5.6	12.3	2.7	4.8	8.0	7.7	5.0	7.3	25.6	14.5	2.7	5.1	9.6	14.6	5.6	15.4	4.9	21.3	23.3	14.8	20.4	12.8	12.1	14.2	25.5	11.7	9.6	8.6	20.4	6.5	7.5	23.3	27.1	28.5	6.4	6.8	10.7	21.7	9.6	8.4	24.1	12.6	8.5	24.1	21.6	8.6	20.6	19.1	16.1	8.5	18.2	14.1	11.9	5.5	5.6	11.6	12.4	11.5	6.6	29.8	27.3	24.0	17.9	13.9	6.7	9.2	7.6	23.1	7.3	5.7	8.7	12.2	11.6	7.8	7.2	11.9	15.8	12.2	28.0	6.7	6.9	5.0	15.6	4.9	8.7	10.5	13.6	17.2	8.8	9.1	10.6	10.0	11.3	9.5	9.7	14.2	23.2	9.6	14.4	8.5	24.7	18.9	33.4	36.0	34.7	66.9	27.4	39.0	15.8	15.7	26.4	12.9	14.6	14.6	13.7	10.0	45.0	12.2	27.2	25.8	6.1	16.2	28.3	34.0	7.1	24.8	8.7	19.6	14.8	13.2	8.8	7.2	7.5	24.1	9.1	42.1	8.6	19.9	32.6	8.8	8.9	7.2	19.9	17.4	7.2	5.6	14.6	67.8	11.3	9.5	22.0	14.6	12.9	9.8	12.3	15.8	13.7	28.5	48.7	39.2	13.1	21.1	21.3	113.2	38.7	22.4	26.1	9.6	21.6	9.0	11.7	26.7
TUBA4A	"FLJ30169, H2-ALPHA, TUBA1"	ENSG00000127824	"Tubulin alpha 4a"	P68366	2	219249710-219278170	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Amyotrophic lateral sclerosis, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 360.2;tongue: 210.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 423.0;Late spermatids: 823.0;Pancreatic endocrine cells: 613.5;Smooth muscle cells: 408.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 265.9;HBEC3-KT: 439.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004621, CAB005887, HPA039247, HPA043684, HPA063394"	Approved		Enhanced	Microtubules		NA	NA		130000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 10: Non-specific - Unknown function"	Microtubules		"CAB004621: AB_628411, CAB005887: AB_2288001, HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"unprognostic (8.08e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.56e-2)"	"unprognostic (5.18e-3)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (4.54e-6)"	"unprognostic (1.52e-3)"	"unprognostic (4.47e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.38e-3)"	"unprognostic (9.32e-2)"	14.3	41.4	33.6	34.1	47.5	107.1	16.4	22.3	133.1	27.7	8.1	32.9	18.6	9.8	10.1	84.8	12.6	13.5	97.7	42.6	32.3	31.9	29.5	26.7	56.7	46.3	27.3	12.9	18.2	34.6	23.1	5.0	31.4	19.7	27.8	39.2	46.9	22.4	360.2	161.4	35.5	12.8	3.9	56.8	30.6	32.4	14.9	16.9	12.3	210.3	63.4	22.6	57.3	54.0	106.0	90.0	0.0	0.3	9.1	6.9	0.3	16.2	49.7	2.8	1.9	20.4	106.7	144.2	172.2	11.7	172.7	265.9	49.3	439.9	3.9	81.7	0.7	184.2	154.5	15.4	7.3	60.9	60.8	6.7	158.0	23.7	49.2	27.4	17.3	2.4	20.5	91.3	100.6	4.3	0.3	107.9	32.3	83.2	107.4	6.5	139.0	84.5	129.7	7.5	85.8	1.5	213.2	18.7	0.7	1.8	8.0	50.9	12.3	49.8	27.4	58.4	56.7	38.0	48.8	171.4	183.3	116.4	2.5	141.7	63.3	170.2	107.1	45.7	110.1	124.9	150.3	142.8	20.9	95.5	140.2	138.4	331.2	82.0	71.9	3.8	143.8	270.9	33.6	47.5	22.3	133.1	42.6	32.3	46.3	27.3	31.4	3.9	14.9	54.0	55.3	44.8	47.1	16.3	160.6	181.8	201.2	235.3	68.9	123.3	42.3	51.6	60.9	28.6	62.0	49.7	77.2	0.7	311.6	87.3	140.8	199.3	423.0	9.8	3.3	36.5	107.9	56.2	34.8	205.6	0.5	11.5	40.8	26.1	15.8	0.1	36.0	33.0	6.0	67.3	22.5	141.9	48.8	15.3	54.9	823.0	16.8	159.5	78.2	9.4	27.8	38.6	50.4	10.6	10.6	613.5	51.2	7.5	202.3	46.7	87.5	137.5	11.1	72.9	0.0	21.1	408.5	5.7	5.0	130.6	244.5	2.5	290.1	1.4	58.9	113.0
TUBA4B	"FLJ13940, TUBA4"	ENSG00000243910	"Tubulin alpha 4b"	Q9H853	2	219253243-219272197	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	8	"fallopian tube: 40.0"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 148.9;Respiratory ciliated cells: 83.1"	"Cancer enriched"	"Detected in some"	6	"endometrial cancer: 8.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"									NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"		"Cluster 49: Ciliated cells - Cilium organization"				"unprognostic (3.20e-5)"	"unprognostic (1.47e-4)"	"unprognostic (1.85e-1)"	"unprognostic (3.70e-3)"	"unprognostic (9.63e-2)"	"unprognostic (8.97e-2)"	"unprognostic (2.18e-3)"	"unprognostic (7.32e-2)"	"unprognostic (9.50e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.41e-3)"	"unprognostic (3.78e-2)"	"unprognostic (9.57e-2)"	"unprognostic (3.91e-2)"	"unprognostic (4.08e-1)"	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.2	0.1	1.5	4.7	0.0	0.1	0.5	0.7	0.0	40.0	0.0	0.0	0.4	0.8	1.5	0.2	3.5	0.1	1.9	3.6	0.1	0.0	0.0	0.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	1.8	0.0	0.0	0.1	0.7	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.4	0.1	0.1	0.2	0.2	0.3	0.3	0.0	0.2	0.3	0.3	0.6	0.1	0.1	0.0	0.3	1.4	0.8	0.6	0.2	0.1	0.4	0.8	1.9	3.6	1.8	1.8	0.7	1.4	0.0	0.0	3.2	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	4.3	1.8	0.0	0.0	0.0	0.0	1.9	0.0	1.8	148.9	0.9	0.1	1.8	0.0	0.3	0.2	0.0	0.2	0.0	2.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	27.9	83.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1
TXNIP	"ARRDC6, EST01027, HHCPA78, THIF, VDUP1"	ENSG00000265972	"Thioredoxin interacting protein"	Q9H3M7	1	145992435-145996579	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"		"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 2550.5;NK-cells: 2028.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 951.8;HSkMC: 1276.5;hTCEpi: 664.0;hTERT-RPE1: 781.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031085, HPA053694"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Cytosol	"HPA031085: AB_10601706, HPA053694: AB_2682232"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.67e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.51e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.22e-3)"	1542.7	466.8	130.3	566.5	159.9	404.7	1396.7	137.1	158.5	846.0	133.8	965.4	223.3	811.8	381.2	428.7	730.3	395.0	745.2	120.3	136.6	532.6	204.0	841.9	800.8	182.0	144.9	382.9	580.5	634.0	192.3	594.0	185.4	352.4	487.5	14.5	567.0	554.5	1446.1	1060.4	810.7	658.7	157.1	946.4	713.4	106.4	159.2	373.7	556.6	2306.2	1068.8	740.9	638.7	217.3	56.5	0.2	13.0	0.9	291.6	951.8	29.7	66.0	131.3	58.5	79.7	35.3	74.6	15.8	379.6	18.1	9.7	15.0	13.0	124.8	154.8	74.2	7.1	45.7	20.2	32.6	13.8	189.7	91.7	1276.5	664.0	119.0	206.7	781.9	23.2	61.8	184.8	121.2	30.2	76.5	31.9	180.2	36.3	112.5	48.5	28.5	107.8	498.3	151.6	122.8	61.7	99.9	283.1	80.5	239.0	26.2	29.1	266.6	56.5	160.1	10.0	304.2	108.7	169.3	170.7	13.8	39.3	86.6	86.3	1059.6	571.2	1219.2	792.2	551.3	729.8	519.3	668.8	710.4	334.4	542.4	650.2	708.5	1246.6	637.1	496.3	154.8	674.5	1684.4	130.3	159.9	137.1	158.5	120.3	136.6	182.0	144.9	185.4	157.1	159.2	217.3	2550.5	227.6	328.5	26.4	1360.4	70.7	236.9	129.8	413.8	6.5	167.4	111.2	526.0	185.8	184.4	272.2	29.2	5.0	1004.6	578.0	450.0	79.7	8.3	179.8	594.5	740.2	164.2	270.8	0.2	53.8	4.1	666.5	160.5	464.2	377.4	53.6	349.8	114.8	231.9	6.7	0.5	320.9	136.3	845.1	184.9	35.5	654.5	730.8	108.5	36.5	892.0	3.6	2028.9	45.2	55.8	225.7	459.4	447.2	639.6	370.7	79.0	169.3	155.8	3.7	1196.5	452.4	398.7	7.6	63.7	160.1	72.2	10.9	1142.8	303.9	186.9	516.2
U2AF1L5		ENSG00000275895	"U2 small nuclear RNA auxiliary factor 1 like 5"	P0DN76	21	6484623-6499261	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 12.8;Alveolar cells type 2: 18.0;Club cells: 14.2;granulocytes: 30.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA044833, HPA052083"	Supported		Uncertain	Nucleoplasm		NA	NA		28000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm		"HPA044833: AB_10960990, HPA052083: AB_2681720"	"unprognostic (6.54e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.75e-2)"	"unprognostic (8.31e-3)"	"unprognostic (2.80e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.42e-2)"	"unprognostic (5.39e-3)"	"unprognostic (3.14e-1)"	"unprognostic (2.79e-2)"	"unprognostic (5.98e-2)"	"unprognostic (8.20e-2)"	48.0	41.4	34.1	50.7	33.1	71.5	47.4	33.0	42.7	40.8	29.2	45.3	44.2	43.2	54.4	39.6	47.4	26.1	39.8	33.3	34.7	47.7	44.4	32.0	55.4	35.1	32.9	58.1	47.6	34.9	41.7	52.8	35.0	34.2	54.1	48.7	31.8	31.0	40.1	41.5	36.4	47.5	35.4	52.3	34.3	39.6	33.7	86.5	49.4	39.0	80.9	55.6	19.9	36.2	195.0	186.6	156.9	128.0	107.5	76.0	80.6	118.0	103.5	164.3	88.2	83.2	88.6	571.9	105.2	149.3	191.6	143.2	275.3	223.6	195.6	143.0	266.8	226.8	170.8	311.9	178.1	401.0	125.5	61.1	64.6	91.6	121.6	77.5	179.7	58.4	479.7	186.2	150.5	85.4	216.3	131.2	212.7	250.6	76.2	277.6	91.4	108.7	167.9	274.8	164.7	124.3	70.3	139.5	91.0	63.8	78.1	222.5	234.7	121.5	217.1	51.1	86.7	184.5	212.6	538.1	105.0	260.3	176.3	175.4	197.4	182.8	147.0	189.1	162.2	210.7	176.6	172.2	207.3	236.6	188.1	165.4	348.0	169.9	127.9	297.9	246.3	235.8	34.1	33.1	33.0	42.7	33.3	34.7	35.1	32.9	35.0	35.4	33.7	36.2	2.6	12.8	18.0	0.0	0.8	0.0	4.2	0.0	0.0	0.2	4.7	2.7	0.0	2.8	14.2	0.0	0.0	1.4	3.2	0.4	1.9	4.8	0.7	2.8	3.1	2.9	2.4	0.0	0.0	7.1	1.9	7.5	0.0	3.6	30.3	3.8	1.4	1.2	1.1	0.0	0.0	1.5	0.0	0.8	0.0	0.2	0.3	2.9	0.0	0.0	2.9	0.5	1.0	0.0	0.0	6.4	2.1	1.2	0.9	3.8	1.5	1.7	10.2	0.4	0.0	1.8	1.5	1.9	2.0	0.0	0.0	2.1	2.0	3.9	1.4	2.0
UBAP1	UBAP	ENSG00000165006	"Ubiquitin associated protein 1"	Q9NZ09	9	34179005-34252523	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019804	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Vesicles, Plasma membrane"	"HPA019804: AB_1858494"	"unprognostic (1.83e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.54e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.63e-1)"	"prognostic favorable (7.49e-6)"	"unprognostic (1.24e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.17e-1)"	40.7	55.5	46.4	24.5	47.1	131.5	35.8	48.0	53.4	45.0	46.4	38.5	22.3	34.0	25.5	69.7	33.9	30.4	38.2	45.6	48.2	34.8	53.1	42.5	23.8	48.5	48.5	40.9	28.0	34.4	25.6	29.3	49.4	30.4	24.8	44.8	29.6	30.6	110.0	39.5	26.3	35.2	46.3	28.2	33.6	47.8	49.9	31.6	25.6	71.7	32.7	38.0	45.8	48.2	56.7	31.7	35.2	38.4	63.6	39.3	29.8	44.4	61.6	48.4	65.6	34.3	23.0	39.3	19.5	66.5	41.1	28.3	49.2	69.5	46.4	57.1	22.3	35.1	65.4	35.5	57.8	39.3	44.8	48.7	113.0	57.5	75.0	73.4	54.4	37.9	27.4	38.0	45.7	23.7	36.5	55.0	38.2	38.8	45.9	32.6	24.8	22.8	104.2	36.9	19.9	28.1	49.0	50.2	22.5	31.1	24.6	38.5	39.2	24.7	38.0	37.4	41.5	18.9	25.3	41.0	49.5	31.5	74.2	26.8	50.9	66.6	38.0	45.2	65.8	26.8	38.1	40.0	47.1	23.2	36.3	29.8	120.2	50.1	41.0	26.7	52.9	55.0	46.4	47.1	48.0	53.4	45.6	48.2	48.5	48.5	49.4	46.3	49.9	48.2	21.6	67.3	26.0	44.4	22.4	46.9	66.3	20.4	45.5	15.8	27.9	23.1	13.1	20.0	33.5	7.3	25.0	33.2	21.6	25.8	19.6	34.8	77.5	56.9	37.2	21.4	16.1	50.7	33.1	40.1	35.4	31.2	44.4	90.0	25.9	15.4	17.5	25.3	22.0	6.7	42.9	18.5	30.5	21.4	39.8	62.9	29.2	38.2	24.9	26.2	23.1	26.0	13.4	38.7	35.4	44.3	23.0	42.5	25.0	47.9	22.5	21.0	22.5	10.9	19.7	44.0	32.5	51.0	22.9	54.6	59.0	89.6	28.6	20.8	18.8	70.9
UBOX5	"KIAA0860, RNF37, Ubce7ip5, UIP5"	ENSG00000185019	"U-box domain containing 5"	O94941	20	3107573-3160196	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028871	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA028871: AB_10603140"	"unprognostic (4.11e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (4.52e-5)"	"unprognostic (2.58e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.61e-1)"	"prognostic favorable (1.80e-5)"	"unprognostic (4.02e-2)"	"unprognostic (9.71e-3)"	"unprognostic (3.33e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.61e-2)"	4.5	4.4	4.3	2.7	5.1	6.9	4.5	5.5	5.1	4.8	2.4	6.2	2.8	5.9	2.7	4.4	4.8	2.6	3.8	4.5	3.8	4.4	3.5	3.7	3.7	3.8	3.7	5.0	6.1	5.4	4.4	3.4	3.5	5.2	2.9	3.8	4.8	4.4	11.2	7.6	4.2	4.1	3.2	4.3	4.7	4.8	3.9	3.8	3.8	6.8	3.0	5.6	4.2	6.1	6.1	6.1	4.8	3.1	6.3	3.5	2.6	4.9	4.7	6.1	6.0	5.8	5.2	4.8	2.0	4.2	7.0	8.5	3.2	7.8	3.6	1.4	2.7	7.9	2.1	5.4	5.0	3.9	2.9	4.5	5.6	4.9	6.2	5.0	3.9	3.7	6.7	4.4	3.5	4.5	7.0	5.0	3.7	6.3	3.7	4.7	5.8	3.3	3.8	6.7	5.9	5.7	3.4	18.8	4.0	3.7	8.1	2.5	4.3	4.0	2.7	4.6	4.4	5.9	9.4	4.2	2.1	3.5	3.0	7.9	5.1	9.4	4.4	5.1	5.0	6.3	5.2	3.6	5.5	4.8	5.3	5.1	8.1	5.2	5.3	3.7	5.6	4.6	4.3	5.1	5.5	5.1	4.5	3.8	3.8	3.7	3.5	3.2	3.9	6.1	2.4	12.8	6.0	6.8	3.6	1.9	4.1	3.4	0.6	6.6	2.8	2.0	1.1	1.5	3.1	0.0	6.2	6.9	1.9	5.6	0.0	4.0	1.4	2.5	2.5	3.6	10.2	0.4	9.6	4.2	4.4	3.5	5.1	2.7	2.5	4.5	4.6	4.3	4.9	6.7	8.5	4.9	6.1	5.0	3.2	1.9	6.8	3.5	3.6	3.7	6.6	4.5	4.1	4.5	10.4	3.9	3.4	3.8	2.3	5.8	4.7	5.2	2.7	5.2	6.6	5.2	2.8	10.2	5.2	1.6	2.4	10.1	3.1	3.8	5.3	5.9
UFD1	UFD1L	ENSG00000070010	"Ubiquitin recognition factor in ER associated degradation 1"	Q92890	22	19449911-19479202	"Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 121.1;Ductal cells: 115.7;Exocrine glandular cells: 142.2;Extravillous trophoblasts: 107.3;Pancreatic endocrine cells: 149.9;Syncytiotrophoblasts: 170.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 782.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030286, HPA030287"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA030286: , HPA030287: AB_10601830"	"unprognostic (2.52e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.61e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (9.79e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.02e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (4.50e-8)"	"unprognostic (1.45e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-2)"	43.8	39.8	23.6	36.8	26.3	64.8	37.8	27.6	29.8	33.9	25.7	42.5	32.1	46.8	54.4	48.4	31.4	29.3	44.8	24.6	28.6	36.7	51.9	37.2	43.4	28.9	26.7	31.8	39.3	44.7	31.7	35.3	29.5	32.1	38.4	21.7	38.1	30.1	98.3	42.5	35.7	39.5	27.2	38.6	40.8	53.3	27.1	61.6	34.9	42.5	47.5	40.2	37.0	29.7	187.5	132.4	110.6	168.5	89.0	62.0	86.0	150.2	148.8	202.9	187.1	147.8	78.8	129.2	114.1	126.7	93.3	157.5	131.5	132.1	175.1	239.8	138.0	136.5	88.3	119.4	84.4	218.6	177.7	57.4	133.0	173.2	84.4	59.1	164.7	67.9	782.0	240.5	125.1	268.5	142.0	133.4	79.8	232.2	111.9	170.1	262.0	50.1	126.6	172.5	90.5	102.2	118.2	126.0	123.3	114.2	75.9	103.5	180.9	169.6	230.8	143.2	164.1	102.9	221.7	168.8	142.5	110.3	158.6	150.9	90.6	158.1	107.0	140.3	103.7	87.7	122.5	112.4	81.0	82.6	104.6	102.9	167.1	105.7	140.7	113.1	224.5	129.5	23.6	26.3	27.6	29.8	24.6	28.6	28.9	26.7	29.5	27.2	27.1	29.7	68.3	25.6	34.5	0.0	16.4	0.0	0.0	0.0	0.0	0.0	39.7	55.2	0.0	0.0	16.7	27.6	0.0	121.1	44.9	0.0	84.1	115.7	0.0	43.1	36.9	32.6	0.0	0.0	0.0	142.2	107.3	25.4	0.0	44.9	27.8	36.0	0.0	0.0	88.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	76.0	0.0	0.0	0.0	0.0	149.9	0.0	0.0	7.5	0.0	0.0	81.0	27.7	0.0	0.0	0.0	37.2	0.0	0.0	0.0	0.0	170.3	26.3	61.5	0.0	0.0
USP4	"UNP, Unph"	ENSG00000114316	"Ubiquitin specific peptidase 4"	Q13107	3	49277144-49340712	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 131.8;Late spermatids: 104.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018499	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cytosol"		"HPA018499: AB_1858689"	"unprognostic (2.34e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.22e-3)"	"unprognostic (6.12e-2)"	"unprognostic (3.51e-1)"	"unprognostic (4.33e-2)"	"unprognostic (9.42e-2)"	"prognostic favorable (4.46e-5)"	"unprognostic (3.54e-1)"	"unprognostic (9.07e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.70e-3)"	"prognostic favorable (4.29e-5)"	"unprognostic (7.30e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.65e-2)"	25.2	20.3	24.2	26.5	26.3	53.7	24.9	24.5	28.2	27.7	27.1	25.4	18.3	24.4	21.6	26.0	22.4	18.3	26.5	23.7	23.4	21.8	20.2	29.5	30.9	23.9	24.4	24.5	19.0	24.1	16.4	23.3	23.9	23.7	23.4	26.9	21.0	21.7	31.6	31.4	22.5	24.0	22.4	33.7	20.2	28.0	24.8	37.0	23.0	28.8	33.7	25.8	25.0	24.5	14.2	15.8	21.6	28.8	38.7	40.1	14.7	36.4	32.9	46.7	41.3	16.8	34.8	27.1	14.4	53.9	27.4	18.9	28.6	52.6	42.5	42.1	8.4	60.3	31.9	19.6	57.0	32.5	34.0	42.8	23.3	51.0	41.5	34.3	55.0	29.9	21.6	41.6	42.1	24.5	38.3	55.8	18.7	17.7	26.9	15.6	13.3	23.9	37.5	29.2	17.5	24.0	27.2	19.3	14.0	21.6	13.5	51.2	50.1	31.1	17.2	39.6	22.5	33.6	17.3	38.6	28.6	50.1	36.5	70.1	83.6	94.8	48.1	69.2	53.7	51.0	50.2	48.9	74.6	41.4	47.7	42.2	179.2	72.4	81.2	28.4	59.7	78.0	24.2	26.3	24.5	28.2	23.7	23.4	23.9	24.4	23.9	22.4	24.8	24.5	24.3	41.7	25.1	28.1	24.7	18.7	17.9	17.2	22.2	17.5	10.9	10.3	17.9	10.0	23.2	20.2	20.9	22.7	27.9	13.6	21.5	16.5	131.8	17.3	18.3	22.1	10.7	31.6	30.8	13.6	14.3	17.9	27.5	21.1	33.6	21.4	17.5	14.6	24.0	11.8	26.4	13.8	16.2	38.6	21.0	104.9	15.5	34.2	16.0	16.9	36.0	13.9	23.7	25.6	20.2	18.9	7.6	19.2	29.2	17.6	14.5	13.4	28.6	20.5	13.1	18.4	17.0	35.3	14.5	17.9	18.5	24.2	29.4	17.0	13.9	14.5
VPS13B	"CHS1, COH1"	ENSG00000132549	"Vacuolar protein sorting 13 homolog B"	Q7Z7G8	8	99013266-99877580	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Astrocytes: 160.9;Excitatory neurons: 235.2;Inhibitory neurons: 253.2;Microglial cells: 204.2;Oligodendrocyte precursor cells: 217.1;Oligodendrocytes: 238.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043865			Approved	"Cell Junctions"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Cell Junctions"		"HPA043865: AB_2678704"	"unprognostic (4.23e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.60e-3)"	"unprognostic (5.72e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.65e-3)"	"unprognostic (8.60e-2)"	"unprognostic (5.95e-2)"	"unprognostic (6.52e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.93e-3)"	"unprognostic (2.90e-1)"	4.0	3.0	2.4	4.4	3.3	13.4	4.7	4.5	3.0	5.4	8.2	3.6	2.3	7.2	3.8	4.4	4.9	4.4	2.3	2.0	1.9	3.8	3.1	3.5	4.8	3.6	2.4	8.1	3.4	6.8	2.3	4.0	3.6	4.9	3.7	6.0	3.2	4.1	2.9	4.0	3.0	5.4	2.2	4.2	3.6	4.9	4.9	7.1	4.7	4.4	5.0	4.5	3.7	5.3	8.6	6.1	7.2	5.3	13.3	15.9	3.6	5.4	9.9	5.3	7.0	3.6	4.3	4.8	6.9	9.3	3.9	3.9	5.0	5.0	9.6	7.7	4.6	10.3	6.5	2.8	4.3	5.0	7.4	10.3	4.6	8.5	12.2	7.4	7.6	7.9	7.9	12.4	6.1	5.3	10.5	2.9	2.3	8.9	2.2	8.3	5.1	9.1	3.5	8.0	2.1	6.0	8.4	4.0	4.0	6.4	7.2	5.6	10.8	7.9	7.4	7.1	4.6	5.0	6.2	12.7	6.0	7.9	5.6	3.0	1.2	2.8	1.2	1.0	1.1	3.3	1.0	0.9	0.5	1.6	1.7	1.1	6.1	0.7	2.3	0.6	1.4	0.5	2.4	3.3	4.5	3.0	2.0	1.9	3.6	2.4	3.6	2.2	4.9	5.3	15.5	19.2	12.2	160.9	24.2	8.8	7.6	9.2	15.4	15.1	8.9	7.6	12.8	10.0	11.9	3.7	37.5	4.9	21.6	7.3	0.0	4.9	8.6	10.9	42.7	11.5	9.0	22.9	235.2	4.6	4.0	18.2	28.1	12.7	3.8	10.4	6.4	5.2	6.5	11.8	253.2	11.9	8.2	15.6	11.3	9.6	27.7	17.8	7.2	204.2	15.0	9.4	17.5	217.1	238.1	4.0	11.0	20.7	19.2	6.2	9.8	2.9	8.2	12.9	0.0	15.7	14.7	23.9	7.3	13.0	9.7	4.2	19.5	14.6	7.4	5.7
VPS37B	FLJ12750	ENSG00000139722	"VPS37B subunit of ESCRT-I"	Q9H9H4	12	122865330-122896127	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038217, HPA038218"	Enhanced					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA038217: AB_10672740, HPA038218: AB_2675898"	"unprognostic (1.63e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.25e-2)"	"unprognostic (8.26e-3)"	"unprognostic (2.51e-1)"	"unprognostic (5.57e-2)"	"unprognostic (3.01e-1)"	"prognostic favorable (1.35e-6)"	"unprognostic (2.58e-3)"	"unprognostic (6.38e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.44e-2)"	19.9	28.3	24.1	15.7	19.6	46.6	18.7	17.2	26.1	13.8	23.6	29.5	17.8	11.8	5.2	63.4	14.9	18.1	23.5	25.5	16.4	30.6	11.0	28.1	14.5	19.5	17.7	15.3	27.2	10.8	23.5	10.7	16.4	19.5	17.4	9.3	36.2	9.2	10.3	23.0	23.6	7.2	17.9	34.5	37.3	25.4	19.6	10.8	28.3	6.8	16.7	17.1	19.2	21.6	55.2	19.2	52.0	21.0	8.7	15.6	49.6	26.6	24.7	20.5	17.6	21.4	42.1	1.4	19.3	16.8	33.7	35.6	29.1	39.0	15.6	15.1	28.3	106.2	13.3	15.2	19.8	13.9	82.7	18.9	34.3	28.2	24.8	38.5	30.5	65.3	40.6	34.5	27.1	10.4	33.0	40.5	29.3	57.1	52.4	25.3	32.2	17.0	31.8	51.3	31.4	35.4	23.6	25.7	58.8	21.9	45.5	23.2	28.2	20.7	28.3	24.3	48.1	116.5	116.8	0.6	26.3	20.4	123.6	12.1	4.5	10.4	14.2	6.6	10.2	10.3	4.7	8.3	1.7	12.7	4.2	6.0	27.6	8.3	9.0	0.2	4.5	4.7	24.1	19.6	17.2	26.1	25.5	16.4	19.5	17.7	16.4	17.9	19.6	21.6	57.3	54.5	34.3	18.9	159.3	43.2	98.7	66.6	46.1	32.0	30.8	18.8	2.6	25.8	75.0	31.3	68.8	19.9	198.7	123.1	17.6	53.6	40.5	88.1	24.8	37.6	44.3	30.5	26.2	42.7	34.1	16.0	141.2	168.2	90.9	14.1	30.0	13.4	17.6	10.1	16.7	49.5	63.1	19.0	66.3	52.5	8.1	46.7	39.2	19.7	9.5	20.8	62.8	12.1	27.2	71.0	83.6	7.9	168.3	104.4	43.8	5.8	56.6	20.7	6.6	14.1	29.1	14.1	12.5	49.2	44.6	43.6	119.0	30.6	61.3	158.0
VRK3		ENSG00000105053	"VRK serine/threonine kinase 3"	Q8IV63	19	49976468-50025946	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 135.6"	"Group enriched"	"Detected in all"	7	"Early spermatids: 557.6;Late spermatids: 1646.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056489	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA056489: AB_2683150"	"unprognostic (2.09e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.22e-3)"	"unprognostic (9.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (1.83e-4)"	"unprognostic (9.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.66e-4)"	17.4	23.3	25.9	17.6	26.6	23.6	17.7	26.1	28.6	17.9	30.2	21.9	25.8	15.9	19.5	17.6	33.2	20.9	17.5	25.4	27.9	36.5	35.6	16.9	28.5	27.6	31.1	21.2	22.1	15.9	20.6	16.9	30.4	20.2	22.0	64.8	21.9	15.4	26.9	16.8	32.9	14.1	25.2	26.0	21.6	135.6	27.9	35.6	19.7	17.4	25.7	18.0	16.8	29.3	31.0	31.3	22.6	24.5	29.2	26.9	23.3	21.7	25.7	31.6	34.5	16.8	33.7	37.1	15.2	21.2	22.1	22.5	21.3	18.6	25.5	32.6	43.5	28.9	20.4	29.4	21.9	36.7	48.7	24.2	27.3	18.3	19.2	28.4	26.5	39.9	35.8	53.7	23.2	13.0	49.7	24.5	12.2	54.6	26.7	39.3	23.9	47.6	27.2	32.2	25.3	12.3	21.5	26.0	24.7	20.0	23.9	38.5	20.2	32.2	18.6	13.1	17.1	34.3	47.4	19.6	25.8	22.3	22.5	110.0	42.8	81.1	53.7	46.1	43.3	58.9	48.7	51.9	47.9	53.3	49.2	45.3	112.5	82.7	55.1	45.4	76.1	48.4	25.9	26.6	26.1	28.6	25.4	27.9	27.6	31.1	30.4	25.2	27.9	29.3	19.6	6.4	28.6	10.1	26.6	6.6	16.0	27.2	6.8	34.3	17.9	14.5	8.4	24.3	29.8	14.7	143.9	43.8	27.9	49.9	31.3	31.0	557.6	50.7	12.0	16.0	22.2	38.7	13.9	32.7	38.6	15.5	18.8	26.8	18.3	24.1	28.5	44.5	34.8	32.0	15.9	35.4	34.6	25.4	9.3	1646.8	22.1	22.9	14.2	6.5	40.6	33.2	41.2	10.1	15.3	34.2	67.9	25.9	18.6	20.6	87.5	91.4	71.8	116.0	13.1	12.0	15.2	142.8	52.6	10.5	10.9	57.3	28.0	24.9	36.0	30.1
WBP2	"GRAMD6, WBP-2"	ENSG00000132471	"WW domain binding protein 2"	Q969T9	17	75845699-75856507	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 321.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065682, HPA068819"	Approved		Supported	Nucleoplasm,Cytosol		No	No		440000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Cytosol"		"HPA065682: AB_2685530, HPA068819: AB_2686042"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.12e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.68e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.54e-3)"	"unprognostic (6.18e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.86e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.76e-1)"	113.2	223.6	239.5	57.1	238.6	82.7	114.1	225.1	340.9	103.2	163.6	109.7	65.2	84.6	44.3	94.7	106.1	62.8	183.1	243.0	242.2	125.7	184.4	118.1	60.9	293.9	256.8	113.9	134.5	100.7	116.0	55.4	286.4	103.5	39.0	129.7	137.7	73.5	250.2	131.3	85.7	52.0	226.4	112.5	123.2	95.4	259.8	49.2	83.8	91.9	51.8	97.8	94.7	256.6	104.6	119.9	43.4	52.5	88.0	87.2	57.9	32.7	102.1	74.3	91.8	59.7	104.2	52.9	81.9	47.0	232.2	61.0	45.2	100.9	66.3	40.1	90.4	97.7	66.4	97.6	182.2	40.8	161.6	96.4	94.6	89.4	120.8	127.0	143.8	82.1	68.2	156.7	60.2	107.3	85.8	85.8	37.3	70.8	78.8	57.8	85.4	101.5	109.7	62.3	72.6	114.8	58.5	99.9	163.1	76.3	134.9	102.1	84.3	75.8	66.1	73.6	52.3	145.4	109.6	38.8	212.5	38.3	54.9	239.9	85.0	288.7	53.8	102.6	59.1	68.9	59.5	54.6	54.8	55.3	55.8	47.5	308.9	57.4	136.4	42.0	77.4	93.2	239.5	238.6	225.1	340.9	243.0	242.2	293.9	256.8	286.4	226.4	259.8	256.6	73.5	83.3	79.0	34.9	62.7	60.9	127.2	85.9	30.1	109.7	75.2	53.3	73.2	55.8	59.9	53.3	75.0	64.9	45.9	65.9	162.4	124.3	264.5	41.5	21.7	63.4	33.6	124.0	23.6	188.6	65.1	43.5	34.1	44.3	67.0	40.0	54.3	61.9	138.4	112.7	23.4	48.9	71.2	65.5	71.2	321.1	59.4	90.2	60.5	23.4	90.8	104.8	52.5	21.1	38.6	126.5	72.6	53.8	35.6	120.2	88.4	100.7	44.8	120.7	26.3	43.8	44.9	45.5	25.7	24.8	80.0	184.7	51.7	62.5	27.1	95.6
WDR20	"DMR, FLJ33659, MGC33177"	ENSG00000140153	"WD repeat domain 20"	Q8TBZ3	14	102139503-102224847	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 241.9;Late spermatids: 250.6;Oligodendrocytes: 201.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 34: Spermatids - Unknown function"				"unprognostic (5.59e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.45e-2)"	"unprognostic (7.70e-2)"	"unprognostic (5.48e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.26e-2)"	"prognostic favorable (3.26e-9)"	"unprognostic (6.62e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.41e-2)"	12.2	17.0	11.2	9.4	16.3	10.7	11.7	18.7	15.6	11.5	13.3	10.8	16.0	10.3	12.0	13.5	10.7	8.9	10.0	12.3	15.0	12.5	10.9	8.8	11.5	16.5	14.0	12.3	12.3	11.9	10.5	9.9	16.1	10.2	10.5	29.9	11.4	7.4	11.8	16.0	13.1	9.1	11.6	10.4	10.6	23.9	14.3	12.3	14.1	13.0	10.8	10.4	12.1	28.7	16.2	20.6	14.6	13.0	16.4	14.3	19.2	19.8	16.4	21.9	17.7	17.6	15.2	17.7	12.9	18.6	11.9	19.3	21.6	17.8	27.7	25.0	9.8	9.3	14.8	19.4	12.6	14.4	16.1	11.2	16.7	15.8	15.5	22.0	15.4	14.2	12.3	18.6	23.9	37.2	13.3	21.8	13.0	22.3	22.7	13.3	14.5	11.9	31.8	25.4	18.4	20.8	17.3	22.2	13.9	16.2	24.1	13.8	17.0	20.3	9.3	32.2	18.7	14.6	21.9	18.8	18.5	11.7	22.2	28.5	20.7	37.7	25.8	21.2	27.0	27.6	28.4	24.2	21.0	19.9	28.9	27.4	40.2	30.4	21.4	12.4	33.6	21.0	11.2	16.3	18.7	15.6	12.3	15.0	16.5	14.0	16.1	11.6	14.3	28.7	17.5	9.6	14.5	48.6	21.0	25.1	15.4	19.6	16.5	20.5	16.3	12.7	10.4	10.0	16.7	11.0	16.7	25.6	22.8	19.6	21.5	17.9	241.9	20.1	14.5	12.9	11.4	25.0	43.3	17.3	19.4	15.6	14.3	21.1	22.9	15.0	15.0	12.7	13.4	33.7	42.9	12.8	18.3	10.4	13.8	250.6	13.1	12.9	21.4	48.7	15.6	23.8	22.6	68.9	201.5	18.9	17.6	15.1	17.4	19.0	27.5	25.1	15.6	54.6	13.1	18.6	17.4	43.0	25.3	16.4	27.4	34.9	22.3	8.7	12.1	21.7
WIPF1	"WASPIP, WIP"	ENSG00000115935	"WAS/WASL interacting protein family member 1"	O43516	2	174559572-174682916	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 126.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 172.7;monocytes: 187.2;NK-cells: 245.1;Oligodendrocytes: 217.2;Plasma cells: 162.8;T-cells: 208.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 209.1;Karpas-707: 296.8;U-266/70: 233.0"	"Low region specificity"	"Detected in all"							"HPA003739, CAB009737, HPA070706"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	No		520000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Plasma membrane"	"CAB009737: AB_2288577, HPA003739: AB_1858783, HPA070706: AB_2686300"	"unprognostic (4.76e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (3.65e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.50e-2)"	31.0	14.7	14.2	93.0	37.2	56.8	21.0	36.1	20.5	30.6	11.1	26.0	18.2	22.4	11.5	14.2	14.4	34.8	16.0	14.9	28.8	13.0	16.4	31.8	126.9	46.2	38.6	12.3	7.3	12.9	4.8	33.5	42.3	14.9	20.8	3.4	17.7	23.0	5.9	9.9	32.5	29.1	27.9	89.7	21.8	4.7	35.1	66.4	15.4	11.5	110.5	31.5	17.0	53.8	0.7	7.0	16.3	0.2	40.4	70.9	16.9	31.1	26.4	12.1	18.7	1.9	1.4	209.1	9.2	47.0	15.6	0.5	2.8	0.0	15.1	144.8	4.1	106.5	26.9	0.0	15.1	94.9	167.2	29.6	5.1	27.7	2.6	16.0	25.0	18.7	3.3	296.8	34.4	0.1	106.6	87.1	19.1	0.0	1.4	90.0	6.6	37.9	11.3	0.7	2.6	33.8	0.3	8.8	18.7	30.4	0.4	46.8	21.2	41.0	11.5	30.1	29.9	233.0	165.2	113.7	60.4	64.7	111.7	41.5	35.4	87.2	71.6	37.3	59.4	35.1	47.6	71.1	26.1	28.6	38.0	51.4	166.1	57.4	43.7	11.2	57.7	54.7	14.2	37.2	36.1	20.5	14.9	28.8	46.2	38.6	42.3	27.9	35.1	53.8	32.1	19.2	21.7	27.7	134.5	12.5	6.3	0.9	2.8	2.1	3.3	4.3	10.5	1.5	4.6	3.7	25.0	2.0	172.7	0.3	5.9	1.7	40.2	3.3	21.9	30.8	4.9	30.1	5.3	11.6	82.5	40.5	9.7	2.1	67.2	2.1	36.8	3.7	86.2	0.0	7.2	1.6	0.0	142.2	128.0	96.9	25.1	139.8	26.6	98.4	187.2	1.2	245.1	120.6	217.2	16.8	0.8	18.0	162.8	5.0	0.2	35.9	0.1	3.4	13.1	15.7	21.4	4.4	4.1	1.2	11.1	4.1	208.1	8.8	2.1	3.1
XRCC1	RCC	ENSG00000073050	"X-ray repair cross complementing 1"	P18887	19	43543311-43580473	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005427, HPA006717"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"CAB005427: AB_2215661, HPA006717: AB_1858896"	"unprognostic (1.10e-2)"	"unprognostic (3.51e-3)"	"unprognostic (4.59e-1)"	"unprognostic (2.81e-2)"	"unprognostic (4.08e-1)"	"unprognostic (2.68e-2)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (5.07e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.00e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.34e-3)"	"unprognostic (2.20e-2)"	"unprognostic (5.69e-2)"	18.5	16.4	15.3	18.0	15.6	24.4	17.9	18.5	17.1	23.6	13.5	20.4	14.6	23.5	16.2	16.1	23.2	14.4	15.5	14.6	15.6	15.7	10.8	16.2	22.9	15.7	15.2	32.0	19.6	17.6	32.3	16.6	14.0	16.2	11.4	16.7	16.3	15.6	19.5	21.0	15.7	17.3	13.5	20.1	18.5	23.9	16.6	29.0	20.6	15.7	20.9	18.6	18.0	15.6	57.4	51.4	54.4	48.2	23.6	24.6	27.0	28.4	36.0	42.5	46.3	32.0	40.4	44.1	39.1	28.9	39.1	30.0	33.2	36.8	24.7	46.4	33.9	57.5	49.4	36.1	23.2	34.5	42.9	27.3	24.8	53.5	26.4	48.8	37.2	49.1	35.9	42.5	37.3	48.9	57.5	52.5	18.5	44.2	21.3	57.0	35.4	25.8	34.3	44.1	44.5	26.5	41.6	35.3	20.7	26.8	33.9	67.4	23.3	55.7	40.4	16.3	39.9	44.2	44.2	32.0	42.8	28.0	58.7	18.6	13.1	15.6	10.8	11.9	12.3	11.7	13.8	14.6	11.6	10.5	11.3	10.9	15.1	10.4	7.9	9.1	14.5	11.7	15.3	15.6	18.5	17.1	14.6	15.6	15.7	15.2	14.0	13.5	16.6	15.6	10.2	16.0	9.8	5.9	13.4	6.1	7.1	17.5	12.5	12.6	10.2	9.0	7.6	7.2	14.7	7.3	6.2	29.8	12.5	9.1	19.6	15.4	32.2	18.7	13.3	12.2	13.7	15.4	8.2	11.6	19.2	13.3	8.2	13.7	19.7	22.0	11.4	7.1	21.0	5.0	9.2	15.3	10.2	18.0	10.1	19.5	10.2	12.6	14.2	3.7	14.3	8.6	8.2	4.5	8.1	12.2	9.7	12.8	17.7	4.1	9.2	16.9	39.0	12.7	6.6	9.6	17.7	21.4	14.1	10.8	7.1	20.0	14.6	16.4	13.7	4.7
YIPF6	"FinGER6, MGC21416"	ENSG00000181704	"Yip1 domain family member 6"	Q96EC8	X	68498562-68537282	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 278.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003720	Uncertain		Approved	Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"HPA003720: AB_1080626"	"unprognostic (5.07e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.17e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.85e-3)"	"unprognostic (8.48e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.25e-1)"	"unprognostic (6.32e-2)"	14.3	14.7	13.9	7.8	15.7	6.6	14.9	15.6	15.4	14.5	15.4	12.5	11.7	13.3	14.5	11.6	13.2	11.1	11.6	12.9	16.0	18.9	21.6	12.4	6.4	15.9	16.5	10.5	14.5	20.6	15.0	18.2	14.9	19.9	14.1	14.3	16.4	14.5	16.9	10.7	11.4	12.9	15.1	8.3	15.3	6.2	15.7	6.7	21.8	16.4	7.4	12.4	8.4	15.5	23.5	22.4	22.6	7.9	28.7	17.8	24.8	18.0	22.5	13.8	17.4	23.5	23.5	0.1	32.6	15.1	22.8	18.2	29.8	12.2	23.2	6.8	20.2	10.4	22.6	19.6	26.4	11.4	14.3	17.6	22.3	20.5	25.4	24.1	13.8	13.4	16.6	22.3	18.8	24.8	6.6	9.7	24.0	34.0	23.3	6.7	27.5	12.3	22.9	25.9	23.5	24.6	30.6	20.9	21.7	20.4	12.9	11.8	18.8	15.4	14.8	49.2	35.0	12.2	15.0	4.6	22.8	17.2	26.1	5.3	4.0	4.7	2.2	4.7	1.5	3.9	2.2	2.0	3.0	2.1	2.2	1.9	10.5	2.9	4.2	3.6	2.6	2.8	13.9	15.7	15.6	15.4	12.9	16.0	15.9	16.5	14.9	15.1	15.7	15.5	42.1	70.5	99.6	25.5	25.6	34.9	62.3	110.0	21.6	54.6	47.4	32.3	33.7	32.9	88.6	57.0	47.9	101.6	19.8	43.8	35.2	47.4	25.9	50.9	35.2	41.7	54.4	80.4	18.8	43.9	111.3	53.1	27.5	47.8	53.7	33.6	42.1	60.2	44.1	45.4	21.9	61.8	93.6	25.9	42.0	63.2	42.6	38.5	35.6	23.4	23.4	63.5	29.9	26.7	34.9	47.3	34.7	47.4	42.7	90.4	42.4	62.4	81.6	52.7	26.3	50.8	44.6	31.5	28.1	31.4	43.3	278.8	29.0	29.6	33.5	89.5
YPEL3	MGC10500	ENSG00000090238	"Yippee like 3"	P61236	16	30092314-30096915	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"basophil: 23.2;eosinophil: 31.0;neutrophil: 47.4"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 47.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 74.1;RPMI-8226: 102.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030501, HPA045621"	Uncertain					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA030501: AB_10602683, HPA045621: "	"unprognostic (1.11e-1)"	"unprognostic (1.14e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.58e-2)"	"prognostic favorable (1.09e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.64e-1)"	"unprognostic (5.42e-3)"	"unprognostic (3.90e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.16e-2)"	"unprognostic (4.40e-3)"	96.3	64.9	97.1	34.4	107.7	51.9	95.4	99.8	193.7	84.1	37.8	96.6	31.7	75.9	15.8	97.7	85.0	23.4	98.5	114.0	70.7	84.5	54.5	101.5	41.4	104.1	82.7	97.9	97.8	35.1	80.3	37.7	105.0	84.7	11.8	25.5	97.3	26.9	190.5	119.6	106.1	14.8	74.8	178.9	76.9	24.4	92.3	39.1	81.6	58.3	31.5	83.2	97.5	120.7	13.5	3.3	8.8	2.9	33.1	32.9	36.6	21.4	13.7	5.1	12.4	1.8	44.9	4.4	74.1	16.2	0.2	7.6	5.1	11.4	2.2	26.6	17.3	5.2	9.6	18.3	24.6	0.0	40.8	54.8	15.6	7.5	2.0	47.0	17.8	0.4	4.4	33.4	7.0	25.7	0.9	4.2	8.1	4.9	2.8	24.4	0.1	102.2	10.3	11.5	18.2	47.7	8.7	10.9	18.7	10.9	15.3	16.3	18.7	1.4	9.0	4.1	0.1	55.9	19.2	7.4	14.7	7.9	4.2	23.2	3.2	31.0	2.4	1.5	2.7	3.3	4.4	3.2	2.0	3.8	4.1	2.3	47.4	5.8	1.3	2.0	4.1	1.4	97.1	107.7	99.8	193.7	114.0	70.7	104.1	82.7	105.0	74.8	92.3	120.7	128.6	41.7	54.4	44.7	119.0	53.8	87.0	26.7	87.6	90.3	105.3	146.3	56.8	80.1	33.7	71.7	54.2	174.7	149.6	43.2	92.0	80.9	25.1	72.9	35.7	72.9	47.4	232.8	67.3	69.0	126.1	69.7	42.3	61.4	23.5	75.0	127.8	22.0	48.1	55.5	71.5	51.9	26.4	107.7	39.9	33.3	98.5	85.3	32.0	36.5	68.7	139.7	134.9	36.7	61.2	144.7	46.9	63.9	162.7	113.2	68.4	91.3	33.8	103.2	59.2	89.4	75.6	6.4	22.7	55.0	77.0	113.6	111.4	51.7	22.5	152.1
ZBP1	"C20orf183, DAI, dJ718J7.3, DLM-1, DLM1"	ENSG00000124256	"Z-DNA binding protein 1"	Q9H171	20	57603846-57620576	"Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Innate immunity, Necrosis"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.7;lymphoid tissue: 25.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 34.0;dendritic cells: 42.7;NK-cells: 53.5;Plasma cells: 189.2;T-cells: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 34.1;U-266/70: 16.6;U-266/84: 22.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA041256	Enhanced					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA041256: AB_2677380"	"unprognostic (5.78e-3)"	"unprognostic (9.86e-2)"	"unprognostic (6.14e-2)"	"unprognostic (6.20e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.05e-4)"	"unprognostic (1.37e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.38e-3)"	"unprognostic (7.19e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.58e-8)"	"unprognostic (8.29e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.65e-2)"	"unprognostic (9.79e-2)"	2.6	1.4	0.6	18.8	0.7	28.7	3.6	4.6	2.8	2.1	0.1	9.8	13.1	1.9	2.2	2.1	1.0	7.8	1.9	1.5	0.0	1.3	2.1	5.1	23.9	0.6	0.2	1.8	2.0	0.2	0.4	1.3	1.3	1.8	10.8	4.1	6.2	1.6	0.8	3.9	10.6	1.2	0.7	21.8	8.4	2.2	0.4	5.0	2.7	1.3	25.1	8.5	0.8	2.9	0.8	0.6	1.9	3.5	0.6	0.5	1.0	0.6	0.3	0.2	0.9	3.0	1.6	9.3	0.7	0.0	1.1	1.5	0.0	1.1	0.0	0.8	2.0	2.9	5.5	1.4	0.5	2.5	2.2	0.0	0.4	1.1	0.9	1.8	0.4	1.5	1.2	34.1	1.3	4.7	1.5	4.8	2.2	0.5	4.1	1.4	0.2	10.0	0.0	4.3	1.9	2.0	0.3	1.6	1.4	1.3	1.3	1.4	1.6	4.3	1.5	2.8	1.6	16.6	22.8	4.1	1.6	2.8	0.8	1.6	3.8	17.5	18.8	3.9	12.5	16.2	12.6	11.4	4.4	12.1	5.6	7.8	38.0	19.6	2.4	0.2	18.4	7.0	0.6	0.7	4.6	2.8	1.5	0.0	0.6	0.2	1.3	0.7	0.4	2.9	1.2	0.0	0.6	0.0	34.0	0.3	1.0	0.2	0.0	0.0	0.5	0.3	1.0	0.0	0.0	0.0	2.1	0.1	42.7	12.9	0.0	0.1	0.1	0.1	0.2	0.5	0.0	0.8	0.0	0.2	0.0	0.5	3.1	0.4	3.8	0.0	0.0	0.0	1.0	0.0	0.1	1.1	0.0	1.0	0.4	0.0	0.0	2.1	14.2	0.0	3.1	0.5	53.5	0.0	0.1	1.3	3.4	0.0	189.2	1.8	0.8	0.2	0.0	0.3	0.0	1.5	0.8	0.0	0.0	0.0	0.3	0.0	25.8	0.0	1.0	0.8
ZDHHC5	"DHHC5, KIAA1748, ZNF375"	ENSG00000156599	"Zinc finger DHHC-type palmitoyltransferase 5"	Q9C0B5	11	57667747-57701182	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014670	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	Nucleoplasm	"HPA014670: AB_2257442"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.74e-3)"	"unprognostic (4.36e-2)"	"unprognostic (9.78e-2)"	"prognostic unfavorable (6.74e-5)"	"unprognostic (1.76e-1)"	"unprognostic (4.72e-3)"	"unprognostic (2.16e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.74e-3)"	29.0	21.7	8.3	27.2	7.8	29.2	25.8	8.3	9.5	27.0	11.0	36.4	29.6	22.3	24.1	60.9	25.0	27.9	27.9	7.5	9.2	28.2	36.7	29.0	24.4	8.5	8.9	20.7	31.6	45.3	12.6	36.7	8.7	28.0	34.4	35.9	35.0	26.7	40.9	45.2	31.0	29.0	6.9	25.5	30.2	36.2	10.9	30.6	36.9	45.5	35.0	42.3	28.7	8.9	80.3	86.2	33.7	34.7	74.9	57.4	64.9	72.8	89.8	61.8	46.3	52.3	97.0	53.4	91.9	89.5	53.1	110.1	53.6	88.9	55.4	66.5	24.4	45.8	40.1	49.3	81.5	85.9	73.7	81.3	79.3	88.8	92.9	51.1	71.0	45.6	61.5	66.2	79.7	48.4	49.1	29.3	41.1	61.0	52.2	47.8	66.6	67.1	74.8	115.2	25.3	30.7	67.6	77.0	78.5	45.4	81.9	52.6	80.7	76.5	40.7	82.9	52.2	48.2	63.0	45.9	59.1	44.4	68.0	11.6	5.2	7.1	6.9	6.8	8.3	5.8	6.7	6.0	5.4	5.7	6.7	6.9	6.9	5.0	8.1	9.0	7.0	6.8	8.3	7.8	8.3	9.5	7.5	9.2	8.5	8.9	8.7	6.9	10.9	8.9	28.8	16.0	10.5	14.7	13.4	16.2	12.7	13.7	16.5	21.4	20.4	15.2	21.6	12.8	19.8	12.9	37.5	10.1	20.3	41.3	3.9	14.4	21.3	19.9	22.1	17.1	11.5	10.8	16.4	18.2	9.9	15.5	15.8	35.5	19.7	24.9	16.1	15.1	13.0	13.5	17.9	17.5	18.3	16.3	10.2	9.8	11.8	18.4	1.8	14.0	16.0	14.0	17.5	17.6	14.7	26.0	20.8	7.5	12.4	15.1	22.9	11.4	17.4	47.7	0.0	18.4	18.5	13.3	7.1	31.5	19.9	18.6	15.9	16.8	19.7	20.5
ZEB1	"AREB6, BZP, FECD6, NIL-2-A, PPCD3, TCF8, ZEB, Zfhep, Zfhx1a"	ENSG00000148516	"Zinc finger E-box binding homeobox 1"	P37275	10	31318495-31529814	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 287.8;Excitatory neurons: 276.1;Inhibitory neurons: 261.9;Microglial cells: 479.7;Oligodendrocyte precursor cells: 968.6"	"Cancer enhanced"	"Detected in all"		"glioma: 15.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 113.1;TIME: 87.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027524, CAB058686, CAB079943"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Nucleoli	"CAB058686: AB_2665569, CAB079943: , HPA027524: AB_1844977"	"unprognostic (1.54e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.85e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (7.34e-6)"	"unprognostic (5.59e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.66e-2)"	26.6	8.6	16.4	12.9	16.2	8.6	16.8	14.0	20.1	33.2	9.9	49.2	6.0	38.7	13.4	11.7	18.6	20.0	34.8	15.2	22.8	7.5	10.4	16.0	9.6	21.1	19.2	9.3	3.8	3.4	7.9	17.5	21.2	14.5	12.3	14.8	8.0	26.9	54.4	7.0	11.8	39.9	16.8	8.1	18.1	10.1	18.2	29.9	11.2	60.5	9.7	24.4	16.4	18.5	0.1	11.1	35.1	43.9	58.4	113.1	0.0	32.7	44.9	6.6	9.3	0.2	0.1	11.3	15.6	39.6	9.3	0.0	14.9	0.0	11.8	19.1	7.9	0.0	7.0	6.3	44.4	9.8	0.3	53.4	0.1	19.6	17.6	21.4	54.9	9.5	7.5	14.4	42.7	0.1	33.7	6.2	2.3	0.0	6.6	11.6	66.0	5.1	12.9	0.0	0.9	15.6	11.1	0.0	0.0	7.2	0.0	6.7	87.7	40.8	9.4	10.0	16.7	9.1	6.3	12.8	10.9	0.0	4.2	4.9	0.0	5.4	2.4	0.0	3.2	4.1	3.2	1.7	1.3	3.1	6.8	3.5	8.5	6.6	0.0	3.1	5.0	1.6	16.4	16.2	14.0	20.1	15.2	22.8	21.1	19.2	21.2	16.8	18.2	18.5	104.4	0.0	7.7	212.9	34.6	11.2	3.0	2.0	0.6	42.7	1.4	2.8	106.3	1.5	3.6	1.8	45.9	0.3	22.0	0.0	0.0	2.1	110.1	7.2	287.8	110.6	0.0	12.2	276.1	2.7	0.5	66.1	2.0	6.5	1.3	17.0	49.6	13.4	1.2	10.1	261.9	0.0	0.0	3.8	25.6	141.8	30.7	6.3	26.6	479.7	10.7	7.2	7.2	968.6	7.3	2.5	0.0	102.0	33.2	3.7	0.0	1.6	1.5	43.4	78.9	99.2	74.2	17.4	15.7	1.1	8.7	0.7	36.2	12.0	0.0	3.8
ZER1	"C9orf60, Hzyg, ZYG, ZYG11BL"	ENSG00000160445	"Zyg-11 related cell cycle regulator"	Q7Z7L7	9	128729786-128772414	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 67.7;Inhibitory neurons: 61.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048464			Approved	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA048464: AB_2756306"	"unprognostic (1.37e-1)"	"prognostic favorable (1.18e-6)"	"unprognostic (9.11e-3)"	"unprognostic (2.36e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.81e-3)"	"unprognostic (3.65e-1)"	"unprognostic (4.90e-3)"	"unprognostic (6.65e-3)"	"unprognostic (1.69e-1)"	"prognostic favorable (5.15e-11)"	"unprognostic (5.77e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.14e-1)"	24.3	31.0	57.4	12.4	56.4	17.1	23.8	28.3	72.8	26.7	23.2	38.9	33.3	29.8	13.1	28.6	25.9	17.4	44.1	59.7	48.2	26.5	22.9	19.9	13.9	44.6	40.1	28.1	26.6	31.9	33.5	15.9	44.8	31.7	13.0	17.3	27.4	24.7	72.0	33.8	31.5	16.4	28.5	19.6	26.9	36.6	43.8	19.2	26.5	43.6	11.3	31.0	24.7	46.1	17.3	19.1	12.4	17.0	36.4	24.9	34.3	16.7	28.4	22.6	18.1	17.3	19.6	10.6	18.1	29.3	16.9	37.1	13.8	24.8	9.5	21.2	17.7	7.0	34.2	12.4	28.3	11.1	20.1	31.1	36.6	22.9	16.1	30.6	19.5	21.2	13.7	22.9	15.5	65.9	20.9	12.5	12.3	24.6	24.4	18.6	15.6	41.4	16.8	23.4	23.7	17.9	26.7	35.4	18.9	14.4	52.0	12.7	22.2	18.4	7.8	23.5	10.2	28.7	29.3	8.6	27.2	6.6	13.5	11.5	3.2	8.8	4.4	4.7	6.0	3.0	4.7	5.7	3.3	3.8	4.9	4.7	13.6	5.1	5.2	4.9	4.7	5.0	57.4	56.4	28.3	72.8	59.7	48.2	44.6	40.1	44.8	28.5	43.8	46.1	10.7	12.8	16.8	33.0	8.0	2.8	2.9	5.2	6.2	20.2	13.0	12.6	22.6	4.3	4.7	5.5	14.6	4.8	4.8	41.7	1.9	5.8	7.1	15.2	8.6	9.0	7.2	17.9	67.7	9.6	2.5	8.6	13.7	11.8	10.2	12.0	7.1	13.0	6.2	21.9	61.2	15.0	2.0	4.4	1.0	2.4	11.1	5.7	8.8	16.9	9.5	9.8	6.2	23.1	48.9	7.1	23.2	10.5	8.7	6.4	25.4	13.8	13.5	13.4	13.1	9.2	9.1	10.6	3.5	8.0	5.8	8.5	7.1	16.0	9.6	3.4
ZNF143	"pHZ-1, SBF, STAF"	ENSG00000166478	"Zinc finger protein 143"	P52747	11	9460319-9528524	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Sertoli cells: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003263, HPA003264, HPA074818"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Vesicles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear bodies, Golgi apparatus, Vesicles"	"HPA003263: AB_1080672, HPA003264: , HPA074818: AB_2686715"	"unprognostic (2.30e-2)"	"unprognostic (2.12e-2)"	"unprognostic (5.51e-2)"	"unprognostic (9.72e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.76e-5)"	"unprognostic (4.87e-3)"	"unprognostic (2.57e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (1.20e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.55e-2)"	9.0	6.1	8.6	11.4	10.1	18.6	9.6	17.3	9.9	10.0	10.8	9.7	9.5	10.5	14.4	9.8	10.1	8.4	9.3	7.9	9.3	8.6	9.6	9.1	15.7	9.9	8.8	13.7	7.7	7.9	7.1	10.4	11.2	8.7	9.9	16.1	8.9	8.0	17.3	10.2	8.2	9.5	9.8	11.1	7.7	16.9	9.0	18.9	14.6	11.5	14.1	11.2	8.4	14.9	20.0	18.8	23.4	15.2	18.9	17.4	21.5	21.8	17.3	16.4	17.9	26.7	24.3	19.6	9.7	17.7	14.0	22.5	23.1	17.3	24.5	20.0	27.7	18.5	27.7	18.7	15.6	25.9	17.8	15.3	20.4	22.2	19.4	21.4	16.3	17.9	20.5	23.3	18.3	17.1	24.1	10.6	26.3	23.0	19.9	21.4	21.2	12.3	14.7	24.0	16.1	15.8	24.0	16.0	14.3	20.6	14.9	14.6	15.6	21.4	15.3	15.1	19.6	11.5	21.6	33.4	13.8	14.8	12.5	39.1	24.6	57.3	28.0	24.9	25.0	23.0	24.6	22.9	20.9	18.2	22.8	19.6	45.1	19.4	28.2	10.1	29.7	19.6	8.6	10.1	17.3	9.9	7.9	9.3	9.9	8.8	11.2	9.8	9.0	14.9	17.9	6.4	12.1	6.2	14.7	26.6	34.1	12.1	17.6	9.3	8.7	13.2	15.5	7.2	10.3	5.5	8.4	10.0	17.1	10.1	3.9	12.5	20.3	18.7	14.9	13.0	6.6	25.4	8.1	11.5	16.2	14.5	9.7	16.3	14.0	7.7	6.8	7.6	9.9	5.0	7.4	6.9	14.2	8.3	22.0	10.0	11.8	15.8	10.6	12.2	16.3	15.5	17.5	7.5	9.8	14.1	7.7	6.8	15.4	20.1	6.3	7.7	15.0	14.3	59.2	18.3	16.7	50.5	21.3	12.8	23.4	18.3	18.1	7.3	7.9	26.9
ZNF230	FDZF2	ENSG00000159882	"Zinc finger protein 230"	Q9UIE0	19	44002957-44013924	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA006172			Approved	Mitochondria		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"HPA006172: AB_2667532"	"unprognostic (3.55e-3)"	"unprognostic (5.21e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.89e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.08e-4)"	"unprognostic (2.45e-2)"	"unprognostic (1.14e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.42e-5)"	2.0	2.1	1.1	2.2	1.3	3.2	3.2	2.8	2.0	2.3	1.5	2.0	1.3	2.3	2.1	1.4	2.5	1.6	1.8	1.1	1.4	1.7	2.1	2.4	3.4	1.2	1.3	4.2	1.4	2.7	2.7	2.4	1.4	2.2	2.0	4.6	1.9	2.5	0.8	2.9	2.4	1.8	1.3	3.9	1.9	1.8	1.3	4.0	3.0	1.9	3.9	2.0	1.7	1.8	2.1	1.7	3.4	3.5	2.7	3.3	1.3	2.9	2.9	2.6	4.7	1.0	1.1	1.7	1.9	2.1	1.6	1.7	2.9	2.6	3.9	2.1	3.6	2.9	4.1	1.2	1.5	3.8	2.4	2.5	2.4	2.9	3.0	3.5	1.8	2.0	0.5	0.0	2.7	1.1	4.3	2.7	2.0	1.4	1.6	3.1	4.7	0.8	1.5	2.4	1.9	4.3	4.1	1.4	2.1	2.3	1.2	8.7	2.3	4.1	3.0	1.2	2.2	2.1	2.2	0.3	2.0	2.8	2.6	6.2	3.3	8.7	3.6	4.0	3.8	4.2	4.1	3.7	3.6	4.2	4.5	4.2	11.5	2.9	2.0	2.2	3.7	2.9	1.1	1.3	2.8	2.0	1.1	1.4	1.2	1.3	1.4	1.3	1.3	1.8	4.7	0.0	2.2	1.6	8.3	2.8	2.6	3.0	4.6	8.5	3.3	3.9	6.0	10.0	3.5	3.7	16.7	4.0	9.9	2.7	3.9	3.0	2.7	2.9	3.3	4.2	1.2	2.1	4.6	2.4	3.2	4.4	2.6	1.7	1.3	4.8	3.9	2.7	3.2	8.4	3.8	2.4	10.2	4.4	3.3	1.7	6.5	3.6	3.6	3.7	7.9	5.4	7.2	2.5	4.0	1.2	0.8	4.5	1.4	2.0	4.1	1.6	2.9	9.6	6.6	3.9	4.3	13.7	7.9	2.8	2.7	3.1	6.7	3.7	3.2	2.0
ZNF267	HZF2	ENSG00000185947	"Zinc finger protein 267"	Q14586	16	31873807-31917357	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 131.1;Macrophages: 82.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003866	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA003866: AB_1080698"	"unprognostic (2.73e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.84e-2)"	"unprognostic (6.24e-2)"	"unprognostic (5.60e-3)"	"unprognostic (8.64e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (1.58e-6)"	"unprognostic (2.34e-1)"	"unprognostic (3.34e-2)"	"unprognostic (3.95e-1)"	"unprognostic (8.21e-2)"	6.3	3.7	3.2	18.6	3.8	27.4	7.3	3.4	11.6	5.5	5.4	6.1	7.1	6.7	3.1	7.1	6.0	10.0	4.4	2.9	4.4	5.0	6.6	9.3	17.9	4.6	4.4	6.2	4.8	4.5	2.3	10.0	4.8	5.2	7.1	2.5	5.3	3.9	6.1	4.0	5.9	5.9	4.2	13.2	6.8	9.8	6.4	11.4	5.9	6.6	18.4	13.6	4.4	5.5	8.8	10.0	8.8	7.0	6.2	7.2	26.9	7.0	11.7	9.6	14.7	17.9	13.7	15.6	12.6	5.7	9.6	11.3	14.4	11.4	18.5	23.6	12.1	15.8	5.6	16.1	5.6	17.0	35.3	10.3	7.7	13.6	9.7	7.0	14.0	11.8	25.9	35.9	13.2	12.2	11.4	11.3	8.2	6.8	5.8	11.4	24.8	13.7	10.9	38.8	2.8	4.3	10.8	9.6	10.3	15.3	5.7	23.6	16.8	9.3	8.5	8.2	12.0	20.1	12.3	15.7	12.3	13.6	5.7	36.6	24.0	33.4	12.4	23.4	18.6	21.2	16.2	12.5	18.8	15.9	12.6	15.2	75.3	16.5	27.5	11.3	20.3	12.3	3.2	3.8	3.4	11.6	2.9	4.4	4.6	4.4	4.8	4.2	6.4	5.5	23.7	9.6	8.0	3.6	37.0	31.9	39.6	15.2	13.1	4.5	12.3	12.2	5.6	8.6	14.0	3.7	0.0	14.1	27.2	5.4	7.9	19.1	23.3	34.8	10.3	33.5	7.7	10.9	7.1	20.0	10.4	17.2	13.7	31.4	60.3	5.4	7.5	2.8	21.5	11.8	3.7	7.0	14.2	25.3	131.1	8.8	5.9	82.2	14.2	15.0	68.5	5.0	22.6	9.5	7.7	49.7	8.0	3.4	19.9	30.1	4.2	12.4	26.2	3.9	0.0	10.8	12.2	20.7	29.6	33.1	25.6	8.3	47.6	5.9	5.6	48.9
ZNF274	"ZKSCAN19, ZSCAN51"	ENSG00000171606	"Zinc finger protein 274"	Q96GC6	19	58183029-58213562	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 67.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 77.1"					"Low region specificity"	"Detected in all"			HPA028880	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Centrosome	"HPA028880: AB_10601929"	"unprognostic (2.38e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.84e-1)"	"prognostic favorable (6.16e-4)"	"unprognostic (2.73e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (2.91e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.47e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.58e-3)"	12.0	11.5	10.1	9.9	11.1	13.1	13.0	13.5	10.3	11.3	15.2	14.4	8.6	10.2	13.6	14.9	14.5	8.8	18.0	9.6	9.5	16.4	19.2	13.1	14.0	10.8	10.5	21.7	8.7	21.7	14.4	9.4	11.0	12.9	7.5	17.3	10.3	10.7	17.7	15.1	14.8	8.9	10.0	17.3	11.4	14.4	10.7	11.5	18.9	14.6	14.3	12.7	11.8	14.5	18.5	12.3	20.9	8.5	12.9	19.1	20.3	14.3	7.9	15.9	14.1	7.5	13.1	6.2	9.4	9.3	16.9	5.1	10.1	20.3	21.8	12.7	77.1	29.5	12.8	12.1	20.8	20.9	46.1	15.0	25.7	19.6	37.2	16.6	12.8	9.7	22.5	26.8	12.0	12.0	11.5	19.1	20.0	10.6	12.2	26.0	5.3	26.8	11.9	7.4	13.6	6.1	19.6	8.6	16.9	15.7	20.4	39.4	12.5	8.5	12.8	10.0	16.9	12.5	14.1	20.9	3.8	23.3	18.4	23.0	7.3	36.9	13.5	8.0	21.1	20.5	17.7	19.7	10.3	26.3	26.1	18.5	26.1	22.1	13.4	5.0	24.4	13.2	10.1	11.1	13.5	10.3	9.6	9.5	10.8	10.5	11.0	10.0	10.7	14.5	15.2	16.0	19.6	17.6	33.5	10.5	40.1	12.8	8.0	32.6	10.2	8.3	14.5	15.7	14.1	18.4	43.8	11.3	12.7	10.4	1.9	13.5	18.5	8.3	8.1	13.9	6.6	10.8	4.4	5.6	11.7	9.2	13.7	11.9	29.2	11.2	13.2	9.9	7.1	20.2	3.7	9.0	4.1	13.0	15.9	10.7	12.2	11.9	7.2	10.3	10.4	22.3	18.6	16.6	21.0	12.3	17.9	12.0	7.8	26.7	18.0	10.3	12.4	67.0	19.7	14.1	16.6	21.6	14.6	8.8	12.1	16.7	23.7	5.5	8.3	25.5
ZNF487	"KRBO1, ZNF487P"	ENSG00000243660	"Zinc finger protein 487"		10	43436841-43483181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in all"		"testis: 28.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 191.2;Endometrial ciliated cells: 65.7;Late spermatids: 289.9;Respiratory ciliated cells: 73.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA037820			Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA037820: AB_10697083"	"unprognostic (1.97e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.42e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.10e-2)"	"unprognostic (4.84e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.97e-4)"	"unprognostic (5.85e-2)"	"unprognostic (3.97e-4)"	"unprognostic (2.91e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.92e-2)"	2.9	2.1	2.1	2.0	2.1	4.3	2.8	2.0	6.3	3.2	4.5	2.6	2.4	3.8	2.1	2.1	6.0	3.7	2.1	2.3	1.9	2.3	2.2	3.0	2.4	7.5	6.0	4.2	1.6	3.6	2.4	1.9	5.0	2.3	1.9	8.9	1.5	2.7	1.2	2.1	2.5	3.0	4.7	2.4	2.3	28.2	2.2	3.6	3.3	1.6	2.2	3.3	2.1	3.8	1.7	1.6	2.0	2.1	2.4	4.8	0.6	2.7	4.7	2.5	2.7	2.6	4.7	4.3	0.4	3.4	2.4	2.7	0.6	1.0	2.4	0.5	0.9	1.4	0.4	1.5	3.1	1.4	1.7	5.0	2.3	4.2	3.0	5.2	0.9	0.9	0.7	0.6	1.9	3.0	2.9	1.1	0.4	0.8	0.9	1.5	0.7	1.8	5.7	1.9	1.7	1.3	2.4	1.3	1.1	1.2	2.2	1.6	1.5	2.4	1.5	1.4	0.7	0.3	1.1	4.7	5.6	2.0	0.9	1.8	3.0	4.5	3.3	2.2	2.6	1.9	2.4	2.9	3.9	2.5	1.9	2.3	10.4	2.9	1.2	2.9	1.6	2.1	2.1	2.1	2.0	6.3	2.3	1.9	7.5	6.0	5.0	4.7	2.2	3.8	4.0	22.4	4.8	11.8	6.2	1.8	6.3	6.6	3.4	5.4	6.6	7.7	3.3	7.2	8.3	5.5	8.4	1.4	9.8	6.1	11.7	4.5	191.2	65.7	6.5	5.3	7.8	1.3	19.4	2.1	4.0	5.4	5.6	6.3	0.0	3.4	3.3	2.7	3.3	6.7	21.1	4.4	10.2	5.6	3.1	289.9	4.7	6.3	1.8	0.0	7.3	12.6	2.1	6.0	7.1	2.1	3.9	6.8	3.6	3.2	13.0	12.7	73.5	18.7	0.0	6.3	5.1	16.7	7.5	1.9	2.8	1.6	5.6	3.8	3.5	6.1
ZNF611	MGC5384	ENSG00000213020	"Zinc finger protein 611"	Q8N823	19	52702813-52735073	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"																	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"				"unprognostic (9.92e-3)"	"unprognostic (1.36e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.02e-4)"	"unprognostic (2.93e-1)"	"unprognostic (2.70e-3)"	"unprognostic (1.40e-2)"	"unprognostic (4.06e-3)"	"unprognostic (1.34e-1)"	"prognostic favorable (3.33e-4)"	"unprognostic (6.43e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.40e-2)"	3.0	1.5	1.8	2.8	2.8	3.4	3.7	3.2	2.5	2.6	1.8	2.7	2.4	3.3	3.5	1.6	6.9	2.9	2.9	2.0	2.6	3.9	1.8	3.0	3.5	2.5	1.9	4.4	4.2	2.9	2.3	4.3	2.6	3.6	3.1	4.3	2.1	4.4	1.5	1.7	1.9	3.2	2.0	3.5	2.6	3.2	2.1	4.4	3.9	1.9	3.9	2.5	2.2	4.6	3.5	3.5	4.2	5.9	4.2	4.3	6.2	4.4	5.0	4.3	5.2	4.7	2.7	5.2	2.6	3.5	4.6	2.0	6.1	3.0	5.4	0.4	4.0	7.2	6.3	2.0	2.7	0.0	5.5	3.9	1.5	3.6	5.9	2.8	4.7	4.8	3.6	0.1	4.3	2.3	5.6	2.4	3.4	2.7	4.2	5.7	5.7	2.2	5.6	12.2	3.4	3.8	6.1	3.0	1.1	10.1	3.8	3.8	5.6	2.7	3.8	2.8	3.9	1.3	7.3	8.4	0.0	0.8	4.7	6.8	2.6	8.8	5.4	2.6	6.2	4.4	4.3	4.8	2.8	3.8	4.3	3.4	9.3	3.5	4.0	2.3	3.4	2.8	1.8	2.8	3.2	2.5	2.0	2.6	2.5	1.9	2.6	2.0	2.1	4.6	6.3	12.8	5.9	10.4	10.1	3.8	6.8	3.8	3.4	9.0	3.8	3.8	5.0	8.6	9.3	23.9	14.6	10.7	12.0	4.9	7.9	5.1	9.8	17.4	7.6	6.2	7.8	13.7	17.0	2.7	9.3	5.6	5.6	32.8	17.1	14.8	4.2	2.4	4.8	6.7	23.5	3.9	6.1	5.7	2.9	1.3	4.1	5.6	0.0	18.7	7.5	3.4	19.6	15.1	24.3	4.9	2.5	2.6	7.4	11.7	4.6	7.8	6.2	7.0	13.1	6.8	5.8	3.6	6.9	3.7	6.1	9.3	12.1	6.0	3.0	11.8
ZSWIM1	"C20orf162, dJ337O18.5"	ENSG00000168612	"Zinc finger SWIM-type containing 1"	Q9BR11	20	45881227-45885266	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041147, HPA046751"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane, Cytosol"		"HPA041147: AB_2677329, HPA046751: AB_2679785"	"unprognostic (6.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (5.47e-4)"	"unprognostic (9.06e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.77e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.64e-1)"	"unprognostic (4.29e-2)"	3.0	4.1	2.7	3.7	2.6	6.0	3.5	4.6	2.9	3.1	2.7	4.1	4.6	3.4	3.5	3.5	4.2	3.2	4.9	2.7	2.5	3.6	1.9	3.3	5.0	2.6	2.7	5.8	4.2	4.9	1.1	4.0	2.5	4.1	3.5	8.2	4.9	3.4	15.9	6.5	4.4	3.5	1.9	4.6	4.3	3.8	2.9	3.9	4.5	5.1	4.9	3.4	1.4	3.1	7.2	8.6	6.4	7.8	11.2	6.3	6.5	4.8	5.9	10.2	9.3	19.5	8.4	8.4	13.9	6.7	11.2	17.0	10.1	12.9	7.7	3.4	6.1	10.7	11.5	14.0	6.8	9.2	10.9	9.2	10.6	8.6	8.2	7.8	7.9	7.3	9.8	6.7	6.0	20.8	10.0	7.9	3.6	8.1	9.7	7.8	9.1	6.0	6.7	10.1	8.6	5.5	16.2	24.0	5.8	5.7	14.6	7.2	7.0	11.5	7.3	6.4	7.0	6.6	5.0	8.2	9.2	6.8	6.0	2.4	1.4	3.6	0.5	1.8	0.3	2.4	1.7	0.7	0.7	2.2	2.3	2.1	1.6	0.6	1.8	2.2	1.4	0.8	2.7	2.6	4.6	2.9	2.7	2.5	2.6	2.7	2.5	1.9	2.9	3.1	0.8	3.2	2.7	0.7	1.4	1.1	2.4	2.4	2.2	3.0	0.8	0.5	5.7	4.3	1.2	0.0	0.0	2.9	0.3	4.2	3.9	2.4	0.6	1.1	1.7	1.7	2.4	4.4	0.8	3.8	2.8	1.9	4.1	1.5	3.8	2.5	2.5	2.1	1.7	6.7	0.9	2.8	2.0	1.4	1.9	0.7	3.4	0.7	0.0	0.0	1.8	1.6	1.0	0.0	0.8	3.3	3.7	1.5	0.5	1.6	2.4	1.2	0.4	3.8	0.0	2.0	1.8	1.0	2.0	1.4	1.6	2.3	1.8	3.6	3.0	2.0
ZYG11B	"FLJ13456, ZYG11"	ENSG00000162378	"Zyg-11 family member B, cell cycle regulator"	Q9C0D3	1	52726453-52827336	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 78.9;tongue: 62.0"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028156	Uncertain		Approved	"Golgi apparatus,Intermediate filaments"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Golgi apparatus, Intermediate filaments"		"HPA028156: AB_10602360"	"unprognostic (2.54e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (5.42e-6)"	"unprognostic (1.58e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.04e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.84e-3)"	"unprognostic (5.06e-2)"	"unprognostic (2.76e-1)"	"unprognostic (6.08e-2)"	"prognostic favorable (9.80e-7)"	"unprognostic (2.22e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.57e-2)"	9.4	8.4	13.5	5.5	14.5	7.6	7.2	15.9	14.0	9.1	3.5	9.9	4.3	10.8	5.9	9.5	6.8	6.6	17.1	13.7	16.0	12.9	18.6	7.6	5.1	8.5	9.7	10.8	5.1	10.0	4.6	7.1	11.1	9.4	7.5	13.4	6.3	8.6	78.9	6.3	4.6	12.5	8.0	5.6	5.0	8.6	16.3	6.9	12.8	62.0	5.4	7.7	5.7	10.3	10.8	9.9	12.1	15.1	21.7	18.5	10.0	11.7	15.3	9.4	8.7	8.4	3.5	10.2	11.1	23.6	12.6	5.5	14.1	10.6	14.9	7.9	8.6	13.1	10.4	5.3	11.5	9.9	7.7	13.5	11.2	13.4	9.4	13.1	16.6	2.3	12.0	2.1	17.2	4.4	3.9	6.4	12.3	5.4	10.0	6.7	22.4	9.3	9.6	17.2	5.5	10.9	20.6	12.8	10.6	15.2	7.7	7.8	19.1	14.4	8.2	14.3	7.4	8.6	10.8	7.4	9.8	6.6	9.5	0.3	0.7	0.9	0.5	0.3	0.6	0.6	0.7	0.4	0.7	0.5	1.1	0.8	1.7	0.6	0.6	0.4	1.0	0.3	13.5	14.5	15.9	14.0	13.7	16.0	8.5	9.7	11.1	8.0	16.3	10.3	26.8	25.6	28.8	29.0	13.4	11.3	10.5	12.1	10.2	49.5	13.6	11.9	88.3	20.0	14.0	14.7	20.9	24.6	6.9	37.2	7.9	12.2	5.7	13.2	40.9	22.1	10.2	9.0	72.4	11.1	12.0	26.3	12.2	18.6	8.2	32.0	32.5	107.7	20.6	97.6	82.6	11.4	14.2	37.5	11.8	7.9	24.5	21.5	21.4	36.5	21.9	21.6	4.1	46.3	52.0	16.3	17.9	30.9	11.6	26.0	14.0	30.0	11.1	24.4	26.3	35.7	25.9	11.4	23.7	17.3	14.6	34.8	9.7	19.5	15.5	19.0